---
title: 'Medicine ğŸŠâ­'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Cardiology / å¾ªç’°å™¨ç§‘

## Ischemic Heart Disease and Heart Failure / è™šè¡€æ€§å¿ƒç–¾æ‚£ãƒ»å¿ƒä¸å…¨

### Effort Angina / åŠ´ä½œæ€§ç‹­å¿ƒç—‡

* **Overview**
  * Transient myocardial ischemia due to coronary artery stenosis (from atherosclerosis) and increased oxygen demand (during exertion)
  * Risk factors: Hypertension, DM, dyslipidemia, smoking, aging
* **Presentation**
  * **Chest tightness/pressure during exertion (lasting 3-5 minutes)**: Temporary myocardial ischemia, rapid relief with nitroglycerin
* **Examination**
  * **[ECG] ST depression (during attack or exercise stress)**: Ischemia
  * **[Echocardiography] Wall motion abnormality**: Ischemia
  * **[Blood] No elevation in cardiac biomarkers**: Excludes myocardial necrosis
  * **[Myocardial perfusion SPECT] Reduced uptake during stress, improved at rest**: Reversible ischemia
* **Management**
  * **Nitroglycerin (sublingual)**: Rapid relief of acute attacks (relax coronary artery)
  * **Î²-blockers, calcium channel blockers**: Prevent attacks (decrease oxygen demand)
  * **Antiplatelet drugs, statins**: Prevent thrombosis, improve atherosclerosis
  * **Percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)**: For severe cases
  * **Lifestyle modifications**
{: .notice--info}

### Vasospastic Angina / å† æ”£ç¸®æ€§ç‹­å¿ƒç—‡

* **Overview**
  * Transient myocardial ischemia caused by coronary artery spasm
  * Risk factors: Smoking, hypertension, DM, dyslipidemia
* **Presentation**
  * **Chest tightness/pressure at night to early morning or at rest (lasting several to 15 minutes)**: Coronary artery spasm, triggered by hyperventilation, alcohol, or early morning exercise
* **Examination**
  * **[ECG] ST elevation or depression (during attack)**: Ischemia due to spasm
  * **[Blood] No elevation in cardiac biomarkers**: Excludes myocardial infarction
  * **[Coronary angiography] Hyperventilation or drug-induced spasm**: Confirms diagnosis
* **Management**
  * **Nitroglycerin (sublingual)**: Rapid relief of acute attacks (relax coronary artery)
  * **Calcium channel blockers, nitrates**: Prevent attacks (relax coronary artery)
  * **Lifestyle modifications**
{: .notice--info}

### Acute Coronary Syndrome / æ€¥æ€§å† ç—‡å€™ç¾¤

* **Overview**
  * Myocardial ischemia and necrosis due to rapid narrowing or obstruction of coronary artery by thrombosis formation, encompasses unstable angina, acute myocardial infarction, and sudden cardiac death due to ischemia
  * Classified as non-ST elevation ACS (NSTE-ACS) and ST elevation myocardial infarction (STEMI)
  * Risk factors: Hypertension, DM, dyslipidemia, smoking, aging
* **Presentation**
  * **Chest pain at rest or during exertion (lasting several to >15 minutes)**: Acute myocardial ischemia
* **Examination**
  * **[ECG] ST elevation (or depression for NSTE-ACS), hyperacute T, abnoraml Q**:  Infarction or ischemia
  * **[Blood] Elevated cardiac troponin**: Confirms myocardial injury
  * **[Echocardiography]**: Abnormal wall motions
* **Management**
  * **[Initial treatment] Morphine, oxygen, nitroglycerin, aspirin**: Stabilize general condition
  * **[Reperfusion therapy] Percutaneous coronary intervention (PCI), thrombolysis (t-PA), coronary artery bypass grafting (CABG)**: Reopen obstructed coronary artery (first choice: PCI)
  * **[Antiplatelet drugs] Aspirin, clopidogrel, prasugrel**: Prevent thrombosis
  * **[Anti-anginal drugs] Î²-blockers, nitrates, calcium channel blockers**: Reduce oxygen demant and relax coronary artery
  * **[Anti-hypertensive drugs] ACE inhibitors, ARBs, MRAs**: Reduce afterload
  * **[Anti-hyperlipidemic drugs] Statins**: Prevent recurrence
  * **[Complications management] Arrhythmias, heart failure, stroke, cardiac rehabilitation**
{: .notice--info}

### Heart Failure / å¿ƒä¸å…¨

* **Overview**
  * Cardiac pump dysfunction leading to pulmonary and systemic congestion
  * Causes: Ischemic heart disease, valvular heart disease, cardiomyopathy, hypertension
* **Presentation**
  * **Dyspnea, tachypnea, orthopnea, paroxysmal nocturnal dyspnea**: Left-sided heart failure (pulmonary congestion)
  * **Leg edema, jugular vein distension**: Right-sided heart failure (systemic congestion)
* **Examination**
  * **[Auscultation] Coarse crackles, S3 or S4 gallop**: Pulmonary congestion, ventricular dysfunction
  * **[Chest X-ray] Cardiomegaly, pulmonary vascular markings, butterfly shadow, Kerley's lines, pleural effusion**: Cardiac enlargement and congestion
  * **[Blood] BNPâ†‘, NT-proBNPâ†‘**: Sensitive markers of heart failure
  * **[Echocardiography] Systolic dysfunction, diastolic dysfunction**: Cardiac function assessment
* **Management**
  * **Diuretics, vasodilators**: Improve hemodynamics and symptoms
  * **ACE inhibitors, ARBs, ARNI, MRAs, Î²-blockers, ivabradine**: Cardioprotective effects
  * **ICD, CRT, MitraClip, IABP, ECMO, IMPELLA, VAD**: Cardiac and circulatory support for severe cases
  * **Heart transplantation**: For end-stage heart failure
  * **Disease management**: Address underlying causes
{: .notice--info}

## Arrhythmia / ä¸æ•´è„ˆ

### Atrial Premature Contraction / å¿ƒæˆ¿æœŸå¤–åç¸®

* **Overview**
  * Premature excitation from atria earlier than sinus node firing
* **Presentation**
  * **Asymptomatic, palpitations, chest discomfort**: Mostly asymptomatic
* **Examination**
  * **[ECG] Early P wave**: Premature atrial depolarization
* **Management**
  * **Observation**: For asymptomatic cases
  * **Î²-blockers , Na channel blockers**: For symptomatic cases
{: .notice--info}

### Paroxysmal Supraventricular Tachycardia / ç™ºä½œæ€§ä¸Šå®¤é »æ‹

* **Overview**
  * Supraventricular tachycardia due to reentry involving AV node (AVNRT) or accessory pathway (AVRT)
* **Presentation**
  * **Palpitations (sudden onset and termination)**: Reentry mechanism
  * **Dizziness, syncope (in severe cases)**: Due to reduced cardiac output
* **Examination**
  * **[ECG] Regular narrow QRS complexes at 120-220 bpm**: Supraventricular origin of tachycardia
* **Management**
  * **Vagal maneuvers, ATP, calcium channel blockers**: For stable hemodynamics
  * **Cardioversion, overdrive pacing**: For unstable hemodynamics
  * **Catheter ablation**: Curative treatment
{: .notice--info}

### Wolff-Parkinson-White Syndrome / WPWç—‡å€™ç¾¤

* **Overview**
  * Presence of accessory pathway directly connecting atria and ventricles, can cause AVRT or AF resembling VT
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Palpitations, syncope**: During tachycardia episodes
* **Examination**
  * **[ECG] Delta wave, short PQ interval, wide QRS complex**: Ventricular pre-excitation through accessory pathway
  * **[ECG] AVRT or AF resembling VT (during episodes)**: Reentry or direct connection
* **Management**
  * **Observation**: For asymptomatic cases
  * **Vagal maneuvers, ATP, Ca channel blockers**: For AVRT
  * **Na channel blockers**: For AF resembling VT (digitalis and Ca channel blockers contraindicated)
  * **Cardioversion**: For hemodynamically unstable AVRT or AF
  * **Catheter ablation**: Curative treatment
{: .notice--info}

### Atrial Flutter / å¿ƒæˆ¿ç²—å‹•

* **Overview**
  * Regular reentrant circuit in atria with consistent conduction to ventricles
* **Presentation**
  * **Palpitations, dyspnea**: Due to rapid heart rate
* **Examination**
  * **[ECG] Regular RR intervals, narrow QRS complexes, regular flutter waves (~300/min)**: Regular tachycardia with consistent AV conduction ratio
* **Management**
  * **Na channel blockers, K channel blockers, Ca channel blockers, cardioversion**: Termination of episodes
  * **Catheter ablation**: Prevention of recurrence
  * **Anticoagulation**: For thromboembolic prevention
  * **Upstream therapy**: Treatment of underlying diseases
{: .notice--info}

### Atrial Fibrillation / å¿ƒæˆ¿ç´°å‹•

* **Overview**
  * Rapid and disorganized electrical activity in atria leading to irregular ventricular conduction
  * Common in elderly, hypertension, valvular disease, heart failure, ischemic heart disease, hyperthyroidism
  * High risk of thromboembolism due to left atrial thrombus formation
* **Presentation**
  * **Palpitations, irregular pulse**: Due to irregular ventricular conduction
* **Examination**
  * **[ECG] Irregular RR intervals, narrow QRS complexes, absence of P waves with fine baseline oscillations**: Rapid atrial activation with irregular conduction to ventricles
* **Management**
  * **Anticoagulation (warfarin, DOAC)**: Thromboembolism prevention
  * **Î²-blockers, Ca channel blockers, digitalis**: Rate control
  * **Na channel blockers, K channel blockers, cardioversion**: Rhythm control
  * **Catheter ablation**: Prevention of recurrence
  * **Upstream therapy**: Treatment of underlying diseases
{: .notice--info}

### Ventricular Premature Contraction / å¿ƒå®¤æœŸå¤–åç¸®

* **Overview**
  * Premature ectopic excitation from ventricles, seen in patients with underlying heart diseases
* **Presentation**
  * **Asymptomatic, palpitations, chest discomfort**
* **Examination**
  * **[ECG] Wide QRS complex without preceding P wave**: Premature ventricular depolarization
* **Management**
  * **Observation**: For asymptomatic cases without risk factors
  * **Na channel blockers, K channel blockers, Î²-blockers**: For symptomatic cases or risk of VT/VF (myocardial infarction)
{: .notice--info}

### Ventricular Tachycardia / å¿ƒå®¤é »æ‹

* **Overview**
  * Consecutive VPCs causing tachycardia, dangerous arrhythmia with risk of pulselessness and VF
* **Presentation**
  * **Palpitations, shortness of breath**: Due to rapid heart rate
  * **Dizziness, syncope, loss of consciousness**: Due to reduced cardiac output
* **Examination**
  * **[ECG] Wide QRS complexes occurring regularly**: Regular ventricular tachycardia
* **Management**
  * **Amiodarone, nifekalant, procainamide**: Acute termination (hemodynamically stable)
  * **Cardioversion, electrical defibrillation**: Acute termination (hemodynamically unstable)
  * **Amiodarone, sotalol, bepridil, catheter ablation**: Prevention of recurrence (normal cardiac function)
  * **Implantable cardioverter-defibrillator (ICD)**: Prevention of recurrence (reduced cardiac function)
{: .notice--info}

### Ventricular Fibrillation / å¿ƒå®¤ç´°å‹•

* **Overview**
  * Completely disorganized ventricular excitation resulting in zero cardiac output, rapidly fatal without immediate treatment
  * Common in: STEMI, cardiomyopathy, Brugada syndrome, long QT syndrome, hypoxemia, hypothermia
* **Presentation**
  * **Dizziness followed by immediate syncope, absence of pulse**: Sudden loss of cardiac output
* **Examination**
  * **[ECG] Completely irregular waves with variable amplitude and frequency**: Chaotic ventricular activity
* **Management**
  * **Immediate electrical defibrillation**: First-line treatment
  * **CPR 2 minutes, IV adrenaline, defibrillation**: If above unsuccessful
  * **CPR 2 minutes, IV nifekalant or amiodarone, defibrillation**: If above unsuccessful
  * **CPR 2 minutes, IV Î²-blockers, left stellate ganglion block**: If above unsuccessful
  * **Treatment of underlying disease**: If defibrillation successful
{: .notice--info}

### Sick Sinus Syndrome / æ´ä¸å…¨ç—‡å€™ç¾¤

* **Overview**
  * Dysfunction of sinoatrial node or surrounding tissue, leading to sinus bradycardia, sinoatrial block, or sinus arrest
* **Presentation**
  * **Dizziness, lightheadedness, syncope**: Cerebral hypoperfusion due to bradycardia
  * **Fatigue, shortness of breath**: Heart failure symptoms
* **Examination**
  * **[ECG] Sinus bradycardia (HR < 50 bpm), sinus arrest (absence of P waves)**: Dysfunction of sinoatrial node
* **Management**
  * **Observation**: For asymptomatic cases
  * **Pacemaker implantation**: For persistent symptomatic bradycardia
  * **Atropine, isoproterenol, theophylline, cilostazol**: For cases where pacemaker is not suitable
{: .notice--info}

### Atrioventricular Block / æˆ¿å®¤ãƒ–ãƒ­ãƒƒã‚¯

* **Overview**
  * Delayed or interrupted conduction from atria to ventricles at AV node or His bundle
* **Presentation**
  * **Syncope, heart failure**: Due to decreased cardiac output
* **Examination**
  * **[ECG] Prolonged PQ intervals**: 1st degree AV block
  * **[ECG] Progressive lengthing of PQ intervals with subsequent QRS drop**: Mobitz I 2nd degree AV block
  * **[ECG] Regular PQ intervals with random QRS drop**: Mobitz II 2nd degree AV block
  * **[ECG] P and QRS independently at regular intervals**: 3rd degree AV block
  * **[Auscultation] Cannon sound**: Loud S1 every few beats (3rd degree AV block)
* **Management**
  * **Observation**: For 1st degree and Mobitz I 2nd degree AV block
  * **Pacemaker implantation**: For Mobitz II 2nd degree and 3rd degree AV block
  * **Atropine, isoproterenol**: Bridge therapy before pacemaker implantation
{: .notice--info}

### Bundle Branch Block / è„šãƒ–ãƒ­ãƒƒã‚¯

* **Overview**
  * Impaired conduction in right or left bundle branch due to myocardial ischemia or degeneration
* **Presentation**
  * Asymptomatic
* **Examination**
  * **[ECG] Wide QRS, rSR' in V1, wide S in V6**: Right bundle branch block
  * **[ECG] Wide QRS, QS or rS in V1, absent septal Q and notched QRS in V6**: Left bundle branch block
* **Management**
  * **Observation**: Mostly
  * **Cardiac resynchronization therapy (CRT)**: For some left bundle branch block 
{: .notice--info}

### Brugada Syndrome / Brugadaç—‡å€™ç¾¤

* **Overview**
  * Genetic disorder causing ventricular fibrillation during parasympathetic dominance
  * More common in young to middle-aged men, often associated with family history of sudden death
* **Presentation**
  * **Recurrent syncope, loss of consciousness**: Due to VF episodes
  * **Sudden cardiac death**: Especially during sleep or rest after meals
* **Examination**
  * **[ECG] Right bundle branch block pattern, characteristic ST elevation**: Diagnostic feature
* **Management**
  * **Implantable cardioverter defibrillator (ICD)**: Only effective prevention for sudden death
  * **Pharmacological therapy, catheter ablation**: Considered in some cases
{: .notice--info}

### Long QT Syndrome / QTå»¶é•·ç—‡å€™ç¾¤

* **Overview**
  * Prolongation of myocardial action potential leading to extended QT interval, can cause torsades de pointes (a type of polymorphic VT)
* **Presentation**
  * **Recurrent syncope**: Due to TdP episodes
  * **Sudden cardiac death**: In severe cases
* **Examination**
  * **[ECG] Corrected QT interval > 0.48 seconds**: Diagnostic feature
* **Management**
  * **Beta-blockers, temporary pacing**: For congenital LQTS
  * **Remove underlying cause**: For acquired LQTS
  * **Magnesium sulfate**: During TdP episodes
{: .notice--info}

## Endocardium and Valvular Disease / å¿ƒå†…è†œãƒ»å¼è†œç–¾æ‚£

### Mitral Stenosis / åƒ§å¸½å¼ç‹­çª„ç—‡

* **Overview**
  * Narrowing of mitral valve, impeding blood flow from left atrium to left ventricle
  * Common in women over 40-50 years, often with history of rheumatic fever
* **Presentation**
  * **Dyspnea on exertion, palpitations, irregular pulse**: Due to pulmonary congestion and atrial fibrillation
  * **Embolism**: Thrombus formation in left atrium
* **Examination**
  * **[Auscultation] Accentuated S1, opening snap, diastolic rumble, presystolic murmur**: Mitral valve stenosis
  * **[ECG] Left atrial enlargement, atrial fibrillation**: Increase left atrium pressure
  * **[Chest X-ray] Prominent left 3rd arc**: Enlarged left atrium
  * **[Echocardiography] Reduced valve area, dome-shaped anterior mitral leaflet**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Anticoagulation**: For patients with AF
  * **Percutaneous mitral commissurotomy (PTMC)**: Catheter-based valve opening
  * **Open mitral commissurotomy (OMC) or mitral valve replacement (MVR)**: Surgical options
{: .notice--info}

### Mitral Regurgitation / åƒ§å¸½å¼é–‰é–ä¸å…¨ç—‡

* **Overview**
  * Backflow of blood from left ventricle to left atrium during systole
  * Common causes: mitral valve prolapse, ischemic heart disease
* **Presentation**
  * **Dyspnea on exertion, palpitations, fatigue, paroxysmal nocturnal dyspnea, orthopnea**: Left heart failure symptoms
* **Examination**
  * **[Auscultation] Holosystolic murmur at apex, diminished S1, S3**: Mitral valve regurgitation
  * **[ECG] Left atrial enlargement, left ventricular hypertrophy, atrial fibrillation**: Increased volume load
  * **[Chest X-ray] Prominent left 3rd and 4th arcs**: Left atrial and ventricular enlargement
  * **[Echocardiography] Valve abnormalities, left heart enlargement, regurgitation**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Mitral valve repair or replacement (MVR)**: Surgical options
{: .notice--info}

### Mitral Valve Prolapse / åƒ§å¸½å¼é€¸è„±ç—‡

* **Overview**
  * Syndrome characterized by prolapse of mitral valve leaflets into left atrium during systole
  * Often idiopathic, can be associated with Marfan syndrome
* **Presentation**
  * **Asymptomatic, chest pain, dizziness**: Mild cases
  * **Heart failure symptoms**: Severe mitral regurgitation
* **Examination**
  * **[Auscultation] Mid-systolic click or Holosystolic murmur**: Mitral valve prolapse or regurgitation
  * **[Echocardiography] Prolapse of mitral valve leaflets during systole**: Confirms diagnosis
* **Management**
  * **Î² blockers**: For chest pain and dizziness
{: .notice--info}

### Aortic Stenosis / å¤§å‹•è„ˆå¼ç‹­çª„ç—‡

* **Overview**
  * Narrowing of aortic valve, impeding blood flow from left ventricle to aorta
  * Causes: Degeneration due to aging, abnormal number of valves
* **Presentation**
  * **Dyspnea, angina**: Left heart failure, myocardial ischemia due to ventricular hypertrophy
  * **Syncope, dizziness, slow and weak pulse, hypotension**: Reduced cardiac output
* **Examination**
  * **[Auscultation] Ejection click, systolic ejection murmur, diminished and paradoxical splitting of S2**: Aortic valve stenosis
  * **[ECG] Left ventricular hypertrophy**
  * **[Echocardiography] Restricted valve opening, reduced valve area, increased transvalvular gradient**: Confirms diagnosis
* **Management**
  * **Aortic valve replacement (AVR)**: Surgical option
  * **Transcatheter aortic valve implantation (TAVI)**: Less invasive option
{: .notice--info}

### Aortic Regurgitation / å¤§å‹•è„ˆå¼é–‰é–ä¸å…¨ç—‡

* **Overview**
  * Backflow of blood from aorta to left ventricle during diastole
  * Causes left ventricular volume and pressure overload, leading to LV enlargement and hypertrophy
  * Can be compensated for long periods, but poor prognosis once heart failure develops
* **Presentation**
  * **Palpitations**: Increased stroke volume
  * **Dyspnea, angina**: Pulmonary congestion, decreased diastolic aortic pressure
  * **Strong and fast pulse, capillary pulsations of fingernail bed (Quincke's sign)**: Increased pulse pressure
* **Examination**
  * **[Auscultation] Diastolic decrescendo murmur, systolic ejection murmur, Austin-Flint murmur**: Aortic valve regurgitation, relative AS, functional MS
  * **[Chest X-ray] Prominent left 4th arc**: Left ventricular enlargement
  * **[ECG] Left ventricular hypertrophy**
  * **[Echocardiography] Valve abnormalities, left ventricular enlargement, regurgitation, fluttering of mitral valve**: Confirms diagnosis
* **Management**
  * **Aortic valve replacement (AVR) or aortic valvuloplasty (AVP)**: Surgical option
{: .notice--info}


### Tricuspid Stenosis / ä¸‰å°–å¼ç‹­çª„ç—‡

* **Overview**
  * Narrowing of tricuspid valve, impeding blood flow from right atrium to right ventricle
  * Mostly due to rheumatic fever
* **Presentation**
  * **Asymptomatic**
  * **Right heart failure symptoms**: In advanced cases
* **Examination**
  * **[Auscultation] Diastolic rumble**: Tricuspid valve stenosis
  * **[Echocardiography] Restricted tricuspid valve, increased transvalvular gradient**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Tricuspid valve replacement**: Surgical options
{: .notice--info}

### Tricuspid Regurgitation / ä¸‰å°–å¼é–‰é–ä¸å…¨ç—‡

* **Overview**
  * Backflow of blood from right ventricle to right atrium during systole
  * Common causes: Pulmonary hypertension due to left valvular heart disease
* **Presentation**
  * **Asymptomatic**
  * **Right heart failure symptoms**: In advanced cases
* **Examination**
  * **[Auscultation] Holosystolic murmur**: Tricuspid valve regurgitation
  * **[Echocardiography] Valve abnormalities, regurgitation**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Tricuspid valve repair or replacement**: Surgical options
{: .notice--info}

### Infective Endocarditis / æ„ŸæŸ“æ€§å¿ƒå†…è†œç‚

* **Overview**
  * Systemic septic disease with vegetation formation on heart valves or endocardium due to bacterial infection
  * Common cause: Dental intervention, with underlying congenital heart disease or valvular heart disease
* **Presentation**
  * **Fever, joint pain, muscle pain**: Systemic infection
  * **Petechiae, splinter hemorrhages, Osler nodes, Janeway lesions, Roth spots**: Peripheral embolism
  * **Stroke, renal infarction, splenic infarction**: Systemic embolism
  * **Congestive heart failure**: Valve destruction, regurgitation, or chordae tendineae rupture
* **Examination**
  * **[Auscultation] Heart murmur**: Valvular damage
  * **[Blood] WBCâ†‘, ESRâ†‘, CRPâ†‘, Î³-globulinâ†‘, fibrinogenâ†‘**: Inflammatory response
  * **[Blood culture] Pathogen detection**: Confirms causative microorganism
  * **[Echocardiography] Vegetation**: Confirms cardiac involvement
* **Management**
  * **High-dose, long-term intravenous antibiotics**: Based on causative microorganism
  * **Surgical intervention**: If antibiotics ineffective
{: .notice--info}

### Cardiac Myxoma / å¿ƒè‡“ç²˜æ¶²è…«

* **Overview**
  * Most common primary cardiac tumor, mostly occur in the left atrium
* **Presentation**
  * **Fatigue, weight loss, fever, joint pain**: Systemic effects due to IL-6 secreted by tumor
* **Examination**
  * **[Auscultation] Variable diastolic murmur with position changes, tumor plop**: Tumor movement mimicking mitral stenosis
  * **[Blood] ESRâ†‘, WBCâ†‘, CRPâ†‘, Î³-globulinâ†‘**: Inflammation due to IL-6 secreted by tumor
  * **[Echocardiography] Mass in atrium**: Confirms diagnosis
* **Management**
  * **Surgical resection**: Prevents potentially fatal embolization
{: .notice--info}

## Myocardium Disease / å¿ƒç­‹ç–¾æ‚£

### Dilated Cardiomyopathy / æ‹¡å¼µå‹å¿ƒç­‹ç—‡

* **Overview**
  * Degenerative myocardial disease with left ventricular dilation and reduced contractility
  * More common in males aged 40-70, about 20-30% are familial
* **Presentation**
  * **Palpitations, dyspnea, pulsus alternans, edema**: Chronic progressive heart failure
* **Examination**
  * **[Auscultation] S3 or S4 (gallop rhythm), systolic murmur**: Heart failure, ventricular dilation leading to mitral regurgitation
  * **[ECG] Left ventricular high voltage, wide QRS**: Left ventricular hypertrophy
  * **[Chest X-ray] Cardiomegaly**: Heart failure
  * **[Echocardiography, MRI] Dilated left ventricle, diffuse hypokinesis**: Left ventricular dilation
  * **[Cardiac catheterization] LVEDPâ†‘, PAWPâ†‘**: Left heart failure
* **Management**
  * **Lifestyle modifications (restrict water and salt), medication (Î²-blockers, ACE inhibitors, ARBs, MRAs)**: For heart failure
  * **Cardiac resynchronization therapy (CRT), ventricular assist devices (VAD), heart transplantation**: For severe heart failure
  * **Anticoagulation**: For thromboembolism prevention
  * **Antiarrhythmic drugs, implantable cardioverter-defibrillator (ICD), pacemaker**: For arrhythmia management
{: .notice--info}

### Hypertrophic Cardiomyopathy / è‚¥å¤§å‹å¿ƒç­‹ç—‡

* **Overview**
  * Degenerative myocardial disease with asymmetric ventricular hypertrophy, with high risk of sudden death
  * 50% familial (autosomal dominant, mutation of sarcomere protein gene)
* **Presentation**
  * **Chest pain, dyspnea, palpitations**: Due to increased oxygen demand, pulmonary congestion, and arrhythmia
  * **Dizziness, syncope**: Due to left ventricular outflow tract obstruction or arrhythmia
* **Examination**
  * **[Auscultation] S4, S3, increased apical impulse**: Ventricular diastolic dysfunction
  * **[ECG] Left ventricular high voltage, ST depression, negative T waves**: Left ventricular hypertrophy, relative ischemia
  * **[Chest X-ray] Normal or mild cardiomegaly, upper lung field congestion**: Pulmonary congestion
  * **[Echocardiography, MRI] Asymmetric left ventricular wall hypertrophy (thickness â‰¥15 mm), diastolic dysfunction**: Left ventricular hypertrophy
  * **[Cardiac catheterization] LVEDPâ†‘**: Diastolic dysfunction
* **Management**
  * **Lifestyle modifications (Avoid strenuous exercise), implantable cardioverter-defibrillator (ICD)**: Prevent sudden death
  * **Medications (Î²-blockers, CCBs, diuretics, ACE inhibitors, ARBs)**: For heart failure
  * **Antiarrhythmic drugs, anticoagulants**: For arrhythmia management
{: .notice--info}

### Hypertrophic Obstructive Cardiomyopathy / é–‰å¡æ€§è‚¥å¤§å‹å¿ƒç­‹ç—‡

* **Overview**
  * Subset of HCM with left ventricular outflow tract obstruction (about 25% of HCM cases)
* **Presentation**
  * **Symptoms of HCM**
  * **Bifid pulse**: Due to dynamic obstruction
* **Examination**
  * **[Auscultation] Ejection systolic murmur**: Outflow obstruction
  * **[Echocardiography] Systolic anterior motion of mitral valve**: Due to increased outflow speed and Venturi phenomenon
  * **[Cardiac catheterization] Brockenbrough phenomenon**: Increased LV-aorta systolic pressure gradient after premature ventricular contraction
* **Management**
  * **Treatmnents of HCM**
  * **Medications (Î²-blockers, CCBs, antiarrhythmics)**: Decrease LV-aorta systolic pressure gradient
  * **Surgical myectomy, pacemaker implantation, percutaneous transluminal septal myocardial ablation (PTSMA)**: For refractory cases
{: .notice--info}

### Restrictive Cardiomyopathy / æ‹˜æŸå‹å¿ƒç­‹ç—‡

* **Overview**
  * Characterized by reduced left ventricular compliance and diastolic dysfunction
* **Presentation**
  * **Generalized edema, pulmonary congestion, pleural effusion**: Heart failure symptoms
* **Examination**
  * **[Cardiac catheterization] Dip and plateau pattern in ventricular pressure curve**: Diastolic restriction
* **Management**
  * **Symptom management (diuretics)**
{: .notice--info}

### Cardiac Sarcoidosis / å¿ƒè‡“ã‚µãƒ«ã‚³ã‚¤ãƒ‰ãƒ¼ã‚·ã‚¹

* **Overview**
  * Part of systemic sarcoidosis, forming non-caseating epithelioid granulomas in multiple organs
* **Presentation**
  * **Complete atrioventricular block, ventricular arrhythmias**: Damage to conduction pathways and cardiac muscles
* **Examination**
  * **[Ga scintigraphy, PET] Focal uptake in heart**: Inflammation
* **Management**
  * **Corticosteroid**: Control inflammation
{: .notice--info}

### Cardiac Amyloidosis / å¿ƒã‚¢ãƒŸãƒ­ã‚¤ãƒ‰ãƒ¼ã‚·ã‚¹

* **Overview**
  * Systemic syndrome with amyloid protein deposition in various organs (AL amyloidosis or ATTR amyloidosis)
* **Presentation**
  * **Cardiac hypertrophy, diastolic dysfunction**: Deposition of amyloid protein
* **Examination**
  * **[ECG] Low voltage, conduction disorders**: Damage to conduction pathways
  * **[Echocardiography] Cardiac hypertrophy, diastolic dysfunction**: Deposition of amyloid protein
  * **[Cardiac biopsy] Amyloid deposition in myocardium**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure and arrhythmias
{: .notice--info}

### Acute Myocarditis / æ€¥æ€§å¿ƒç­‹ç‚

* **Overview**
  * Acute myocardial necrosis and dysfunction due to infection (mostly virus) or idiopathic, may cause of sudden death but good prognosis if overcome acute phase
* **Presentation**
  * **Flu-like symptoms, gastrointestinal symptoms**: Prodromal phase of infection
  * **Heart failure symptoms, chest pain, fever**: Acute cardiac inflammation
* **Examination**
  * **[Auscultation] S3, crackles**: Heart failure signs
  * **[ECG] ST-T changes, arrhythmia**: Myocardial injury and conduction disturbances
  * **[Echocardiography] Diffuse wall thickening, hypokinesis, small cardiac chambers, pericardial effusion**: Myocardial inflammation and dysfunction
  * **[Blood] Troponin Tâ†‘, CK-MBâ†‘, ASTâ†‘, LDHâ†‘, CRPâ†‘**: Myocardial injury and inflammation
  * **[Endomyocardial biopsy] Inflammatory cell infiltration, myocyte necrosis, interstitial edema**: Confirms diagnosis
* **Management**
  * **Bed rest, hospitalization**: Supportive care
  * **Diuretics, catecholamines, IABP, ECMO**: For heart failure and cardiogenic shock
  * **Pacemaker, defibrillation**: For arrhythmia
{: .notice--info}

## Pericardium Disease / å¿ƒè†œç–¾æ‚£

### Acute Pericarditis / æ€¥æ€§å¿ƒè†œç‚

* **Overview**
  * Acute inflammation of the pericardium, mostly idiopathic (90%) or viral, generally good prognosis
* **Presentation**
  * **Chest pain worsening in supine position and during inspiration**: Pericardial irritation
  * **Fever**: Inflammatory response
* **Examination**
  * **[Auscultation] Pericardial friction rub**: Inflamed pericardial surfaces rubbing together
  * **[ECG] Diffuse concave ST elevation**: Pericardial inflammation
  * **[Blood] WBCâ†‘, ESRâ†‘, CRPâ†‘**: Inflammatory response
  * **[Echocardiography] Small pericardial effusion**: May be present
  * **[Chest X-ray] Usually normal**: Distinguishes from pleuritis
* **Management**
  * **Symptomatic treatment (NSAIDs)**: Often self-resolving
  * **Treat primary cause**: If secondary to underlying disease
{: .notice--info}

### Cardiac Tamponade / å¿ƒã‚¿ãƒ³ãƒãƒŠãƒ¼ãƒ‡

* **Overview**
  * Life-threatening condition where pericardial fluid accumulation impairs cardiac filling
  * Causes include aortic dissection, cardiac rupture after MI, trauma, malignancies invading pericardium
* **Presentation**
  * **Hypotension, jugular vein distension, muffled heart sounds**: Decreased cardiac output, increased venous pressure, pericardial fluid accumulation
  * **Hepatomegaly, ascites, leg edema**: Right heart failure signs
  * **Narrow pulse pressure, tachycardia, pulsus paradoxus (systolic BP drop during inspiration)**: Decreased cardiac output, exaggerated when increased venous return compress left ventricle
* **Examination**
  * **[Chest X-ray] Enlarged flask-shaped cardiac silhouette**: Pericardial effusion
  * **[Echocardiography] Echo-free space in pericardium, ventricular free wall collapse**: Confirmatory findings
* **Management**
  * **Pericardiocentesis**: Definitive treatment to drain fluid
  * **Treat underlying cause**
{: .notice--info}

### Constrictive Pericarditis / åç¸®æ€§å¿ƒè†œç‚

* **Overview**
  * Chronic inflammation causing fibrotic thickening and calcification of pericardium, impairing cardiac filling
  * Causes include idiopathic, tuberculosis, viral, post-radiation, post-cardiac surgery
* **Presentation**
  * **Dyspnea on exertion, fatigue**: Decreased cardiac output
  * **Jugular vein distension (exaggerated during inspiration = Kussmaul's sign), ascites, edema, hepatomegaly, congestive cirrhosis**: Right heart failure signs
* **Examination**
  * **[Auscultation] Pericardial knock**: Abrupt cessation of ventricular filling
  * **[ECG] Low voltage, nonspecific ST-T changes**: Thickening of pericardium
  * **[Echocardiography, Chest X-ray, CT, MRI] Thickened or calcified pericardium**: Thickening of pericardium
  * **[Cardiac catheterization] M or W-shaped RAP curve, RVP dip and plateau pattern**: Impaired ventricular filling lead to increased pressure of RA, rapid filling and termination of RV
* **Management**
  * **Pericardiectomy**: Definitive treatment
{: .notice--info}

## Congenital Heart Disease / å…ˆå¤©æ€§å¿ƒç–¾æ‚£

### Atrial Septal Defect / å¿ƒæˆ¿ä¸­éš”æ¬ æç—‡

* **Overview**
  * Congenital defect in atrial septum causing left-to-right shunt
* **Presentation**
  * **Asymptomatic (childhood)**: Left-to-right shunt compensated
  * **Dyspnea on exertion, fatigue (adolescence/adulthood)**: Right heart volume overload
* **Examination**
  * **[Auscultation] Fixed splitting of S2, systolic ejection murmur, accentuated S1, tricuspid diastolic rumble**: Relative pulmonary stenosis and tricuspid stenosis due to right atrial volume overload
  * **[ECG] Right axis deviation, incomplete right bundle branch block, right ventricular hypertrophy, atrial fibrillation**: Right heart strain
  * **[Echocardiography] Left atrium to right atrium shunt**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in right atrium**: Quantifies shunt
* **Management**
  * **Observation**: For mild cases (pulmonary-to-systemic flow ratio <1.5)
  * **Surgical or catheter-based closure**: For significant shunts (ratio >1.5)
{: .notice--info}

### Ventricular Septal Defect / å¿ƒå®¤ä¸­éš”æ¬ æç—‡

* **Overview**
  * Congenital defect in ventricular septum causing left-to-right shunt
* **Presentation**
  * **Asymptomatic**: Left-to-right shunt compensated (small VSD)
  * **Tachypnea, feeding difficulties, poor weight gain, sweating**: Heart failure symptoms (large VSD)
* **Examination**
  * **[Auscultation] Holosystolic murmur, palpable thrill**: Shunt through defect (small VSD)
  * **[Auscultation] Accentuated S2, diastolic rumble**: Pulmonary hypertension, relative mitral stenosis (large VSD)
  * **[ECG] Biventricular hypertrophy, left atrial overload**: Pulmonary hypertension (large VSD)
  * **[Chest X-ray] Marked ventricular and atrial enlargement, prominent pulmonary artery, increased pulmonary vascularity**: Left-to-right shunt (large VSD)
  * **[Echocardiography, left ventriculography] Left ventricle to right ventricle shunt**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in right atrium to ventricle**: Quantifies shunt
* **Management**
  * **Observation**: Many small defects close spontaneously
  * **Diuretics, surgical closure**: For large VSD
{: .notice--info}

### Atrioventricular Septal Defect / æˆ¿å®¤ä¸­éš”æ¬ æç—‡

* **Overview**
  * Developmental defect of atrioventricular septum, classified into incomplete and complete type based on existence of VSD
  * Associated with Down syndrome
* **Presentation**
  * **Asymptomatic, dyspnea**: Heart failure symptoms
* **Examination**
  * **[Auscultation] Systolic regurgitant murmur, systolic ejection murmur, diastolic rumble, fixed S2 splitting**: MR + ASD (imcomplete AVSD)
  * **[Auscultation] Systolic regurgitant murmur, diastolic rumble, accentuated S2**: MR + VSD (complete AVSD)
  * **[ECG] Left axis deviation, incomplete right bundle branch block, prolonged PQ interval, right ventricular hypertrophy**: Conduction abnormalities and right heart strain
  * **[Chest X-ray] Cardiomegaly, increased pulmonary vascularity**: Volume overload and increased pulmonary flow
  * **[Echocardiography] ASD, VSD (in complete type), left-to-right shunt, valve abnormalities**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in right heart chambers**: Quantifies shunt
  * **[Left ventriculography] Goose-neck sign**: Characteristic appearance of AVSD
* **Management**
  * **Surgical closure of defects, mitral valve repair**: For incomplete and complete AVSD
{: .notice--info}

### Patent Ductus Arteriosus / å‹•è„ˆç®¡é–‹å­˜ç—‡

* **Overview**
  * Persistence of fetal ductus arteriosus between aortic isthmus and pulmonary artery
  * Associated with congenital rubella syndrome
* **Presentation**
  * **Asymptomatic**: In mild cases
  * **Widened pulse pressure, bounding pulse, Quincke's sign**: Increased systolic and decreased diastolic pressures
* **Examination**
  * **[Auscultation] Continuous machinery murmur**: Aorta-to-pulmonary artery shunt
  * **[ECG] Left ventricular hypertrophy**: Increased pulmonary flow
  * **[Chest X-ray] Prominent left 1st/2nd/4th arches, increased pulmonary vascularity**: Volume overload and increased pulmonary flow
  * **[Echocardiography, aortography] Aorta-to-pulmonary artery shunt**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in pulmonary artery**: Quantifies shunt
* **Management**
  * **Coil embolization, Amplatzer duct occluder, PDA ligation**: If continuous murmur present
  * **Indomethacin or ibuprofen**: Pharmacological closure in premature infants
{: .notice--info}

### Pulmonary Stenosis / è‚ºå‹•è„ˆç‹­çª„ç—‡

* **Overview**
  * Congenital narrowing of pulmonary artery (most commonly pulmonary valve)
* **Presentation**
  * **Asymptomatic**: Compensated right heart function
* **Examination**
  * **[Auscultation] Ejection click, systolic ejection murmur, weakened and pathological splitting of S2**: Obstruction in pulmonary outflow
  * **[ECG] Right ventricular hypertrophy**: Right heart pressure overload
  * **[Chest X-ray] Prominent left 2nd arc, rounded left 4th arc**: Post-stenotic dilatation of pulmonary artery
  * **[Echocardiography, right ventriculography] Stenotic valve, post-stenotic dilatation**: Confirms diagnosis
  * **[Cardiac catheterization] Pressure gradient between pulmonary artery and right ventricle, elevated right heart pressures**: Quantifies stenosis severity
* **Management**
  * **Observation**: For mild cases
  * **Percutaneous balloon pulmonary valvuloplasty (PTPV), surgical valvotomy**: For moderate to severe cases
{: .notice--info}

### Coarctation of the Aorta / å¤§å‹•è„ˆç¸®çª„ç—‡

* **Overview**
  * Local narrowing of aortic isthmus or descending aorta, classified into simple and complex types based on existence of associated defects
* **Presentation**
  * **Asymptomatic**: Gradual development of collateral circulation (simple CoA)
  * **Dyspnea, pallor, oliguria, differential cyanosis**: Heart failure and upper-lower body perfusion difference (complex CoA)
  * **Weak/absent lower limb pulses, upper limb hypertension**: Aortic narrowing
* **Examination**
  * **[Auscultation] Accentuated S2, systolic murmur**: Increased flow velocity at coarctation
  * **[ECG] Left ventricular or biventricular hypertrophy**: Cardiac strain
  * **[Chest X-ray] 3-sign, rib notching, cardiomegaly, increased pulmonary vascularity**: Collateral circulation and heart failure
  * **[Echocardiography] Narrowing at aortic isthmus, associated defects**: Confirms diagnosis
* **Management**
  * **Balloon angioplasty, stent placement, aortic arch reconstruction**: Intervention for pressure gradient â‰¥20mmHg (simple CoA)
  * **Prostaglandin E1, aortic arch reconstruction with/without intracardiac repair**: Urgent surgery (complex CoA) 
{: .notice--info}

### Ruptured Aneurysm of the Sinus of Valsalva / Valsalvaæ´å‹•è„ˆç˜¤ç ´è£‚

* **Overview**
  * Sudden rupture of aneurysm in right or non-coronary sinus into right ventricle/atrium
* **Presentation**
  * **Sudden onset of palpitations, dyspnea, chest pain**: Aneurysm rupture
  * **Bounding pulse**: Increased stroke volume due to left-to-right shunt
* **Examination**
  * **[Auscultation] Continuous murmur**: Shunt from aorta to right heart
  * **[Chest X-ray] Prominence of left second arch, increased pulmonary vascularity**: Pulmonary volume overload
  * **[Echocardiography] Coronary sinus to right ventricle shunt**: Confirms diagnosis
* **Management**
  * **Aneurysm resection, fistula closure with patch**: Early surgical intervention
  * **VSD closure, aortic valve repair**: If necessary
{: .notice--info}

### Tetralogy of Fallot / Fallotå››å¾´ç—‡

* **Overview**
  * Congenital heart defect with four main features: pulmonary stenosis, ventricular septal defect, overriding aorta, right ventricular hypertrophy
* **Presentation**
  * **Cyanosis (from neonatal period)**: Right-to-left shunt
  * **Hypoxic spells (from 2-3 months)**: Right ventricular outflow tract spasm
  * **Squatting posture (after age 2)**: Increases systemic vascular resistance
* **Examination**
  * **[Auscultation] Systolic ejection murmur, single S2**: PS, weak pulmonary component
  * **[ECG] Right ventricular hypertrophy, right axis deviation**: Right heart overload
  * **[Chest X-ray] Boot-shaped heart, decreased pulmonary vascular markings**: Characteristic findings
  * **[Echocardiography] Pulmonary stenosis, ventricular septal defect, overriding aorta, right ventricular hypertrophy**: Confirms diagnosis
* **Management**
  * **Blalock-Taussig shunt**: Subclavian artery to pulmonary artery shunt (palliative surgery)
  * **VSD closure, right ventricular outflow tract reconstruction**: Complete repair (after 6 months of age)
  * **Sedation, oxygen, knee-chest position, Î²-blockers, Î±-agonists**: Hypoxic spell management
{: .notice--info}

### Complete Transposition of the Great Arteries / å®Œå…¨å¤§è¡€ç®¡è»¢ä½ç—‡

* **Overview**
  * Aorta from right ventricle, pulmonary artery from left ventricle, classified into Types I-III based on associated defects
* **Presentation**
  * **Cyanosis, tachypnea, respiratory distress**: Separation of systemic and pulmonary circulations
* **Examination**
  * **[Auscultation] Single and accentuated S2**: Anterior displacement of aorta
  * **[ECG] Right ventricular hypertrophy, right axis deviation**: Right heart overlaod due to high resistance
  * **[Chest X-ray] Egg-shaped cardiac silhouette**: Characteristic findings
  * **[Echocardiography] Aorta from right ventricle (anterior), pulmonary artery from left ventricle**: Confirms diagnosis
* **Management**
  * **PGE1 infusion, balloon atrial septostomy, diuretics**: Emergency measures
  * **Jatene procedure**: Arterial switch operation (type I, II)
  * **Rastelli procedure**: Creates intracardiac tunnel to redirect blood flow (type III)
{: .notice--info}

### Total Anomalous Pulmonary Venous Return / ç·è‚ºé™è„ˆé‚„æµç•°å¸¸ç—‡

* **Overview**
  * All four pulmonary veins drain into the right heart system
* **Presentation**
  * **Respiratory distress, right heart failure symptoms, cyanosis**: Abnormal pulmonary venous return
* **Examination**
  * **[Auscultation] Accentuated S2**: Pulmonary hypertension
  * **[ECG] Right ventricular hypertrophy, right axis deviation**: Right heart strain
  * **[Chest X-ray] Cardiomegaly, increased pulmonary vascular markings, snowman appearance (Type Ia)**: Right heart volume overload and pulmonary congestion
  * **[Echocardiography, MDCT] Enlarged right atrium and ventricle, abnormal pulmonary vein course**: Confirms diagnosis
* **Management**
  * **Anastomosis of common pulmonary vein to left atrium, ASD closure**: Urgent intracardiac repair
{: .notice--info}

### Tricuspid Atresia / ä¸‰å°–å¼é–‰é–ç—‡

* **Overview**
  * Absent tricuspid valve blocking right atrium-ventricle communication, always with ASD
* **Presentation**
  * **Cyanosis, heart failure symptoms**: Right-to-left shunt
* **Examination**
  * **[ECG] Left ventricular hypertrophy, left axis deviation**: Right-to-left shunt through ASD
  * **[Chest X-ray] Prominent left 4th arc**: Left ventricular enlargement
  * **[Echocardiography] Absence of right atrium-right ventricle communication**: Confirms diagnosis
* **Management**
  * **PGE1 administration, Blalock-Taussig shunt**: For decreased pulmonary flow type (palliative treatment)
  * **Pulmonary artery banding**: For increased pulmonary flow type (palliative treatment)
  * **Bidirectional Glenn procedure, Fontan procedure**: Connect SVC and IVC to pulmonary artery
{: .notice--info}

### Ebstein's Anomaly / Ebsteinç—…

* **Overview**
  * Malformation of right ventricle and tricuspid valve causing tricuspid regurgitation
* **Presentation**
  * **Cyanosis, heart failure symptoms**: Severity varies widely
* **Examination**
  * **[Auscultation] Holosystolic murmur, S3, S4**: TR, heart failure
  * **[ECG] Right atrial P waves, prolonged PQ interval, right bundle branch block, WPW syndrome**: Conduction abnormalities
  * **[Chest X-ray] Prominent right second arc**: Enlarged right atrium
  * **[Echocardiography] Tricuspid valve displaced towards right ventricle, tricuspid regurgitation**: Confirms diagnosis
* **Management**
  * **Observation**: For mild cyanosis and heart failure symptoms
  * **Tricuspid valve repair (Carpentier procedure), ASD closure if needed**: For severe cyanosis or heart failure
  * **Starnes procedure, Fontan operation**: For severe neonatal cases
{: .notice--info}

## Arterial Disorder / å‹•è„ˆç–¾æ‚£

### Aortic Aneurysm / å¤§å‹•è„ˆç˜¤

* **Overview**
  * Abnormal dilation of aorta due to atherosclerosis, potentially fatal if ruptured
  * More common in middle-aged and elderly men
* **Presentation**
  * **Asymptomatic**: Most common
  * **Hoarseness, Horner's syndrome**: Compression of recurrent laryngeal nerve or sympathetic nerves
  * **Dysphagia, nausea, vomiting**: Compression of esophagus
  * **Cough, hemoptysis, dyspnea**: Compression of trachea or lungs
  * **Altered consciousness, abdominal pain, leg numbness**: Organ ischemia
* **Examination**
  * **[Physical] Pulsatile abdominal mass**: Expansion of abdominal aorta
  * **[Chest X-ray] Widened mediastinal shadow**: Expansion of thoracic aorta
  * **[CT, MRI, Ultrasound] Aneurysm**: Confirmation of size and location
* **Management**
  * **Lifestyle modification, blood pressure control**: Conservative management
  * **Artificial graft replacement, endovascular stent grafting**: If aneurysm >5-6 cm or rapid expansion
{: .notice--info}

### Ruptured Aortic Aneurysm / å¤§å‹•è„ˆç˜¤ç ´è£‚

* **Overview**
  * Life-threatening complication of aortic aneurysm
* **Presentation**
  * **Sudden severe chest/back/lumbar pain, anemia, shock**: Rupture and rapid blood loss
  * **Hemoptysis, hematemesis**: Blood leaking into adjacent structures
* **Examination**
  * **[CT, Ultrasound] Aneurysm and hematoma**: Confirmation of rupture
* **Management**
  * **Artificial graft replacement, endovascular stent grafting, open stent grafting**: Immediate intervention required
{: .notice--info}

### Aortic Dissection / å¤§å‹•è„ˆè§£é›¢

* **Overview**
  * Tear in aortic intima leads to blood flow separating the medial layer and forming a false lumen, high mortality rate
  * Risk factors: Chronic hypertension, congenital connective tissue disorders
* **Presentation**
  * **Sudden severe chest/back pain**: Aortic wall disruption
  * **Hypertension, blood pressure difference between arms**: Organ ischemia
* **Examination**
  * **[ECG] No specific findings**: Rules out myocardial infarction
  * **[Blood] Elevated D-dimer**: Indicates thrombosis
  * **[Chest X-ray] Widened mediastinal shadow**: Aortic dilatation
  * **[CT] Intimal flap, true and false lumens**: Confirms diagnosis
  * **[Echocardiography] Aortic regurgitation, pericardial effusion**: Complications
* **Management**
  * **[Stanford Type A] Emergency surgical graft replacement**: Involving ascending aorta
  * **[Stanford Type B] Blood pressure and heart rate control, pain management**: Not involving ascending aorta 
  * **[Stanford Type B] Endovascular stent graft**: For complications or refractory cases
{: .notice--info}

### Takayasu's Arteritis / é«˜å®‰å‹•è„ˆç‚

* **Overview**
  * Chronic vasculitis affecting aorta and its major branches
  * More common in young women
* **Presentation**
  * **Fever, fatigue**: Systemic inflammation
  * **Dizziness, syncope**: Common carotid artery stenosis
  * **Upper limb numbness/coldness**: Subclavian artery stenosis
  * **Heart murmur**: Often due to aortic regurgitation
* **Examination**
  * **[Physical] Weak/absent pulses, BP differences, bruits**: Vascular stenosis
  * **[Blood] ESRâ†‘, CRPâ†‘, WBCâ†‘, Î³-globulinâ†‘**: Inflammatory markers
  * **[DSA, CT, MRA, FDG-PET] Vessel wall calcification, stenosis/occlusion/dilation**: Confirms diagnosis
* **Management**
  * **Corticosteroids, immunosuppressants**: Suppress inflammation
  * **Surgery**: For cardiac or aortic lesions
{: .notice--info}

### Arteriosclerosis Obliterans / é–‰å¡æ€§å‹•è„ˆç¡¬åŒ–ç—‡

* **Overview**
  * Chronic occlusive disease of arteries in lower limbs due to arteriosclerosis
  * Common in males over 50 with risk factors of atherosclerosis
* **Presentation**
  * **Intermittent claudication, rest pain, ulcers/necrosis**: Chronic lower limb ischemia
* **Examination**
  * **[Physical] Weakened or absent arterial sounds, ankle-brachial index (ABI) â‰¤ 0.9**: Reduced blood flow
  * **[Angiography, ultrasound, MRA, CTA] Arterial stenosis or occlusion**: Confirms diagnosis
* **Management**
  * **Exercise therapy, antiplatelet drugs (cilostazol), vasodilators**: For intermittent claudication
  * **Percutaneous transluminal angioplasty (PTA), stenting, bypass surgery, thromboembolectomy**: For severe ischemia
{: .notice--info}

### Thromboangiitis Obliterans / é–‰å¡æ€§è¡€æ “è¡€ç®¡ç‚

* **Overview**
  * Inflammatory occlusive disease of arteries in distal extremities
  * Affects male smokers under 50
* **Presentation**
  * **Cold sensation, numbness, Raynaud's phenomenon in extremities**: Reduced blood flow
  * **Intermittent claudication, painful ulcers/necrosis in fingers or toes**: Progressive vascular occlusion
* **Examination**
  * **[Doppler] Decreased ankle blood pressure, low ankle-brachial index (ABI)**: Reduced distal blood flow
  * **[Angiography] Abrupt vessel cutoffs, corkscrew collaterals**: Characteristic vascular changes
* **Management**
  * **Smoking cessation**: Essential for disease control
  * **Antiplatelet drugs (cilostazol), vasodilators**: Improve blood flow
  * **Sympathectomy, bypass surgery, amputation**: Surgical interventions
{: .notice--info}

### Acute Arterial Occlusive Disease / æ€¥æ€§å‹•è„ˆé–‰å¡ç—‡

* **Overview**
  * Sudden occlusion of peripheral arteries due to embolism or thrombosis, high mortality rate if not treated
  * Risk factors: Atrial fibrillation, cardiac myxoma, hypercoagulability, atherosclerosis
* **Presentation**
  * **Pain, pulselessness, pallor, paralysis, paresthesia (5P)**: Acute limb ischemia
* **Examination**
  * **[Physical] Absent peripheral pulses, decreased ankle-brachial index (ABI)**: Signs of arterial occlusion
  * **[Ultrasound, angiography, MDCT, MRA] Arterial occlusion**: Confirms diagnosis
* **Management**
  * **Urgent thromboembolectomy, catheter-directed thrombolysis, bypass surgery**: Revascularization
  * **Anticoagulants (heparin)**: Conservative treatment
{: .notice--info}

## Venous Disorder / é™è„ˆç–¾æ‚£

### Varicose Vein of the Lower Extremity / ä¸‹è‚¢é™è„ˆç˜¤

* **Overview**
  * Dilated and tortuous superficial veins in lower limbs due to venous valve incompetence
  * More common in women over 30, influenced by pregnancy, prolonged standing, obesity, aging
* **Presentation**
  * **Dilated and tortuous veins**: Venous reflux and stasis
  * **Dull pain, heaviness, itching, eczema, skin pigmentation**: Chronic blood stasis
* **Examination**
  * **[Ultrasound] Reflux and valve incompetence in superficial veins**: Confirms diagnosis
* **Management**
  * **Compression stockings, leg elevation**: Conservative therapy to improve venous return
  * **Endovenous ablation, stripping, varicectomy, sclerotherapy**: Occlusion or removal of incompetent veins
{: .notice--info}

### Deep Vein Thrombosis / æ·±éƒ¨é™è„ˆè¡€æ “ç—‡

* **Overview**
  * Thrombosis in deep veins of lower limbs, can lead to pulmonary thromboembolism
  * Risk factors: Surgery, trauma, prolonged bed rest, intravenous catheterization, pregnancy, malignancy
* **Presentation**
  * **Unilateral leg swelling, superficial vein dilation, color changes**: Venous obstruction and congestion
  * **Leg tension, pain, Homans' sign**: Vascular inflammation
* **Examination**
  * **[Blood] D-dimerâ†‘, FDPâ†‘**: Fibrin degradation products
  * **[Ultrasound] Reduced blood flow**: Venous obstruction
  * **[Contrast CT] Confirmation of thrombus**: Definitive diagnosis
* **Management**
  * **Anticoagulation (heparin, warfarin, DOACs)**: Prevent clot propagation
  * **Thrombolysis (urokinase)**: Dissolve existing clots
  * **Catheter-directed therapy, surgical thrombectomy**: For severe cases
  * **Early ambulation, compression stockings, intermittent compression**: Reduce risk in high-risk situations
{: .notice--info}

### Superior Vena Cava Syndrome / ä¸Šå¤§é™è„ˆç—‡å€™ç¾¤

* **Overview**
  * Obstruction of venous return through superior vena cava, often caused by malignant tumors or aortic aneurysms
* **Presentation**
  * **Edema of head/face/unilateral arm, headache, dyspnea**: Upper body congestion
  * **Distended neck and upper body superficial veins**: Impaired venous return
* **Examination**
  * **[Chest X-ray] Widened upper mediastinum**: Mass effect
  * **[CT, MRI] Stenosis or occlusion of superior vena cava**: Definitive diagnosis
* **Management**
  * **Treatment of underlying cause**: Malignant tumors, benign mediastinal tumors, thoracic aortic aneurysm
  * **Stent placement, bypass surgery**: Endovascular or surgical treatment
{: .notice--info}

### Lymphedema / ãƒªãƒ³ãƒ‘æµ®è…«

* **Overview**
  * Impaired lymphatic drainage causing tissue swelling, 
  * Primary (rare) or secondary (often due to cancer treatment)
* **Presentation**
  * **Unilateral or bilateral limb swelling**: Impaired lymph drainage
* **Examination**
  * **[Physical] Asymmetric limb swelling, skin changes**: Visual and tactile assessment
* **Management**
  * **Limb elevation, compression stockings, massage, infection prevention**: Complex decongestive therapy
  * **Lymphaticovenous anastomosis**: For refractory cases
{: .notice--info}

## Blood Pressure Disorder / è¡€åœ§ç•°å¸¸

### Essential Hypertension / æœ¬æ…‹æ€§é«˜è¡€åœ§

* **Overview**
  * High blood pressure without identifiable cause
  * Accounts for about 90% of hypertension cases
* **Presentation**
  * **Asymptomatic**: Gradual onset and progression
* **Examination**
  * **[Blood Pressure] â‰¥140/90 mmHg**: Persistent elevation of blood pressure
* **Management**
  * **Salt reduction, weight loss, exercise, smoking cessation, alcohol moderation**: Lifestyle modifications
  * **CCBs, ARBs, ACE inhibitors, MRAs, diuretics, Î²-blockers**: Vasodilation, fluid excretion, cardiac output reduction
{: .notice--info}

### Malignant Hypertension / åŠ é€Ÿå‹æ‚ªæ€§é«˜è¡€åœ§

* **Overview**
  * Severe hypertension with rapid progression of organ damage
  * More common in males 40-50 years old
* **Presentation**
  * **Headache, visual disturbances**: Hypertensive encephalopathy
  * **Oliguria, uremia**: Rapidly progressing renal dysfunction
  * **Heart failure symptoms**: Cardiac overload
* **Examination**
  * **[Blood pressure] Diastolic BP â‰¥120-130 mmHg**: Severe elevation of blood pressure
  * **[Fundoscopy] Retinal hemorrhages, papilledema**: Hypertensive retinopathy
* **Management**
  * **Immediate IV or oral antihypertensives**: Hypertensive emergency
  * **Dialysis**: For severe renal dysfunction
{: .notice--info}

### Renovascular Hypertension / è…è¡€ç®¡æ€§é«˜è¡€åœ§

* **Overview**
  * Hypertension caused by renal artery stenosis and increased RAA system activity
  * Common in patients <30 or >60 years old
* **Presentation**
  * **Treatment-resistant or malignant hypertension**: Due to persistent RAAS activation
  * **Worsening renal function after ACE inhibitors or ARBs**: Impaired glomerular filtration
* **Examination**
  * **[Auscultation] Abdominal bruit**: Severe vascular stenosis
  * **[Ultrasound, MR/CT angiography] Renal artery stenosis**: Primary screening method
  * **[Blood] Elevated plasma renin activity (PRA)**: RAAS activation
* **Management**
  * **Combination of antihypertensives**: ACE inhibitors/ARBs contraindicated in bilateral cases
  * **Percutaneous transluminal renal angioplasty (PTRA)**: For significant stenosis
{: .notice--info}

### Hypotension / ä½è¡€åœ§

* **Overview**
  * Low blood pressure due to various causes, including essential hypotension, orthostatic hypotension, postprandial hypotension
* **Presentation**
  * **Asymptomatic**: Especially in essential hypotension
  * **Dizziness, fatigue, syncope**: Inadequate cerebral perfusion
* **Examination**
  * **[Blood pressure] Systolic BP <100 mmHg**: Basic diagnostic criteria
  * **[Orthostatic test] BP drop after standing (â‰¥20 mmHg systolic or â‰¥10 mmHg diastolic)**: Diagnoses orthostatic hypotension
* **Management**
  * **Improve sleep, diet, exercise habits**: Lifestyle modifications
  * **Sympathomimetics, mineralocorticoids**: Vasoconstriction, increase plasma volume
{: .notice--info}

<!-- ## Introduction / ç·è«–

### Cardiovascular Drugs / å¾ªç’°å™¨ç–¾æ‚£æ²»ç™‚è–¬

* **Calcium channel blocker (DHP)**
  * **Drugs**: Amlodipine, nifedipine
  * **Mechanism**: Decrease intracellular calcium, relax smooth muscle
  * **Indication**: Hypertension, angina pectoris
  * **Adverse effect**: Tachycardia, flush
* **Calcium channel blocker (non-DHP)**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Decrease intracellular calcium, inhibit SA node and AV node
  * **Indication**: Supraventribular tachycardia
  * **Adverse effect**: Bradycardia
* **Î² blockers**
* **Î±Î² blockers**
{: .notice--info}


### Adrenergic Agonist / ã‚¢ãƒ‰ãƒ¬ãƒŠãƒªãƒ³ä½œå‹•è–¬

* **Î±Î² agonist**
  * **Drugs**: Epinephrine, norepinephrine, dopamine
  * **Mechanism**: Î±Î² agonist (epinephrine: Î²>Î±, norepinephrine: Î±>Î², dopamine: D>Î²>Î±)
  * **Indication**: Shock (dopamine preserve renal blood flow), glaucoma (epinephrine)
* **Î±1 agonist**
  * **Drugs**: Oxymetazoline, phenylephrine, midodrine
  * **Mechanism**: Î±1 agonist
  * **Indication**: Nasal congestion (Oxymetazoline, phenylephrine), midodrine (orthostatic hypotension)
* **Î±2 agonist**
  * **Drugs**: Clonidine, methyldopa, brimonidine
  * **Mechanism**: Î±2 agonist
  * **Indication**: Hypertension (methyldopa: for pregnant women), glaucoma (brimonidine)
* **Î² agonist**
  * **Drugs**: Isoproterenol
  * **Mechanism**: Î²1-Î²2 agonist
  * **Indication**: Bradycardia
* **Î²1 agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: Î²1 agonist
  * **Indication**: Heart failure
* **Î²2 agonist**
  * **Drugs**: Albuterol (salbutamol), terbutaline, fenoterol, metaproterol, procaterol, salmeterol, formoterol, ritodrine
  * **Mechanism**: Î²2 agonist
  * **Indication**: Asthma, COPD, tocolytic (ritodrine)
* **Î²3 agonist**
  * **Drugs**: Mirabegron
  * **Mechanism**: Î²3 agonist
  * **Indication**: Overactive bladder
* **Indirect agonist**
  * **Drugs**: Amphetamine, methylphenidate, modafinil, cocaine, amitryptiline
  * **Mechanism**: Increase catecholamine release (amphetamine), inhibit catecholamine reuptake (others)
  * **Indication**: ADHD, narcolepsy
* **Mixed agonist**
  * **Drugs**: Ephedrine, pseudoephedrine
  * **Mechanism**: Direct and indirect agonist
  * **Indication**: Nasal congestion, nocturnal neuresis
{: .notice--info}

### Adrenergic Antagonist / ã‚¢ãƒ‰ãƒ¬ãƒŠãƒªãƒ³æ‹®æŠ—è–¬

* **Î± antagonist**
  * **Drugs**: Phentolamine, phenoxybenzamine
  * **Mechanism**: Non-selective Î± antagonist
  * **Indication**: Pheochromocytoma diagnosis (Phentolamine), pheochromocytoma treatment (phenoxybenzamine)
* **Î±1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin, tamsulosin, indoramin, urapidil
  * **Mechanism**: Î±1 antagonist
  * **Indication**: Hypertension, BPH
* **Î±2 antagonist**
  * **Drugs**: Mirtazapine
  * **Mechanism**: Î±2 antagonist
  * **Indication**: Depression
* **Î² antagonist**
  * **Drugs**: Nadolol, pindolol, propranolol, timolol
  * **Mechanism**: Non-selective Î² antagonist
  * **Indication**: Hypertension, arrhythmia, heart failure, glaucoma (timolol)
* **Î²1 antagonist**
  * **Drugs**: Acebutolol, atenolol, betaxolol, bisoprolol, esmolol, metoprolol
  * **Mechanism**: Î²1 antagonist
  * **Indication**: Same as Î² antagonist
* **Î±Î² antagonist**
  * **Drugs**: Labetalol, carvedilol
  * **Mechanism**: Î±Î² antagonist
  * **Indication**: Hypertension, heart failure
* **Indirect antagonist**
  * **Drugs**: Reserpine, guanethidene, bretylium, metyrosine
  * **Mechanism**: Deplete neurotransmitter in vesicle (reserpine), inhibit vesicle release (guanethidine, bretylium), inhibit tyrosine hydroxylase (metyrosine)
  * **Indication**: Hypertension, heart failure
{: .notice--info}

### Cholinergic Agonist / ã‚³ãƒªãƒ³ä½œå‹•è–¬

* **Direct agonist**
  * **Drugs**: Acetylcholine, bethanechol, carbachol, methacholine, pilocarpine, cevimeline
  * **Mechanism**: Muscarinic agonist (+ nicotinic agonist: acetylcholine, carbachol)
  * **Indication**: Ileus and urinary retension, asthma diagnosis (methacholine), glaucoma (pilocarpine), Sjogren syndrome (cevimeline)
* **Indirect agonist (anti-cholinesterase)**
  * **Drugs**: Physostigmine, neostigmine, pyridostigmine, edrophonium, ambenonium
  * **Mechanism**: Inhibit cholinesterase to increase acetylcholine
  * **Indication**: Myasthenia gravis, ileus and urinary retension, glaucoma (physostigmine)
  * **Organic phosphate**: Irreversible anti-cholinesterase (treatment: pyridostigmine, atropine, pralidoxime)
{: .notice--info}

### Cholinergic Antagonist / ã‚³ãƒªãƒ³æ‹®æŠ—è–¬

* **Muscarinic antagonist**
  * **Drugs and indication**
    * Reduce exocrine: Atropine
    * Ophthalmoscopic examination: Homatropine, cyclopentolate, tropicamide
    * Motion sickness: Scopolamine
    * Gastric ulcer: Pirenzepine, propantheline
    * Diarrhea and IBS: Dicyclomine, clidinium
    * Asthama and COPD: Ipratropium, tiotropium
    * Overactive bladder: Oxybutynin
    * Parkinson disease: Trihexyphenidyl, bentropine, biperidin
  * **Mechanism**: Muscarinic antagonist
* **Nitotinic antagonist (ganglion blocker)**
  * **Drugs**: Mecamylamine, trimethaphan, hexamethonium
  * **Mechanism**: Nitotinic antagonist at autonomic ganglion
  * **Indication**: Hypertension
* **Nitotinic antagonist (muscle relaxant)**
  * **Drugs**: Tubocurarine, mivacurium, atracurium, cisatracurium, pancuronium, vecuronium, rocuronium, succinylcholine, decamothonium
  * **Mechanism**: Nitotinic antagonist at neuromuscular junction (non-depolarizing: tubocurarine ~ rocuronium, depolarizing: succinylcholine, decamothonium)
  * **Indication**: Anesthesia
* **Other muscle relaxant**
  * **Drugs**: Diazepam, baclofen, tizanidine, dantroline, hemicholinium, botulinum toxin, tetrodotoxin
  * **Mechanism**: GABA-A agonist (diazepam), GABA-B agonist (baclofen), Î±2 agonist (tizanidine), ryodine receptor blocker (dantroline), inhibit cholien uptake (hemicholinium), inhibit vesicle release (botulinum toxin), inhibit Na+ channel (tetrodotoxin)
  * **Indication**: Spasmolytic
{: .notice--info}

### Antihypertensive Drug / é™åœ§è–¬

* **ACE inhibitor**
  * **Drugs**: Captopril, enalapril, lisinopril
  * **Mechanism**: Angiotensin converting enzyme inhibitor
  * **Indication**: Hypertension (heart failure, diabetes)
  * **Adverse effect**: Nonproductive cough, angioadema
* **Angiotensin II receptor blocker**
  * **Drugs**: Losartan, valsartan, candesartan
  * **Mechanism**: Angiotensin II receptor blocker
  * **Indication**: Hypertension
* **Renin inhibitor**
  * **Drugs**: Aliskiren
  * **Mechanism**: Renin inhibitor
  * **Indication**: Hypertension
* **Î²-blocker**
  * **Drugs**: Acebutolol, atenolol, carvedilol, esmolol, labetalol, metoprolol, pindolol, propranolol
  * **Mechanism**: Î²1-blocker (reduce cardial output, inhibit renin secretion)
  * **Indication**: Hypertension
  * **Adverse effect**: Asthma
* **Calcium channel blocker**
  * **Drugs**: DHP: Amlodipine, nifedipine, felodipine / Non-DHP: verapamil, diltiazem, bepridil
  * **Mechanism**: Calcium channel blocker (vessel: DHP, heart: non-DHP)
  * **Indication**: Hypertension
* **Vasodilator**
  * **Drugs**: Minoxidil, diazoxide, hydralazine, nitroprusside
  * **Mechanism**: Activate K channel (minoxidil, diazoxide), increase cGMP (hydralazine, nitroprusside)
  * **Indication**: Hypertension
  * **Adverse effect**: Hirsutism (minoxidil), hyperglycemia (diazoxide), lupus-like syndrome (hydralazine), nitroprusside (cyanide toxicity)
* **Î±1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin
  * **Mechanism**: Î±1 antagonist 
  * **Indication**: Hypertension (with BPH)
* **Î±2 agonist**
  * **Drugs**: Clonidine, methyldopa
  * **Mechanism**: Î±2 agonist 
  * **Indication**: Hypertension (pregnancy)
* **D1 agonist**
  * **Drugs**: Fenoldopam
  * **Mechanism**: D1 agonist
  * **Indication**: Malignant hypertension
* **PDE5 inhibitor**
  * **Drugs**: Sildenafil, vardenafil
  * **Mechanism**: PDE5 inhibitor, increase cGMP
  * **Indication**: Pulmonary hypertension, erectile dysfunction
* **Diuretics**
  * See diuretics
{: .notice--info}

### Heart Failure Drug / å¿ƒä¸å…¨ã®è–¬

* **Cardiac glycoside**
  * **Drugs**: Digoxin, digitoxin
  * **Mechanism**: Inhibit Na/K ATPase, elevate intreacellular Ca
  * **Indication**: Congestive heart failure
  * **Adverse effect**: GI distress, visual disturbance, digoxin toxicity (treat with potassium and antibody)
* **PDE3 inhibitor**
  * **Drugs**: Melrinone, amrinone
  * **Mechanism**: Inhibit PDE3, increase cAMP
  * **Indication**: Heart failure
* **Adrenergic agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: Î²1 agonist
  * **Indication**: Heart failure
* **BNP agonist**
  * **Drugs**: Nesiritide, sacubitril
  * **Mechanism**: BNP agonist (nersiritide), increase BNP (sacubitril)
  * **Indication**: Heart failure
{: .notice--info}

### Antianginal Drug / æŠ—ç‹­å¿ƒç—‡è–¬

* **Nitrates**
  * **Drugs**: Nitroglycerin, isosorbide mononitrate, isosorbide dinitrate
  * **Mechanism**: Increase cGMP
  * **Indication**: Angina pectoris
  * **Adverse effect**: Headache, flushing
* **Ranolazine**
  * **Drugs**: Ranolazine
  * **Mechanism**: Inhibit Na current, decrease intracellular Ca
  * **Indication**: Angina pectoris
  * **Adverse effect**: QT prolongation
{: .notice--info}

### Antiarrhythmic Drug / æŠ—ä¸æ•´è„ˆè–¬

* **Class IA**
  * **Drugs**: Quinidine, procainamide, disopyramide
  * **Mechanism**: Na (and K) channel blocker (prolong QRS)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, cinchonism (quinidine), lupus-like syndrome (procainamide)
* **Class IB**
  * **Drugs**: Mexiletine, lidocaine, phenytoin
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class IC**
  * **Drugs**: Flecanide, propafenone
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class II**
  * **Drugs**: Propranolol, metoprolol, pindolol, esmolol
  * **Mechanism**: Î² blocker (prolong PR)
  * **Indication**: Tachycardia, Post-MI
* **Class III**
  * **Drugs**: Amiodarone, dronedarone, sotalol, ibutilide, dofetilide
  * **Mechanism**: K channel blocker (prolong QT)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, thyroid dysfunction (amiodarone), liver dysfunction (amiodarone), pulmonary fibrosis (amiodarone)
* **Class IV**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Ca channel blocker (prolong PR)
  * **Indication**: Tachycardia
* **Class V**
  * **Drugs**: Adenosine, MgSO4
  * **Mechanism**: Gi (adenosine)
  * **Indication**: PSVT (adenosine), torsade de pointes (MgSO4)
{: .notice--info} -->

<!-- ## Heart Failure / å¿ƒä¸å…¨

### Left-Sided Heart Failure / å·¦å¿ƒä¸å…¨
### Right-Sided Heart Failure / å³å¿ƒä¸å…¨

## Arrhythmia / ä¸æ•´è„ˆ

### Sinus Tachycardia / æ´æ€§é »è„ˆ
### Paroxysmal Supraventricular Tachycardia / ç™ºä½œæ€§ä¸Šå®¤é »æ‹
### Wolff-Parkinson-White Syndrome / WPWç—‡å€™ç¾¤
### Atrial Flutter / å¿ƒæˆ¿ç²—å‹•
### Atrial Fibrillation / å¿ƒæˆ¿ç´°å‹•
### Atrial Premature Contraction / å¿ƒæˆ¿æœŸå¤–åç¸®
### Ventricular Premature Contraction / å¿ƒå®¤æœŸå¤–åç¸®
### Ventricular Tachycardia / å¿ƒå®¤é »æ‹
### Ventricular Fibrillation / å¿ƒå®¤ç´°å‹•
### Long QT Syndrome / QTå»¶é•·ç—‡å€™ç¾¤
### Brugada Syndrome / Brugadaç—‡å€™ç¾¤
### Sick Sinus Syndrome / æ´ä¸å…¨ç—‡å€™ç¾¤
### Atrioventricular Block / æˆ¿å®¤ãƒ–ãƒ­ãƒƒã‚¯
### Bundle Branch Block / è„šãƒ–ãƒ­ãƒƒã‚¯

## Ischemic Heart Disease / è™šè¡€æ€§å¿ƒç–¾æ‚£

### Effort Angina Pectoris / åŠ´ä½œæ€§ç‹­å¿ƒç—‡
### Vasospastic Angina Pectoris / å† æ”£ç¸®æ€§ç‹­å¿ƒç—‡
### Unstable Angina Pectoris / ä¸å®‰å®šç‹­å¿ƒç—‡
### Acute Myocardial Infarction / æ€¥æ€§å¿ƒç­‹æ¢—å¡
### Complication of Myocardial Infarction / å¿ƒç­‹æ¢—å¡ã®åˆä½µç—‡

## Valvular Heart Disease / å¿ƒè‡“å¼è†œç—‡

### Mitral Stenosis / åƒ§å¸½å¼ç‹­çª„ç—‡
### Mitral Regurgitation / åƒ§å¸½å¼é–‰é–ä¸å…¨ç—‡
### Mitral Valve Prolapse / åƒ§å¸½å¼é€¸è„±ç—‡
### Aortic Stenosis / å¤§å‹•è„ˆå¼ç‹­çª„ç—‡
### Aortic Regurgitation / å¤§å‹•è„ˆå¼é–‰é–ä¸å…¨ç—‡
### Tricuspid Stenosis / ä¸‰å°–å¼ç‹­çª„ç—‡
### Tricuspid Regurgitation / ä¸‰å°–å¼é–‰é–ä¸å…¨ç—‡

## Endocardium, Myocardium and Pericardium Disease / å¿ƒå†…è†œãƒ»å¿ƒç­‹ãƒ»å¿ƒè†œç–¾æ‚£

### Infectious Endocarditis / æ„ŸæŸ“æ€§å¿ƒå†…è†œç‚
### Cardiac Myxoma / å¿ƒè‡“ç²˜æ¶²è…«
### Dilated Cardiomyopathy / æ‹¡å¼µå‹å¿ƒç­‹ç—‡
### Hypertrophic Cardiomyopathy / è‚¥å¤§å‹å¿ƒç­‹ç—‡
### Restrictive Cardiomyopathy / æ‹˜æŸå‹å¿ƒç­‹ç—‡
### Takotsubo-Type Cardiomyopathy / ãŸã“ã¤ã¼å‹å¿ƒç­‹ç—‡
### Myocarditis / å¿ƒç­‹ç‚
### Acute Pericarditis / æ€¥æ€§å¿ƒè†œç‚
### Cardiac Tamponade / å¿ƒã‚¿ãƒ³ãƒãƒŠãƒ¼ãƒ‡
### Constrictive Pericarditis / åç¸®æ€§å¿ƒè†œç‚

## Arterial Disease / å‹•è„ˆç–¾æ‚£

### Arteriosclerosis / å‹•è„ˆç¡¬åŒ–
### Aortic Aneurysm / å¤§å‹•è„ˆç˜¤
### Aortic Dissection / å¤§å‹•è„ˆè§£é›¢
### Arterio-Venous Fistula / å‹•é™è„ˆç˜»
### Acute Arterial Occlusive Disease / æ€¥æ€§å‹•è„ˆé–‰å¡ç—‡
### Arteriosclerosis Obliterans / é–‰å¡æ€§å‹•è„ˆç¡¬åŒ–ç—‡
### Thromboangiitis Obliterans / é–‰å¡æ€§è¡€æ “è¡€ç®¡ç‚
### Raynaud Disease / Raynaudç—…

## Venous Disease / é™è„ˆç–¾æ‚£

### Deep Vein Thrombosis / æ·±éƒ¨é™è„ˆè¡€æ “ç—‡
### Varicose Vein / ä¸‹è‚¢é™è„ˆç˜¤
### SVC Syndrome / ä¸Šå¤§é™è„ˆç—‡å€™ç¾¤
### Lymphedema / ãƒªãƒ³ãƒ‘æµ®è…«

## Blood Pressure Disorder / è¡€åœ§ç•°å¸¸

### Essential Hypertension / æœ¬æ…‹æ€§é«˜è¡€åœ§ç—‡
### Secondary Hypertension / äºŒæ¬¡æ€§é«˜è¡€åœ§ç—‡
### Malignant Hypertension / æ‚ªæ€§é«˜è¡€åœ§ç—‡
### Hypotension / ä½è¡€åœ§ -->

# Pulmonology/ å‘¼å¸å™¨ç§‘

## Infectious Disorder / æ„ŸæŸ“æ€§ç–¾æ‚£

### Common Cold Syndrome / ã‹ãœç—‡å€™ç¾¤

* **Overview**
  * Most common respiratory infection affecting upper respiratory tract mucosa, mostly caused by viruses
  * Transmitted through droplets and contact
* **Presentation**
  * **Rhinorrhea, nasal congestion, sneezing**: Nasal inflammation
  * **Sore throat, dry throat, hoarseness**: Upper respiratory tract inflammation
  * **Cough, sputum**: Lower respiratory tract inflammation
  * **Mild fever, headache, fatigue**: Systemic inflammatory response
* **Examination**
  * **Clinical**
* **Management**
  * **Rest, warmth, gargling, hand washing**: Supportive care
  * **Traditional medicines (Kakkonto, Maoto), acetaminophen, NSAID, antihistamine**: Symptom relief
{: .notice--info}

### Acute Bronchiolitis / æ€¥æ€§ç´°æ°—ç®¡æ”¯ç‚

* **Overview**
  * Acute inflammation of bronchioles causing airway narrowing and obstruction, mainly caused by RSV and parainfluenza virus
  * Most common in infants under 1 year
* **Presentation**
  * **Fever, cough, rhinorrhea**: Initial cold-like symptoms
  * **Expiratory wheezing**: Bronchiolar narrowing
  * **Nasal flaring, chest retractions, tachypnea**: Respiratory distress
* **Examination**
  * **[Antigen test] Positive for RSV**: Confirm diagnosis
* **Management**
  * **Oxygen therapy, nebulizer humidification, IV fluids**: Supportive care
{: .notice--info}

### Influenza / ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶

* **Overview**
  * Infectious disease with seasonal epidemic caused by influenza virus, more severe than common cold and can be fatal
  * Transmitted through droplets and contact, common in winter to spring
* **Presentation**
  * **High fever (>38Â°C), chills, headache, muscle/joint pain, fatigue**: Rapid onset systemic symptoms
  * **Cough, sore throat, rhinorrhea**: Respiratory symptoms
* **Examination**
  * **[Antigen test]] Positive for influenza virus**: Confirm diagnosis
* **Management**
  * **Neuraminidase inhibitor (Oseltamivir, Zanamivir), RNA polymerase inhibitor (Favipiravir)**: Shorten fever duration, prevent severe complications
{: .notice--info}

### COVID-19 / æ–°å‹ã‚³ãƒ­ãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

* **Overview**
  * Novel infectious disease caused by SARS-CoV-2, can be severe and fatal especially in elderly or immunocompromised patients
  * Transmitted through droplets and contact 
* **Presentation**
  * **Fever, fatigue, dry cough, shortness of breath**: Systemic and respiratory symptoms
  * **Loss of smell/taste**: Characteristic symptoms
  * **Acute respiratory distress syndrome, thrombotic events, shock, organ failure**: Complications in severe cases
* **Examination**
  * **[PCR, Antigen test] Positive for SARS-CoV-2**: Confirm diagnosis
  * **[Blood] Lymphopenia**: Indicates disease severity
  * **[Blood] D-dimer elevation**: Suggests thromboembolism/DIC
* **Management**
  * **Remdesivir, Molnupiravir, Nirmatrelvir, Ritonavir**: Antiviral treatment
  * **Dexamethasone, Baricitinib, Tocilizumab (severe case)**: Anti-inflammatory treatment
  * **Mechanical ventilation (severe case)**: Respiratory support
{: .notice--info}

### Bacterial Pneumonia / ç´°èŒæ€§è‚ºç‚

* **Overview**
  * Acute purulent inflammation of lung caused by bacterial infection
  * [Streptococcus pneumoniae] 1st common
  * [Haemophilus influenzae] 2nd common
  * [Klebsiella pneumoniae] Often serious in underlying diseases
  * [Staphylococcus aureus] Often with local destruction
  * [Moraxella catarrhalis] Often cause deterioration of COPD
  * [Pseudomonas aeruginosa] Often in immunocompromised or ventilator-associated 
* **Presentation**
  * **Cough, purulent sputum, chest pain, dyspnea**: Local inflammation of lung
  * **Fever, fatigue, loss of appetite**: Systemic inflammatory response
* **Examination**
  * **[Physical] Dullness on percussion, decreased breath sounds, coarse crackles**: Consolidation of lung tissue
  * **[Blood] WBCâ†‘, CRPâ†‘, ESRâ†‘, hypoxemia**: Inflammatory response
  * **[Chest X-ray, CT] Infiltrative shadows, air bronchogram**: Alveolar filling
  * **[Sputum] Gram stain, culture, rapid antigen test**: Identify causative bacteria
* **Management**
  * **Antibiotics based on pathogen**: Target causative bacteria
  * **Rest, temperature/fluid/electrolyte control**: Supportive care
  * **Oxygen therapy, mechanical ventilation**: Treat respiratory failure
{: .notice--info}

### Aspiration Pneumonia / èª¤åš¥æ€§è‚ºç‚

* **Overview**
  * Pneumonia caused by aspiration due to swallowing dysfunction, aspiration often silent
  * Common in elderly, major cause of healthcare-associated pneumonia
* **Presentation**
  * **Decreased ADL, appetite loss, incontinence**: Atypical symptoms in elderly
  * **Less fever, cough, or sputum**: May lack typical pneumonia symptoms
* **Examination**
  * **[Physical] Respiratory rateâ†‘, SpO2â†“**: Impaired gas exchange
  * **[Blood] WBCâ†‘, CRPâ†‘, ESRâ†‘**: Inflammatory response
  * **[Chest X-ray] Infiltrative shadows**: Alveolar filling
* **Management**
  * **Empiric antibiotics**: Cover anaerobes and streptococci
  * **Prevention**: Swallowing rehabilitation, oral care, proper positioning
{: .notice--info}

### Chlamydial Pneumonia / ã‚¯ãƒ©ãƒŸã‚¸ã‚¢è‚ºç‚

* **Overview**
  * Atypical pneumonia caused by C. pneumoniae, C. trachomatis, C. psittaci (psittacosis)
  * Common in young adults and elderly, bird exposure (psittacosis)
* **Presentation**
  * **Persistent dry cough, mild fever**: Atypical pneumonia pattern
  * **[Psittacosis] Dry cough, high fever >39â„ƒ, headache, relative bradycardia, hepatosplenomegaly**: More severe systemic symptoms
* **Examination**
  * **[Clinical] No response to Î²-lactams**: Characteristic of atypical bacteria
  * **[Antibody/Gene test] Positive for chlamydia**: Confirm diagnosis
* **Management**
  * **Tetracyclines, macrolides, fluoroquinolones**: Target atypical bacteria
{: .notice--info}

### Mycoplasma Pneumonia / ãƒã‚¤ã‚³ãƒ—ãƒ©ã‚ºãƒè‚ºç‚

* **Overview**
  * Atypical pneumonia caused by Mycoplasma pneumoniae, transmitted by contact/droplets
  * Common in healthy young people
* **Presentation**
  * **Persistent dry cough, minimal physical findings**: Atypical pneumonia pattern
  * **Fever, headache, fatigue**: Systemic symptoms
* **Examination**
  * **[Clinical] No response to Î²-lactams**: Characteristic of atypical bacteria
  * **[Blood] WBCâ†’, ESRâ†‘, CRPâ†‘, cold agglutinin(+)**: Non-specific inflammation
  * **[Antibody/Gene test] Positive for mycoplasma**: Confirm diagnosis
* **Management**
  * **Macrolides, tetracyclines, fluoroquinolones**: Target atypical bacteria
{: .notice--info}

### Legionella Pneumonia / ãƒ¬ã‚¸ã‚ªãƒãƒ©è‚ºç‚

* **Overview**
  * Pneumonia caused by inhaling aerosols containing Legionella
  * Common in middle-aged adults with exposure to water systems (hot springs, circulating baths)
* **Presentation**
  * **High fever, cough, chest pain**: Inflammation of lungs
  * **Relative bradycardia, neuropsychiatric symptoms, diarrhea**: Characteristic of Legionella pneumonia
* **Examination**
  * **[Blood] Naâ†“, CKâ†‘**: Characteristic laboratory findings
  * **[Chest X-ray] Infiltrates, pleural effusion**: Lung involvement
  * **[Clinical] No response to Î²-lactams**: Characteristic of atypical bacteria
  * **[Urine antigen] Positive for Legionella**: Rapid diagnosis
  * **[Sputum] Culture on BCYEÎ± agar**: Confirmatory tests
* **Management**
  * **Fluoroquinolones, macrolides (IV)**: First-line treatment
  * **Rifampicin, tetracyclines**: Alternative options
{: .notice--info} 

### Cytomegalovirus Pneumonia / ã‚µã‚¤ãƒˆãƒ¡ã‚¬ãƒ­ã‚¦ã‚¤ãƒ«ã‚¹è‚ºç‚

* **Overview**
  * CMV acquired in childhood and remains latent, reactivates in immunocompromised patients
  * Common in patients on steroids/immunosuppressants, malignancy, HIV/AIDS
* **Presentation**
  * **Fever, dyspnea, dry cough**: Inflammation of lungs
* **Examination**
  * **[Chest X-ray] Bilateral diffuse ground-glass opacities**: Interstitial pneumonia
  * **[Sputum, Lung biopsy] Giant cells with nuclear inclusions**: Characteristic finding
  * **[Gene/Antigen test] Positive for CMV**: Confirmatory test
* **Management**
  * **Ganciclovir, valganciclovir**: First-line antiviral treatment
  * **Foscarnet**: For drug-resistant cases
{: .notice--info} 

### Lung Abscess / è‚ºè†¿ç˜

* **Overview**
  * Severe complication of pneumonia with destruction of lung tissue forming pus-filled cavity
  * Common in alcoholics, diabetics
* **Presentation**
  * **Fever, cough, foul-smelling sputum, hemoptysis**: Purulent inflammation and tissue destruction
  * **Chest pain**: When lesion reaches pleura
* **Examination**
  * **[Blood] WBCâ†‘, CRPâ†‘**: Infection
  * **[CT] Well-defined mass, air-fluid level (niveau)**: Abscess formation
* **Management**
  * **Combination antibiotics**: Target multiple bacterial species
  * **Drainage**: For persistent cases
{: .notice--info}

### Pulmonary Tuberculosis / è‚ºçµæ ¸ç—‡

* **Overview**
  * Respiratory infection caused by Mycobacterium tuberculosis, classified as primary (initial infection) and secondary (reactivation)
* **Presentation**
  * **Cough >2 weeks, sputum, hemoptysis**: Active infection in airways
  * **Fever, fatigue, night sweat**: Systemic inflammatory response
* **Examination**
  * **[Chest X-ray] Hilar lymphadenopathy, nodular shadows, cavitary lesions**: Different stages of infection
  * **[CT] Bronchiolar nodules (tree-in-bud sign)**: Bronchiolar spread of infection
  * **[Sputum smear] Fluorescent or red-stained bacilli with Ziehl-Neelsen stain**: Acid-fast bacteria
  * **[Culture, PCR] Identification of M. tuberculosis**: Confirmatory test
* **Management**
  * **Multi-drug therapy with RFP, INH, PZA, EB/SM**: Different mechanisms to prevent drug resistance
{: .notice--info}

### Miliary Tuberculosis / ç²Ÿç²’çµæ ¸

* **Overview**
  * Hematogenous spread of tuberculosis forming multiple tubercles in various organs
  * Common in children, elderly, immunocompromised patients
* **Presentation**
  * **Persistent high fever, headache, fatigue**: Systemic infection
* **Examination**
  * **[Blood] ESRâ†‘, CRPâ†‘**: Systemic inflammation
  * **[Tuberculin test] Sometimes negative**: Anergic state due to overwhelming infection
  * **[Chest X-ray] Diffuse miliary nodules in both lungs**: Disseminated infection
  * **[Biopsy, Culture] Identification of M. tuberculosis**: Confirmatory test
* **Management**
  * **Multi-drug therapy with RFP, INH, PZA, EB/SM**: Different mechanisms to prevent drug resistance
{: .notice--info}

### MAC Disease / éçµæ ¸æ€§æŠ—é…¸èŒç—‡

* **Overview**
  * Caused by Mycobacterium avium complex, environmental organism without human-to-human transmission
  * Common in patients without underlying disease (nodular/bronchiectatic), patients with previous TB or COPD (fibrocavitary), younger patients (hypersensitivity)
* **Presentation**
  * **Cough, sputum, hemoptysis**: Airway infection
* **Examination**
  * **[Chest X-ray, CT] Multiple nodules with bronchiectasis, upper lobe cavities, diffuse ground-glass opacities**: Nodular/bronchiectatic, fibrocavitary, or hypersensitivity type
  * **[Sputum culture] Positive MAC cultures**: Confirmatory test
* **Management**
  * **Multi-drug therapy with CAM, RFP, EB**: Different mechanisms to prevent drug resistance
  * **Lobectomy**: Surgical option for localized disease
{: .notice--info}

### Simple Pulmonary Aspergilloma / å˜ç´”æ€§è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ­ãƒ¼ãƒ

* **Overview**
  * Aspergillus colonization in pre-existing lung cavity forming fungus ball
  * Common in patients with previous tuberculosis, fibrosis, emphysema
* **Presentation**
  * **Asymptomatic**
  * **Fever, cough, hemoptysis**: Local inflammation
* **Examination**
  * **[Chest X-ray, CT] Fungus ball, meniscus sign, thickened cavity wall and pleura**: Characteristic findings
  * **[Blood] Anti-aspergillus precipitating antibodies (+)**: Immune response to infection
  * **[Sputum, BALF, TBLB] Fungal hyphae, positive culture**: Confirms diagnosis
* **Management**
  * **Surgical resection**: Curative treatment
  * **Voriconazole, itraconazole**: For inoperable cases
{: .notice--info}

### Chronic Progressive Pulmonary Aspergillosis / æ…¢æ€§é€²è¡Œæ€§è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ«ã‚¹ç—‡

* **Overview**
  * Progressive Aspergillus infection with cavity expansion and infiltrates
  * Common in patients with pre-existing lung cavities or immunocompromised states
* **Presentation**
  * **Persistent cough, sputum/hemoptysis, fever, weight loss**: Chronic inflammation
* **Examination**
  * **[Chest X-ray] New/expanding cavities, thickened cavity walls, air-fluid levels**: Progressive nature of disease
  * **[Blood] WBCâ†‘, CRPâ†‘, ESRâ†‘**: Chronic inflammation
  * **[Blood] Anti-aspergillus precipitating antibodies (+), galactomannan antigen (+)**: Fungal infection markers
  * **[Sputum, BALF, TBLB] Fungal hyphae, positive culture**: Confirms diagnosis
* **Management**
  * **Micafungin, voriconazole, caspofungin, amphotericin B**: Target fungal cells
{: .notice--info}

### Invasive Pulmonary Aspergillosis / ä¾µè¥²æ€§è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ«ã‚¹ç—‡

* **Overview**
  * Severe Aspergillus infection with tissue invasion
  * Common in immunocompromised patients (neutropenia, leukemia, GVHD, steroid, immunosuppressant)
* **Presentation**
  * **Sudden fever, cough, hemoptysis**: Aggressive fungal invasion
* **Examination**
  * **[Chest X-ray] Rapidly progressing wedge-shaped shadows**: Vascular invasion
  * **[CT] Halo sign, air crescent sign**: Characteristic findings
  * **[Blood] Î²-D-glucanâ†‘, galactomannan antigen (+)**: Fungal infection markers
  * **[Sputum, BALF, TBLB] Fungal hyphae, positive culture**: Confirms diagnosis
* **Management**
  * **Voriconazole, amphotericin B, itraconazole, micafungin, caspofungin** Target fungal cell
{: .notice--info}

### Pulmonary Cryptococcosis / è‚ºã‚¯ãƒªãƒ—ãƒˆã‚³ãƒƒã‚¯ã‚¹ç—‡

* **Overview**
  * Infection by Cryptococcus neoformans through inhalation from soil contaminated with bird droppings
  * Occurs in both immunocompetent and immunocompromised patients
* **Presentation**
  * **[Immunocompetent] Asymptomatic, mild fever, cough**: Limited immune response
  * **[Immunocompromised] Fever, fatigue, chest pain, dyspnea,  cough, hemoptysis**: More severe symptoms due to poor immune function
* **Examination**
  * **[Chest X-ray, CT] Solitary/multiple nodules, cavitation, infiltrates**: Different patterns based on immune status
  * **[Blood] GXM antigen (+)**: Confirms diagnosis
* **Management**
  * **Fluconazole ,itraconazole, voriconazole, amphotericin B,**:  Target fungal cells
{: .notice--info}

### Pneumocystis Pneumonia / ãƒ‹ãƒ¥ãƒ¼ãƒ¢ã‚·ã‚¹ãƒã‚¹è‚ºç‚

* **Overview**
  * Severe pneumonia caused by Pneumocystis jirovecii in immunocompromised patients
  * Common in patents with AIDS, malignancy, autoimmune disease, steroid, immunosuppressant
* **Presentation**
  * **Sudden fever, dry cough, dyspnea**: Acute inflammatory response
* **Examination**
  * **[Blood] LDHâ†‘, KL-6â†‘, Î²-D-glucanâ†‘, PaO2â†“**: Lung damage and fungal infection markers
  * **[Chest X-ray, CT] Diffuse ground-glass opacity, multiple cystic shadows**: Characteristic radiological findings
  * **[Sputum, BALF, TBLB] Detection of pneumocystis**: Confirms diagnosis
* **Management**
  * **Trimethoprim-sulfamethoxazole, pentamidine, atovaquone**: Target fungal cells
  * **Steroids**: For severe respiratory compromise
{: .notice--info}

## Immune and Allergic Disorder / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§ç–¾æ‚£

### Acute Eosinophilic Pneumonia / æ€¥æ€§å¥½é…¸çƒæ€§è‚ºç‚

* **Overview**
  * Rapidly progressive diffuse eosinophilic lung infiltration
  * Common in young males within 1 month of starting smoking
* **Presentation**
  * **Fever, dyspnea, dry cough, chest pain**: Acute inflammatory response and lung infiltration
  * **Severe hypoxemia**: Rapid onset respiratory failure
* **Examination**
  * **[Chest X-ray] Diffuse ground-glass opacity/infiltrates, Kerley B lines, pleural effusion**: Lung inflammation and edema
  * **[Blood] CRPâ†‘**: Acute inflammation
  * **[BALF] Eosinophilsâ†‘**: Diagnostic criteria
* **Management**
  * **High-dose steroids**: Good prognosis
{: .notice--info}

### Chronic Eosinophilic Pneumonia / æ…¢æ€§å¥½é…¸çƒæ€§è‚ºç‚

* **Overview**
  * Subacute to chronic eosinophilic lung infiltration
  * Common in middle-aged women with allergic history
* **Presentation**
  * **Fever, cough, sputum, dyspnea,**: Chronic inflammatory response and lung infiltration
  * **Weight loss, general fatigue**: Chronic inflammatory condition
* **Examination**
  * **[Chest X-ray] Migratory peripheral infiltrates**: Characteristic findings
  * **[Blood] Eosinophilsâ†‘, CRPâ†‘**: Eosinophilic inflammation
  * **[BALF, Lung biopsy] Eosinophilsâ†‘**: Confirms diagnosis
* **Management**
  * **High-dose steroids followed by gradual reduction**: Good prognosis but high relapse rate
{: .notice--info}

### Allergic Bronchopulmonary Aspergillosis / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§æ°—ç®¡æ”¯è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ«ã‚¹ç—‡

* **Overview**
  * Allergic respiratory disease caused by Aspergillus species
  * Common in patients with atopic predisposition
* **Presentation**
  * **Fever, cough, paroxysmal dyspnea**: Allergic bronchial response
  * **Thick brownish sputum**: Mucoid impaction
* **Examination**
  * **[Blood] Eosinophilsâ†‘, IgEâ†‘, specific IgE to Aspergillus**: Allergic response
  * **[PFT] FEV1%â†“, %VCâ†’orâ†“**: Obstructive or mixed ventilatory disorder
  * **[Chest X-ray, CT] Recurrent transient infiltrates, central bronchiectasis, mucoid plugging**: Characteristic findings
  * **[Skin test] Immediate reaction to Aspergillus antigen**: Type I allergy
* **Management**
  * **Systemic steroids**: Control asthma
  * **Itraconazole**: Antifungal therapy
{: .notice--info}

### Hypersensitivity Pneumonitis / éæ•æ€§è‚ºè‡“ç‚

* **Overview**
  * Diffuse granulomatous interstitial pneumonia caused by repeated inhalation of antigens
  * Commonly improves with environment change but relapses with re-exposure
* **Presentation**
  * **Fever, dry cough, dyspnea on exertion, fine crackles**: Interstitial inflammation
* **Examination**
  * **[Blood] WBCâ†‘, ESRâ†‘, CRPâ†‘, IgEâ†’, eosinophilsâ†’, specific antibody**: Inflammatory response
  * **[PFT] %VCâ†“, FEV1%â†’, PaO2â†“, DLCOâ†“**: Restrictive ventilatory disorder with diffusion impairment
  * **[Chest X-ray, HRCT] Bilateral diffuse ground-glass opacities, nodular shadows**: Interstitial inflammation
  * **[BALF] T-cellsâ†‘, CD4/CD8 ratio varies by type**: Immunological abnormality
  * **[Inhalation test] Positive inhalation challenge test**: Confirm diagnosis
* **Management**
  * **Antigen avoidance**: Primary treatment
  * **Corticosteroids**: For severe or persistent cases
{: .notice--info}

### Sarcoidosis / ã‚µãƒ«ã‚³ã‚¤ãƒ‰ãƒ¼ã‚·ã‚¹

* **Overview**
  * Non-caseating epithelioid granulomatous disease involving multiple organs
  * Common in young adults and middle-aged women
* **Presentation**
  * **Fatigue, fever, joint pain**: Systemic inflammation
  * **Cough, exertional dyspnea**: Pulmonary involvement
  * **Visual disturbance, photophobia, floaters**: Ocular involvement
  * **Erythema nodosum, scar infiltration**: Cutaneous involvement
  * **Facial nerve palsy, diabetes insipidus**: Neurological involvement
  * **Advanced AV block**: Cardiac involvement
  * **Hypercalcemia**: Renal involvement
* **Examination**
  * **[Chest X-ray] Bilateral hilar lymphadenopathy, Ga-67 increased uptake**: Active inflammation
  * **[Blood] Lymphocytesâ†“, Î³-globulinâ†‘, ACEâ†‘, Caâ†‘**: Systemic inflammation
  * **[BALF] Lymphocytesâ†‘, CD4/CD8 ratioâ†‘**: Local inflammation
  * **[Tuberculin test] Negative conversion**: Decreased cellular immunity
  * **[Biopsy] Non-caseating epithelioid granuloma**: Diagnostic finding
* **Management**
  * **Observation**: Often resolve spontaneously
  * **Corticosteroids**: For serious cases
{: .notice--info}

### Microscopic Polyangiitis / é¡•å¾®é¡çš„å¤šç™ºè¡€ç®¡ç‚

* **Overview**
  * Necrotizing vasculitis affecting lungs and kidneys
  * Common in 50-70s
* **Presentation**
  * **Alveolar hemorrhage, interstitial pneumonia**: Pulmonary involvement
  * **Hematuria, proteinuria, casts, rapidly progressive glomerulonephritis**: Renal involvement
  * **Fever, weight loss, fatigue, myalgia, arthralgia**: Systemic inflammation
  * **Purpura, GI bleeding, mononeuritis multiplex**: Multi-organ involvement
* **Examination**
  * **[Blood] CRPâ†‘, WBCâ†‘, MPO-ACNA(+)**: Systemic inflammation
  * **[Blood] BUNâ†‘, Crâ†‘**: Renal damage
* **Management**
  * **Steroids, high-dose steroids + cyclophosphamide pulse**: Induction therapy
  * **Low-dose steroids + immunosuppressants**: Maintenance therapy
{: .notice--info}

### Eosinophilic Granulomatosis with Polyangiitis / å¥½é…¸çƒæ€§å¤šç™ºè¡€ç®¡ç‚æ€§è‚‰èŠ½è…«ç—‡

* **Overview**
  * Granulomatous necrotizing vasculitis with eosinophilic infiltration affecting upper airways and peripheral nerves
  * Common in 40-60s
* **Presentation**
  * **Asthma, eosinophilic sinusitis**: Respiratory tract involvement
  * **Numbness, muscle weakness**: Neurological involvement
  * **Fever, weight loss**: Systemic inflammation
  * **GI bleeding, purpura, arthralgia, myalgia**: Multi-organ involvement
* **Examination**
  * **[Blood] CRPâ†‘, WBCâ†‘ (eosinophilia), plateletsâ†‘, IgEâ†‘, RF(+), MPO-ANCA(+)**: Systemic inflammation
  * **[Chest X-ray] Migratory infiltrates**: Eosinophilic pneumonia
  * **[Biopsy] Granulomatous necrotizing vasculitis with eosinophilic infiltration**: Confirms diagnosis
* **Management**
  * **Moderate-dose steroids**: Control inflammation
  * **High-dose steroids + cyclophosphamide pulse, IVIG, anti-IL-5**: For severe or resistant cases
{: .notice--info}

### Granulomatosis with Polyangiitis / å¤šç™ºè¡€ç®¡ç‚æ€§è‚‰èŠ½è…«ç—‡

* **Overview**
  * Necrotizing granulomatous vasculitis affecting upper airways, lungs, and kidneys
  * Common in 40-50s
* **Presentation**
  * **Otitis media, chronic sinusitis, oral ulcers, exophthalmos**: Upper airway involvement
  * **Hemoptysis, cough, dyspnea**: Pulmonary involvement
  * **Hematuria, proteinuria, edema, hypertension**: Renal involvement
  * **Fever, weight loss**: Systemic inflammation
  * **Purpura, arthritis, episcleritis, mononeuritis multiplex**: Multi-organ involvement
* **Examination**
  * **[Blood] CRPâ†‘, WBCâ†‘, PR3-ANCA or MPO-ANCA(+)**: Systemic inflammation
  * **[Blood] BUNâ†‘, Crâ†‘**: Renal damage
  * **[Chest X-ray/CT] Multiple nodules with cavitation**: Granulomatous inflammation
  * **[Biopsy] Necrotizing granulomas with giant cells**: Confirms diagnosis
* **Management**
  * **High-dose steroids + cyclophosphamide pulse**: Induction therapy
  * **Low-dose steroids + immunosuppressants**: Maintenance therapy
{: .notice--info}

### Goodpasture Syndrome / Goodpastureç—‡å€™ç¾¤

* **Overview**
  * Autoimmune disease caused by anti-GBM antibodies targeting basement membranes in lungs and kidneys
* **Presentation**
  * **Cough, hemoptysis, dyspnea**: Pulmonary involvement
  * **Hematuria, proteinuria, oliguria/anuria**: Renal involvement
* **Examination**
  * **[Sputum] Hemosiderin-laden macrophages**: Alveolar hemorrhage
  * **[Chest X-ray] Diffuse reticulonodular infiltrates**: Alveolar damage
  * **[PFT] Restrictive pattern, DLCOâ†‘**: Alveolar damage
  * **[Urine] Proteinuria, hematuria**: Glomerular damage
  * **[Blood] Anti-GBM antibodies(+)**: Confirms diagnosis
  * **[Biopsy] Linear IgG deposits along basement membranes**: Definitive diagnosis
* **Management**
  * **High-dose steroids + immunosuppressants**: Control inflammation
  * **Plasma exchange**: Remove anti-GBM antibodies
  * **Dialysis**: For severe renal dysfunction
{: .notice--info}

## Interstitial Lung Disease / é–“è³ªæ€§è‚ºç–¾æ‚£

### Idiopathic Pulmonary Fibrosis / ç‰¹ç™ºæ€§è‚ºç·šç¶­ç—‡

* **Overview**
  * Progressive lung fibrosis and honeycomb formation
  * Common in male smokers over 50
* **Presentation**
  * **Dry cough, exertional dyspnea, fine crackles**: Progressive lung fibrosis
  * **Clubbing**: Chronic hypoxemia
* **Examination**
  * **[Blood] LDHâ†‘, ESRâ†‘, CRPâ†‘, WBCâ†‘, IgGâ†‘, KL-6â†‘, SP-Aâ†‘, SP-Dâ†‘**: Inflammation and tissue damage
  * **[PFT] VCâ†“, DLCOâ†“, PaO2â†“, A-aDO2â†‘**: Restrictive ventilatory disorder and diffusion impairment
  * **[HRCT, X-ray] Honeycomb pattern with reticular shadows**: Characteristic fibrotic changes
* **Management**
  * **Pirfenidone, nintedanib**: Anti-fibrotic effect
  * **N-acetylcysteine inhalation**: Antioxidant effect
  * **Steroids, immunosuppressants**: For acute exacerbations
{: .notice--info}

### Pneumoconiosis / ã˜ã‚“è‚º

* **Overview**
  * Fibroproliferative lung disease caused by inhalation of dust particles
  * Common in patients with history of long-term dust inhalation
* **Presentation**
  * **Dry cough, dyspnea, fine crackles**: Progressive lung fibrosis
* **Examination**
  * **[PFT] %VCâ†“, DLCOâ†“**: Restrictive ventilatory disorder and diffusion impairment
  * **[X-ray, CT] Diffuse or merged nodular shadows**: Silicosis
  * **[X-ray, CT] Reticular shadows, pleural plaques**: Asbestosis
  * **[Pathology] Silicotic nodules**: Silicosis
  * **[Pathology] Asbestos bodies**: Asbestosis
* **Management**
  * **Antitussives, expectorants**: Symptomatic treatment
  * **Smoking cessation, respiratory rehabilitation**: Preservation of remaining lung function
{: .notice--info}

### Radiation Pneumonitis / æ”¾å°„ç·šè‚ºç‚

* **Overview**
  * Interstitial lung disease caused by radiation therapy
  * Common complication of chest radiation for lung or breast cancer
* **Presentation**
  * **Dry cough, dyspnea**: Focal lung fibrosis
* **Examination**
  * **[CT] Infiltrates corresponding to radiation field**: Characteristic radiation-induced changes
* **Management**
  * **Supportive care**: For mild cases
  * **Corticosteroids**: For severe cases
{: .notice--info}

### Drug-induced Lung Injury / è–¬å‰¤æ€§è‚ºéšœå®³

* **Overview**
  * Interstitial lung disease caused by drugs
  * Causative drugs include chemotherapy or immunosuppressive drugs
* **Presentation**
  * **Dry cough, dyspnea**: Lung fibrosis
* **Examination**
  * **[CT] Infiltrates, irregular shadows**: Interstitial pneumonitis and fibrosis 
* **Management**
  * **Discontinuation of suspected drug**: Primary treatment
  * **Corticosteroids**: For severe cases
{: .notice--info}

### Pulmonary Langerhans Cell Histiocytosis / è‚ºLangerhansç´°èƒçµ„ç¹”çƒç—‡

* **Overview**
  * Proliferation and infiltration of Langerhans cells in lungs
  * Common 20-40s smokers
* **Presentation**
  * **Asymptomatic**: 10-20% cases
  * **Dry cough, exertional dyspnea, sputum**: Lung infiltration
  * **Chest pain, pneumothorax**: Cyst rupture
* **Examination**
  * **[CT] Multiple nodules and cysts**: Disease progression pattern
  * **[Pathology] Langerhans cell infiltration with eosinophils**: Diagnostic finding
* **Management**
  * **Smoking cessation**: Primary treatment for smokers
  * **Corticosteroids**: For progressive or symptomatic cases
{: .notice--info}

## Obstructive Lung Disease / é–‰å¡æ€§è‚ºç–¾æ‚£

### Bronchial Asthma / æ°—ç®¡æ”¯å–˜æ¯

* **Overview**
  * Chronic airway inflammation causing variable obstructive ventilatory impairment
* **Presentation**
  * **Recurrent dyspnea, wheezing, cough (often nocturnal or early morning)**: Bronchial narrowing
* **Examination**
  * **[Auscultation] Wheezes**: High-pitched sounds from narrowed airways
  * **[Spirometry] Decreased FEV1 and FEV1%, obstructive pattern on flow-volume curve**: Airway obstruction
  * **[Bronchial test] FEV1 increase after Î²2-agonist, FEV1 decrease after bronchoconstrictor**: Airflow limitation reversibility
  * **[Blood, Sputum] Eosinophilsâ†‘, ECPâ†‘**: Eosinophilic inflammation
* **Management**
  * **[Long-term control] Inhaled corticosteroids (ICS), leukotriene receptor antagonists (LTRA), sustained-release theophylline (SRT), long-acting Î²2-agonists (LABA) , long-acting muscarinic antagonists (LAMA)**: Suppress airway inflammation and bronchodilation
  * **[Long-term control] Bronchial thermoplasty**: Reduce bronchial smooth muscle
  * **[Acute exacerbation] Short-acting Î²2-agonists (SABA), systemic steroids, aminophylline, epinephrine, short-acting muscarinic antagonists (SAMA)**: Rapid bronchodilation
  * **[Acute exacerbation] Oxygen therapy, intubation**: For life-threatening cases
{: .notice--info}

### Aspirin-Exacerbated Respiratory Disease / ã‚¢ã‚¹ãƒ”ãƒªãƒ³å–˜æ¯

* **Overview**
  * Asthma triggered by NSAIDs with COX-1 inhibitory action
  * Common in non-atopic refractory asthma
* **Presentation**
  * **Nasal congestion, dyspnea, wheezing, cough after NSAIDs intake**: Bronchial constriction triggered by COX-1 inhibition
  * **Chronic rhinosinusitis with nasal polyps**: Associated upper airway inflammation
* **Examination**
  * **[Spirometry] Decreased FEV1, reversible airway obstruction**: Confirms asthma
* **Management**
  * **Inhaled Î²2 agonists, IV aminophylline, SC epinephrine**: Rapid bronchodilation
  * **Intubation, oxygen, mechanical ventilation**: For life-threatening cases
{: .notice--info}

### Chronic Obstructive Pulmonary Disease / æ…¢æ€§é–‰å¡æ€§è‚ºç–¾æ‚£

* **Overview**
  * Irreversible airflow limitation due to long-term exposure to harmful substances mainly tobacco
  * Common in smokers >40s
* **Presentation**
  * **Chronic cough, sputum production, exertional dyspnea**: Airway inflammation and obstruction
* **Examination**
  * **[Spirometry] Post-bronchodilator FEV1% < 70%**: Irreversible obstructive ventilatory impairment
  * **[Chest X-ray, CT] Hyperinflation, emphysematous changes**: Air trapping and tissue destruction
* **Management**
  * **[Stable] Smoking cessation, vaccinations, pulmonary rehabilitation**: Conservative treatment
  * **[Stable] Bronchodilators (anticholinergics, Î²2-agonists, methylxanthines), inhaled steroids**: Reduce airway obstruction
  * **[Exacerbation] Antibiotics, bronchodilators, corticosteroids**: Treat infection and inflammation
  * **[Exacerbation] Oxygen therapy, ventilation support**: Manage respiratory failure
{: .notice--info}

### Diffuse Panbronchiolitis / ã³ã¾ã‚“æ€§æ±ç´°æ°—ç®¡æ”¯ç‚

* **Overview**
  * Chronic inflammation of respiratory bronchioles in both lungs
  * Common in patients with chronic sinusitis, associated with HLA-B54
* **Presentation**
  * **Chronic purulent sputum, cough, exertional dyspnea**: Airway inflammation and obstruction
  * **Coarse crackles**: Sputum retention in airways
* **Examination**
  * **[Chest X-ray] Diffuse nodular shadows, hyperinflation**: Bronchiolar inflammation and remodeling
  * **[Chest CT] Centrilobular nodules, bronchiectasis**: Bronchiolar inflammation and remodeling
  * **[Spirometry] FEV1% < 70%**: Obstructive ventilatory impairment
* **Management**
  * **Low-dose long-term erythromycin**: Immunomodulatory effects
{: .notice--info}

## Lung Tumor / è‚ºè…«ç˜

### Pulmonary Hamartoma / è‚ºéèª¤è…«

* **Overview**
  * Benign tumor with abnormal proliferation of normal lung tissue components
* **Presentation**
  * **Asymptomatic**: Incidental finding
  * **Obstructive pneumonia**: Due to bronchial obstruction
* **Examination**
  * **[CT] Well-defined shadow, popcorn-like calcification**: Characteristic radiological finding
  * **[Biopsy] Mixed mesenchymal and epithelial components**: Hamartoma nature
* **Management**
  * **Observation**: For asymptomatic cases
  * **Surgical resection**: Rule out malignancy
{: .notice--info}

### Squamous Cell Carcinoma / æ‰å¹³ä¸Šçš®ç™Œ

* **Overview**
  * Type of non-small cell lung cancer showing keratinization and intercellular bridges
  * Common in males over 50 with smoking history
* **Presentation**
  * **Cough, sputum, hemoptysis**: Due to bronchial invasion
  * **Clubbing**: Paraneoplastic manifestation
  * **Hypercalcemia**: Due to PTHrP production
* **Examination**
  * **[Chest X-ray, CT] Mass shadow, atelectasis**: Due to airway obstruction
  * **[Sputum cytology] Orange-stained cells on Papanicolaou stain**: Shows keratinized cancer cells
  * **[Blood] Elevated SCC antigen, CYFRA, CEA**: Tumor markers
  * **[Biopsy] Keratinization, intercellular bridges**: Diagnostic features
* **Management**
  * **Surgery + adjuvant chemotherapy**: Stage IA-IIIA
  * **Radiation therapy alone**: Stage I-III (inoperable)
  * **Chemoradiotherapy**: Stage IIIB-IIIC
  * **Systemic therapy**: Stage III (inoperable), Stage IV (metastatic)
{: .notice--info}

### Adenocarcinoma / è…ºç™Œ

* **Overview**
  * Type of non-small cell lung cancer showing glandular differentiation
  * Common in both genders including non-smokers
* **Presentation**
  * **Asymptomatic**: Peripheral location of tumor
  * **Chest pain, cough, sputum**: Due to tumor growth and invasion
* **Examination**
  * **[Chest X-ray, CT] Spicula, vessel convergence, pleural indentation**: Due to fibrosis and contraction of tumor
  * **[Sputum cytology] Clusters of abnormal cells**: Shows adenocarcinoma cells
  * **[Blood] Elevated CEA, SLX**: Tumor markers
  * **[Biopsy] Glandular differentiation, mucin production**: Diagnostic features
* **Management**
  * **Surgery + adjuvant chemotherapy**: Stage IA-IIIA
  * **Radiation therapy alone**: Stage I-III (inoperable)
  * **Chemoradiotherapy**: Stage IIIB-IIIC
  * **Systemic therapy**: Stage III (inoperable), Stage IV (metastatic)
{: .notice--info}

### Small Cell Lung Cancer / å°ç´°èƒè‚ºç™Œ

* **Overview**
  * Malignant neuroendocrine tumor with small cancer cells, rapid progression and poor prognosis
  * Common in male with smoking history
* **Presentation**
  * **Cough, sputum, hemoptysis**: Due to bronchial invasion
  * **SIADH, Cushing syndrome, Lambert-Eaton syndrome**: Paraneoplastic syndromes due to hormone production
* **Examination**
  * **[Chest X-ray, CT] Hilar mass, lymphadenopathy**: Central location with lymph node metastasis
  * **[Sputum cytology] Small cells with scant cytoplasm**: Characteristic appearance
  * **[Blood] Elevated NSE, Pro-GRP**: Tumor markers
  * **[Biopsy] Small undifferentiated cells, neuroendocrine markers**: Diagnostic features
* **Management**
  * **Chemoradiotherapy**: Limited Disease
  * **Systemic therapy**: Extensive Disease
  * **Prophylactic cranial irradiation**: Prevent brain metastasis
{: .notice--info}

### Metastatic Lung Tumor / è»¢ç§»æ€§è‚ºè…«ç˜

* **Overview**
  * Malignant tumors from other organs metastasizing to lungs
* **Presentation**
  * **Symptoms of primary tumor**: Varies by origin
* **Examination**
  * **[Chest X-ray, CT] Single or multiple nodules**: Various radiological patterns
  * **[Biopsy] Histology matching primary tumor**: Confirms diagnosis and origin
* **Management**
  * **Systemic therapy**: Based on primary tumor sensitivity
  * **Radiation therapy**: For symptom palliation
  * **Surgery**: Selected cases with controlled primary and resectable metastases
{: .notice--info}

## Circulatory Disorder / å¾ªç’°éšœå®³

### Idiopathic Pulmonary Arterial Hypertension / ç‰¹ç™ºæ€§è‚ºå‹•è„ˆæ€§è‚ºé«˜è¡€åœ§ç—‡

* **Overview**
  * Elevated pulmonary arterial pressure due to narrowing of small pulmonary arteries without identifiable cause
  * Common in women aged 20-40s
* **Presentation**
  * **Exertional dyspnea, fatigue, chest pain, cyanosis, syncope**: Reduced pulmonary blood flow and cardiac output
  * **Jugular vein distention, leg edema, hepatomegaly**: Right heart failure
* **Examination**
  * **[Physical] Accentuated P2, Graham Steell murmur**: Pulmonary hypertension
  * **[ECG] Right axis deviation, right ventricular hypertrophy, P pulmonale**: Right heart strain
  * **[Chest X-ray, CT] Enlarged pulmonary trunk, right heart enlargement**: Pulmonary hypertension
  * **[Echocardiogram] Right heart dilation, septal flattening**: Right ventricular pressure overload
  * **[Right heart catheterization] PAP â‰¥25mmHg, PAWP â‰¤15mmHg**: Confirms diagnosis
* **Management**
  * **Prostacyclin derivatives, endothelin antagonists, PDE5 inhibitors, continuous IV prostacyclin**:  Relax pulmonary arteries
  * **Anticoagulation**: Prevent thrombosis
  * **Oxygen therapy, diuretics**: For right heart failure
  * **Lung transplantation**: For refractory cases
{: .notice--info}

### Cardiogenic Pulmonary Edema / å¿ƒåŸæ€§è‚ºæ°´è…«

* **Overview**
  * Pulmonary edema due to left heart failure
  * Common causes: Myocardial infarction, valvular disease, cardiomyopathy, hypertensive heart disease
* **Presentation**
  * **Exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, cyanosis, pink frothy sputum**: Pulmonary congestion due to left heart failure
* **Examination**
  * **[Physical] Bilateral coarse crackles**: Fluid in alveoli
  * **[Blood gas] PaO2â†“, PaCO2â†“**: Type I respiratory failure
  * **[Blood] BNPâ†‘**: Heart failure
  * **[Chest X-ray] Enlarged cardiac silhouette, butterfly shadow, Kerley lines, vanishing tumor**: Pulmonary edema
  * **[Echocardiogram] Left ventricular enlargement, reduced wall motion**: Left heart failure
* **Management**
  * **Oxygen therapy**: Treat hypoxemia
  * **Diuretics, inotropes, vasodilators, morphine**: Treat heart failure
{: .notice--info}

### Acute Respiratory Distress Syndrome / æ€¥æ€§å‘¼å¸çª®è¿«ç—‡å€™ç¾¤

* **Overview**
  * Acute onset of increased permeability pulmonary edema with severe hypoxemia
  * Common causes: Sepsis, trauma, severe burns, pneumonia, aspiration
* **Presentation**
  * **Rapidly progressive dyspnea, tachypnea, cyanosis**: Acute respiratory failure
* **Examination**
  * **[Physical] Bilateral coarse crackles**: Pulmonary edema
  * **[Blood gas] PaO2â†“, PaCO2â†“, A-aDO2â†‘**: Type I respiratory failure
  * **[Chest X-ray] Bilateral infiltrates**: Pulmonary edema
  * **[Echocardiogram] Normal cardiac function**: Rules out cardiogenic pulmonary edema
* **Management**
  * **Oxygen therapy, mechanical ventilation**: Treat hypoxemia
  * **Antibiotics, diuretics**: Treat sepsis/pneumonia, prevent fluid overload
{: .notice--info}

### Acute Pulmonary Thromboembolism / æ€¥æ€§è‚ºè¡€æ “å¡æ “ç—‡

* **Overview**
  * Acute blockage of pulmonary arteries by blood clots from deep vein thrombosis
  * Common after surgery, prolonged bed rest, long flights
* **Presentation**
  * **Sudden dyspnea, tachypnea, chest pain**: Acute pulmonary arterial obstruction
* **Examination**
  * **[Blood gas] PaO2â†“, PaCO2â†“, A-aDO2â†‘**: Type I respiratory failure
  * **[Blood] D-dimerâ†‘, FDPâ†‘**: Evidence of thrombosis
  * **[Chest X-ray] Enlarged cardiac silhouette, dilated pulmonary arteries**: Pulmonary hypertension
  * **[Echocardiogram] Right ventricular dilation and dysfunction**: Right ventricular pressure overload
  * **[Leg ultrasound] Deep vein thrombosis**: Source of embolism
  * **[Contrast CT] Filling defects in pulmonary arteries**: Confirms diagnosis
* **Management**
  * **Oxygen therapy**: Treat hypoxemia
  * **Heparin followed by warfarin/DOAC**: Remove and prevent thrombosis
  * **Thrombolysis, catheter thrombectomy**: For severe or refractory cases
{: .notice--info}

### Chronic Thromboembolic Pulmonary Hypertension / æ…¢æ€§è¡€æ “å¡æ “æ€§è‚ºé«˜è¡€åœ§ç—‡

* **Overview**
  * Pulmonary hypertension caused by organized thrombi in pulmonary arteries
* **Presentation**
  * **Exertional dyspnea**: Reduced pulmonary blood flow
  * **Leg edema**: Right heart failure
* **Examination**
  * **[Right heart catheterization] Elevated pulmonary arterial pressure**: Confirms pulmonary hypertension
  * **[V/Q scan] Mismatched perfusion defects**: Characteristic finding
* **Management**
  * **Pulmonary endarterectomy**: Remove thrombi
  * **Balloon pulmonary angioplasty, pulmonary vasodilators**: Relax pulmonary arteries
  * **Lung transplantation**: For severe cases
{: .notice--info}

### Pulmonary Arteriovenous Fistula / è‚ºå‹•é™è„ˆç˜»

* **Overview**
  * Vascular malformation with direct shunt between pulmonary artery and vein
* **Presentation**
  * **Exertional dyspnea, cyanosis, clubbing**: Reduced gas exchange efficiency
  * **Polycythemia (RBCâ†‘, Hbâ†‘, Htâ†‘)**: Compensatory response to chronic hypoxemia
* **Examination**
  * **[Blood gas] PaO2â†“**: Type I respiratory failure
  * **[Chest X-ray] Well-defined nodular shadow**: Vascular malformation
  * **[Contrast CT] Homogeneously enhanced nodule**: Diagnostic finding
* **Management**
  * **Transcatheter embolization**: Treat fistula
  * **Surgical resection**: Alternative option
{: .notice--info}

## Functional Disorder / æ©Ÿèƒ½éšœå®³

### Obstructive Sleep Apnea Syndrome / é–‰å¡æ€§ç¡çœ æ™‚ç„¡å‘¼å¸ç—‡å€™ç¾¤

* **Overview**
  * Recurrent upper airway obstruction during sleep leading to apnea or hypopnea
  * Common in middle-aged obese men and postmenopausal women
* **Presentation**
  * **Snoring, breathing pauses during sleep**: Upper airway obstruction
  * **Daytime sleepiness, reduced concentration**: Sleep fragmentation
* **Examination**
  * **[Polysomnography] Obstructive apnea, AHI â‰¥5**: Confirms diagnosis
* **Management**
  * **Weight reduction**: Lifestyle modification
  * **Nasal CPAP**: Maintains airway patency
{: .notice--info}

### Hyperventilation Syndrome / éæ›æ°—ç—‡å€™ç¾¤

* **Overview**
  * Episodic hyperventilation triggered by psychological factors
  * Common in young women
* **Presentation**
  * **Tachypnea, dyspnea, palpitations, chest pain**: Triggered by stress or anxiety
  * **Dizziness, altered consciousness, numbness, spasm**: Respiratory alkalosis and hypocalcemia
* **Examination**
  * **[Blood gas] PaCO2â†“, pHâ†‘**: Respiratory alkalosis
* **Management**
  * **Calm patient, guide slow breathing**: Normalize respiratory rate
{: .notice--info}

### CO2 Narcosis / CO2ãƒŠãƒ«ã‚³ãƒ¼ã‚·ã‚¹

* **Overview**
  * Severe accumulation of CO2 leading to central nervous system dysfunction
* **Presentation**
  * **Drowsiness, confusion, coma**: High CO2 levels affecting brain function
  * **Decreased respiratory rate**: Respiratory center depression
* **Examination**
  * **[Blood gas] PaCO2â†‘, HCO3-â†‘**: Severe CO2 retention
* **Management**
  * **Reduce O2 concentration**: High-concentration O2 suppress respiration
  * **NPPV, intubation**: For persistent hypoxemia
{: .notice--info}

## Pleural Disorder / èƒ¸è†œç–¾æ‚£

### Pleuritis / èƒ¸è†œç‚

* **Overview**
  * Inflammation of pleura due to malignancy or infection
* **Presentation**
  * **Chest pain (worsening with deep breathing or coughing), dyspnea**: Inflammation of pleural membrane
  * **Cough, fever**: Underlying infection or inflammation
* **Examination**
  * **[Physical] Dullness to percussion, pleural friction rub, decreased breath sounds, egophony**: Pleural effusion
  * **[Chest X-ray] Blunting of costophrenic angle, band-like opacity**: Pleural effusion
  * **[Pleural fluid] Exudative effusion**: Identify malignant, tuberculous, or parapneumonic causes
* **Management**
  * **Treat underlying cause**: Primary management
  * **Thoracentesis, chest tube drainage**: Remove pleural fluid
{: .notice--info}

### Empyema / è†¿èƒ¸

* **Overview**
  * Collection of purulent fluid in pleural space due to infection, classified into acute or chronic forms
* **Presentation**
  * **Chest pain, dyspnea, fever**: Infection and inflammation of pleural space
* **Examination**
  * **[Chest X-ray] Pleural opacity, possible air-fluid level**: Purulent effusion
  * **[Pleural fluid] Purulent fluid, bacterial culture positive**: Confirms diagnosis
* **Management**
  * **[Acute] Antibiotics, chest tube drainage**: Treat infection and remove pus
  * **[Chronic] Decortication**: Remove thickened pleura
{: .notice--info}

### Spontaneous Pneumothorax / è‡ªç„¶æ°—èƒ¸

* **Overview**
  * Air in pleural space without obvious cause
  * Common in males (20s, tall, thin) and patients with underlying lung diseases (COPD, interstitial pneumonia, tuberculosis)
* **Presentation**
  * **Sudden onset dyspnea, chest pain**: Lung collapse due to air entrance
* **Examination**
  * **[Physical] Hyperresonance to percussion, decreased breath sounds**: Air in pleural space
  * **[Chest X-ray] Transparency without lung markings, collapsed lung**: Pneumothorax with lung collapse
* **Management**
  * **Observation, needle aspiration**: For small pneumothorax
  * **Chest tube drainage**: For larger pneumothorax
{: .notice--info}

### Tension Pneumothorax / ç·Šå¼µæ€§æ°—èƒ¸

* **Overview**
  * Air continuously enters pleural space, medical emergency due to rapid respiratory and circulatory deterioration
  * Occurs in spontaneous pneumothorax, chest trauma, or mechanical ventilation
* **Presentation**
  * **Chest pain, dry cough, tachypnea, dyspnea, cyanosis**: Ventilation impairment
  * **Sudden hypotension, tachycardia, jugular vein distention**: Circulatory shock due to mediastinal compression
* **Examination**
  * **[Physical] Hyperresonance to percussion, decreased breath sounds**: Air in pleural space
  * **[Chest X-ray] Severe lung collapse, mediastinal shift to opposite side, depressed hemidiaphragm**: High pressure pneumothorax
* **Management**
  * **Immediate needle decompression, chest tube drainage**: Emergent treatment
{: .notice--info}

### Pleural Mesothelioma / èƒ¸è†œä¸­çš®è…«

* **Overview**
  * Malignant tumor arising from pleural mesothelial cells
  * Strong association with asbestos exposure, 20-40 years latency period
* **Presentation**
  * **Chest pain, exertional dyspnea**: Tumor invasion and pleural effusion
* **Examination**
  * **[Chest X-ray, CT] Pleural masses, irregular pleural thickening, pleural effusion**: Tumor invasion and pleural effusion
  * **[Pleural fluid] Elevated hyaluronic acid**: Characteristic finding
  * **[Biopsy] Pleural malignant cells**: Confirm diagnosis
* **Management**
  * **Extrapleural pneumonectomy, pleurectomy**: For resectable cases
  * **Chemotherapy, radiation therapy**: Combined or palliative treatment
{: .notice--info}

## Mediastinal Disorder / ç¸¦éš”ç–¾æ‚£

### Mediastinitis / ç¸¦éš”ç‚

* **Overview**
  * Inflammation of mediastinum due to descending infection, trauma, or esophageal perforation
* **Presentation**
  * **Fever, chest pain, dyspnea, neck swelling**: Severe inflammation in mediastinum
* **Examination**
  * **[Blood] WBCâ†‘, CRPâ†‘**: Active inflammation
  * **[Chest X-ray] Widened mediastinum**: Inflammatory changes and edema
* **Management**
  * **Antibiotics, drainage**: Control infection
{: .notice--info}

### Thymoma / èƒ¸è…ºè…«

* **Overview**
  * Mediastinal tumor arising from thymic epithelial cells, commonly in anterior mediastinum
 * Common in adults over 40s
* **Presentation**
  * **Asymptomatic, chest pressure, dyspnea, cough**: Mass effect in mediastinum
  * **Muscle weakness, ptosis, diplopia**: Associated myasthenia gravis
* **Examination**
  * **[Chest X-ray, CT, MRI] Mass in anterior mediastinum**: Evaluate tumor extent and characteristics
  * **[Biopsy] Proliferation of epithelial cells and lymphocytes**: Confirm diagnosis
* **Management**
  * **Thymectomy, radiation therapy**: Complete resection
  * **Chemotherapy**: For metastatic cases
{: .notice--info}

### Germ Cell Tumor / èƒšç´°èƒæ€§è…«ç˜

* **Overview**
  * Mediastinal tumor derived from primitive germ cells, commonly in anterior mediastinum
  * Common in young adults
* **Presentation**
  * **Asymptomatic, chest pain, dyspnea**: Mass effect in mediastinum
* **Examination**
  * **[Chest X-ray, CT, MRI] Mass in anterior mediastinum**: Evaluate tumor extent and characteristics
  * **[Biopsy] Teratoma, seminoma, nonseminoma**: Confirm diagnosis
* **Management**
  * **[Mature teratoma] Surgery**: Complete resection
  * **[Seminoma, non-seminoma] Chemotherapy, combined with other therapies**: Multimodal therapy
{: .notice--info}

### Neurogenic Tumor / ç¥çµŒåŸæ€§è…«ç˜

* **Overview**
  * Mediastinal tumor derived from peripheral nerve tissues, commonly in posterior mediastinum
* **Presentation**
  * **Asymptomatic, Horner's syndrome**: Tumor compressing adjacent nerves
* **Examination**
  * **[Chest X-ray, CT, MRI] Mass in posterior mediastinum**: Evaluate tumor extent and characteristics
  * **[Pathology] Diagnosis after resection**: Difficult location for biopsy
* **Management**
  * **Surgical resection**: Complete resection
{: .notice--info}

## Miscellaneous Respiratory Disorder / ãã®ä»–ã®å‘¼å¸å™¨ç–¾æ‚£

### Bronchiectasis / æ°—ç®¡æ”¯æ‹¡å¼µç—‡

* **Overview**
  * Irreversible dilation of peripheral airways due to recurrent infection or inflammation
* **Presentation**
  * **Chronic cough, substantial sputum, hemoptysis, recurrent fever**: Chronic airway infection
* **Examination**
  * **[Physical] Coarse crackles**: Airway secretions
  * **[Chest X-ray] Tram lines**: Thickened bronchial walls
  * **[Chest CT] Dilated bronchi**: Confirms diagnosis
* **Management**
  * **Postural drainage, respiratory rehabilitation, expectorants**: Remove airway secretions
  * **Long-term low-dose macrolide**: Anti-inflammatory effect
  * **Hemostatic drugs, bronchoscopic hemostasis, bronchial artery embolization**: Treat hemoptysis
  * **Antibiotics**: Treat secondary bacterial infection during acute exacerbation
{: .notice--info}

### Pulmonary Sequestration / è‚ºåˆ†ç”»ç—‡

* **Overview**
  * Abnormal lung tissue receiving blood supply directly from aorta without normal airway connection, classified as intralobar or extralobar
  * Common in young adults (intralobar) and infants (extralobar)
* **Presentation**
  * **[Intralobar] Cough, sputum, fever**: Recurrent infection
  * **[Extralobar] Dyspnea, cyanosis**: Developmental abnormality
* **Examination**
  * **[Chest X-ray] Mass or cystic shadow in left lower lung**: Abnormal lung tissue
  * **[CTA, MRA] Aberrant artery from descending aorta**: Diagnostic finding
* **Management**
  * **Surgical resection**: Prevent infection
{: .notice--info}

### Pulmonary Cyst Disease / è‚ºå›Šèƒç—‡

* **Overview**
  * Formation of sac-like structures in lungs, including bullae/blebs (air-filled) and bronchogenic cysts (mucus-filled)
* **Presentation**
  * **[Bullae/Blebs] Asymptomatic, occasionally pneumothorax**: Rupture of subpleural bullae/blebs
  * **[Bronchogenic cysts] Asymptomatic, occasionally dyspnea**: Airway compression
* **Examination**
  * **[Bullae/Blebs, CT] Air-filled spaces in subpleural region**: Confirm bullae/blebs
  * **[Bronchogenic cysts, CT] Mucus-filled cyst in middle mediastinum**: Confirm bronchogenic cysts
* **Management**
  * **[Bullae/Blebs] Surgical resection**: For recurrent pneumothorax
  * **[Bronchogenic cysts] Surgical resection**: For symptomatic cases
{: .notice--info}

### Autoimmune Pulmonary Alveolar Proteinosis / è‡ªå·±å…ç–«æ€§è‚ºèƒè›‹ç™½ç—‡

* **Overview**
  * Abnormal accumulation of surfactant-derived lipoprotein in alveoli and terminal bronchioles, mostly associated with anti-GM-CSF antibodies
  * Common in 30-50s smoking males
* **Presentation**
  * **Cough, exertional dyspnea**: Accumulation of surfactant material
* **Examination**
  * **[Blood] LDHâ†‘, KL-6â†‘, CEAâ†‘, SP-Aâ†‘, SP-Dâ†‘**: Markers of alveolar damage and surfactant accumulation
  * **[Chest X-ray] Bilateral ground-glass opacities**: Surfactant accumulation
  * **[CT] Crazy-paving pattern**: Combined ground-glass and septal thickening
  * **[BAL] Milky-white lavage fluid**: Surfactant accumulation
  * **[Blood] Anti-GM-CSF antibody positive**: Confirms autoimmune nature
* **Management**
  * **Whole lung or segmental lavage**: Remove accumulated material
{: .notice--info}

### Lymphangioleiomyomatosis / ãƒªãƒ³ãƒ‘è„ˆç®¡ç­‹è…«ç—‡

* **Overview**
  * Proliferation of smooth muscle-like cells (LAM cells) in lungs, kidneys, and lymphatics, associated with tuberous sclerosis
  * Common in 20-40s women
* **Presentation**
  * **Exertional dyspnea, cough, bloody sputum**: Lung destruction 
  * **Recurrent pneumothorax**: Rupture of lung cysts
* **Examination**
  * **[Blood] VEGF-Dâ†‘**: Marker for LAM
  * **[PFT] Diffusion impairment, obstructive pattern**: Airway obstruction and parenchymal destruction
  * **[Chest X-ray] Reticular shadows, hyperinflation**: Formation of multiple cysts
  * **[CT] Multiple thin-walled cysts**: Characteristic finding
  * **[Biopsy] LAM cell proliferation**: Confirms diagnosis
* **Management**
  * **Sirolimus (mTor inhibitors)**: Inhibit LAM cells proliferation
  * **Bronchodilators**: For obstructive symptoms
  * **Surgery**: For recurrent pneumothorax
  * **Oxygen therapy, lung transplantation**: For respiratory failure
{: .notice--info}

### Airway Foreign Bodies / æ°—é“ç•°ç‰©

* **Overview**
  * Foreign objects obstructing or narrowing airways
  * Common in children and elderly with history of aspiration 
* **Presentation**
  * **Cough, wheezing, dyspnea, cyanosis**: Airway obstruction
* **Examination**
  * **[Chest X-ray] Visible foreign body, Holzknecht sign**: Identify foreign body
* **Management**
  * **Heimlich maneuver**: Immediate intervention for complete obstruction
  * **Bronchoscopic removal**: For accessible foreign bodies
{: .notice--info}

### Flail Chest / ãƒ•ãƒ¬ã‚¤ãƒ«ãƒã‚§ã‚¹ãƒˆ

* **Overview**
  * Multiple rib fractures cause chest wall segment to lose continuity
  * Commonly due to severe chest trauma
* **Presentation**
  * **Paradoxical chest wall movement**: Affected segment moves inward during inspiration, outward during expiration
* **Examination**
  * **[Physical] Chest wall instability on palpation**: Loss of normal thoracic cage rigidity
  * **[Imaging] Multiple rib fractures**: Confirms diagnosis
* **Management**
  * **Chest tube drainage**: For pneumothorax or hemothorax
  * **Positive pressure ventilation**: For respiratory failure
  * **Analgesics**: Pain control
  * **Surgical fixation**: For refractory cases
{: .notice--info}


<!-- ### Inferior Respiratory Tract / ä¸‹æ°—é“

* **Bronchial tree**
  * **Structure**: Trachea, main bronchus, lobar bronchus, segmental bronchus, terminal bronchus (conduction) \| (respiratory) respiratory bronchus, alveolar duct, alveolus
  * **Trachea and broncus**: Smooth muscle, cartilage, gland, globet cell, pseudostratified columnar
  * **Bronchiole**: Smooth muscle, simple columnar to cuboid, Clara cell (surfactant)
  * **Alveoli**: Simple squamous, type I pneumocyte (septum), type II pneumocyte (surfactant), alveolar macrophate
* **Lung**
  * **Structure**: 2 left lobe (9 segment), 3 right lobe (10 segment), horizontal fissure, oblique fissure
  * **Root**: Main bronchus, pulmonary artery and vein, bronchiolar artery and vein, phrenic nerve (anterior), vagus nerve (posterior)
  * **Hilum**: Left (heart, aortic arch, thoracic aorta, aorta-bronchus-vein), right (vena cava, azygos vein, bronchus-aorta-vein)
  * **Artery**: Pulmonary artery (exchange), bronchial artery (nutrition)
  * **Nerve**: Sympathetic nerve (bronchodilation, vasoconstriction), Parasympathetic nerve (bronchoconstriction, vasodilation, sensation)
  * **Pleura**: Visceral pleura (autonomic nerve), parietal pleura (intercostal nerve, phrenic nerve), pleural cavity
  * **Inferior**: Lung (R6-R8-R10), pleura (R8-R10-R12)
{: .notice--info} -->

<!-- ## Infectious Disease / æ„ŸæŸ“æ€§ç–¾æ‚£

### Acute Bronchiolitis / æ€¥æ€§ç´°æ°—ç®¡æ”¯ç‚
### Community-Acquired Pneumonia / å¸‚ä¸­è‚ºç‚
### Hospital-Acquired Pneumonia / é™¢å†…è‚ºç‚
### Aspiration Pneumonia / èª¤åš¥æ€§è‚ºç‚
### Streptococcus Penumoniae Pneumonia / è‚ºç‚çƒèŒè‚ºç‚
### Haemophilus Influenzae Pneumonia / ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶èŒè‚ºç‚
### Klebsiella Pneumoniae Pneumonia / ã‚¯ãƒ¬ãƒ–ã‚·ã‚¨ãƒ©è‚ºç‚
### Staphylococcus Aureus Pneumonia / é»„è‰²ãƒ–ãƒ‰ã‚¦çƒèŒè‚ºç‚
### Moraxella Catarrhalis Pneumonia / ãƒ¢ãƒ©ã‚¯ã‚»ãƒ©è‚ºç‚
### Pseudomonas Aeruginosa Pneumonia / ç·‘è†¿èŒè‚ºç‚
### Legionella Pneumophila Pneumonia / ãƒ¬ã‚¸ã‚ªãƒãƒ©è‚ºç‚
### Mycoplasma Pneumoniae Pneumonia / ãƒã‚¤ã‚³ãƒ—ãƒ©ã‚ºãƒè‚ºç‚
### Chlamydophila Pneumoniae Pneumonia / ã‚¯ãƒ©ãƒŸã‚¸ã‚¢è‚ºç‚
### Psittacosis / ã‚ªã‚¦ãƒ ç—…
### Viral Pneumonia / ã‚¦ã‚¤ãƒ«ã‚¹æ€§è‚ºç‚
### Lung Abscess / è‚ºè†¿ç˜
### Pulmonary Tuberculosis / è‚ºçµæ ¸
### Miliary Tuberculosis / ç²Ÿç²’çµæ ¸
### Nontuberculous Mycobacteriosis / éçµæ ¸æ€§æŠ—é…¸èŒç—‡
### Simple Pulmonary Aspergilloma / å˜ç´”æ€§è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ­ãƒ¼ãƒ
### Chronic Progressive Pulmonary Aspergillosis / æ…¢æ€§é€²è¡Œæ€§è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ«ã‚¹ç—‡
### Invasive Pulmonary Aspergillosis / ä¾µè¥²æ€§è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ«ã‚¹ç—‡
### Pulmonary Cryptococcosis / è‚ºã‚¯ãƒªãƒ—ãƒˆã‚³ãƒƒã‚«ã‚¹ç—‡

## Obstructive Lung Disease / é–‰å¡æ€§è‚ºç–¾æ‚£

### Chronic Obstructive Pulmonary Disease / æ…¢æ€§é–‰å¡æ€§è‚ºç–¾æ‚£
### Diffuse Panbronchiolitis / ã³ã¾ã‚“æ€§æ±ç´°æ°—ç®¡æ”¯ç‚
### Lymphangioleiomyomatosis / ãƒªãƒ³ãƒ‘è„ˆç®¡ç­‹è…«ç—‡

## Interstitial Lung Disease / é–“è³ªæ€§è‚ºç–¾æ‚£

### Idiopathic Pulmonary Fibrosis / ç‰¹ç™ºæ€§è‚ºç·šç¶­ç—‡
### Non-Specific Interstitial Pneumonia / éç‰¹ç•°æ€§é–“è³ªæ€§è‚ºç‚
### Cryptogenic Organizing Pneumonia / ç‰¹ç™ºæ€§å™¨è³ªåŒ–è‚ºç‚
### Asbestosis / çŸ³ç¶¿è‚º
### Silicosis / çªè‚º
### Radiation Pneumonitis / æ”¾å°„ç·šè‚ºç‚
### Drug-Induced Pneumonia / è–¬å‰¤æ€§è‚ºç‚

## Immune and Allergic Lung Disease / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§è‚ºç–¾æ‚£

### Bronchial Asthma / æ°—ç®¡æ”¯å–˜æ¯
### Aspirin-Induced Asthma / ã‚¢ã‚¹ãƒ”ãƒªãƒ³å–˜æ¯
### Acute Eosinophilic Pneumonia / æ€¥æ€§å¥½é…¸çƒæ€§è‚ºç‚
### Chronic Eosinophilic Pneumonia / æ…¢æ€§å¥½é…¸çƒæ€§è‚ºç‚
### Allergic Bronchopulmonary Aspergillosis / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§æ°—ç®¡æ”¯è‚ºã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ«ã‚¹ç—‡
### Hypersensitivity Pneumonitis / éæ•æ€§è‚ºç‚

## Lung and Bronchus Malformation / è‚ºãƒ»æ°—ç®¡æ”¯ã®å½¢æ…‹ç•°å¸¸
### Bronchiectasis / æ°—ç®¡æ”¯æ‹¡å¼µç—‡
### Atelectasis / ç„¡æ°—è‚º
### Pulmonary Sequestration / è‚ºåˆ†ç”»ç—‡
### Pulmonary Cystic Disease / è‚ºåš¢èƒç—‡
### Pulmonary Alveolar Proteinosis / è‚ºèƒè›‹ç™½ç—‡

## Lung Tumor / è‚ºè…«ç˜

### Pulmonary Hamartoma / è‚ºéèª¤è…«
### Squamous Cell Carcinoma / æ‰å¹³ä¸Šçš®ç™Œ
### Adenocarcinoma / è…ºç™Œ
### Small Cell Lung Carcinoma / å°ç´°èƒè‚ºç™Œ
### Metastatic Lung Tumor / è»¢ç§»æ€§è‚ºè…«ç˜

## Pulmonary Circulation Disorder / è‚ºå¾ªç’°éšœå®³

### Pulmonary Thromboembolism / è‚ºè¡€æ “å¡æ “ç—‡
### Idiopathic Pulmonary Arterial Hypertension / ç‰¹ç™ºæ€§è‚ºå‹•è„ˆæ€§è‚ºé«˜è¡€åœ§ç—‡
### Cor Pulmonale / è‚ºæ€§å¿ƒ
### Pulmonary Arteriovenous Fistula / è‚ºå‹•é™è„ˆç˜»
### Pulmonary Edema / è‚ºæ°´è…«
### Acute Respiratory Distress Syndrome / æ€¥æ€§å‘¼å¸çª®è¿«ç—‡å€™ç¾¤

## Functional Respiratory Disease / æ©Ÿèƒ½çš„å‘¼å¸éšœå®³

### Hyperventilation Syndrome / éæ›æ°—ç—‡å€™ç¾¤
### CO2 Narcosis / CO2ãƒŠãƒ«ã‚³ãƒ¼ã‚·ã‚¹
### Sleep Apnea Syndrome / ç¡çœ æ™‚ç„¡å‘¼å¸ç—‡å€™ç¾¤

## Pleural Disease / èƒ¸è†œç–¾æ‚£

### Pneumothorax / æ°—èƒ¸
### Pleuritis / èƒ¸è†œç‚
### Pyothorax / è†¿èƒ¸
### Chylothorax / ä¹³ã³èƒ¸
### Pleural Mesothelioma / èƒ¸è†œä¸­çš®è…«

## Mediastinal Disease / ç¸¦éš”ç–¾æ‚£

### Acute Mediastinitis / æ€¥æ€§ç¸¦éš”ç‚
### Mediastinal Emphysema / ç¸¦éš”æ°—è…«
### Thymoma / èƒ¸è…ºè…«
### Neurogenic Tumor / ç¥çµŒåŸæ€§è…«ç˜
### Germ Cell Tumor / èƒšç´°èƒè…«ç˜ -->

# Gastroenterology / æ¶ˆåŒ–å™¨ç§‘

## Esophagus Disorder / é£Ÿé“ç–¾æ‚£

### Esophageal Achalasia / é£Ÿé“ã‚¢ã‚«ãƒ©ã‚·ã‚¢

* **Overview**
  * Functional disease due to degeneration of Auerbach's plexus in lower esophageal muscle layer
  * Common in 20-60s adults
* **Presentation**
  * **Dysphagia, chest pain, food regurgitation**: Impaired esophageal peristalsis and lower esophageal sphincter relaxation
* **Examination**
  * **[Barium swallow] Beak-like narrowing of lower esophagus, dilated proximal esophagus**: Impaired LES relaxation and esophageal motility
  * **[Endoscopy] Fluid/food retention, dilated esophagus, wrap-around at cardia**: Impaired esophageal emptying
  * **[Manometry] Elevated LES pressure, absent esophageal peristalsis**: Confirms diagnosis
* **Management**
  * **Calcium channel blockers, nitrates**: Relax LES
  * **Balloon dilation**: Extend LES
  * **Per-Oral Endoscopic Myotomy (POEM), Heller-Dor procedure**: Endoscopic or laparoscopic myotomy
{: .notice--info}

### Mallory-Weiss Syndrome / Mallory-Weissç—‡å€™ç¾¤

* **Overview**
  * Mucosal tear at gastroesophageal junction due to sudden increase in intra-abdominal pressure (vomiting)
  * Common causes: Excessive alcohol intake, hyperemesis gravidarum, chemotherapy, endoscopy
* **Presentation**
  * **Hematemesis after forceful vomiting**: Bleeding from mucosal tear
* **Examination**
  * **[Endoscopy] Longitudinal mucosal tear at gastroesophageal junction**: Confirms diagnosis
* **Management**
  * **Conservative treatment (NPO, IV fluids, hemostatic drugs)**: If bleeding stopped
  * **Endoscopic hemostasis (clipping, hemostatic forceps, injection therapy)**: If active bleeding
{: .notice--info}

### Spontaneous Esophageal Rupture / ç‰¹ç™ºæ€§é£Ÿé“ç ´è£‚

* **Overview**
  * Full-thickness rupture of esophageal wall due to sudden increase in intra-abdominal pressure (vomiting)
* **Presentation**
  * **Severe chest pain, dyspnea, shock**: Full-thickness rupture with mediastinal involvement
* **Examination**
  * **[X-ray, CT] Pleural effusion, mediastinal emphysema, pneumothorax**: Air and fluid in mediastinum
  * **[Contrast CT] Contrast leakage into mediastinum**: Confirm diagnosis
* **Management**
  * **Emergency surgery**: Surgical closure and drainage
 {: .notice--info}

### Esophageal Hiatal Hernia / é£Ÿé“è£‚å­”ãƒ˜ãƒ«ãƒ‹ã‚¢

* **Overview**
  * Protrusion of stomach through esophageal hiatus into mediastinum
  * Common in obese middle-aged men and elderly women
* **Presentation**
  * **Heartburn, chest pain, epigastric pain, dysphagia**: Due to associated GERD
* **Examination**
  * **[Barium swallow] Protrusion of stomach into mediastinum**: Confirm diagnosis
  * **[Endoscopy] Gastric mucosa extending above diaphragm**: Confirm diagnosis
* **Management**
  * **Observation**: For asymptomatic cases
  * **Weight loss, elevation of upper body during sleep, acid suppressants**: For GERD cases
  * **Surgical repair (Nissen fundoplication)**: For incarceration cases
{: .notice--info}

### Gastroesophageal Reflux Disease / èƒƒé£Ÿé“é€†æµç—‡

* **Overview**
  * Reflux of gastric contents into esophagus causing symptoms, risk factor for Barrett's esophagus and adenocarcinoma
* **Presentation**
  * **Heartburn, acid regurgitation (worse after meals, at night, bending forward)**: Typical symptoms from acid reflux
  * **Chest pain, cough, wheezing, throat discomfort, ear pain, hoarseness**: Extra-esophageal symptoms
* **Examination**
  * **[Endoscopy] Mucosal redness, erosions, ulcers**: Erosive GERD
  * **[Endoscopy, 24h pH monitoring] No visible lesions + abnormal acid exposure**: Non-erosive GERD (NERD)
* **Management**
  * **Lifestyle modifications**: Avoid late meals, elevate head of bed, weight loss, discontinue causative drugs
  * **PPI/P-CAB, H2RAs, antacids, prokinetics**: Reduce acid secretion, improve gastric motility
  * **Endoscopic or surgical treatment (Nissen fundoplication)**: For refractory cases
{: .notice--info}

### Esophageal Cancer / é£Ÿé“ç™Œ

* **Overview**
  * Malignant epithelial tumor of esophagus, mainly squamous cell carcinoma but also adenocarcinoma
  * Common in 60-70s men, risk factors include alcohol, smoking, achalasia, Barrett's esophagus (adenocarcinoma)
* **Presentation**
  * **[Early] Asymptomatic, mild burning sensation during swallowing**: Early mucosal changes
  * **[Advanced] Dysphagia, weight loss, chest discomfort, hoarseness, cough**: Local invasion and obstruction
* **Examination**
  * **[Endoscopy] Subtle redness, elevation/depression, iodine-unstained areas, brownish areas on NBI**: Mucosal changes in early stage
  * **[Endoscopy] Irregular ulcers, masses, strictures**: Tumor growth in advanced stage
* **Management**
  * **[Stage 0] EMR, ESD**: Remove early mucosal lesions
  * **[Stage I-III] Surgery, lymph node dissection, reconstruction**: Curative resection
  * **[Stage IV] Chemotherapy (5-FU + cisplatin), radiation**: For unresectable cases
  * **[Palliative] Stenting, bypass surgery, gastrostomy**: Relieve obstruction and fistulas
{: .notice--info}

### Esophagogastric Varices / é£Ÿé“ãƒ»èƒƒé™è„ˆç˜¤

* **Overview**
  * Dilated submucosal veins in esophagus and stomach due to portal hypertension, asymptomatic but life-threatening if ruptured
  * Common in liver cirrhosis
* **Presentation**
  * **Asymptomatic**: Found during screening
* **Examination**
  * **[Endoscopy, esophagogram] Dilated submucosal veins**: Assess risk of bleeding
  * **[Contrast CT] Dilated vessels in esophagus and stomach**: Confirm diagnosis and extent
* **Management**
  * **[Endoscopic] Endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL)**: First choice for esophageal varices
  * **[Interventional] B-RTO, TIPS**: For gastric varices resistant to endoscopic treatment
  * **[Medical] Î²-blockers, nitrates**: Prevent bleeding and recurrence
  * **[Surgical] Hassab operation, esophageal transection**: Less common
{: .notice--info}

### Rupture of Esophagogastric Varices / é£Ÿé“ãƒ»èƒƒé™è„ˆç˜¤ç ´è£‚

* **Overview**
  * Life-threatening bleeding from esophagogastric varices
* **Presentation**
  * **Sudden hematemesis, melena**: Massive bleeding from ruptured varices
  * **Shock**: Blood loss leading to circulatory failure
* **Examination**
  * **[Physical] Vital signs**: Assess severity
* **Management**
  * **[Initial] IV fluids, blood transfusion**: Stabilize hemodynamics
  * **[Endoscopic] Endoscopic variceal ligation (EVL), cyanoacrylate injection (CA)**: Hemostasis of esophageal or gastric bleeding
  * **[Temporary] Balloon tamponade (SB tube)**: Hemostasis when endoscopic treatment fails
  * **[Medical] Vasopressin, nitroglycerin**: Reduce portal pressure
{: .notice--info}

## Stomach Disorder / èƒƒç–¾æ‚£

### Functional Dyspepsia / æ©Ÿèƒ½æ€§ãƒ‡ã‚£ã‚¹ãƒšãƒ—ã‚·ã‚¢

* **Overview**
  * Functional gastrointestinal disorder without organic, systemic, or metabolic causes, associated with stress
* **Presentation**
  * **Postprandial fullness, early satiety**: Postprandial distress syndrome
  * **Epigastric pain, burning**: Epigastric pain syndrome
* **Examination**
  * **[Endoscopy, blood tests] Normal**: Rules out organic or systemic disease
* **Management**
  * **Patient education, lifestyle modification, cognitive behavior therapy**: Stress management, regular meals
  * **Prokinetics (acotiamide), acid suppressants**: Improve gastric motility, reduce acid secretion
{: .notice--info}

### Acute Gastric Mucosal Lesion / æ€¥æ€§èƒƒç²˜è†œç—…å¤‰

* **Overview**
  * Acute epigastric pain with multiple erosions and bleeding in gastric mucosa
  * Causes: NSAIDs, alcohol, stress, H. pylori, Anisakis infection
* **Presentation**
  * **Sudden epigastric pain, nausea, vomiting, hematemesis**: Acute mucosal inflammation
* **Examination**
  * **[Endoscopy] Multiple erosions, ulcers, edema, bleeding in gastric mucosa**: Acute mucosal damage
* **Management**
  * **Remove causative factors**: Stop NSAIDs, remove Anisakis
  * **Acid suppressants (PPI, H2-receptor antagonist)**: Reduce acid secretion
  * **Endoscopic hemostasis (clipping, injection therapy)**: For bleeding cases
{: .notice--info}

### H. pylori Gastritis / H. pyloriæ„ŸæŸ“èƒƒç‚

* **Overview**
  * Chronic gastritis caused by H. pylori infection, may progress to intestinal metaplasia and gastric cancer
* **Presentation**
  * **Epigastric pain, bloating, nausea, vomiting, loss of appetite**: Chronic gastritis
* **Examination**
  * **[Endoscopy] Atrophic changes, diffuse redness, enlarged folds**: Chronic inflammation
  * **[Endoscopy] Nodular gastritis, xanthoma, intestinal metaplasia**: Advanced changes
  * **[H. pylori tests] Rapid urease test, urea breath test**: Detect active infection
  * **[Biopsy] Inflammatory cell infiltration, atrophic changes**: Histological confirmation
* **Management**
  * **PPI/P-CAB + Amoxicillin + Clarithromycin (or metronidazole)**: Eradication of H. pylori
{: .notice--info}

### Gastroduodenal Ulcer / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜

* **Overview**
  * Deep mucosal defect extending beyond muscularis mucosae
  * Causes: H. pylori infection, NSAIDs use
* **Presentation**
  * **Epigastric pain, bloating, nausea, vomiting, loss of appetite**: Chronic mucosal damage
  * **Coffee-ground vomiting, melena, anemia, shock (severe cases)**: Gastrointestinal bleeding
* **Examination**
  * **[Endoscopy] Smooth-edged ulcer**: Direct visualization of ulcer
  * **[Upper GI series] Niche sign, converging folds**: Radiological signs of ulcer
* **Management**
  * **H. pylori eradication, discontinue NSAIDs**: Remove underlying cause
  * **PPI/P-CAB, H2-blockers, mucosal protective agents, anticholinergics**: Acid suppression, enhance mucosal defense
  * **[Bleeding] Stabilize vital signs (if shock) , endoscopic hemostasis (clipping, injection therapy)**: Emergent hemostasis
  * **[Stenosis] Endoscopic balloon dilation, surgery**: Resolve stenosis
{: .notice--info}

### Perforated Gastroduodenal Ulcer / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜ç©¿å­”

* **Overview**
  * Deep ulcer penetrating through stomach/duodenal wall into peritoneal cavity, leads to peritonitis and requires urgent treatment
  * Common in patients with gastroduodenal ulcer history
* **Presentation**
  * **Sudden severe epigastric pain, muscle guarding, rebound tenderness**: Peritoneal irritation from gastric contents
  * **Decreased bowel sounds, loss of liver dullness**: Paralytic ileus, free air
* **Examination**
  * **[Chest/Abdominal X-ray] Free air under diaphragm**: Perforation sign
  * **[CT] Free air around liver surface**: Perforation sign
* **Management**
  * **[Mild] NPO, IV fluids, antibiotics, acid suppression, nasogastric tube**: Conservative treatment
  * **[Severe] Laparoscopic surgery (peritoneal lavage and drainage, perforation repair, omental patch)**: Repair surgery
{: .notice--info}

### Gastric Polyps / èƒƒãƒãƒªãƒ¼ãƒ—

* **Overview**
  * Localized mucosal protrusions into gastric lumen excluding tumors
  * Classified as fundic gland polyps (associated with PPI use) and hyperplastic polyps (associated with H. pylori)
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Anemia**: Due to polyp bleeding
* **Examination**
  * **[Endoscopy] Mucosal color polyp in fundic gland area**: Fundic gland polyps
  * **[Endoscopy] Reddish color polyp in atrophic mucosa**: Hyperplastic polyps
* **Management**
  * **Remove causative factors**: Reduce PPI use, H. pylori eradication
{: .notice--info}

### Gastric Adenoma / èƒƒè…ºè…«

* **Overview**
  * Benign epithelial tumor of stomach with risk of malignant transformation, associated with H. pylori infection
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Anemia**: Due to bleeding
* **Examination**
  * **[Endoscopy] Whitish elevated lesion with uniform granular surface**: Differentiates from early gastric cancer
* **Management**
  * **Endoscopic resection**: For lesions showing growth or >2cm
{: .notice--info}

### Gastrointestinal Stromal Tumor / æ¶ˆåŒ–ç®¡é–“è³ªè…«ç˜

* **Overview**
  * Mesenchymal tumor from interstitial cells of Cajal, with c-kit gene mutation and KIT constitutive activation
  * Common in 50-60s
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Abdominal discomfort, pain, palpable mass**: Tumor growth
  * **Melena, anemia**: Tumor bleeding
* **Examination**
  * **[Endoscopy, GI series, EUS] Smooth submucosal elevation, bridging fold, delle**: Submucosal tumor features
  * **[Pathology] KIT(+), CD34(+), DOG1(+)**: Confirms Cajal cell origin
* **Management**
  * **Surgical resection**: Risk of malignant transformation
  * **Imatinib, sunitinib, regorafenib**: For unresectable or recurrent cases
{: .notice--info}

### Gastric Cancer / èƒƒç™Œ

* **Overview**
  * Malignant tumor of gastric mucosa ,mostly adenocarcinoma
  * Risk factors: H. pylori infection, atrophic gastritis, high salt intake, smoking
* **Presentation**
  * **Asymptomatic**: Found during screening
  * **Epigastric discomfort, weight loss, appetite loss, nausea**: Tumor growth
  * **Black stool, fatigue**: Gastrointestinal bleeding
* **Examination**
  * **[Endoscopy, Upper GI series, EUS] Irregular depressed lesions, converging folds**: Early gastric cancer (â‰¤submucosal invasion)
  * **[Endoscopy, Upper GI series, EUS] Irregular ulcers with raised margins**: Advanced gastric cancer (â‰¥muscularis propria invasion)
* **Management**
  * **[Early] EMR, ESD, partial gastrectomy + lymph node dissection**: Endoscopic or limited surgery
  * **[Advanced] Extended gastrectomy + lymph node dissection**: Standard surgery
  * **[Unresectable] S-1 + cisplatin, capecitabine + cisplatin + trastuzumab**: Various combination of chemotherapy 
{: .notice--info}

### Dumping Syndrome / ãƒ€ãƒ³ãƒ”ãƒ³ã‚°ç—‡å€™ç¾¤

* **Overview**
  * Post-gastrectomy condition with food rapidly entering small intestine
  * Classified as early (within 30 min) and late (2-3 hours after meals)
* **Presentation**
  * **[Early] Abdominal pain, diarrhea, nausea**: Rapid intestinal distension
  * **[Early] Palpitations, sweating, dizziness, syncope**: Vasomotor symptoms
  * **[Late] Palpitations, cold sweat, tremor, weakness**: Reactive hypoglycemia
* **Examination**
  * **Clinical**
* **Management**
  * **Dietary modification**: Small frequent meals, high protein/fat and low carb diet
  * **[Early] Antihistamines, antiserotonin drugs**: Relieve vasomotor symptoms
  * **[Late] Î±-glucosidase inhibitors**: Prevent postprandial hyperglycemia
{: .notice--info}

## Intestine Disorder / è…¸ç–¾æ‚£

### Irritable Bowel Syndrome / éæ•æ€§è…¸ç—‡å€™ç¾¤

* **Overview**
  * Functional gastrointestinal disorder with chronic abdominal symptoms, stress-related but exact cause unknown
  * Common disease in adults
* **Presentation**
  * **Abdominal pain/discomfort, diarrhea, constipation**: Chronic symptoms lasting several months
  * **No alarm symptoms (fever, bloody stool, weight loss)**: Distinguishes from organic diseases
* **Examination**
  * **[Endoscopy] Normal**: Distinguishes from organic diseases
* **Management**
  * **Patient education, lifestyle modification, relaxation, cognitive behavioral therapy**: Benign nature of condition
  * **Probiotics, polycarboxylate calcium, trimebutine**: Improve gut function
  * **Lubiprostone, linaclotide, mosapride**: For constipation-predominant cases
  * **Ramosetron, loperamide**: For diarrhea-predominant cases
{: .notice--info}

### Simple Intestinal Obstruction / å˜ç´”æ€§è…¸é–‰å¡

* **Overview**
  * Mechanical bowel obstruction without vascular compromise
  * Most commonly due to postoperative adhesions, also due to colon cancer
* **Presentation**
  * **Intermittent abdominal pain, distension, vomiting, absence of defecation**: Gradual progression of obstruction
* **Examination**
  * **[Physical] Increased bowel sounds, metallic sounds, tympanic sound, visible peristalsis**: Signs of obstruction
  * **[Blood] Hemoconcentration, metabolic alkalosis**: Due to dehydration and vomiting
  * **[X-ray] Dilated bowel loops, niveau**: Gas and fluid accumulation in lumen
* **Management**
  * **NPO, IV fluids**: Correct dehydration and electrolyte imbalance
  * **Nasogastric/ileus tube**: Decompress bowel
  * **Antibiotics**: Prevent sepsis from bacterial overgrowth
  * **Surgery**: For resistant cases
{: .notice--info}

### Complex Intestinal Obstruction / è¤‡é›‘æ€§è…¸é–‰å¡

* **Overview**
  * Mechanical bowel obstruction with vascular compromise
  * Causes include adhesions, intussusception, volvulus, incarcerated hernia
* **Presentation**
  * **Sudden onset severe abdominal pain, vomiting, distension, shock**: Rapid progression
* **Examination**
  * **[Physical] Severe tenderness, decreased bowel sounds, muscle guarding, rebound tenderness**: Peritoneal irritation
  * **[Blood] Hemoconcentration, WBCâ†‘, CKâ†‘, LDHâ†‘, metabolic acidosis**: Indicates bowel necrosis
  * **[X-ray] Gasless abdomen, niveau**: Fluid accumulation in lumen
  * **[Contrast CT] Severe bowel wall edema, poor enhancement, ascites**: Confirms strangulation
* **Management**
  * **IV fluids, antibiotics**: Initial stabilization
  * **Surgery (release strangulation, resect necrotic bowel)**: Emergency surgery
{: .notice--info}

### Paralytic Ileus / éº»ç—ºæ€§ã‚¤ãƒ¬ã‚¦ã‚¹

* **Overview**
  * Functional ileus due to impaired intestinal nerve and muscle function
  * Causes include post-surgery, acute peritonitis, acute mesenteric artery occlusion, diabetes, medications
* **Presentation**
  * **Minimal pain, abdominal distension**: Due to intestinal paralysis
* **Examination**
  * **[Physical] Decreased bowel sounds**: Intestinal paralysis
  * **[X-ray] Dilated bowel loops, air-fluid levels**: Gas and fluid accumulation in lumen
* **Management**
  * **Treat underlying cause**: Primary treatment
  * **Metoclopramide, neostigmine**: Improve intestinal motility
  * **Nasogastric/ileus tube**: Decompress bowel
{: .notice--info}

### Superior Mesenteric Artery Syndrome / ä¸Šè…¸é–“è†œå‹•è„ˆç—‡å€™ç¾¤

* **Overview**
  * Compression of horizontal part of duodenum between superior mesenteric artery and aorta/vertebrae
  * Common in thin females
* **Presentation**
  * **Nausea, vomiting, loss of appetite, upper abdominal pain**: Due to duodenal obstruction
* **Examination**
  * **[Upper GI series] Dilated proximal duodenum, cutoff at SMA crossing**: Duodenal compression
  * **[CT] Narrow aortomesenteric angle**: Confirms diagnosis
* **Management**
  * **Weight gain, positional changes**: Conservative treatment
  * **Duodenojejunostomy**: For resistant cases
{: .notice--info}

### Crohn's Disease / Crohnç—…

* **Overview**
  * Granulomatous inflammatory disease with skip lesions affecting all layers of digestive tract wall
  * Common in 10-20s adults
* **Presentation**
  * **Abdominal pain, diarrhea**: Transmural inflammation of intestinal wall
  * **Fever, weight loss**: Systemic inflammation
  * **Perianal abscess/fistula, oral aphthae, arthritis**: Extra-intestinal manifestations
* **Examination**
  * **[Blood] Anemia, WBCâ†‘, CRPâ†‘, ESRâ†‘, hypoproteinemia**: Chronic inflammation
  * **[Endoscopy] Skip lesions, longitudinal ulcers, cobblestone appearance, strictures, fistulas**: Non-continuous inflammation
  * **[Biopsy] Non-caseating epithelioid granulomas**: Chronic granulomatous inflammation
* **Management**
  * **Nutritional therapy (enteral nutrition, TPN)**: Rest bowel and eliminate dietary allergens
  * **Corticosteroids, 5-ASA (mesalazine, sulfasalazine)**: Anti-inflammatory drugs for remission induction
  * **5-ASA, biologics (anti-TNF-Î±, anti-IL-12/23, anti-integrin), immunomodulators (azathioprine, mercaptopurine)**: Anti-inflammatory drugs for remission maintenance
  * **Surgery**: For strictures, fistula, bleeding
{: .notice--info}

### Ulcerative Colitis / æ½°ç˜æ€§å¤§è…¸ç‚

* **Overview**
  * Diffuse inflammatory disease with continuous lesions affecting colonic mucosa
  * Common in 10-30s adults
* **Presentation**
  * **Bloody diarrhea, abdominal pain, tenesmus**: Mucosal inflammation and ulceration
  * **Fever, weight loss**: Systemic inflammation
* **Examination**
  * **[Blood] Anemia, CRPâ†‘, ESRâ†‘, hypoproteinemia**: Chronic inflammation
  * **[Endoscopy] Continuous lesions, loss of vascular pattern, erosions/ulcers, pseudopolyps, loss of haustra**: Continuous inflammation from rectum
  * **[Biopsy] Diffuse inflammatory cell infiltration, crypt abscess, reduced goblet cells**: Chronic mucosal inflammation
* **Management**
  * **5-ASA (mesalazine, sulfasalazine), corticosteroids, calcineurin inhibitors (tacrolimus, cyclosporine)**: Anti-inflammatory drugs for remission induction
  * **5-ASA, immunomodulators (azathioprine, mercaptopurine) , biologics (anti-TNF-Î±, anti-integrin), JAK inhibitors**: Anti-inflammatory drugs for remission maintenance
  * **Surgery (total colectomy)**: For refractory cases, cancer, toxic megacolon
{: .notice--info}

### Intestinal Tuberculosis / è…¸çµæ ¸

* **Overview**
  * Tuberculosis infection of intestinal tract causing ulcers and scarring
* **Presentation**
  * **Abdominal pain, diarrhea, bloody stool**: Intestinal inflammation and ulceration
  * **Fever, weight loss**: Systemic effects of TB infection
* **Examination**
  * **[Endoscopy] Deformed ileocecal valve, ulcers**: Characteristic TB changes
  * **[Biopsy] Granulomas, caseous necrosis**: Confirms TB infection
* **Management**
  * **Anti-tuberculosis drugs**: Standard TB treatment
{: .notice--info}

### Pseudomembranous Colitis / å½è†œæ€§å¤§è…¸ç‚

* **Overview**
  * Caused by Clostridioides difficile overgrowth after antibiotic use
  * Common in elderly and patients with underlying diseases
* **Presentation**
  * **Watery diarrhea, abdominal pain, fever (after antibiotic use)**: CD toxin damage colonic mucosa
* **Examination**
  * **[Blood] WBCâ†‘, CRPâ†‘**: Inflammatory response
  * **[Stool] CD toxin A/B positive, GDH antigen positive, culture positive**: Confirms C. difficile infection
  * **[Endoscopy] Multiple yellow-white pseudomembranes**: Lesions due to CD toxin
* **Management**
  * **Discontinue causative antibiotics**: Primary intervention
  * **Metronidazole, vancomycin**: Treat C. difficile infection
  * **Fidaxomicin, anti-toxin B antibody, fecal transplantation**: For refractory cases
{: .notice--info}

### Ischemic Colitis / è™šè¡€æ€§å¤§è…¸ç‚

* **Overview**
  * Small vessel ischemia leading to localized mucosal damage in colon
  * Common in elderly with atherosclerotic risk factors
* **Presentation**
  * **Sudden left lower abdominal pain**: Ischemia primarily affects left colon
  * **Diarrhea, bloody stool**: Mucosal damage and inflammation
* **Examination**
  * **[Endoscopy] Mucosal edema, erosions, submucosal hemorrhage, longitudinal ulcers**: Mucosal damage in left colon
  * **[Barium enema] Thumb printing sign, longitudinal ulcers**: Mucosal edema in left colon
* **Management**
  * **Rest, fasting, fluid therapy**: Conservative treatment
  * **Balloon dilation, emergency surgery**: For stricture or gangrenous type
{: .notice--info} 

### Acute Mesenteric Artery Occlusion / æ€¥æ€§è…¸é–“è†œå‹•è„ˆé–‰å¡ç—‡

* **Overview**
  * Acute occlusion of mesenteric artery (mainly SMA) leading to bowel necrosis, peritonitis, and sepsis
  * Common in patients with atrial fibrillation, valvular diseases, or atherosclerosis
* **Presentation**
  * **Sudden severe abdominal pain, nausea, vomiting**: Visceral ischemia
  * **Peritoneal signs, paralytic ileus, shock**: Bowel necrosis and peritonitis
* **Examination**
  * **[Contrast CT] Filling defect in SMA, poor bowel wall enhancement**: Arterial occlusion and bowel ischemia
* **Management**
  * **Emergency laparotomy**: Remove thrombus and resect necrotic bowel
  * **Thrombolytic, vasodilator drugs**: Catheter infusion before surgery
{: .notice--info}

### Acute Appendicitis / æ€¥æ€§è™«å‚ç‚

* **Overview**
  * Acute inflammation of appendix due to obstruction by fecalith, food debris, or lymphoid hyperplasia
  * Common in 10-20s children and adults
* **Presentation**
  * **Initial epigastric/periumbilical pain, anorexia, nausea, vomiting**: Visceral pain from appendiceal distention
  * **Later right lower quadrant pain, low-grade fever**: Somatic pain due to peritoneal inflammation
* **Examination**
  * **[Physical] McBurney's point tenderness, rebound tenderness (Blumberg sign), muscle guarding**: Peritoneal irritation
  * **[Blood] WBCâ†‘, CRPâ†‘**: Acute inflammation
  * **[Ultrasound, CT] Enlarged appendix, fecalith, surrounding exudate**: Confirms appendiceal inflammation
* **Management**
  * **Appendectomy**: Remove inflamed appendix
  * **Antibiotics, fasting**: Conservative treatment
{: .notice--info}

### Colonic Diverticulitis / å¤§è…¸æ†©å®¤ç‚

* **Overview**
  * Inflammation of colonic diverticula due to fecal impaction and bacterial overgrowth
  * Common in middle-aged to elderly adults with chronic constipation
* **Presentation**
  * **Lower abdominal pain and tenderness, low-grade fever**: Local inflammation around diverticulum
* **Examination**
  * **[Blood] WBCâ†‘, CRPâ†‘**: Acute inflammation
  * **[CT] Thickened bowel wall, surrounding inflammation**: Inflammation around diverticulum
  * **[Colonoscopy, Barium enema] Diverticula at tender points**: Visualization of diverticulum
* **Management**
  * **Fasting, IV fluids, antibiotics**: Conservative treatment
  * **Abscess drainage, colectomy**: For abscess or perforation
{: .notice--info}

### Colonic Diverticular Hemorrhage / å¤§è…¸æ†©å®¤å‡ºè¡€

* **Overview**
  * Bleeding of colonic diverticula
  * Common in elderly
* **Presentation**
  * **Painless bleeding, bloody stool**: Direct bleeding from diverticular vessels
* **Examination**
  * **[Endoscopy] Active bleeding from diverticula**: Confirms diagnosis
  * **[Contrast CT] Identifies bleeding site**: Localization of bleeding
* **Management**
  * **Rest, fasting, IV fluids**: Conservative treatment
  * **Endoscopic hemostasis (clipping, ligation)**: For active bleeding with identified source
  * **Transcatheter arterial embolization (TAE)**: For massive bleeding
{: .notice--info}

### Gastrointestinal Neuroendocrine Neoplasm / æ¶ˆåŒ–ç®¡ç¥çµŒå†…åˆ†æ³Œè…«ç˜

* **Overview**
  * Slow-growing but malignant submucosal tumors, classified as well-differentiated NET or poorly-differentiated NEC
* **Presentation**
  * **Asymptomatic, GI bleeding, abdominal pain**: Due to local tumor growth
  * **Flushing, wheezing, diarrhea**: Carcinoid syndrome due to hormone secretion
* **Examination**
  * **[Endoscopy] Smooth elevated lesion, bridging fold, delle**: Submucosal tumor
  * **[Urine, Blood] 5-HIAAâ†‘, Serotoninâ†‘**: Hormone production by tumor
  * **[Biopsy] Small uniform cells in cord/ribbon/rosette pattern, chromogranin A(+), silver stain(+)**: Confirms diagnosis
* **Management**
  * **Surgical resection, EMR**: For resectable cases
  * **Octreotide, lanreotide, everolimus, streptozocin**: For unresectable cases and carcinoid syndrome
{: .notice--info}

### Colonic Polyps / å¤§è…¸ãƒãƒªãƒ¼ãƒ—

* **Overview**
  * Protruding lesions from colonic mucosa into lumen, most commonly adenomas (neoplastic) or hyperplastic polyps (non-neoplastic)
* **Presentation**
  * **Asymptomatic, positive fecal occult blood test**: Found during screening
  * **Bloody stool**: With larger polyps
* **Examination**
  * **[Endoscopy] Protruding lesions, pit pattern analysis**: Determines polyp type and risk
  * **[Pathology] Adenoma, hyperplastic, serrated lesions**: Confirm polyp type
* **Management**
  * **Observation**: Small hyperplastic polyps
  * **Polypectomy, EMR**: For large symptomatic polyps or suspected cancer
{: .notice--info}

### Colorectal Cancer / å¤§è…¸ç™Œ

* **Overview**
  * Malignant tumor arising from colon/rectal mucosa, mostly adenocarcinoma
  * Common in 50-70s adults
* **Presentation**
  * **Asymptomatic, positive fecal occult blood test**: Found during screening
  * **Constipation, diarrhea, bloody stool, thin stools, abdominal pain**: Due to tumor growth and obstruction
* **Examination**
  * **[Endoscopy] Elevated or depressed lesions, pit pattern analysis**: Early colorectal cancer (â‰¤submucosal invasion)
  * **[Endoscopy] Ulcerative lesions with raised edges**: Advanced colorectal cancer (â‰¥muscularis propria invasion)
  * **[Barium enema] Irregular filling defects, apple core sign**: Tumor causing luminal narrowing
  * **[Blood] Anemia, CEAâ†‘, CA19-9â†‘**: Tumor markers (especially with liver metastasis)
  * **[CT] Multiple low-density areas in liver**: Common site of metastasis
* **Management**
  * **[Early] Polypectomy, EMR, ESD**: For early tumor
  * **[Advanced] Surgical resection + lymph node dissection**: For advanced tumor
  * **[Metastasis] Chemotherapy (FOLFOX/FOLFIRI), surgical resection**: For metastatic tumor
{: .notice--info}

### Familial Adenomatous Polyposis / å®¶æ—æ€§å¤§è…¸è…ºè…«ç—‡

* **Overview**
  * Multiple adenomatous polyps throughout colon with risk of developing cancer, autosomal dominant disorder caused by APC gene mutation
  * Common in 15-40s adults with familial history
* **Presentation**
  * **Bloody stools, diarrhea, abdominal pain**: Due to numerous polyps
* **Examination**
  * **[Endoscopy, Barium enema] Numerous polyps throughout colon**
  * **[Biopsy] Adenomatous polyps**: Confirm polyps type
  * **[Genetic testing] APC gene mutation**: Confirms diagnosis
* **Management**
  * **Total colectomy**: Prevent development of colon cancer
  * **Endoscopic polypectomy, aspirin**: For cases with fewer polyps
{: .notice--info}

### Peutz-Jeghers Syndrome / Peutz-Jeghersç—‡å€™ç¾¤

* **Overview**
  * Multiple hamartomatous polyps throughout GI tract, autosomal dominant disorder caused by STK11/LKB1 gene mutation
* **Presentation**
  * **Mucocutaneous pigmentation around lips**: Resembling freckles/moles
  * **Abdominal pain, bloody stools**: GI symptoms due to polyps
* **Examination**
  * **[Endoscopy] Hamartomatous polyps**: Confirm polyps type
  * **[Genetic testing] STK11/LKB1 mutation**: Confirms diagnosis
* **Management**
  * **Endoscopic polypectomy**: For symptomatic or large polyps
{: .notice--info}

## Peritoneum Disorder / è…¹è†œç–¾æ‚£

### Acute Peritonitis / æ€¥æ€§è…¹è†œç‚

* **Overview**
  * Acute inflammation of peritoneum, may progress to septic shock or SIRS
  * Commonly secondary to GI perforation or appendicitis
* **Presentation**
  * **Severe abdominal pain, nausea, vomiting**: Peritoneal inflammation
  * **Fever, shallow breathing, tachycardia**: Systemic response
* **Examination**
  * **[Physical] Tenderness, muscle guarding, rebound tenderness, rigidity, reduced bowel sounds**: Peritoneal irritation
  * **[Blood] WBCâ†‘, CRPâ†‘**: Inflammatory response
  * **[X-ray, CT, Ultrasound] Free fluid, free air, abscess**: Identify cause and complications
  * **[Paracentesis] Fluid analysis**: Determine nature of inflammation
* **Management**
  * **IV fluids, antibiotics**: Stabilization and infection control
  * **Emergency surgery**: Treat underlying cause
{: .notice--info}

### Pseudomyxoma Peritonei / è…¹è†œå½ç²˜æ¶²è…«

* **Overview**
  * Low-grade mucin-producing tumors spreading in peritoneal cavity, usually originates from appendix or ovary
* **Presentation**
  * **Asymptomatic, abdominal distension, abdominal pain**: Accumulation of mucinous material
* **Examination**
  * **[CT] Jelly-like masses, septated fluid collections**: Mucinous deposits in peritoneal cavity
  * **[Pathology] Low-grade epithelial cells in mucin pools**: Characteristic finding
* **Management**
  * **Cytoreductive surgery**: Remove tumor and mucinous deposits
{: .notice--info}

### Inguinal Hernia / é¼ å¾„éƒ¨ãƒ˜ãƒ«ãƒ‹ã‚¢

* **Overview**
  * Protrusion of abdominal contents through defects in inguinal area, divided into indirect inguinal (most common), direct inguinal, and femoral hernias
* **Presentation**
  * **[Indirect inguinal] Bulge above inguinal ligament, lateral to inferior epigastric vessels**: Common in male infants and adults
  * **[Direct inguinal] Bulge above inguinal ligament, medial to inferior epigastric vessels**: Common in middle-aged obese men
  * **[Femoral] Bulge below inguinal ligament**: Common in middle-aged women
* **Examination**
  * **[Physical] Location of bulge**: Distinguishes between types
  * **[Physical] Tenderness, redness**: Signs of incarceration
* **Management**
  * **[Children] High ligation of hernia sac**: Remove hernia sac
  * **[Adults] Mesh repair**: Strengthen weakened area
  * **[Incarcerated hernia] Manual reduction, emergency surgery**: Prevent complications
{: .notice--info}

## Anus Disorder / è‚›é–€ç–¾æ‚£

### Hemorrhoids / ç—”æ ¸

* **Overview**
  * Enlargement of anal cushions due to weakening of supporting tissue and venous congestion, classified as grade I to IV
* **Presentation**
  * **Prolapse, bleeding during defecation**: Enlargement and congestion of hemorrhoidal tissue
  * **Severe pain in acute state**: Incarcerated internal hemorrhoids, thrombosed external hemorrhoids
* **Examination**
  * **[Physical] Digital rectal exam, anoscopy**: Assess location and severity
* **Management**
  * **Suppositories, ointments**: Conservative treatment
  * **ALTA injection**: Sclerotherapy for internal hemorrhoids
  * **Surgical ligation and excision**: For Grade III-IV hemorrhoids
{: .notice--info}

### Perianal Abscess and Anal Fistula / è‚›é–€å‘¨å›²è†¿ç˜ãƒ»ç—”ç˜»

* **Overview**
  * Bacterial infection of anal glands leads to perianal abscess, can develop into chronic fistula
  * Common in males aged 30-40s, associated with Crohn's disease
* **Presentation**
  * **[Perianal Abscess] Severe anal pain, fever, perianal mass and redness**: Acute bacterial infection
  * **[Anal Fistula] Persistent pus drainage, intermittent swelling and tenderness**: Chronic infection with fistula formation
* **Examination**
  * **[Physical] Primary and secondary opening**: Identifies fistula
* **Management**
  * **[Perianal Abscess] Drainage, antibiotics**: Treat acute infection
  * **[Anal Fistula] Surgery**: Open fistula
{: .notice--info}

### Anal Fissure / è£‚è‚›

* **Overview**
  * Linear tear in anal canal epithelium caused by passage of hard stools
  * Common in young women, associated with constipation
* **Presentation**
  * **Pain during and after defecation, bleeding**: Tear in anal canal
  * **Anal stenosis**: Chronic inflammation and scarring
* **Examination**
  * **[Physical] Tear, sentinel pile, polyp**: Chronic inflammation leads to tissue changes
* **Management**
  * **Conservative treatment**: Primary treatment
  * **Surgery**: For severe cases
{: .notice--info}

## Liver Disorder / è‚ç–¾æ‚£

### Acute Viral Hepatitis / æ€¥æ€§ã‚¦ã‚¤ãƒ«ã‚¹æ€§è‚ç‚

* **Overview**
  * Acute liver inflammation caused by hepatitis viruses (A-E), generally self-limiting but risk of fulminant hepatitis or chronicity
  * Transmitted through fecal-oral route (HAV, HEV) or blood/body fluids (HBV, HCV, HDV)
* **Presentation**
  * **Fatigue, anorexia, nausea, vomiting, fever, muscle pain**: Systemic inflammatory response
  * **Jaundice, dark urine, hepatomegaly, abdominal pain**: Liver inflammation and dysfunction
* **Examination**
  * **[Blood] ASTâ†‘, ALTâ†‘, bilirubinâ†‘, PT prolonged**: Hepatocyte damage and liver dysfunction
  * **[Blood] IgM-HA-Ab, HBs-Ag, IgM-HBc-Ab, HCV-RNA, HCV-Ab**: Acute viral infection
* **Management**
  * **Bed rest**: Increase hepatic blood flow
  * **Diet therapy**: Carbohydrate-rich diet, protein restriction
  * **[HBV] Lamivudine**: For HBV severe cases
  * **[HCV] Direct-acting antivirals**: For HCV chronic cases
{: .notice--info}

### Chronic Viral Hepatitis / æ…¢æ€§è‚ç‚

* **Overview**
  * Chronic liver inflammation >6 months, can progress to liver cirrhosis and hepatocellular carcinoma
  * Mainly caused by chronic infection of HBV or HCV
* **Presentation**
  * **Asymptomatic, general fatigue, poor appetite**: Chronic liver inflammation
* **Examination**
  * **[Blood] ASTâ†‘, ALTâ†‘**: Liver cell damage
  * **[Blood] HBs-Ag , IgG-HBc-Ab, HCV-RNA, HCV-Ab**: Chronic viral infection
  * **[Liver biopsy] Bridging fibrosis, piecemeal necrosis**: Chronic inflammation and fibrosis
* **Management**
  * **[HBV] Pegylated interferon, entecavir, tenofovir**: Suppress HBV replication
  * **[HCV] Direct acting antivirals**: Suppress HCV replication
  * **UDCA, glycyrrhizin**: Liver protection
{: .notice--info}

### Fulminant Hepatitis / åŠ‡ç—‡è‚ç‚

* **Overview**
  * Acute liver failure with hepatic encephalopathy within 8 weeks of symptom onset
  * Commonly after acute hepatitis (viral, metabolic, autoimmune)
* **Presentation**
  * **High fever, tachycardia, anorexia, nausea, vomiting**: Systemic inflammatory response
  * **Jaundice, ascites, edema**: Liver dysfunction
  * **Hepatic encephalopathy**: Ammonia toxicity and cerebral edema
* **Examination**
  * **[Blood] ASTâ†‘, ALTâ†‘, bilirubinâ†‘, LDHâ†‘**: Severe hepatocellular damage
  * **[Blood] PT<40%, INR>1.5, albuminâ†“, ChEâ†“**: Impaired liver synthesis
  * **[Blood] Fischer ratioâ†“, NH3â†‘**: Impaired liver metabolism
  * **[Imaging] Liver atrophy, ascites**: Advanced liver damage
* **Management**
  * **Glucose-based fluids, respiratory control, antibiotics**: Support vital functions
  * **Hemodiafiltration + plasma exchange**: Remove toxins artificially
  * **Lactulose (hepatic encephalopathy), mannitol (cerebral edema), FFP (coagulation dysfunction)**: Treat complications
  * **Antiviral therapy (HBV), steroids (autoimmune)**: Treat underlying cause
  * **Liver transplantation**: Definitive treatment
{: .notice--info}

### Liver Cirrhosis / è‚ç¡¬å¤‰

* **Overview**
  * End-stage liver disease with fibrosis and regenerative nodules, leading to liver failure and hepatocellular carcinoma
  * Common in chronic viral hepatitis or alcoholism
* **Presentation**
  * **Asymptomatic, fatigue, anorexia, ascites, edema, jaundice**: Liver dysfunction
  * **Spider angiomas, palmar erythema, gynecomastia**: Estrogen excess due to impaired metabolism
  * **Esophageal varices, GI bleeding**: Portal hypertension
  * **Altered consciousness, flapping tremor**: Hepatic encephalopathy
  * **Fever, abdominal pain, peritoneal irritation**: Spontaneous bacterial peritonitis
* **Examination**
  * **[Blood] Pancytopenia (especially platelets)**: Hypersplenism
  * **[Blood] ASTâ†‘, bilirubinâ†‘, Î³-GTâ†‘, ALPâ†‘**: Liver damage and cholestasis
  * **[Blood] PT prolonged, albuminâ†“, ChEâ†“**: Decreased synthetic function
  * **[Blood] Type IV collagenâ†‘, hyaluronic acidâ†‘**: Fibrosis markers
  * **[Imaging] Irregular liver surface, blunt edge, splenomegaly, ascites**: Chronic liver disease
* **Management**
  * **Direct-acting antivirals, nucleoside analogues**: Treat underlying cause
  * **High-energy low-salt diet, glycyrrhizin, UDCA**: Liver protection
  * **[Ascites] Salt restriction, diuretics, albumin**: Manage fluid
  * **[Varices] Endoscopic treatment**: Prevent bleeding
  * **[Encephalopathy] Low-protein diet, lactulose, branched-chain amino acids**: Maintain consciousness 
  * **[Peritonitis] Antibiotics**: Control infection
  * **Liver transplantation**: Ultimate treatment
{: .notice--info}

### Liver Abscess / è‚è†¿ç˜

* **Overview**
  * Infectious collection in liver caused by bacteria (gram-negative rods) or amebae
  * Infection routes include biliary tract, portal vein, hepatic artery, direct spread
* **Presentation**
  * **Fever, general fatigue**: Systemic inflammatory response
  * **RUQ pain, hepatomegaly, liver tenderness**: Enlarged inflamed liver
* **Examination**
  * **[Blood] WBCâ†‘, ESRâ†‘, CRPâ†‘**: Infection
  * **[Blood] ALPâ†‘, Î³-GTâ†‘**: Cholestasis
  * **[Ultrasound] Heterogeneous hypoechoic lesion**: Abscess formation
  * **[CT] Ring-enhancing hypodense lesion**: Confirms abscess
  * **[Aspiration] Yellow malodorous pus (bacterial) or chocolate-colored viscous pus (amebic)**: Identifies causative pathogen
* **Management**
  * **[Bacterial] Antibiotics, percutaneous drainage**: Treat infection and remove pus
  * **[Amebic] Metronidazole**: Eliminate amebae
  * **Surgical drainage**: For failed percutaneous drainage or rupture
{: .notice--info}

### Fatty Liver / è„‚è‚ªè‚

* **Overview**
  * Abnormal accumulation of triglycerides in liver
  * Major causes include alcohol, obesity, diabetes mellitus
* **Presentation**
  * **Asymptomatic, RUQ heaviness/pain**: Enlarged liver
* **Examination**
  * **[Ultrasound] Bright liver, increased hepatorenal contrast, deep echo attenuation, blurred vessels**: Fat accumulation
  * **[CT] Low density liver**: Fat accumulation
  * **[Liver biopsy] Fat deposits**: Confirms diagnosis
* **Management**
  * **Alcohol cessation**: Treat alcoholism 
  * **Calorie restriction, diet modification, exercise**: Treat obesity
{: .notice--info}

### Alcoholic Hepatitis / ã‚¢ãƒ«ã‚³ãƒ¼ãƒ«æ€§è‚ç‚

* **Overview**
  * Acute alcoholic liver injury triggered by sudden increase in alcohol consumption
  * Common in chronic heavy drinkers
* **Presentation**
  * **Abdominal pain, fever, vomiting, diarrhea**: Acute liver inflammation
  * **Jaundice, altered consciousness, hepatomegaly**: Liver dysfunction
* **Examination**
  * **[Blood] ASTâ†‘ (AST>ALT), WBCâ†‘, Î³-GTâ†‘, ALPâ†‘**: Liver damage and cholestasis
  * **[Liver biopsy] Hepatocyte ballooning, Mallory-Denk bodies, neutrophil infiltration**: Confirms diagnosis
* **Management**
  * **Alcohol cessation**: Treat alcoholism
  * **Vitamin B1, hydration, balanced diet**: Nutritional support
  * **Glycyrrhizin, UDCA**: Liver protection
  * **Corticosteroids, plasma exchange, hemodiafiltration**: Treatment for severe inflammation
{: .notice--info}

### Non-alcoholic Steatohepatitis / éã‚¢ãƒ«ã‚³ãƒ¼ãƒ«æ€§è„‚è‚ªè‚ç‚

* **Overview**
  * Advanced non-alcoholic fatty liver disease with hepatocyte inflammation
  * Common in obesity, diabetes mellitus, hypertension
* **Presentation**
  * **Fatigue, insomnia, hepatomegaly**: Liver dysfunction
* **Examination**
  * **[Blood] ASTâ†‘, Î³-GTâ†‘, plateletsâ†“, hyaluronic acidâ†‘, ferritinâ†‘, TGâ†‘, T.Choâ†‘**: Liver dysfunction with metabolic abnormalities
  * **[Ultrasound] Bright liver, increased hepatorenal contrast, deep echo attenuation**: Fat accumulation
  * **[CT] Low liver density**: Fat accumulation
  * **[Liver biopsy] Steatosis, hepatocyte ballooning, inflammation**: Confirms diagnosis
* **Management**
  * **Diet, exercise therapy**: Treat obesity
  * **Pioglitazone (diabetes), statins (hyperlipidemia), ARBs (hypertension)**: Treat underlying disease
  * **Vitamin E**: Liver protection
{: .notice--info}

### Drug-Induced Liver Injury / è–¬ç‰©æ€§è‚éšœå®³

* **Overview**
  * Hepatocellular injury or cholestasis due to drug toxicity
  * Common causes include antibiotics, antipyretic analgesics, herbal medicines, supplements
* **Presentation**
  * **Asymptomatic, fatigue, fever, rash, jaundice, pruritus**: Liver injury with various severity
* **Examination**
  * **[Blood]ALTâ†‘, ASTâ†‘**: Liver cell damage
  * **[Blood] ALPâ†‘, Î³-GTâ†‘, T.Bilâ†‘**: Bile stasis
  * **[Blood] Eosinophilsâ†‘**: Allergic reaction
* **Management**
  * **Drug discontinuation**: Improvement in most cases
  * **Glycyrrhizin, UDCA, corticosteroids**: Liver protection
  * **N-acetylcysteine**: For acetaminophen toxicity
{: .notice--info}

### Autoimmune Hepatitis / è‡ªå·±å…ç–«æ€§è‚ç‚

* **Overview**
  * Chronic progressive liver disease of autoimmune origin
  * Common in middle-aged women, often associated with other autoimmune diseases
* **Presentation**
  * **Asymptomatic, fatigue, jaundice, poor appetite**: Chronic liver inflammation
  * **Fever, joint pain, rash**: Systemic autoimmune manifestations
* **Examination**
  * **[Blood] ALTâ†‘ (ALT>AST), bilirubinâ†‘**: Liver cell damage
  * **[Blood] Î³-globulinâ†‘, IgGâ†‘, ESRâ†‘, CRPâ†‘**: Inflammatory response
  * **[Blood] ANA(+), anti-smooth muscle antibody(+)**: Autoimmune nature
  * **[Liver biopsy] Interface hepatitis, liver cell necrosis**: Confirms diagnosis
* **Management**
  * **Corticosteroids, azathioprine**: Anti-inflammatory and immunosuppressive
  * **UDCA**: Liver protection
  * **Liver transplantation**: For advanced cases
{: .notice--info}

### Primary Biliary Cholangitis / åŸç™ºæ€§èƒ†æ±æ€§èƒ†ç®¡ç‚

* **Overview**
  * Chronic intrahepatic cholestasis characterized by chronic nonsuppurative destructive cholangitis
  * Common in middle-aged women, often associated with other autoimmune diseases
* **Presentation**
  * **Asymptomatic, pruritus, jaundice**: Bile stasis
* **Examination**
  * **[Blood] ALPâ†‘, Î³-GTâ†‘, T.Choâ†‘, bilirubinâ†‘**: Cholestasis
  * **[Blood] Eosinophilsâ†‘, ESRâ†‘, IgMâ†‘**: Inflammatory response
  * **[Blood] Anti-mitochondrial antibody(+)**: Autoimmune nature
  * **[Liver biopsy] Chronic nonsuppurative destructive cholangitis**: Confirms diagnosis
* **Management**
  * **UDCA, bezafibrate**: Improve bile flow
  * **Cholestyramine, antihistamines**: For pruritus
  * **Liver transplantation**: For advanced cases
{: .notice--info}

### Idiopathic Portal Hypertension / ç‰¹ç™ºæ€§é–€è„ˆåœ§äº¢é€²ç—‡

* **Overview**
  * Portal hypertension without cirrhosis or portal/hepatic vein obstruction
  * Common in middle-aged women, often associated with autoimmune diseases
* **Presentation**
  * **Esophageal varices, splenomegaly, pancytopenia**: Due to portal hypertension
* **Examination**
  * **[Blood] Î³-globulinâ†‘, autoantibodies**: Suggests autoimmune background
* **Management**
  * **Endoscopic treatment**: For esophageal varices
  * **Partial splenic embolization, splenectomy**: For hypersplenism
{: .notice--info}

### Budd-Chiari Syndrome / Budd-Chiariç—‡å€™ç¾¤

* **Overview**
  * Obstruction/stenosis of hepatic veins or inferior vena cava, causing post-hepatic portal hypertension
  * Primary (coagulation disorders, myeloproliferative disorders) or secondary (liver cancer, thrombosis, heart failure)
* **Presentation**
  * **[Acute] Abdominal pain, ascites, fever**: Rapid development of hepatic congestion
  * **[Chronic] Asymptomatic, progressive portal hypertension**: Gradual hepatic congestion
* **Examination**
  * **[Blood] ASTâ†‘, ALTâ†‘**: Liver cell damage
  * **[Imaging] Obstruction/stenosis of hepatic veins or IVC**: Direct visualization of blockage
* **Management**
  * **Balloon angioplasty, surgical shunting**: Widen or bypass obstructed vessels
{: .notice--info}

### Hepatic Cyst / è‚å›Šèƒ

* **Overview**
  * Fluid-filled sacs in liver, mostly benign but can be polycystic liver disease or echinococcus
* **Presentation**
  * **Asymptomatic**: In most cases
  * **Abdominal discomfort , obstructive jaundice**: In large cysts
* **Examination**
  * **[Ultrasound] Anechoic lesion, posterior acoustic enhancement**: Fluid-filled cyst
  * **[CT, MRI] Well-defined fluid-density lesion**: Confirms cyst
* **Management**
  * **Observation**: For asymptomatic cases
  * **Aspiration, surgical resection**: For symptomatic cases
{: .notice--info}

### Hepatic Hemangioma / è‚è¡€ç®¡è…«

* **Overview**
  * Most common benign primary liver tumor
  * Common in middle-aged women
* **Presentation**
  * **Asymptomatic**: In most cases
  * **Abdominal discomfort, bleeding tendency**: In large tumors or consumption coagulopathy
* **Examination**
  * **[Ultrasound] Hyperechoic lesion**: Endothelium-rich tumor
  * **[CT, MRI] Peripheral nodular enhancement, centripetal filling**: Characteristic vascular pattern
* **Management**
  * **Observation**: For asymptomatic cases
  * **Surgical resection**: For symptomatic cases
{: .notice--info}

### Hepatocellular Carcinoma / è‚ç´°èƒç™Œ

* **Overview**
  * Malignant tumor from hepatocytes, characterized by multistep and multicentric carcinogenesis
  * Common in patients with chronic liver diseases (viral hepatitis B/C, NASH)
* **Presentation**
  * **Asymptomatic**: Often found during screening
* **Examination**
  * **[Blood] AFPâ†‘, PIVKA-IIâ†‘, AFP-L3â†‘**: Tumor markers
  * **[Ultrasound] Well-defined nodule with halo, mosaic pattern**: Tumor with capsule and septum
  * **[Contrast CT/MRI] Hyperenhancement in arterial phase, washout in portal/delayed phase**: Hypervascular tumor
* **Management**
  * **[Child-Pugh A/B, local] Resection, ablation, chemoembolization**: For local compensated tumor
  * **[Child-Pugh A/B, metastatic] Targeted therapy**: For metastatic compensated tumor
  * **[Child-Pugh C] Liver transplantation, palliative care**: For uncompensated tumor
{: .notice--info}

### Intrahepatic Cholangiocarcinoma / è‚å†…èƒ†ç®¡ç™Œ

* **Overview**
  * Malignant tumor from intrahepatic bile duct epithelium
* **Presentation**
  * **Asymptomatic, obstructive jaundice**: Depend on hilar or peripheral types
* **Examination**
  * **[Blood] ALPâ†‘, Î³-GTâ†‘, bilirubinâ†‘**: Bile duct obstruction
  * **[Blood] CA19-9â†‘, CEAâ†‘**: Tumor markers
  * **[CT/MRI] Delayed enhancement, bile duct dilatation**: Differentiate from HCC
* **Management**
  * **Surgical resection**: For local tumor
  * **Gemcitabine + Cisplatin**: For metastatic tumor
{: .notice--info}

### Metastatic Liver Cancer / è»¢ç§»æ€§è‚ç™Œ

* **Overview**
  * Metastatic tumor from other organ, more common than primary liver cancer
  * Common primary sites: colorectal, pancreatic, gastric, biliary tract, lung, breast, ovarian cancer
* **Presentation**
  * **Asymptomatic**: Often found during screening
  * **Abdominal distension, jaundice, ascites, anorexia**: Liver dysfunction in advanced disease
* **Examination**
  * **[Blood] CEAâ†‘ (colorectal), CA19-9â†‘ (pancreatic/biliary)**: Primary tumor markers
  * **[Blood] ALPâ†‘, Î³-GTâ†‘, LDHâ†‘**: Cholestasis
  * **[Ultrasound] Bull's eye sign**: Tumor with capsule and central necrosis
  * **[CT] Ring enhancement of hypodense lesions**: Tumor with capsule and central necrosis
* **Management**
  * **Surgical resection**: For colorectal cancer and GIST
  * **Chemotherapy**: For most cancer
{: .notice--info}

## Biliary Tract Disorder / èƒ†é“ç–¾æ‚£

### Cholelithiasis / èƒ†çŸ³ç—‡

* **Overview**
  * Stones in biliary system (gallbladder, common bile duct, intrahepatic)
  * Common in middle-aged and older adults
* **Presentation**
  * **Asymptomatic, RUQ/epigastric pain after meals, radiate to right shoulder/back, nausea, vomiting**: Gallstone temporarily obstructs bile duct
* **Examination**
  * **[Blood] Î³-GTâ†‘, ALPâ†‘, bilirubinâ†‘**: Biliary obstruction
  * **[Ultrasound] High-echoic image, acoustic shadow**: Stone reflects sound waves
  * **[CT] High-density stone**: Visualize stones
  * **[MRCP, ERCP] Filling defects**: Visualize stones
* **Management**
  * **[Gallbladder stone] Observation, (asymptomatic), laparoscopic/open cholecystectomy (symptomatic), NSAID/anticholinergics**: Remove gallbladder with stones and control pain
  * **[CBD stone] Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilatation (EPBD)**: Remove CBD stones
  * **[Intrahepatic stone] Percutaneous transhepatic cholangioscopy (PTCS), hepatectomy (atrophy, cancer)**: Remove intrahepatic stones or liver
{: .notice--info}

### Acute Cholecystitis / æ€¥æ€§èƒ†å›Šç‚

* **Overview**
  * Acute inflammation of gallbladder caused by gallstones impaction and bacterial infection
  * Common in middle-aged and older adults with gallstone history
* **Presentation**
  * **RUQ pain, fever, nausea, vomiting**: Gallbladder infection
  * **Tenderness, muscle guarding, Murphy's sign**: Local peritoneal irritation
* **Examination**
  * **[Blood] WBCâ†‘, CRPâ†‘**: Active infection
  * **[Blood] ALPâ†‘, Î³-GTâ†‘, bilirubinâ†‘**: Biliary obstruction
  * **[Ultrasound, CT] Gallbladder wall thickening, enlargement, debris, impacted stones, sonographic Murphyâ€™s sign**: Gallbladder inflammation
* **Management**
  * **Fasting, IV fluids, antibiotics, analgesics**: Treat infection and pain
  * **Percutaneous transhepatic gallbladder drainage/aspiration (PTGBD)**: Reduce gallbladder pressure if unstable
  * **Laparoscopic cholecystectomy**: Remove gallbladder if stable
{: .notice--info}

### Acute Cholangitis / æ€¥æ€§èƒ†ç®¡ç‚

* **Overview**
  * Acute inflammation of bile ducts caused by obstruction and bacterial infection, leading to sepsis in severe cases
  * Common in middle-aged and older adults with gallstone history
* **Presentation**
  * **Abdominal pain, fever with chills, jaundice (Charcot's triad)**: Bile duct infection and obstruction
  * **Shock, altered consciousness (Reynolds' pentad)**: Endotoxin and bacteria enter bloodstream in severe cases
* **Examination**
  * **[Blood] WBCâ†‘, CRPâ†‘**: Active infection
  * **[Blood] ALPâ†‘, Î³-GTâ†‘, bilirubinâ†‘**: Biliary obstruction
  * **[Blood] ASTâ†‘, ALTâ†‘**: Liver damage
  * **[Ultrasound, CT] Dilated bile ducts, CBD stones**: CBD obstruction
* **Management**
  * **Fasting, IV fluids, antibiotics, analgesics**: Treat infection and pain
  * **Endoscopic biliary drainage (EBD), percutaneous transhepatic biliary drainage (PTBD)**: Reduce biliary tract pressure if unstable
  * **Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilatation (EPBD)**: Remove stones if stable
{: .notice--info}

### Primary Sclerosing Cholangitis / åŸç™ºæ€§ç¡¬åŒ–æ€§èƒ†ç®¡ç‚

* **Overview**
  * Progressive chronic inflammation of intra/extrahepatic bile ducts causing fibrous stenosis
  * Common in 20s and 60s adults, often associated with ulcerative colitis
* **Presentation**
  * **Asymptomatic, fluctuating jaundice, pruritus**: Cholestasis
* **Examination**
  * **[Blood] Î³-GTâ†‘, ALPâ†‘, bilirubinâ†‘**: Biliary obstruction
  * **[Blood] ASTâ†‘, ALTâ†‘**: Liver damage
  * **[Blood] P-ANCA(+)**: Autoimmune nature
  * **[ERCP, MRCP] Intra/extrahepatic bile duct strictures (beaded appearance)**: Bile duct stenosis
* **Management**
  * **UDCA, bezafibrate, cholestyramine, antihistamines**: Improve bile flow and relieve pruritus
  * **Biliary drainage**: Control cholangitis and reduce jaundice
  * **Liver transplantation**: Only curative treatment for advanced cases
{: .notice--info}

### Congenital Biliary Dilatation / å…ˆå¤©æ€§èƒ†é“æ‹¡å¼µç—‡

* **Overview**
  * Congenital malformation with localized dilatation of extrahepatic bile ducts and pancreaticobiliary maljunction, high risk of biliary tract cancer
  * Common in children and young adults
* **Presentation**
  * **Asymptomatic, abdominal pain, jaundice, abdominal mass**: Biliary dilatation and bile stasis
* **Examination**
  * **[Blood] Î³-GTâ†‘, ALPâ†‘, amylaseâ†‘**: Bile stasis and pancreatic enzyme reflux
  * **[CT, Ultrasound] Dilatation of CBD**: Biliary dilatation
  * **[MRCP, ERCP] Cystic/fusiform dilatation of CBD**: Biliary dilatation
  * **[MRCP, ERCP] Abnormal junction of pancreatic duct and CBD outside duodenal wall**: Pancreaticobiliary maljunction
* **Management**
  * **Extrahepatic bile duct resection, cholecystectomy, biliary reconstruction**: Prevent biliary tract cancer
{: .notice--info}

### Biliary Atresia / èƒ†é“é–‰é–ç—‡

* **Overview**
  * Congenital obstruction of extrahepatic bile ducts
  * Common in female infants
* **Presentation**
  * **Prolonged jaundice, clay-colored stool**: Bile duct obstruction
  * **Bleeding tendency, bone abnormalities**: Fat-soluble vitamin malabsorption
* **Examination**
  * **[Blood] Î³-GTâ†‘, ALPâ†‘, bilirubinâ†‘**: Bile duct obstruction
  * **[CT, Ultrasound] Absent gallbladder or bile ducts**: Biliary atresia
* **Management**
  * **Kasai portoenterostomy**: Bypass biliary atresia
  * **Liver transplantation**: If Kasai procedure fails
{: .notice--info}

### Gallbladder Polyp / èƒ†å›Šãƒãƒªãƒ¼ãƒ—

* **Overview**
  * Localized protruding lesions on gallbladder mucosa
* **Presentation**
  * **Asymptomatic**: Most cases
* **Examination**
  * **[Ultrasound] Protruding lesion in gallbladder**: Often found during screening
* **Management**
  * **Observation**: For typical polyps
  * **Cholecystectomy**: For polyp with cancer risk (>10mmm, broad-based)
{: .notice--info}

### Gallbladder Adenomyomatosis / èƒ†å›Šè…ºç­‹è…«ç—‡

* **Overview**
  * Excessive proliferation of Rokitansky-Aschoff sinuses, hyperplasia of gallbladder epithelium and smooth muscle
* **Presentation**
  * **Asymptomatic**: Most cases
* **Examination**
  * **[Ultrasound] Thickened gallbladder wall, comet-like echo**: Proliferated Rokitansky-Aschoff sinuses
  * **[MRCP] Pearl necklace appearance**: Proliferated Rokitansky-Aschoff sinuses
* **Management**
  * **Observation**: For asymptomatic cases
  * **Laparoscopic cholecystectomy**: For symptomatic cases or lesion with cancer risk
{: .notice--info}

### Gallbladder Cancer / èƒ†å›Šç™Œ

* **Overview**
  * Malignant tumor arising in gallbladder, poor prognosis due to late detection
  * Common in elderly females, risk factors include pancreaticobiliary maljunction and gallbladder dysplasia
* **Presentation**
  * **Asymptomatic, RUQ pain, nausea, vomiting, weight loss**: Local tumor effects
  * **Jaundice, pruritus**: Bile duct obstruction in advanced tumor
* **Examination**
  * **[Blood] ALPâ†‘, Î³-GTâ†‘**: Bile duct obstruction
  * **[Blood] CA19-9â†‘, CEAâ†‘**: Tumor markers
  * **[Ultrasound] Irregular mass, wall thickening**: Suspicious lesions 
  * **[EUS, CT, MRCP, ERCP] Mass lesion, filling defect**: Assess extent of disease
* **Management**
  * **[Resectable] Cholecystectomy + gallbladder bed resection + lymph node dissection**: For local tumor 
  * **[Unresectable] Gemcitabine + cisplatin/S-1**: For metastatic tumor
  * **[Symptomatic] Biliary drainage (ENBD, stent)**: Relieve obstructive jaundice
{: .notice--info}

### Cholangiocarcinoma / èƒ†ç®¡ç™Œ

* **Overview**
  * Malignant tumor arising in extrehepatic bile duct, poor prognosis due to late detection
  * Common in elderly males, risk factors include pancreaticobiliary maljunction and primary sclerosing cholangitis
* **Presentation**
  * **Jaundice, pruritus, painless gallbladder enlargement (Courvoisier's sign)**: Bile duct obstruction
  * **Upper abdominal pain, weight loss, fever**: Local tumor effects
* **Examination**
  * **[Blood] ALPâ†‘, Î³-GTâ†‘**: Bile duct obstruction
  * **[Blood] CA19-9â†‘, CEAâ†‘**: Tumor markers
  * **[Ultrasound] Dilated bile ducts, mass lesion**: Tumor obstruction
  * **[EUS, CT, MRCP, ERCP] Mass lesion, filling defect**: Assess extent of disease
* **Management**
  * **[Resectable] Hepatectomy + bile duct resection + lymph node dissection**: For local tumor in hilar region
  * **[Resectable] Pancreaticoduodenectomy + lymph node dissection**: For local tumor in distal region
  * **[Unresectable] Gemcitabine + cisplatin/S-1**: For metastatic tumor
  * **[Symptomatic] Biliary drainage (ENBD, stent, PTBD)**: Relieve obstructive jaundice
{: .notice--info}

### Peripapillary Carcinoma / ä¹³é ­éƒ¨ç™Œ

* **Overview**
  * Malignant tumor arising in ampulla of Vater
  * Common in 60s males
* **Presentation**
  * **Fluctuating jaundice, dark urine, painless gallbladder enlargement (Courvoisier's sign)**: Bile duct obstruction
  * **Fever, abdominal pain**: Local tumor effects
* **Examination**
  * **[Blood] ALPâ†‘, Î³-GTâ†‘**: Bile duct obstruction
  * **[Blood] CA19-9â†‘, CEAâ†‘**: Tumor markers
  * **[Ultrasound] Dilated pancreatic and bile ducts, mass lesion**: Tumor obstruction
  * **[Endoscopy] Irregular mass at duodenal papilla**: Direct visualization
  * **[EUS, CT, MRCP] Mass lesion, filling defect**: Assess extent of disease
* **Management**
  * **[Resectable] Pancreaticoduodenectomy + lymph node dissection**: For local tumor
  * **[Unresectable] Chemotherapy**: For metastatic tumor
  * **[Symptomatic] Biliary drainage (ENBD, stent, PTBD)**: Relieve obstructive jaundice
{: .notice--info}

## Pancreas Disorder / è†µç–¾æ‚£

### Acute Pancreatitis / æ€¥æ€§è†µç‚

* **Overview**
  * Self-digestion of pancreas by activated pancreatic enzymes, leading to multi-organ failure in severe cases
  * Common causes include alcohol and gallstones
* **Presentation**
  * **Epigastric/back pain, fever, nausea, vomiting**: Pancreatic inflammation, improves in knee-chest position
  * **Abdominal tenderness, muscle guarding, decreased bowel sounds**: Peritoneal irritation
  * **Shock, respiratory failure, oliguria, altered consciousness**: Cytokine storm due to pancreas self-digestion in severe cases
* **Examination**
  * **[Blood] Amylaseâ†‘, lipaseâ†‘**: Pancreatic enzyme activation
  * **[Blood] Plateletsâ†“, Caâ†“, CRPâ†‘, BUNâ†‘, Crâ†‘, coagulation disorders**: Multi-organ dysfunction in severe cases
  * **[CT/MRI/US] Pancreatic swelling, blurred outline, fluid collection**: Pancreatic self-digestion
* **Management**
  * **NPO, IV fluids, pain control**: Conservative treatment in mild cases
  * **Antibiotics, protease inhibitors, enteral nutrition**: Prevent complications in severe cases
  * **ERCP, EST**: Resolve obstruction if gallstone present
  * **Drainage, necrosectomy**: Remove necrotic tissue
{: .notice--info}

### Chronic Pancreatitis / æ…¢æ€§è†µç‚

* **Overview**
  * Progressive and irreversible pancreatic damage with fibrosis and calcification
  * Common in middle-aged men with long-term alcohol use
* **Presentation**
  * **Recurrent epigastric/back pain**: Pancreatic inflammation, worsens with alcohol/fat intake
  * **Steatorrhea, diarrhea**: Exocrine insufficiency in decompensated stage
  * **Diabetes symptoms, weight loss**: Endocrine insufficiency in decompensated stage
* **Examination**
  * **[Blood] Amylase/lipaseâ†‘ or â†“**: Compensated or decompensated pancreatic function
  * **[US/CT] Pancreatic duct dilation, pancreatic stones**: Pancreatic duct obstruction by stones
  * **[MRCP/ERCP] Pancreatic duct dilation, filling defects**: Pancreatic duct obstruction by stones
  * **[BT-PABA test] PABA excretionâ†“**: Exocrine insufficiency
* **Management**
  * **Alcohol/smoking cessation, low-fat diet**: Prevent progression
  * **NSAIDs, anticholinergics, enzyme inhibitors**: Relieve symptoms
  * **ESWL, endoscopic treatment**: Remove stones
  * **Pancreatic enzymes, insulin**: For exocrine and endocrine insufficiency
{: .notice--info}

### Autoimmune Pancreatitis / è‡ªå·±å…ç–«æ€§è†µç‚

* **Overview**
  * Chronic progressive pancreatitis with autoimmune nature
  * Common in elderly males
* **Presentation**
  * **Jaundice, epigastric discomfort**: Pancreatic inflammation
  * **Diabetes mellitus**: Pancreatic endocrine dysfunction
* **Examination**
  * **[Blood] Î³-globulinâ†‘, IgGâ†‘, IgG4â†‘, ANA(+), RF(+)**: Autoimmune nature
  * **[Blood] Amylaseâ†‘, lipaseâ†‘, Î³-GTâ†‘, ALPâ†‘**: Pancreatic inflammation and biliary obstruction
  * **[CT/MRI/US] Pancreatic enlargement**: Pancreatic inflammation
  * **[ERCP/MRCP] Pancreatic duct narrowing**: Pancreas chronic inflammation
  * **[Biopsy] IgG4-positive plasma cell infiltration, fibrosis**: Confirms diagnosis
* **Management**
  * **Corticosteroids**: Suppress inflammation
{: .notice--info}

### Pancreatic Cancer / è†µç™Œ

* **Overview**
  * Malignant tumor arising from pancreatic ductal epithelium, poor prognosis due to late detection
  * Common in elderly, risk factors include chronic pancreatitis, diabetes, smoking
* **Presentation**
  * **Abdominal/back pain**: Local tumor invasion
  * **Jaundice**: Biliary tract obstruction
  * **Weight loss, indigestion, diabetes**: Impaired pancreatic function
* **Examination**
  * **[Blood] Amylaseâ†‘, lipaseâ†‘**: Pancreatic damage
  * **[Blood] CA19-9â†‘, SPAN-1â†‘, DUPAN-2â†‘, CEAâ†‘**: Tumor markers
  * **[CT, US] Hypovascular pancreatic mass, dilated pancreatic duct**: Tumor obstruction
  * **[MRCP, ERCP] Stenosis/obstruction of pancreatic/bile duct**: Tumor obstruction
  * **[EUS-FNA] Malignant ductal cells**: Confirmatory diagnosis
* **Management**
  * **[Resectable] Pancreaticoduodenectomy, distal pancreatectomy (with/without neoadjuvant/adjuvant therapy)**: For tumors without major vessel invasion
  * **[Unresectable] Chemotherapy (FOLFIRINOX, gemcitabine+nab-paclitaxel)**: For tumor with major vessel invasion or metastasis
  * **[Paliative] Biliary stenting, gastric bypass, pain control**: Symptom management
{: .notice--info}

### Pancreatic Pseudocyst / è†µä»®æ€§å›Šèƒ

* **Overview**
  * Non-epithelial-lined pancreatic cyst formed by encapsulation of leaked pancreatic fluid and necrotic material
  * Commonly from pancreatitis or trauma
* **Presentation**
  * **Asymptomatic, abdominal discomfort, nausea, vomiting**: Compression by cysts
* **Examination**
  * **[CT, US] Unilocular cyst**: Confirms diagnosis
* **Management**
  * **Observation**: May resolve spontaneously
  * **Drainage (endoscopic, percutaneous, surgical)**: For persistent symptoms or complications
{: .notice--info}

### Intraductal Papillary Mucinous Neoplasm / è†µç®¡å†…ä¹³é ­ç²˜æ¶²æ€§è…«ç˜

* **Overview**
  * Papillary tumor growing within pancreatic ducts with mucin production, may progress to malignant tumor
  * Common in elderly males, mostly in pancreatic head
* **Presentation**
  * **Asymptomatic, abdominal discomfort, acute pancreatitis**: Tumor compression and duct obstruction
* **Examination**
  * **[US/CT/MRI] Dilated pancreatic duct (main duct type), grape-like multicystic lesions (branch duct type)**: Different patterns of ductal involvement
* **Management**
  * **Observation**: For low malignant risk cases
  * **Pancreaticoduodenectomy**: For high malignant risk cases
{: .notice--info}

### Mucinous Cystic Neoplasm / ç²˜æ¶²æ€§å›Šèƒè…«ç˜

* **Overview**
  * Cystic tumor with mucin-producing epithelium and ovarian-like stroma, may be malignant
  * Common in middle-aged women, mostly in pancreatic body/tail
* **Presentation**
  * **Asymptomatic, abdominal discomfort**: Tumor compression
* **Examination**
  * **[US/CT/MRI] Huge multilocular cyst**: Orange-like appearance
* **Management**
  * **Distal pancreatectomy**: Due to malignant potential
{: .notice--info}

### Serous Cystic Neoplasm / æ¼¿æ¶²æ€§å›Šèƒè…«ç˜

* **Overview**
  * Cystic tumor with serous fluid-filled cysts, mostly benign
  * Common in elderly women, mostly in pancreatic body/tail
* **Presentation**
  * **Asymptomatic**: Smaller tumor
* **Examination**
  * **[US/CT/MRI] Clustered microcysts**: Honeycomb appearance
* **Management**
  * **Observation**: Due to low malignant potential
{: .notice--info}

<!-- 
## Esophageal Disease / é£Ÿé“ç–¾æ‚£

### Achalasia / é£Ÿé“ã‚¢ã‚«ãƒ©ã‚·ã‚¢
### Gastroesophageal Reflux Disease / èƒƒé£Ÿé“é€†æµç—‡
### Eosinophilic Esophagitis / å¥½é…¸çƒæ€§é£Ÿé“ç‚
### Esophageal Candidiasis / é£Ÿé“ã‚«ãƒ³ã‚¸ãƒ€ç—‡
### Mallory-Weiss Syndrome / Mallory-Weissç—‡å€™ç¾¤
### Spontaneous Rupture of the Esophagus / ç‰¹ç™ºæ€§é£Ÿé“ç ´è£‚
### Esophageal Cancer / é£Ÿé“ç™Œ
### Esophagogastric Varices / é£Ÿé“ãƒ»èƒƒé™è„ˆç˜¤
### Esophageal Diverticulum / é£Ÿé“æ†©å®¤

## Gastric and Duodenal Disease / èƒƒãƒ»åäºŒæŒ‡è…¸ç–¾æ‚£

### Acute Gastric Mucosal Lesion / æ€¥æ€§èƒƒç²˜è†œç—…å¤‰
### Chronic Gastritis / æ…¢æ€§èƒƒç‚
### Functional Dyspepsia / æ©Ÿèƒ½æ€§ãƒ‡ã‚£ã‚¹ãƒšãƒ—ã‚·ã‚¢
### Gastro-Duodenal Ulcer / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜
### Gastro-Duodenal Ulcer Perforation / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜ç©¿å­”
### Gastric Polyp / èƒƒãƒãƒªãƒ¼ãƒ—
### GIST / æ¶ˆåŒ–ç®¡é–“è³ªè…«ç˜
### Gastrointestinal Malignant Lymphoma / æ¶ˆåŒ–ç®¡æ‚ªæ€§ãƒªãƒ³ãƒ‘è…«
### Gastric Cancer / èƒƒç™Œ
### Dumping Syndrome / ãƒ€ãƒ³ãƒ”ãƒ³ã‚°ç—‡å€™ç¾¤
### Gastro-Duodenal Diverticulum / èƒƒãƒ»åäºŒæŒ‡è…¸æ†©å®¤
### Superior Mesenteric Artery Syndrome / ä¸Šè…¸é–“è†œå‹•è„ˆç—‡å€™ç¾¤
### MÃ©nÃ©trier's Disease / MÃ©nÃ©trierç—…

## Intestinal and Colonic Disease / å°è…¸ãƒ»å¤§è…¸ç–¾æ‚£

### Crohn's Disease / Crohnç—…
### Ulcerative Colitis / æ½°ç˜æ€§å¤§è…¸ç‚
### Intestinal Tuberculosis / è…¸çµæ ¸
### Infectious Enterocolitis / æ„ŸæŸ“æ€§è…¸ç‚
### Pseudomembranous Colitis / å½è†œæ€§å¤§è…¸ç‚
### Antibiotic-Associated Hemorrhagic Colitis / æŠ—èŒè–¬é–¢é€£å‡ºè¡€æ€§å¤§è…¸ç‚
### MRSA Enteritis / MRSAè…¸ç‚
### Irritable Bowel Syndrome / éæ•æ€§è…¸ç—‡å€™ç¾¤
### Colonic Polyp / å¤§è…¸ãƒãƒªãƒ¼ãƒ—
### Colorectal Cancer / å¤§è…¸ç™Œ
### Lynch Syndrome / Lynchç—‡å€™ç¾¤
### Small Intestine Tumor / å°è…¸è…«ç˜
### Gastrointestinal Neuroendocrine Neoplasm / æ¶ˆåŒ–ç®¡ç¥çµŒå†…åˆ†æ³Œè…«ç˜
### Familial Adenomatous Polyposis / å®¶æ—æ€§è…ºè…«æ€§ãƒãƒªãƒãƒ¼ã‚·ã‚¹
### Peutz-Jeghers Syndrome / Peutz-Jeghersç—‡å€™ç¾¤
### Malabsorption Syndrome / å¸åä¸è‰¯ç—‡å€™ç¾¤
### Protein-Losing Gastroenteropathy / è›‹ç™½æ¼å‡ºæ€§èƒƒè…¸ç—‡
### Ischemic Colitis / è™šè¡€æ€§å¤§è…¸ç‚
### Acute Mesenteric Artery Occlusion / æ€¥æ€§è…¸é–“è†œå‹•è„ˆé–‰å¡ç—‡
### Occlusive Ileus / é–‰å¡æ€§è…¸é–‰å¡
### Strangulation Ileus / çµæ‰¼æ€§è…¸é–‰å¡
### Paralytic Ileus / éº»ç—ºæ€§ã‚¤ãƒ¬ã‚¦ã‚¹
### Colonic Diverticulum / å¤§è…¸æ†©å®¤
### Acute Appendicitis / æ€¥æ€§è™«å‚ç‚

## Anal Disease / è‚›é–€ç–¾æ‚£

### Hemorrhoids / ç—”æ ¸
### Anal Fissure / è£‚è‚›
### Perianal Abscess / è‚›é–€å‘¨å›²è†¿ç˜
### Anal Fistula / ç—”ç˜»
### Rectal Prolapse / ç›´è…¸è„±

## Peritoneal Disease / è…¹è†œç–¾æ‚£

### Inguinal Hernia / é¼ å¾„ãƒ˜ãƒ«ãƒ‹ã‚¢
### Femoral Hernia / å¤§è…¿ãƒ˜ãƒ«ãƒ‹ã‚¢
### Obturator Hernia / é–‰é–å­”ãƒ˜ãƒ«ãƒ‹ã‚¢
### Abdominal Incisional Hernia / è…¹å£ç˜¢ç—•ãƒ˜ãƒ«ãƒ‹ã‚¢
### Umbilical Hernia / è‡ãƒ˜ãƒ«ãƒ‹ã‚¢
### Esophageal Hiatal Hernia / é£Ÿé“è£‚å­”ãƒ˜ãƒ«ãƒ‹ã‚¢
### Acute Peritonitis / æ€¥æ€§è…¹è†œç‚
### Spontaneous Bacterial Peritonitis / ç‰¹ç™ºæ€§ç´°èŒæ€§è…¹è†œç‚
### Cancerous Peritonitis / ç™Œæ€§è…¹è†œç‚
### Pseudomyxoma Peritonei / è…¹è†œå½ç²˜æ¶²è…«

## Liver Disease / è‚ç–¾æ‚£

### Hepatitis A / Aå‹è‚ç‚
### Hepatitis B / Bå‹è‚ç‚
### Hepatitis C / Cå‹è‚ç‚
### Hepatitis D / Då‹è‚ç‚
### Hepatitis E / Eå‹è‚ç‚
### Acute Viral Hepatitis / æ€¥æ€§ã‚¦ã‚¤ãƒ«ã‚¹æ€§è‚ç‚
### Chronic Viral Hepatitis / æ…¢æ€§ã‚¦ã‚¤ãƒ«ã‚¹æ€§è‚ç‚
### Drug-Induced Liver Injury / è–¬å‰¤æ€§è‚éšœå®³
### Acute Liver Failure / æ€¥æ€§è‚ä¸å…¨
### Fatty Liver / è„‚è‚ªè‚
### Nonalcoholic Steatohepatitis / éã‚¢ãƒ«ã‚³ãƒ¼ãƒ«æ€§è„‚è‚ªæ€§è‚ç‚
### Alcoholic Liver Disease / ã‚¢ãƒ«ã‚³ãƒ¼ãƒ«æ€§è‚éšœå®³
### Autoimmune Hepatitis / è‡ªå·±å…ç–«æ€§è‚ç‚
### Primary Biliary Cholangitis / åŸç™ºæ€§èƒ†æ±æ€§èƒ†ç®¡ç‚
### Primary Sclerosing Cholangitis / åŸç™ºæ€§ç¡¬åŒ–æ€§èƒ†ç®¡ç‚
### Liver Cirrhosis / è‚ç¡¬å¤‰
### Hepatocellular Carcinoma / è‚ç´°èƒç™Œ
### Intrahepatic Cholangiocarcinoma / è‚å†…èƒ†ç®¡ç™Œ
### Metastatic Liver Tumor / è»¢ç§»æ€§è‚ç™Œ
### Hepatic Hemangioma / è‚è¡€ç®¡è…«
### Hepatic Cyst / è‚åš¢èƒ
### Liver Abscess / è‚è†¿ç˜
### Idiopathic Portal Hypertension / ç‰¹ç™ºæ€§é–€è„ˆåœ§äº¢é€²ç—‡
### Budd-Chiari Syndrome / Budd-Chiariç—‡å€™ç¾¤

## Biliary Disease / èƒ†é“ç–¾æ‚£

### Cholelithiasis / èƒ†çŸ³ç—‡
### Acute Cholecystitis / æ€¥æ€§èƒ†åš¢ç‚
### Acute Cholangitis / æ€¥æ€§èƒ†ç®¡ç‚
### Gallbladder Adenomyomatosis / èƒ†åš¢è…ºç­‹è…«ç—‡
### Gallbladder Cancer / èƒ†åš¢ç™Œ
### Bile Duct Cancer / èƒ†ç®¡ç™Œ
### Cancer of Pipilla of Vator / ä¹³é ­éƒ¨ç™Œ

## Pancreatic Disease / è†µç–¾æ‚£

### Acute Pancreatitis / æ€¥æ€§è†µç‚
### Chronic Pancreatitis / æ…¢æ€§è†µç‚
### Autoimmune Pancreatitis / è‡ªå·±å…ç–«æ€§è†µç‚
### Pancreatic Carcinoma / è†µç™Œ
### Pancreatic Psuedocyst / è†µä»®æ€§åš¢èƒ
### Intraductal Papillary Mucinous Neoplasm / è†µç®¡å†…ä¹³é ­ç²˜æ¶²æ€§è…«ç˜
### Mucinous Cystic Neoplasm / ç²˜æ¶²æ€§åš¢èƒè…«ç˜
### Serous Cystic Neoplasm / æ¼¿æ¶²æ€§åš¢èƒè…«ç˜
### Pancreatic Neuroendocrine Neoplasm / è†µç¥çµŒå†…åˆ†æ³Œè…«ç˜ -->

# Endocrinology / å†…åˆ†æ³Œç§‘

## Pituitary Gland Disorder / ä¸‹å‚ä½“ç–¾æ‚£

### Acromegaly & Pituitary Gigantism / å…ˆç«¯å·¨å¤§ç—‡ãƒ»ä¸‹å‚ä½“æ€§å·¨äººç—‡

* **Overview**
  * Excess growth hormone secretion from pituitary adenoma
* **Presentation**
  * **Prominent brow, enlarged nose/lips, protruding jaw, enlarged hands/feet, macroglossia**: High GH causes bone and soft tissue overgrowth
  * **Headache, visual disturbance**: Pituitary tumor compressing optic chiasm
* **Examination**
  * **[Blood] GHâ†‘ (not suppressed by glucose load), IGF-1â†‘**: Excess GH secretion
  * **[MRI/CT] Pituitary adenoma**: Identify tumor
  * **[X-ray] Sella turcica ballooning/double floor, enlarged sinuses, cauliflower-like terminal phalanges, enlarged sesamoid bones, thick heel pad**: Bone and soft tissue overgrowth
* **Management**
  * **Transsphenoidal surgery**: Remove pituitary adenoma
  * **Somatostatin analogs (octreotide, lanreotide, pasireotide), GH receptor antagonist (pegvisomant)**: Suppress GH secretion/action
  * **Radiation therapy**: For recurrent or inoperable cases
{: .notice--info}

### Hyperprolactinemia / é«˜ãƒ—ãƒ­ãƒ©ã‚¯ãƒãƒ³è¡€ç—‡

* **Overview**
  * Excessive prolactin secretion from pituitary adenoma or due to medication
* **Presentation**
  * **Galactorrhea, menstrual irregularities, infertility (women)**: High prolactin suppresses LH/FSH
  * **Decreased libido, penile atrophy (men)**: High prolactin suppresses testosterone
  * **Headache, visual disturbance**: Pituitary tumor compressing optic chiasm
* **Examination**
  * **[Blood] Prolactinâ†‘, FT4â†“ (in some cases)**: Excess prolactin secretion
  * **[MRI/CT] Pituitary/hypothalamic lesions**: Identify tumor
* **Management**
  * **Dopamine agonists (bromocriptine, cabergoline)**: Suppress prolactin secretion
  * **Transsphenoidal surgery**: Remove pituitary adenoma or hypothalamic lesions
  * **Radiation therapy**: For recurrent or inoperable cases
  * **Discontinue causative medication, thyroid hormone replacement**: Treat other possible causes 
{: .notice--info}

### Cushing's Disease / Cushingç—…

* **Overview**
  * Excessive ACTH secretion from pituitary adenoma
* **Presentation**
  * **Moon face, central obesity, buffalo hump, purple striae, thin skin**: High cortisol causes abnormal fat distribution and skin
  * **Hypertension, edema, glucose intolerance, osteoporosis, easy bruising**: High cortisol causes metabolic effects
  * **Acne, menstrual irregularities, hirsutism**: High androgens causes reproductive effects
* **Examination**
  * **[Blood] ACTHâ†‘, cortisolâ†‘, DHEA-Sâ†‘**: ACTH-dependent hypercortisolism
  * **[Blood] Naâ†‘, Kâ†“, pHâ†‘**: Mineralocorticoid effects
  * **[Endocrine tests] Cortisol circadian rhythm loss, absence low-dose dexamethasone suppression**: Autonomous ACTH secretion
  * **[MRI/CT] Pituitary adenoma**: Identify tumor
  * **[Inferior petrosal sinus sampling] ACTHâ†‘**: Confirm pituitary source
* **Management**
  * **Transsphenoidal surgery**: Remove pituitary adenoma
  * **Pasireotide, cabergoline, metyrapone, trilostane, mitotane**: Suppress ACTH/cortisol secretion
  * **Radiation therapy**: For recurrent or inoperable cases
{: .notice--info}

### Panhypopituitarism / æ±ä¸‹å‚ä½“æ©Ÿèƒ½ä½ä¸‹ç—‡

* **Overview**
  * Deficiency of multiple anterior pituitary hormones
  * Causes include supresellar/pituitary tumor, lymphocytic hypophysitis, Sheehan syndrome
* **Presentation**
  * **Amenorrhea, breast/genital atrophy (women), decreased libido, testicular atrophy (men)**: LH/FSH deficiency
  * **Decreased muscle mass, increased body fat**: GH deficiency
  * **Cold intolerance, dry skin, constipation, bradycardia**: TSH deficiency
  * **Fatigue, anorexia, hypotension, hypoglycemia**: ACTH deficiency
* **Examination**
  * **[Blood] Hormone levelsâ†“ (LH/FSH, GH, TSH, ACTH)**: Pituitary dysfunction
  * **[Blood] Target organ hormonesâ†“ (sex hormones , IGF-I, FT4/FT3, cortisol)**: End-organ hormone deficiency
  * **[CT/MRI] Pituitary/hypothalamic lesions**: Identify causes
* **Management**
  * **Sex hormones, levothyroxine, hydrocortisone**: Hormone replacement
  * **Surgery, medication, radiation**: Treatment of underlying cause
{: .notice--info}

### Growth Hormone Deficiency / æˆé•·ãƒ›ãƒ«ãƒ¢ãƒ³åˆ†æ³Œä¸å…¨æ€§ä½èº«é•·ç—‡

* **Overview**
  * Insufficient GH secretion leading to decreased growth velocity
  * Causes include idiopathic (peripartum events) or tumor
* **Presentation**
  * **Height < -2.0 SD, growth velocity < -1.5 SD, proportionate stature**: Decreased growth velocity
  * **Hypoglycemia in infants**: Due to GH deficiency
  * **Other pituitary hormone deficiency**: In cases of combined deficiency
* **Examination**
  * **[Stimulation tests] GH peakâ†“ with insulin/arginine/L-dopa/clonidine/glucagon/GHRP-2**: Confirms GH deficiency
  * **[CT/MRI] Pituitary hypoplasia or tumor**: Identify organic causes
* **Management**
  * **GH replacement**: Hormone replacement therapy
{: .notice--info}

### Hypogonadotropic Hypogonadism / ã‚´ãƒŠãƒ‰ãƒˆãƒ­ãƒ”ãƒ³å˜ç‹¬æ¬ æç—‡

* **Overview**
  * Insufficient LH/FSH secretion leading to decreased gonadal function
  * Causes include congenital (Kallmann syndrome, Laurence-Moon-Biedl syndrome, Prader-Willi syndrome) or acquired (tumor, inflammation)
* **Presentation**
  * **Genital atrophy, absent secondary sexual development**: Incomplete sexual development
  * **Amenorrhea, decreased libido, infertility**: Decreased gonadal function
  * **[Kallmann syndrome] Anosmia**: Olfactory nerve hypoplasia
  * **[Prader-Willi syndrome] Hypotonia, hypogonadism, hypomentia, obesity**: Chromosomal loss or inactivation
* **Examination**
  * **[Blood] LH/FSHâ†“, androgens/estrogensâ†“**: Confirms gonadotropin deficiency
* **Management**
  * **Testosterone/estrogen replacement**: For secondary sexual development
  * **Gonadotropin therapy, Holmstrom/Kaufmann therapy**: For fertility treatment
{: .notice--info}

### Isolated ACTH Deficiency / ACTHå˜ç‹¬æ¬ æç—‡

* **Overview**
  * Insufficient ACTH secretion leading to adrenal insufficiency
  * Causes include autoimmune or immune checkpoint inhibitors
* **Presentation**
  * **Fatigue, weight loss, anorexia, hypotension, hypoglycemia, hyponatremia**: Cortisol deficiency
* **Examination**
  * **[Blood] ACTHâ†“, cortisolâ†“**: Confirms ACTH deficiency
* **Management**
  * **Hydrocortisone replacement**: Hormone replacement therapy
{: .notice--info}

### SIADH / ãƒã‚½ãƒ—ãƒ¬ã‚·ãƒ³åˆ†æ³Œéå‰°ç—‡

* **Overview**
  * Water retention and hyponatremia due to inappropriate continuous AVP secretion
  * Causes include malignancies (SCLC), medications (vincristine), CNS diseases, thoracic diseases
* **Presentation**
  * **Fatigue, decreased appetite, altered consciousness**: Brain edema due to dilutional hyponatremia
* **Examination**
  * **[Blood] AVPâ†‘**: Inappropriate AVP secretion
  * **[Blood] Osmolalityâ†“, Naâ†“, BUNâ†“, uric acidâ†“**: Water retention and increased GFR
  * **[Urine] Osmolalityâ†‘, Naâ†‘**: Highly-concentrated urine
* **Management**
  * **[Mild] Water restriction, salt supplementation**: Correct hyponatremia
  * **[Severe] Furosemide + 3% saline**: Rapid correction of severe hyponatremia
  * **[Ectopic] V2 receptor antagonist (mozavaptan), demeclocycline**: Block AVP effect
  * **Treat underlying disease**: Address primary cause
{: .notice--info}

### Diabetes Insipidus / å°¿å´©ç—‡

* **Overview**
  * Excessive dilute urine due to insufficient secretion of AVP (central DI) or kidney resistance to AVP (nephrogenic DI)
* **Presentation**
  * **Polyuria, thirst, polydipsia**: Inability to concentrate urine
* **Examination**
  * **[Urine] Osmolalityâ†“, specific gravityâ†“**: Impaired water reabsorption
  * **[Diagnostic test] No response to hypertonic saline test / water deprivation test**: Differentiate DI from psychogenic polydipsia
  * **[DDAVP test] Response to vasopressin**: Differentiate central DI from nephrogenic DI
* **Management**
  * **[Central] Desmopressin acetate (DDAVP)**: Replaces AVP
  * **[Nephrogenic DI] Thiazide diuretics**: Reduces urine output
{: .notice--info}

## Thyroid Gland Disorder / ç”²çŠ¶è…ºç–¾æ‚£

### Graves' Disease / Basedowç—…

* **Overview**
  * Diffuse goiter and hyperthyroidism due to TSH receptor antibodies
  * Common in women aged 20-40 years
* **Presentation**
  * **Diffuse goiter, exophthalmos**: Antibodies attack thyroid gland and retrobulbar fat
  * **Tachycardia, palpitations, dyspnea, systolic hypertension**: Cardiovascular system activation
  * **Increased appetite, weight loss, fatigue, frequent bowel movements**: Increased metabolism
  * **Tremor, sweating**: Sympathetic nervous system activation
* **Examination**
  * **[Blood] FT4â†‘, FT3â†‘, TSHâ†“**: Thyroid hormone excess
  * **[Blood] TRAb/TSAb positive**: Autoimmune nature
  * **[Ultrasound] Diffuse thyroid enlargement**: Thyroid inflammation
  * **[Scintigraphy] Radioiodine/technetium uptakeâ†‘**: Hyperactive thyroid
* **Management**
  * **Thiamazole, propylthiouracil**: Inhibit thyroid hormone synthesis (stop if agranulocytosis)
  * **Î² blockers**: Control tachycardia
  * **Thyroidectomy, radioactive iodine**: For refractory cases
{: .notice--info}

### Plummer's Disease / Plummerç—…

* **Overview**
  * Hyperthyroidism due to functioning thyroid nodule
* **Presentation**
  * **Hyperthyroidism symptoms, no exophthalmos**: Excess thyroid hormone without autoimmune nature
* **Examination**
  * **[Blood] FT3â†‘, FT4â†‘, TSHâ†“**: Thyroid hormone excess
  * **[Blood] TRAb negative**: Without autoimmune nature
  * **[Scintigraphy] Radioiodine/technetium uptakeâ†‘ (hot nodule)**: Autonomous nodule produces hormone
* **Management**
  * **Surgical removal, radioactive iodine therapy**: Remove autonomous nodule
{: .notice--info}

### Subacute Thyroiditis / äºœæ€¥æ€§ç”²çŠ¶è…ºç‚

* **Overview**
  * Follicular destruction and transient thyrotoxicosis with unknown cause (likely viral infection)
  * Common in women aged 30-50
* **Presentation**
  * **Upper respiratory infection-like symptoms**: Viral infection
  * **Painful thyroid swelling**: Thyroid inflammation
  * **High fever, fatigue, palpitations, sweating, tremor, weight loss**: Thyrotoxicosis due to excessive hormone release
* **Examination**
  * **[Blood] ESRâ†‘, CRPâ†‘**: Thyroid inflammation
  * **[Blood] FT4â†‘, TSHâ†“**: Thyrotoxicosis
  * **[Ultresound] Ill-defined hypoechoic areas**: Thyroid inflammation
  * **[Scintigraphy] Radioiodine/technetium uptakeâ†“**: Destroyed follicular cells
* **Management**
  * **NSAIDs**: Mostly self-limiting
  * **Corticosteroids**: For severe inflammation
  * **Beta blockers**: For thyrotoxicosis symptoms
{: .notice--info}

### Painless Thyroiditis / ç„¡ç—›æ€§ç”²çŠ¶è…ºç‚

* **Overview**
  * Follicular destruction and transient thyrotoxicosis, often developing from chronic thyroiditis
  * Common in women aged 20-40 with chronic thyroiditis
* **Presentation**
  * **Palpitations, tachycardia, sweating, tremor, fatigue, weight loss**: Thyrotoxicosis due to excessive hormone release
  * **No thyroid pain or fever**: Distinguishes from subacute thyroiditis
* **Examination**
  * **[Blood] FT4â†‘, TSHâ†“**: Thyrotoxicosis
  * **[Ultrasound] Decreased thyroid blood flow**: Distinguishes from Graves' disease
  * **[Scintigraphy] Radioiodine/technetium uptakeâ†“**: Destroyed follicular cells
* **Management**
  * **Observation**: Mostly self-limiting
  * **Beta blockers**: For thyrotoxicosis symptoms
{: .notice--info}

### Chronic Thyroiditis / æ…¢æ€§ç”²çŠ¶è…ºç‚ï¼ˆæ©‹æœ¬ç—…ï¼‰

* **Overview**
  * Chronic thyroiditis and hypothyroidism due to auto-antibodies
  * Common in middle-aged women
* **Presentation**
  * **Cold intolerance, dry skin, reduced sweating, non-pitting edema, weight gain, muscle weakness**: Decreased metabolism due to hypothyroidism
  * **Cardiomegaly, bradycardia, hypotension, pericardial effusion**: Cardiovascular effects of hypothyroidism
  * **Constipation, somnolence, slow movement, hoarseness, menorrhagia**: Multiple system effects of hypothyroidism
  * **Delayed tendon reflexes**: Especially delayed Achilles tendon relaxation phase
* **Examination**
  * **[Blood] FT4â†“, TCâ†‘**: Hypothyroidism
  * **[Blood] Anti-Tg antibody(+), Anti-TPO antibody(+)**: Autoimmune nature
  * **[Ultrasound] Diffuse thyroid enlargement**: Thyroid inflammation
  * **[FNA] Lymphocytic infiltration**: Confirms diagnosis
* **Management**
  * **Observation**: For euthyroid cases
  * **T4 replacement**: For hypothyroid cases
{: .notice--info}

### Adenomatous Nodule or Goiter / è…ºè…«æ§˜çµç¯€ãƒ»ç”²çŠ¶è…ºè…«

* **Overview**
  * Hyperplastic lesions of thyroid gland with single or multiple nodules
* **Presentation**
  * **Palpable thyroid nodules**: Nodular enlargement of thyroid gland
* **Examination**
  * **[Ultrasound] Multiple nodules and cysts**: Hyperplastic changes
* **Management**
  * **Observation**: If no suspicious features
{: .notice--info}

### Follicular Adenoma / æ¿¾èƒè…ºè…«

* **Overview**
  * Benign tumor from thyroid follicular epithelium, without capsular/vascular invasion or metastasis
* **Presentation**
  * **Asymptomatic, thyroid nodule**: Nodular enlargement of thyroid gland
* **Examination**
  * **[FNA] Follicular cell clusters**: Cannot differentiate from follicular carcinoma
  * **[Pathology] No capsular/vascular invasion**: Definitive diagnosis after lobectomy
* **Management**
  * **Thyroid lobectomy**: For both diagnosis and treatment
{: .notice--info}

### Papillary Thyroid Carcinoma / ç”²çŠ¶è…ºä¹³é ­ç™Œ

* **Overview**
  * Malignant tumor from thyroid follicular epithelium, good prognosis
  * Commonly in 30-50 years old females
* **Presentation**
  * **Asymptomatic, neck lymph node swelling**: Commonly lymphatic spread
* **Examination**
  * **[Ultrasound] Ill-defined irregular mass, microcalcification**: Characteristic imaging findings
  * **[Pathology, FNA] Papillary structure, ground glass nuclei, nuclear grooves, intranuclear inclusions**: Definite diagnosis
  * **[Blood] Thyroglobulinâ†‘**: Can be used as tumor marker
* **Management**
  * **Lobectomy, total thyroidectomy**: Primary treatment
  * **Radioactive iodine therapy**: For distant metastasis
{: .notice--info}

### Follicular Thyroid Carcinoma / ç”²çŠ¶è…ºæ¿¾èƒç™Œ

* **Overview**
  * Malignant tumor from thyroid follicular epithelium, good prognosis
  * Commonly in 30-50 years old females
* **Presentation**
  * **Asymptomatic, distant metastasis**: Commonly hematogenous spread
* **Examination**
  * **[Pathology, FNA] Follicular structure, capsular/vascular invasion**: Definitive diagnosis requires surgical specimen
  * **[Blood] Thyroglobulinâ†‘**: Can be used as tumor marker
* **Management**
  * **Lobectomy, total thyroidectomy**: Primary treatment
  * **Radioactive iodine therapy**: For distant metastasis
{: .notice--info}

### Anaplastic Thyroid Carcinoma / ç”²çŠ¶è…ºæœªåˆ†åŒ–ç™Œ

* **Overview**
  * Malignant tumor transformed from highly-differentiated thyroid cancer, worse prognosis
* **Presentation**
  * **Rapidly growing neck mass, fever, pain**: Aggressive growth with inflammation
  * **Hoarseness, dyspnea, dysphagia**: Invasion of surrounding tissues
* **Examination**
  * **[Blood] WBCâ†‘, ESRâ†‘, CRPâ†‘**: Marked inflammation
  * **[Pathology, FNA] Large atypical cells, giant/multiple nuclei**: Definite diagnosis
* **Management**
  * **Radiation therapy, chemotherapy, targeted therapy**: Primary treatment
{: .notice--info}

### Medullary Thyroid Carcinoma / ç”²çŠ¶è…ºé«„æ§˜ç™Œ

* **Overview**
  * Malignant tumor from thyroid parafollicular C-cells
  * Commonly hereditary and associated with MEN2
* **Presentation**
  * **Thyroid mass**: Common in upper thyroid
  * **Pheochromocytoma, hyperparathyroidism**: In MEN2 cases
* **Examination**
  * **[Pathology, FNA] Amyloid deposits, medullary structure**: Definite diagnosis
  * **[Blood] CEAâ†‘, calcitoninâ†‘**: Diagnostic and useful as tumor markers
  * **[Genetic testing] RET mutation**: For hereditary (MEN2) cases
* **Management**
  * **Lobectomy, total thyroidectomy**: Primary treatment
  * **Remove pheochromocytoma first**: For MEN2 cases
{: .notice--info}

### Malignant Lymphoma / æ‚ªæ€§ãƒªãƒ³ãƒ‘è…«

* **Overview**
  * Malignant lymphoma develops in elderly patients with Hashimoto's thyroiditis
* **Presentation**
  * **Rapidly growing neck mass**: May mimic anaplastic carcinoma
  * **Local compression symptoms**: Often without B symptoms
* **Examination**
  * **[Pathology, FNA] Diffuse large cell proliferation (DLBCL), diffuse/nodular growth with mixed B-cells (MALT)**: Definitive diagnosis
* **Management**
  * **Radiation therapy, chemotherapy (R-CHOP)**: Primary treatment
{: .notice--info}

## Parathyroid Gland Disorder / å‰¯ç”²çŠ¶è…ºç–¾æ‚£

## Adrenal Gland Disorder / å‰¯è…ç–¾æ‚£

## Neuroendocrine Tumor / ç¥çµŒå†…åˆ†æ³Œè…«ç˜

## Carbohydrate and Lipid Metabolism Disorder / ç³–ãƒ»è„‚è³ªä»£è¬ç•°å¸¸

## Uric Acid and Bone Metabolism Disorder / å°¿é…¸ãƒ»éª¨ä»£è¬ç•°å¸¸

## Congenital Metabolism Disorder / å…ˆå¤©ä»£è¬ç•°å¸¸

## Nutritional Disorder / æ „é¤Šç•°å¸¸

<!-- ### Endocrine Organ / å†…åˆ†æ³Œå™¨

* **Pituitary gland**
  * **Structure**: Anterior lobe (adenophysis), posterior lobe (neurophysis)
  * **Artery**: Superior hypophyseal artery (anterior lobe, hypophyseal portal system), inferior hypophyseal artery (posterior lobe)
  * **Cell (anterior)**: Acidophil (GH, PRL), basophil (TSH, FSL, LH, ACTH), chromophobe
  * **Cell (posterior)**: Nerve fiber (ADH, oxytocin from hypothalamus), pituicyte
* **Thyroid gland**
  * **Structure**: 2 lobes, isthmus
  * **Artery**: Superior thyroid artery (external carotid artery), inferior thyroid artery (thyrocervical trunk)
  * **Vein**: Superior thyroid vein (internal carotid vein), middle thyroid vein (internal carotid vein), inferior thyroid vein (brachiocephalic vein)
  * **Cell**: Follicular cell (thyroid hormone), parafollicular cell (calcitonin)
* **Parathyroid gland**
  * **Structure**: 2 upper glands, 2 lower glands
  * **Cell**: Chief cell (parathyroid hormone), oxyphil cell
* **Adrenal gland**
  * **Structure**: Adrenal cortex, adrenal medulla
  * **Artery**: Superior suprarenal artery (inferior phrenic artery), middle suprarenal artery (abdominal aorta), inferior suprarenal artery (renal artery)
  * **Vein**: Right suprarenal vein (inferior vena cava), left suprarenal vein (left renal vein)
  * **Adrenal cortex**: Zona glomerulosa (mineralcorticoid), zona fasciculata (glucocorticoid), zona reticulata (sex hormone)
  * **Adrenal medulla**: Chromaffin cell (epinephrine, norepinephrine), sympathetic presynaptic fiber
{: .notice--info} -->

<!-- ### Hypothalamus and Pituitary Hormone / è¦–åºŠä¸‹éƒ¨ãƒ»ä¸‹å‚ä½“ãƒ›ãƒ«ãƒ¢ãƒ³

* **Somatostatin analog**
  * **Drugs**: Octreotide, lantreotide
  * **Mechanism**: Somatostatin analog (decrease GH)
  * **Indication**: Acromegaly, esophageal variceal bleeding
* **GH agonist**
  * **Drugs**: Somatropin, somatrem, mecasermin
  * **Mechanism**: recombinant GH (somatropin, somatrem), recombinant IGF-1 (mecasermin)
  * **Indication**: Acromegaly, variceal bleeding
* **GH antagonist**
  * **Drugs**: Pegvisomant
  * **Mechanism**: GH antagonist
  * **Indication**: Acromegaly
* **Dopamine analog**
  * **Drugs**: Bromocriptine, cabergoline
  * **Mechanism**: Dopamine analog (decrease prolactin)
  * **Indication**: Hyperprolactenemia
* **GnRH agonist**
  * **Drugs**: Leuprolide, goserelin
  * **Mechanism**: GnRH agonist (pulsatile: increase FSH and LH, chronic: decrease FSH and LH)
  * **Indication**: Prostate cancer, endometriosis
* **GnRH antagonist**
  * **Drugs**: Abarelix, ganirelix
  * **Mechanism**: GnRH antagonist (decrease FSH and LH)
  * **Indication**: Prostate cancer, controlled ovarian stimulation
* **ADH agonist**
  * **Drugs**: Desmopressin
  * **Mechanism**: ADH V2 agonist
  * **Indication**: Central diabetes indipidus, hemophilia A
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: ADH V1/2 antagonist
  * **Indication**: SIADH
{: .notice--info}

### Thyroid Hormone / ç”²çŠ¶è…ºãƒ›ãƒ«ãƒ¢ãƒ³

* **Thyroid hormone**
  * **Drugs**: Liothyronine (T3), levothyroxine (T4), liotrix (mix)
  * **Mechanism**: Thyroid hormone
  * **Indication**: Hypothyroidism
* **Thioamide**
  * **Drugs**: Propylthiouracil, methimazole, carbimazole
  * **Mechanism**: Inhibit T4/T3 synthesis and conversion
  * **Indication**: Hyperthyroidism
  * **Adverse effect**: Agranulocytosis
* **Iodide**
  * **Drugs**: Iodide, lithium
  * **Mechanism**: Inhibit T4/T3 release, decrease thyroid vascularity
  * **Indication**: Before thyroid surgery 
* **Radioactive iodide**
  * **Drugs**: I-131
  * **Mechanism**: Destruct thyroid gland
  * **Indication**: Hyperthyroidism, thyroid carcinoma
* **Anion inhibitor**
  * **Drugs**: Perchlorate, pertechnetate, thriocyanate
  * **Mechanism**: Inhibit iodide entry
  * **Indication**: Hyperthyroidism
* **Other therapy**
  * **Drugs**: Î²-blocker, hydrocortisone
  * **Mechanism**: Inhibit T4/T3 conversion, release symptom
{: .notice--info}

### Adrenal Cortical Hormone / å‰¯è…é«„è³ªãƒ›ãƒ«ãƒ¢ãƒ³

* **Glucocorticoid**
  * **Drugs**: Short-acting: Cortisol, cortisone / Intermediate-acting: Prednisone, prednisolone, methylprednisolone, triamcinolone / Long-acting: Betamethasone, dexamethasone
  * **Mechanism**: GR receptor agonist
  * **Indication**: Inflammation, replacement therapy, Cushing syndrome diagnosis (dexamethasone)
  * **Adverse effect**: Adrenal suppression, hyperglycemia, osteoporosis, peptic ulcer
* **Mineralcorticoid**
  * **Drugs**: Desoxycorticosterone, fludrocortisone
  * **Mechanism**: MR receptor agonist
  * **Indication**: Replacement therapy
* **Synthesis inhibitor**
  * **Drugs**: Ketoconazole, metyrapone, aminoglutethimide
  * **Mechanism**: 17Î±-hydroxylase inhibitor (ketoconazole), 11Î²-hydroxylase inhibitor (metyrapone), cholesterol side chain cleaving enzyme inhibitor (aminoglutethimide)
  * **Indication**: Cushing syndrome, pituitary function test (metyrapone)
{: .notice--info}

### Sex Hormone / æ€§ãƒ›ãƒ«ãƒ¢ãƒ³

* **Estrogen**
  * **Drugs**: Estradiol, mestranol
  * **Mechanism**: Estrogen
  * **Indication**: Menopausal therapy, contraception
  * **Adverse effect**: Endometrial cancer, breast cancer
* **SERM**
  * **Drugs**: Clomiphene, raloxifene, tamoxifen
  * **Mechanism**: Selective estrogen receptor modulator
  * **Indication**: Ovary dysfunction infertility (clomiphene), osteoporosis (raloxifene), breast cancer (tamoxifen)
* **Estrogen antagonist**
  * **Drugs**: Fulvestrant
  * **Mechanism**: Estrogen antagonist
  * **Indication**: Breast cancer
* **Aromatase inhibitor**
  * **Drugs**: Letrozole, anastrolzole, exemestane
  * **Mechanism**: Aromatase inhibitor (decrease estrogen)
  * **Indication**: Breast cancer
* **Progestin**
  * **Drugs**: Norgestrel, desogestrol
  * **Mechanism**: Progestin
  * **Indication**: Endometriosis, contraception (with estrogen)
* **Progestin antagonist**
  * **Drugs**: Mifepristone
  * **Mechanism**: Progestin antagonist
  * **Indication**: Abortion
* **Androgen**
  * **Drugs**: Testosterone, oxandrolone, danazol
  * **Mechanism**: Androgen
  * **Indication**: Hypogonadism, endometriosis (danazol)
  * **Adverse effect**: Decreased testicular function
* **Androgen antagonist**
  * **Drugs**: Cyproterone, flutamide, bicalutamide, spironolactone
  * **Mechanism**: Androgen antagonist
  * **Indication**: Prostate cancer
* **5Î±-reductase inhibitor**
  * **Drugs**: Finasteride
  * **Mechanism**: 5Î±-reductase inhibitor (decrease DHT)
  * **Indication**: BPH, male-pattern baldness
{: .notice--info}

### Glucose Homeostasis / ç³–ä»£è¬ã®è–¬

* **Insulin**
  * **Drugs**: Rapid-acting: insulin lispro, insulin aspart / Short-acting: Regular insulin / Intermediate-acting: NPH / Long-acting: insulin glargine, insulin detemir, insulin degludec
  * **Mechanism**: Insulin
  * **Indication**: Diabetes mellitus
* **Sulfonylurea**
  * **Drugs**: Glyburide, glipizide, glimepiride, tolbutamide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Meglitinide**
  * **Drugs**: Rapaglinide, nateglinide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **GLP-1 agonist**
  * **Drugs**: Exenatide, liraglutide
  * **Mechanism**: GLP-1 analog (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **DPP-4 inhibitor**
  * **Drugs**: Sitagliptin, saxagliptin
  * **Mechanism**: DPP-4 inhibitor (increase GLP-1, increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Biguanide**
  * **Drugs**: Metformin
  * **Mechanism**: Reduce hepatic gluconeogenesis
  * **Indication**: Diabetes mellitus
* **Thiazolidinedione**
  * **Drugs**: Troglitazone, rosiglitazone
  * **Mechanism**: Activate PPARÎ³ (decrease insulin resistance)
  * **Indication**: Diabetes mellitus
* **Î±-glucosidase inhibitor**
  * **Drugs**: Acarbose
  * **Mechanism**: Î±-glucosidase inhibitor (decrease intestinal glucose absorption)
  * **Indication**: Diabetes mellitus
* **SGLT2 inhibitor**
  * **Drugs**: Canagliflozin, empagliflozin
  * **Mechanism**: SGLT2 inhibitor (decrease renal glucose reabsorption)
  * **Indication**: Diabetes mellitus
* **Amylin analog**
  * **Drugs**: Pramlintide
  * **Mechanism**: Amylin analog
  * **Indication**: Diabetes mellitus
{: .notice--info}

### Calcium Homeostasis Drug / ã‚«ãƒ«ã‚·ã‚¦ãƒ ä»£è¬ã®è–¬

* **Bisphosphonate**
  * **Drugs**: Alendronate, risedronate, pamidronate
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Osteoporosis
* **Anti-RANKL antibody**
  * **Drugs**: Denosumab
  * **Mechanism**: Anti-RANKL antibody (inhibit osteoclast)
  * **Indication**: Osteoporosis
* **Parathyroid hormone**
  * **Drugs**: Teriparatide
  * **Mechanism**: Stimulate osteoblast
  * **Indication**: Osteoporosis
* **Calcitonin**
  * **Drugs**: Calcitonin
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Paget disease
* **Vitamin D**
  * **Drugs**: Cholecalciferol
  * **Mechanism**: Increase Ca absorption and reabsorption
  * **Indication**: Osteomalacia
* **SERM**
  * **Drugs**: Raloxifene, estrogen
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Postmenopausal osteoporosis
{: .notice--info}

### Retinoic Acid / ãƒ¬ãƒãƒã‚¤ãƒ³é…¸

* **Tretinoin**
  * **Drugs**: Tretinoin
  * **Mechanism**: Modify epithelial growth and turnover
  * **Indication**: Acne, photo-aged skin, acute promyelocytic leukemia
  * **Adverse effect**: Sunburn
* **Isotretinoin**
  * **Drugs**: Isotretinoin
  * **Mechanism**: Reduce sebaceous gland size
  * **Indication**: Severe cystic acne
  * **Adverse effect**: Teratogenic
* **Acitretin**
  * **Drugs**: Acitretin
  * **Mechanism**: Inhibit proinflammatory cytokine expression
  * **Indication**: Psoriases
  * **Adverse effect**: Skin and nail abnormality, teratogenic
{: .notice--info} -->

<!-- ## Hypothalamus and Pituitary Gland Disease / è¦–åºŠä¸‹éƒ¨ãƒ»ä¸‹å‚ä½“ç–¾æ‚£

### Hyperprolactinemia / é«˜ãƒ—ãƒ­ãƒ©ã‚¯ãƒãƒ³è¡€ç—‡
### Acromegaly / å…ˆç«¯è‚¥å¤§ç—‡
### Cushing's Disease / Cushingç—…
### Hypopituitarism / ä¸‹å‚ä½“å‰è‘‰æ©Ÿèƒ½ä½ä¸‹ç—‡
### Central Diabetes Insipidus / ä¸­æ¢æ€§å°¿å´©ç—‡
### SIADH / ãƒã‚¾ãƒ—ãƒ¬ã‚·ãƒ³ä¸é©åˆåˆ†æ³Œç—‡å€™ç¾¤

## Thyroid Gland Disease / ç”²çŠ¶è…ºç–¾æ‚£

### Grave's Disease / Basedowç—…
### Plummer Disease / Plummerç—…
### Acute Thyroiditis / æ€¥æ€§ç”²çŠ¶è…ºç‚
### Subacute Thyroiditis / äºœæ€¥æ€§ç”²çŠ¶è…ºç‚
### Painless Thyroiditis / ç„¡ç—›æ€§ç”²çŠ¶è…ºç‚
### Chronic Thyroiditis / æ…¢æ€§ç”²çŠ¶è…ºç‚
### Simple Goiter / å˜ç´”æ€§ç”²çŠ¶è…ºè…«
### Multinodular Goiter / å¤šçµç¯€æ€§ç”²çŠ¶è…ºè…«
### Thyroid Cancer / ç”²çŠ¶è…ºç™Œ

## Parathyroid Gland Disease / å‰¯ç”²çŠ¶è…ºç–¾æ‚£

### Primary Hyperparathyroidism / åŸç™ºæ€§å‰¯ç”²çŠ¶è…ºæ©Ÿèƒ½äº¢é€²ç—‡
### Renal Hyperparathyroidism / è…æ€§å‰¯ç”²çŠ¶è…ºæ©Ÿèƒ½äº¢é€²ç—‡
### Malignancy-Related Hypercalcemia / æ‚ªæ€§è…«ç˜é–¢é€£é«˜ã‚«ãƒ«ã‚·ã‚¦ãƒ è¡€ç—‡
### Hypoparathyroidism / å‰¯ç”²çŠ¶è…ºæ©Ÿèƒ½ä½ä¸‹ç—‡
### Pseudohypoparathyroidism / å½æ€§å‰¯ç”²çŠ¶è…ºæ©Ÿèƒ½ä½ä¸‹ç—‡

## Adrenal Gland Disease / å‰¯è…ç–¾æ‚£

### Cushing's Syndrome / Cushingç—‡å€™ç¾¤
### Primary Aldosteronism / åŸç™ºæ€§ã‚¢ãƒ«ãƒ‰ã‚¹ãƒ†ãƒ­ãƒ³ç—‡
### Addison's Disease / Addisonç—…
### Acute Adrenal Insufficiency / æ€¥æ€§å‰¯è…ä¸å…¨
### Pheochromocytoma / è¤è‰²ç´°èƒè…«

## Other Endocrine Disease / ãã®ä»–ã®å†…åˆ†æ³Œç–¾æ‚£

### MEN / å¤šç™ºæ€§å†…åˆ†æ³Œè…ºè…«ç—‡
### Insulinoma / ã‚¤ãƒ³ã‚¹ãƒªãƒãƒ¼ãƒ
### Gastrinoma / ã‚¬ã‚¹ãƒˆãƒªãƒãƒ¼ãƒ
### Glucagonoma / ã‚°ãƒ«ã‚«ã‚´ãƒãƒ¼ãƒ
### VIPoma / VIPoma

## Glucose Metabolism Disorder / ç³–ä»£è¬ç•°å¸¸

### Type 1 Diabetes Mellitus / 1å‹ç³–å°¿ç—…
### Type 2 Diabetes Mellitus / 2å‹ç³–å°¿ç—…
### Maturity-Onset Diabetes of the Young / è‹¥å¹´ç™ºç—‡æˆäººå‹ç³–å°¿ç—…
### Gestational Diabetes Mellitis / å¦Šå¨ ç³–å°¿ç—…
### Diabetic Ketoacidosis / ç³–å°¿ç—…æ€§ã‚±ãƒˆã‚¢ã‚·ãƒ‰ãƒ¼ã‚·ã‚¹
### Hyperosmolar Hyperglycemic Syndrome / é«˜æµ¸é€åœ§é«˜è¡€ç³–ç—‡å€™ç¾¤
### Diabetic Foot / ç³–å°¿ç—…è¶³ç—…å¤‰
### Hypoglycemia / ä½è¡€ç³–ç—‡

## Lipid and Nutrition Metabolism Disorder / è„‚è³ªãƒ»æ „é¤Šä»£è¬ç•°å¸¸

### Dyslipidemia / è„‚è³ªç•°å¸¸ç—‡
### Familial Hypercholesterolemia / å®¶æ—æ€§é«˜ã‚³ãƒ¬ã‚¹ãƒ†ãƒ­ãƒ¼ãƒ«è¡€ç—‡
### Obesity Disease / è‚¥æº€ç—‡
### Metabolic Syndrome / ãƒ¡ã‚¿ãƒœãƒªãƒƒã‚¯ã‚·ãƒ³ãƒ‰ãƒ­ãƒ¼ãƒ 
### Vitamin A Deficiency / ãƒ“ã‚¿ãƒŸãƒ³Aæ¬ ä¹ç—‡
### Vitamin B1 Deficiency / ãƒ“ã‚¿ãƒŸãƒ³B1æ¬ ä¹ç—‡
### Vitamin B3 Deficiency / ãƒ“ã‚¿ãƒŸãƒ³B3æ¬ ä¹ç—‡
### Vitamin B6 Deficiency / ãƒ“ã‚¿ãƒŸãƒ³B6æ¬ ä¹ç—‡
### Vitamin B12 Deficiency / ãƒ“ã‚¿ãƒŸãƒ³B12æ¬ ä¹ç—‡
### Vitamin C Deficiency / ãƒ“ã‚¿ãƒŸãƒ³Cæ¬ ä¹ç—‡
### Vitamin D Deficiency / ãƒ“ã‚¿ãƒŸãƒ³Dæ¬ ä¹ç—‡
### Vitamin E Deficiency / ãƒ“ã‚¿ãƒŸãƒ³Eæ¬ ä¹ç—‡
### Vitamin K Deficiency / ãƒ“ã‚¿ãƒŸãƒ³Kæ¬ ä¹ç—‡
### Zinc Deficiency / äºœé‰›æ¬ ä¹ç—‡
### Copper Deficiency / éŠ…æ¬ ä¹ç—‡
### Malnutrition Syndrome / æ „é¤Šä¸è‰¯ç—‡å€™ç¾¤

## Other Metabolism Disorder / ãã®ä»–ã®ä»£è¬ç•°å¸¸

### Hyperuricemia / é«˜å°¿é…¸è¡€ç—‡
### Gout / ç—›é¢¨
### Pseudogout / å½ç—›é¢¨
### Osteoporosis / éª¨ç²—é¬†ç—‡
### Osteopetrosis / éª¨ç¡¬åŒ–ç—‡
### Paget's Disease of Bone / éª¨Pagetç—…
### Hemochromatosis / ãƒ˜ãƒ¢ã‚¯ãƒ­ãƒãƒˆãƒ¼ã‚·ã‚¹
### Acute Intermittent Porphyria / æ€¥æ€§é–“æ¬ æ€§ãƒãƒ«ãƒ•ã‚£ãƒªãƒ³ç—‡
### Porphyria Cutanea Tarda / æ™©ç™ºæ€§çš®è†šãƒãƒ«ãƒ•ã‚£ãƒªãƒ³ç—‡
### Amyloidosis / ã‚¢ãƒŸãƒ­ã‚¤ãƒ‰ãƒ¼ã‚·ã‚¹ -->

# Nephrology / è…è‡“ç§‘

## Electrolytes Metabolism Disorder / é›»è§£è³ªä»£è¬ç•°å¸¸

## Glomerular Disorder / ç³¸çƒä½“ç–¾æ‚£

## Tubulointerstitial Disorder / å°¿ç´°ç®¡ãƒ»é–“è³ªæ€§ç–¾æ‚£

## Renal Injury with Systemic Disorder / å…¨èº«æ€§ç–¾æ‚£ã«ä¼´ã†è…éšœå®³

## Renal Vascular Disorder / è…è¡€ç®¡æ€§ç–¾æ‚£

## Renal Failure / è…ä¸å…¨

<!-- ## Introduction /ã€€ç·è«–

### Diuretics / åˆ©å°¿è–¬

* **Carbonic anhydrase inhibitor**
  * **Drugs**: Acetazolamide
  * **Mechanism**: Inhibit carbonic anhydrase
  * **Indication**: Glaucoma, urine alkalinization
  * **Adverse effect**: Acidosis, renal calculi
* **Loop diuretics**
  * **Drugs**: Furosemide, bumetanide, torsemide, ethacrynic acid
  * **Mechanism**: Inhibit Na-K-2Cl contransporter
  * **Indication**: Acute pulmonary edema, congestive heart failure
  * **Adverse effect**: Hypokalemia, hypocalcemia, alkalosis, ototoxicity (with aminoglycoside)
* **Thiazide diuretics**
  * **Drugs**: Hydrochlorothiazide, chlorothiazide
  * **Mechanism**: Inhibit Na-Cl contransporter
  * **Indication**: Hypertension, nephrogenic diabetes insipidus
  * **Adverse effect**: Hypokalemia, hypercalcemia, alkalosis, hyperuricemia, hyperglycemia
* **Potassium-sparing diuretics**
  * **Drugs**: Spironolactone, eplerenone, amiloride, triamterene
  * **Mechanism**: Aldosterone antagonist (spironolactone, eplerenone), ENac blocker (amiloride, triamterene)
  * **Indication**: Hyperaldosteronism, prevent K+ loss
  * **Adverse effect**: Hyperkalemia, acidosis, gynecomastia (spironolactone)
* **Osmotic diuretics**
  * **Drugs**: Mannitol
  * **Mechanism**: Inhibit water reabsorption
  * **Indication**: Reduce intracranial and intraocular pressure 
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: V1 and/or V2 antagonist
  * **Indication**: SIADH
{: .notice--info} -->

<!-- ## Water and Electrolytes Metabolism Disorder / æ°´ãƒ»é›»è§£è³ªä»£è¬ç•°å¸¸

### Hyponatremia / ä½ãƒŠãƒˆãƒªã‚¦ãƒ è¡€ç—‡
### Hypernatremia / é«˜ãƒŠãƒˆãƒªã‚¦ãƒ è¡€ç—‡
### Hypokalemia / ä½ã‚«ãƒªã‚¦ãƒ è¡€ç—‡
### Hyperkalemia / é«˜ã‚«ãƒªã‚¦ãƒ è¡€ç—‡
### Hypocalcemia / ä½ã‚«ãƒ«ã‚·ã‚¦ãƒ è¡€ç—‡
### Hypercalcemia / é«˜ã‚«ãƒ«ã‚·ã‚¦ãƒ è¡€ç—‡
### Hypophosphatemia / ä½ãƒªãƒ³è¡€ç—‡
### Hyperphosphatemia / é«˜ãƒªãƒ³è¡€ç—‡
### Hypomagnesemia / ä½ãƒã‚°ãƒã‚·ã‚¦ãƒ è¡€ç—‡
### Hypermagnesemia / é«˜ãƒã‚°ãƒã‚·ã‚¦ãƒ è¡€ç—‡
### Metabolic Acidosis / ä»£è¬æ€§ã‚¢ã‚·ãƒ‰ãƒ¼ã‚·ã‚¹
### Metabolic Alkalosis / ä»£è¬æ€§ã‚¢ãƒ«ã‚«ãƒ­ãƒ¼ã‚·ã‚¹
### Respiratory Acidosis / å‘¼å¸æ€§ã‚¢ã‚·ãƒ‰ãƒ¼ã‚·ã‚¹
### Respiratory Alkalosis / å‘¼å¸æ€§ã‚¢ãƒ«ã‚«ãƒ­ãƒ¼ã‚·ã‚¹

## Glomerular Disease / ç³¸çƒä½“ç–¾æ‚£

### Acute Glomerulonephritis / æ€¥æ€§ç³¸çƒä½“è…ç‚
### Rapid Progressive Glomerulonephritis / æ€¥é€Ÿé€²è¡Œæ€§ç³¸çƒä½“è…ç‚
### IgA Nephropathy / IgAè…ç—‡
### Minimal Change Nephrotic Syndrome / å¾®å°å¤‰åŒ–å‹ãƒãƒ•ãƒ­ãƒ¼ã‚¼ç—‡å€™ç¾¤
### Membranous Nephropathy / è†œæ€§è…ç—‡
### Focal Segmental Glomerulosclerosis / å·£çŠ¶åˆ†ç¯€æ€§ç³¸çƒä½“ç¡¬åŒ–ç—‡
### Membranoproliferative Glomerulonephritis / è†œæ€§å¢—æ®–æ€§ç³¸çƒä½“è…ç‚
### Alport's Syndrome / Alportç—‡å€™ç¾¤
### Benign Familial Hematuria / è‰¯æ€§å®¶æ—æ€§è¡€å°¿

## Tubulointerstitial Disease / å°¿ç´°ç®¡ãƒ»é–“è³ªæ€§ç–¾æ‚£

### Fanconi Syndrome / Fanconiç—‡å€™ç¾¤
### Bartter's Syndrome / Bartterç—‡å€™ç¾¤
### Pseudo-Bartter's Syndrome / å½æ€§Bartterç—‡å€™ç¾¤
### Gitelman's Syndrome / Gitelmanç—‡å€™ç¾¤
### Liddle's Syndrome / Liddleç—‡å€™ç¾¤
### Nephrogenic Diabetes Insipidus / è…æ€§å°¿å´©ç—‡
### Renal Tubular Acidosis / å°¿ç´°ç®¡æ€§ã‚¢ã‚·ãƒ‰ãƒ¼ã‚·ã‚¹
### Tubulointerstitial Nephritis / å°¿ç´°ç®¡é–“è³ªæ€§è…ç‚

## Renal Injury with Systemic Disease / å…¨èº«æ€§ç–¾æ‚£ã«ä¼´ã†è…éšœå®³

### Diabetic Nephropathy / ç³–å°¿ç—…æ€§è…ç—‡
### Gouty Kidney / ç—›é¢¨è…
### Myeloma Kidney / éª¨é«„è…«è…
### Cryoglobulin Nephropathy / ã‚¯ãƒªã‚ªã‚°ãƒ­ãƒ–ãƒªãƒ³è¡€ç—‡æ€§è…ç—‡
### Amyloid Nephropathy / ã‚¢ãƒŸãƒ­ã‚¤ãƒ‰è…ç—‡
### Lupus Nephritis / ãƒ«ãƒ¼ãƒ—ã‚¹è…ç‚
### Scleroderma Kidney / å¼·çš®ç—‡è…
### Drug-Induced Kidney Injury / è–¬å‰¤æ€§è…éšœå®³

## Renal Vascular Disease / è…è¡€ç®¡æ€§ç–¾æ‚£

### Renovascular Hypertension / è…è¡€ç®¡æ€§é«˜è¡€åœ§
### Benign Nephrosclerosis / è‰¯æ€§è…ç¡¬åŒ–ç—‡
### Malignant Nephrosclerosis / æ‚ªæ€§è…ç¡¬åŒ–ç—‡
### Renal Infarction / è…æ¢—å¡
### Renal Papillary Necrosis / è…ä¹³é ­å£Šæ­»
### Renal Cortical Necrosis / è…çš®è³ªå£Šæ­»
### Renal Vein Thrombosis / è…é™è„ˆè¡€æ “ç—‡

## Renal Failure / è…ä¸å…¨

### Acute Kidney Injury / æ€¥æ€§è…éšœå®³
### Chronic Kidney Disease / æ…¢æ€§è…è‡“ç—…
### Disequilibrium Syndrome / ä¸å‡è¡¡ç—‡å€™ç¾¤
### CKD Mineral and Bone Disorder / CKDã«ä¼´ã†éª¨ãƒŸãƒãƒ©ãƒ«ä»£è¬ç•°å¸¸
### Dialysis Amyloidosis / é€æã‚¢ãƒŸãƒ­ã‚¤ãƒ‰ãƒ¼ã‚·ã‚¹
### Renal Anemia / è…æ€§è²§è¡€ -->

# Hematology / è¡€æ¶²ç§‘

## Hemostasis Disorder (Primary) / æ­¢è¡€ã®ç•°å¸¸ï¼ˆä¸€æ¬¡ï¼‰

## Hemostasis Disorder (Secondary) / æ­¢è¡€ã®ç•°å¸¸ï¼ˆäºŒæ¬¡ï¼‰

## Red Blood Cell Disorder (Nonehemolysis) / èµ¤è¡€çƒã®ç•°å¸¸ï¼ˆéæº¶è¡€ï¼‰

## Red Blood Cell Disorder (Hemolysis) / èµ¤è¡€çƒã®ç•°å¸¸ï¼ˆæº¶è¡€ï¼‰

## White Blood Cell Disorder / ç™½è¡€çƒã®ç•°å¸¸

## Myeloid Neoplasm / éª¨é«„ç³»è…«ç˜

## Lymphoid Neoplasm / ãƒªãƒ³ãƒ‘ç³»è…«ç˜

<!-- ## Introduction /ã€€ç·è«–

### Alkylating Drug / ã‚¢ãƒ«ã‚­ãƒ«åŒ–è–¬

* **Nitrogen mustard**
  * **Drug**: Cyclophosphamide, ifosfamide
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hemorrhagic cystitis (due to acrolein, prevented by mesna)
* **Nitrosoureas**
  * **Drug**: Carmustine, lomustine
  * **Mechanism**: Directly damage DNA
  * **Indication**: Brain tumor (cross BBB)
  * **Adverse effect**: Myelosuppression, pulmonary toxicity
* **Alkyl sulfonate**
  * **Drug**: Busfulfan
  * **Mechanism**: Directly damage DNA
  * **Indication**: Before bone marrow transplantation
  * **Adverse effect**: Myelosuppression, pulmonary fibrosis, hyperpigmentation
* **Platinum analog**
  * **Drug**: Cisplatin, carboplatin, oxaliplatin
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various tumor
  * **Adverse effect**: Myelosuppresion, nephrotoxicity, otoxicity, peripheral neuropathy
{: .notice--info}

### Antimetabolte / ä»£è¬æ‹®æŠ—è–¬

* **Folic acid analog**
  * **Drug**: Methotrexate, pemetrexed
  * **Mechanism**: Inhibit dihydrofolate reductase, inhibit thymidylate synthetase (pemetrexed)
  * **Indication**: Leukemia and lymphoma, autoimmune disease (methotrexate), mesothelioma, non-small cell lung cancer (pemetrexed)
  * **Adverse effect**: Myelosuppresion, mucositis, nephrotoxicity (rescued by leucovorin)
* **5-Fluorouracil**
  * **Drug**: 5-Fluorouracil, capecitabine
  * **Mechanism**:  Inhibit thymidylate synthetase (5F-dUMP)
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hand-and-foot syndrome
* **Pyrimidine analog**
  * **Drug**: Cytarabine, gemticabine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
* **Purine analog**
  * **Drug**: 6-Mercaptopurine, cladribine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Leukemia
  * **Adverse effect**: Myelosuppression, interact with allopurinol
* **Hydroxyuria**
  * **Drug**: Hydroxyuria
  * **Mechanism**: Inhibit ribonucleoside diphosphate reductase
  * **Indication**: Leukemia, sickle cell anemia
  * **Adverse effect**: Myelosuppression, GI distress
{: .notice--info}

### Microtubule Damaging Drug / å¾®å°ç®¡é˜»å®³è–¬

* **Vinca alkaloids**
  * **Drug**: Vinblastine, vincristine, vinorelbine
  * **Mechanism**: Inhibit microtubule polymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy
* **Taxanes**
  * **Drug**: Paclitaxel, docltaxel, cabazitaxel
  * **Mechanism**: Inhibit microtubule depolymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy, hypersensitivity (paclitaxel), fluid retention (docetaxel)
{: .notice--info}

### Topoisomerase Inhibitor / ãƒˆãƒã‚¤ã‚½ãƒ¡ãƒ©ãƒ¼ã‚¼é˜»å®³è–¬

* **Topoisomerase I inhibitor**
  * **Drug**: Topotecan, irinotecan
  * **Mechanism**: Topoisomerase I inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, diarrhea, secondary leukemia
* **Topoisomerase II inhibitor**
  * **Drug**: Etoposide
  * **Mechanism**: Topoisomerase II inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
{: .notice--info}

### Antitumor Antibiotics / æŠ—è…«ç˜æ€§æŠ—ç”Ÿç‰©è³ª

* **Antrhacyclines**
  * **Drug**: Doxorubicin, daunorubicin, idarubicin, epirubicin
  * **Mechanism**: Inhibit topoisomerase II, intercalate between DNA base pairs, form oxygen free radical
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, cardiotoxicity (dexrazoxane protect)
* **Dactinomycin**
  * **Drug**: Dactinomycin
  * **Mechanism**: Intercalate between DNA base pairs
  * **Indication**: Pediatric cancer
  * **Adverse effect**: Myelosuppression
* **Bleomycin**
  * **Drug**: Bleomycin
  * **Mechanism**: Form oxygen free radical
  * **Indication**: Testicular cancer
  * **Adverse effect**: Pulmonary toxicity, hyperpigmentation
{: .notice--info}

### Target Therapy / åˆ†å­æ¨™çš„è–¬

* **Monoclonal antibody (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20
  * **Indication**: Non-Hodgkin lymphoma, chronic lymphocytic leukemia
* **Monoclonal antibody (CD30)**
  * **Drug**: Brentuximab vedotin
  * **Mechanism**: Anti-CD30
  * **Indication**: Hodgkin lymphoma
* **Monoclonal antibody (HER2)**
  * **Drug**: Trastuzumab, pertuzumab
  * **Mechanism**: Anti-HER2
  * **Indication**: Breast cancer, gastric cancer
* **Monoclonal antibody (EGFR)**
  * **Drug**: Cetuximab, panitumumab, necitumumab
  * **Mechanism**: Anti-EGFR
  * **Indication**: Metastatic colorectal cancer (KRAS wild-type)
* **Monoclonal antibody (VEGF)**
  * **Drug**: Bevacizumab, ramucirumab
  * **Mechanism**: Anti-VEGF (inhibit microvascular growth)
  * **Indication**: Various cancer
* **Tyrosine kinase inhibitor (BCR-ABL)**
  * **Drug**: Imatinib, dasatinib, nilotinib, and ponatinib
  * **Mechanism**: BCR-ABL inhibitor
  * **Indication**: Leukemia and lymphoma (Philadelphia chromosome-positive) 
* **Tyrosine kinase inhibitor (EGFR)**
  * **Drug**: Gatitinib, erlotinib
  * **Mechanism**: EFGR inhibitor
  * **Indication**: NSCLC
* **Tyrosine kinase inhibitor (BRAF)**
  * **Drug**: Vemurafenib
  * **Mechanism**: BRAF inhibitor
  * **Indication**: Melanoma (BRAF V600E)
* **Immune checkpoint inhibitor (CTLA-4)**
  * **Drug**: Ipilimumab
  * **Mechanism**: Anti-CTLA-4, enhance T-cell activation
  * **Indication**: Melanoma
* **Immune checkpoint inhibitor (PD-1)**
  * **Drug**: Pembrolizumab, nivolumab, cemiplimab
  * **Mechanism**: Anti-PD-1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immune checkpoint inhibitor (PD-L1)**
  * **Drug**: Atezolizumab, durvalumab, avelumab
  * **Mechanism**: Anti-PD-L1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immunomodulator**
  * **Drug**: Thalidomide, lenalidomide
  * **Mechanism**: Inhibit proinflammatory cytokines secretion, enhance call-mediated immunity
  * **Indication**: Multiple myeloma
  * **Adverse effect**: Birth defect
{: .notice--info} -->

<!-- ## Nonhemolytic Anemia / éæº¶è¡€æ€§è²§è¡€

### Iron Deficiency Anemia / é‰„æ¬ ä¹æ€§è²§è¡€
### Sideroblastic Anemia / é‰„èŠ½çƒæ€§è²§è¡€
### Secondary Anemia / äºŒæ¬¡æ€§è²§è¡€
### Aplastic Anemia / å†ç”Ÿä¸è‰¯æ€§è²§è¡€
### Pure Red Cell Aplasia / èµ¤èŠ½çƒç™†
### Megaloblastic Anemia / å·¨èµ¤èŠ½çƒæ€§è²§è¡€

## Hemolytic Anemia / æº¶è¡€æ€§è²§è¡€

### Hereditary Spherocytosis / éºä¼æ€§çƒçŠ¶èµ¤è¡€çƒç—‡
### Thalassemia / ã‚µãƒ©ã‚»ãƒŸã‚¢
### Sickle Cell Disease / éŒçŠ¶èµ¤è¡€çƒç—‡
### G6PD Deficiency / G6PDç•°å¸¸ç—‡
### Pyruvate Kinase Deficiency / PKç•°å¸¸ç—‡
### Paroxysmal Nocturnal Hemoglobinuria / ç™ºä½œæ€§å¤œé–“ãƒ˜ãƒ¢ã‚°ãƒ­ãƒ“ãƒ³å°¿ç—‡
### Autoimmune Hemolytic Anemia / è‡ªå·±å…ç–«æ€§æº¶è¡€æ€§è²§è¡€
### Red Cell Fragmentation Syndrome / èµ¤è¡€çƒç ´ç •ç—‡å€™ç¾¤

## Leukemia / ç™½è¡€ç—…

### Acute Myeloid Leukemia / æ€¥æ€§éª¨é«„æ€§ç™½è¡€ç—…
### Acute Lymphoblastic Leukemia / æ€¥æ€§ãƒªãƒ³ãƒ‘æ€§ç™½è¡€ç—…
### Chronic Myeloid Leukemia / æ…¢æ€§éª¨é«„æ€§ç™½è¡€ç—…
### Chronic Lymphocytic Leukemia / æ…¢æ€§ãƒªãƒ³ãƒ‘æ€§ç™½è¡€ç—…
### Hairy Cell Leukemia / æœ‰æ¯›ç´°èƒç™½è¡€ç—…
### Adult T-cell Leukemia/Lymphoma / æˆäººTç´°èƒç™½è¡€ç—…ãƒ»ãƒªãƒ³ãƒ‘è…«

## Malignant Lymphoma / æ‚ªæ€§ãƒªãƒ³ãƒ‘è…«

### Hodgkin Lymphoma / Hodgkinãƒªãƒ³ãƒ‘è…«
### Diffuse Large B-cell Lymphoma / ã³ã¾ã‚“æ€§å¤§ç´°èƒå‹Bç´°èƒãƒªãƒ³ãƒ‘è…«
### Follicular Lymphoma / æ¿¾èƒæ€§ãƒªãƒ³ãƒ‘è…«
### MALT Lymphoma / MALTãƒªãƒ³ãƒ‘è…«
### Mantle Cell Lymphoma / ãƒãƒ³ãƒˆãƒ«ç´°èƒãƒªãƒ³ãƒ‘è…«
### Burkitt lymphoma / Burkittãƒªãƒ³ãƒ‘è…«
### Peripheral T-cell Lymphoma / æœ«æ¢¢æ€§Tç´°èƒãƒªãƒ³ãƒ‘è…«
### Mycosis Fungoides and SÃ©zary Syndrome / èŒçŠ¶æ¯è‚‰ç—‡ãƒ»SÃ©zaryç—‡å€™ç¾¤

## Other Hematopoietic Tumors / ãã®ä»–ã®é€ è¡€å™¨è…«ç˜

### Myelodysplastic Syndrome / éª¨é«„ç•°å½¢æˆç—‡å€™ç¾¤
### Polycythemia Vera / çœŸæ€§èµ¤è¡€çƒå¢—åŠ ç—‡
### Essential Thrombocythemia / æœ¬æ…‹æ€§è¡€å°æ¿è¡€ç—‡
### Primary Myelofibrosis / åŸç™ºæ€§éª¨é«„ç·šç¶­ç—‡
### Multiple Myeloma / å¤šç™ºæ€§éª¨é«„è…«
### MGUS / MGUS
### WaldenstrÃ¶m's Macroglobulinemia / åŸç™ºæ€§ãƒã‚¯ãƒ­ã‚°ãƒ­ãƒ–ãƒªãƒ³è¡€ç—‡
### Heavy-Chain Disease / Hé–ç—…

## Other Blood Cell Disorder / ãã®ä»–ã®è¡€çƒç•°å¸¸

### Erythrocytosis / èµ¤è¡€çƒå¢—åŠ ç—‡
### Leukemoid Reaction / é¡ç™½è¡€ç—…åå¿œ
### Agranulocytosis / ç„¡é¡†ç²’çƒç—‡
### Infectious Mononucleosis / ä¼æŸ“æ€§å˜æ ¸ç—‡
### Langerhans Cell Histiocytosis / Langerhansç´°èƒçµ„ç¹”çƒç—‡
### Hemophagocytic Syndrome / è¡€çƒè²ªé£Ÿç—‡å€™ç¾¤

## Hemostasis and Coagulation Disorder / æ­¢è¡€ãƒ»å‡å›ºç³»ã®ç•°å¸¸

### Immune Thrombocytopenic Purpura / å…ç–«æ€§è¡€å°æ¿æ¸›å°‘æ€§ç´«æ–‘ç—…
### Thrombotic Thrombocytopenic Purpura / è¡€æ “æ€§è¡€å°æ¿æ¸›å°‘æ€§ç´«æ–‘ç—…
### Hemolytic Uremic Syndrome / æº¶è¡€æ€§å°¿æ¯’ç—‡ç—‡å€™ç¾¤
### Disseminated Intravascular Coagulation / æ’­ç¨®æ€§è¡€ç®¡å†…å‡å›º
### Vitamin K Deficiency / ãƒ“ã‚¿ãƒŸãƒ³Kæ¬ ä¹ç—‡ -->

# Rheumatology / ãƒªã‚¦ãƒãƒç§‘

## Immunodeficiency / å…ç–«ä¸å…¨

## Allergy / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼

## Collagen Disease (Arthritis) / è† åŸç—…ï¼ˆé–¢ç¯€ç‚ï¼‰

## Collagen Disease (Systemic) / è† åŸç—…ï¼ˆå…¨èº«æ€§ï¼‰

## Collagen Disease (Vasculitis) / è† åŸç—…ï¼ˆè¡€ç®¡ç‚ï¼‰

<!-- ## Introduction /ã€€ç·è«–

### Antiallergic Drug / æŠ—ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼è–¬

* **H1 antagonist (1st generation)**
  * **Drug**: Chlorpheniramine, dimenhydrinate, diphenhydramine, doxylamine, meclizine, promethazine
  * **Mechanism**: H1 receptor antagonist (pass BBB)
  * **Indication**: Allergic symptoms, insomnia, motion sickness, nausea and vomiting
  * **Adverse effect**: Sedation, anticholinergic
* **H1 antagonist (2st generation)**
  * **Drug**: Loratadine, cetirizine, clemastine, fexofenadine, desloratadine
  * **Mechanism**: H1 receptor antagonist (not pass BBB)
  * **Indication**: Allergic rhinitis
{: .notice--info}

### NSAID / éã‚¹ãƒ†ãƒ­ã‚¤ãƒ‰æ€§æŠ—ç‚ç—‡è–¬

* **Aspirin**
  * **Drug**: Aspirin
  * **Mechanism**: Inactivate COX-1 and COX-2 (irreversible)
  * **Indication**: Inflammation, pain, fever, reduce thrombi formation
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, Reye syndrome (during viral infection)
* **NSAID**
  * **Drug**: Ibuprofen, naproxen, fenoprofen, ketoprofen / indomethacin, sulindac, ketorolac, diclofenac / peroxicam, mefenamate, meclofenamate, nabumetone / celecoxib (COX-2 selective)
  * **Mechanism**: Inactivate COX-1 and COX-2 (reversible)
  * **Indication**: Inflammation (indomethacin, diclofenac), pain (ketorolac), fever (ibuprogen, naproxen)
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, cardiovascular event (COX-2 selective)
* **Acetaminophen**
  * **Drug**: Acetaminophen
  * **Mechanism**: Inactivate COX (centrally acting)
  * **Indication**: Pain, fever
  * **Adverse effect**: Hepatotoxicity (due to NAPQI, treat with N-acetylcystein)
* **PGE1 agonist**
  * **Drug**: Misoprostol, alprostadil
  * **Mechanism**: PGE1 agonist
  * **Indication**: NSAID-induced ulcer (misoprostol), erectile dysfunction (alprostadil), ductus arteriosus maintenance (alprostadil)
* **PGE2 agonist**
  * **Drug**: Dinoprostone
  * **Mechanism**: PGE2 agonist
  * **Indication**: Pregnancy termination
* **PGF2Î± agonist**
  * **Drug**: Carboprost, latanoprost
  * **Mechanism**: PGF2Î± agonist
  * **Indication**: Pregnancy termination (carboprost), glaucoma (latanoprost)
* **PGI2 agonist**
  * **Drug**: Epoprostenol, treprostinil, iloprost
  * **Mechanism**: PGI2 agonist
  * **Indication**: Pulmonary hypertension
{: .notice--info}

### Gout Drug / ç—›é¢¨ã®è–¬

* **Colchicine**
  * **Drug**: Colchicine
  * **Mechanism**: Prevent tubulin polymerization, interfere neutrophil migration
  * **Indication**: Acute gouty arthritis
  * **Adverse effect**: Gatrointestinal distress
* **Allopurinol**
  * **Drug**: Allopurinol, feboxostat
  * **Mechanism**: Xanthine oxidase inhibitor
  * **Indication**: Chronic gout
  * **Adverse effect**: Skin rash, GI distress
* **Porbenecid**
  * **Drug**: Compatitively inhibits reabaorption
of urate
  * **Mechanism**: Chronic gout
  * **Indication**: Urolithiasis
  * **Adverse effect**: Reduct other drugs excretion (penicillin)
* **Pegloticase**
  * **Drug**: Pegloticase
  * **Mechanism**: Recombinant uricase
  * **Indication**: Chronic gout
  * **Adverse effect**: Anaphylaxis
{: .notice--info}

### Immunosuppressive Drug / å…ç–«æŠ‘åˆ¶è–¬

* **Calcineurin inhibitor**
  * **Drug**: Cyclosporine, tacralimus
  * **Mechanism**: Calcineurin inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Nephrotoxicity, gingival hyperplasia (cyclosporine)
* **mTOR inhibitor**
  * **Drug**: Sirolimus
  * **Mechanism**: mTOR inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Anemia, increased cholesterol
* **Antimetabolite**
  * **Drug**: Azathioprine, mycophenolate mofetil, leflunomide
  * **Mechanism**: Inhibit DNA synthesis (Azathioprine: converted to 6-MP) (Mycophenolate mofetil: inhibit inosine monophosphate dehydrogenase) (Leflunomide: inhibit dihydroorotate dehydrogenase)
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: GI distress, leukopenia, interact with allopurinol (azathioprine)
* **Biologic agent (TNF-Î±)**
  * **Drug**: Infliximab, adalimumab, certolizumab, golimumab, etanercept
  * **Mechanism**: Block TNF-Î± 
  * **Indication**: Autoimmune diseases
* **Biologic agent (IL-1)**
  * **Drug**: Anakinra
  * **Mechanism**: IL-1 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (IL-6 receptor)**
  * **Drug**: Tocilizumab
  * **Mechanism**: IL-6 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (JAK-STAT)**
  * **Drug**: Tofacitinib
  * **Mechanism**: Block JAK-STAT signaling
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD80/86)**
  * **Drug**: Abatacept
  * **Mechanism**: Block costimulatory signal
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20 antibody
  * **Indication**: Rheumatoid arthritis, leukemia and lymphoma
* **Biologic agent (CD25)**
  * **Drug**: Basiliximab
  * **Mechanism**: Anti-CD25 antibody
  * **Indication**: Acute transplant rejection
* **Biologic agent (Î±4 integrin)**
  * **Drug**: Natalizumab
  * **Mechanism**: Anti-Î±4 integrin antibody
  * **Indication**: Multiple sclerosis, Crohn disease.
* **Antithymocyte globulin**
  * **Drug**: Antithymocyte globulin
  * **Mechanism**: Elimination of T lymphocyte
  * **Indication**: Aplastic anemia, graft-versus-host disease
{: .notice--info} -->

<!-- ## Allergy / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼

### Anaphylaxis / ã‚¢ãƒŠãƒ•ã‚£ãƒ©ã‚­ã‚·ãƒ¼
### Food Allergy / é£Ÿç‰©ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼
### Drug Allergy / è–¬ç‰©ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼
### Serem Sickness / è¡€æ¸…ç—…

## Collagen Disease (Arthritis) / è† åŸç—…ï¼ˆé–¢ç¯€ç‚ï¼‰

### Rheumatoid Arthritis / é–¢ç¯€ãƒªã‚¦ãƒãƒ
### Juvenile Idiopathic Arthritis / è‹¥å¹´æ€§ç‰¹ç™ºæ€§é–¢ç¯€ç‚
### Adult Still's Disease / æˆäººStillç—…
### Ankylosing Spondylitis / å¼·ç›´æ€§è„Šæ¤ç‚
### Psoriatic Arthritis / ä¹¾ç™¬æ€§é–¢ç¯€ç‚
### Reactive Arthritis / åå¿œæ€§é–¢ç¯€ç‚

## Collagen Disease (Systemic) / è† åŸç—…ï¼ˆå…¨èº«æ€§ï¼‰

### Systemic Lupus Erythematosus / å…¨èº«æ€§ã‚¨ãƒªãƒ†ãƒãƒˆãƒ¼ãƒ‡ã‚¹
### Scleroderma / å¼·çš®ç—‡
### Polymyositis and Dermatomyositis / å¤šç™ºæ€§ç­‹ç‚ãƒ»çš®è†šç­‹ç‚
### Mixed Connective Tissue Disease / æ··åˆæ€§çµåˆçµ„ç¹”ç—…
### Polymyalgia Rheumatica / ãƒªã‚¦ãƒãƒæ€§å¤šç™ºç­‹ç—›ç—‡
### Fibromyalgia / ç·šç¶­ç­‹ç—›ç—‡
### SjÃ¶gren's Syndrome / SjÃ¶grenç—‡å€™ç¾¤
### Behcet's Disease / Behcetç—…
### Rheumatic Fever / ãƒªã‚¦ãƒãƒç†±
### Antiphospholipid Syndrome / æŠ—ãƒªãƒ³è„‚è³ªæŠ—ä½“ç—‡å€™ç¾¤
### IgG4-Related Disease / IgG4é–¢é€£ç–¾æ‚£
### Goodpasture Syndrome / Goodpastureç—‡å€™ç¾¤
### Sarcoidosis / ã‚µãƒ«ã‚³ã‚¤ãƒ‰ãƒ¼ã‚·ã‚¹

## Collagen Disease (Vasculitis) / è† åŸç—…ï¼ˆè¡€ç®¡ç‚ï¼‰

### Giant Cell Arteritis / å·¨ç´°èƒæ€§å‹•è„ˆç‚
### Takayasu's Arteritis / é«˜å®‰å‹•è„ˆç‚
### Polyarteritis Nodosa / çµç¯€æ€§å¤šç™ºå‹•è„ˆç‚
### Kawasaki Disease / å·å´ç—…
### Microscopic Polyangiitis / é¡•å¾®é¡çš„å¤šç™ºè¡€ç®¡ç‚
### Granulomatosis with Polyangiitis / å¤šç™ºè¡€ç®¡ç‚æ€§è‚‰èŠ½è…«ç—‡
### Eosinophilic Granulomatosis with Polyangiitis / å¥½é…¸çƒæ€§å¤šç™ºè¡€ç®¡ç‚æ€§è‚‰èŠ½è…«ç—‡
### IgA Vasculitis / IgAè¡€ç®¡ç‚ -->

# Infectious Diseases / æ„ŸæŸ“ç—‡ç§‘

## Gram-Positive Bacteria Infection / ã‚°ãƒ©ãƒ é™½æ€§èŒæ„ŸæŸ“ç—‡

## Gram-Negative Bacteria Infection / ã‚°ãƒ©ãƒ é™°æ€§èŒæ„ŸæŸ“ç—‡

## Miscellaneous Bacteria Infection / ãã®ä»–ã®ç´°èŒæ„ŸæŸ“ç—‡

## DNA Virus Infection / DNAã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

## RNA Virus Infection / RNAã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

## Fungus Infection / çœŸèŒæ„ŸæŸ“ç—‡

## Parasite Infection / å¯„ç”Ÿè™«æ„ŸæŸ“ç—‡

<!-- ## Introduction /ã€€ç·è«–

### Cell Wall Synthesis Inhibitor / ç´°èƒå£åˆæˆé˜»å®³è–¬

* **Penicillins**
  * **Drug**: (Original) penicillin G, penicillin V, benzathine penicillin / (Î²-lactamase resistant) oxacillin, dicloxacillin, methicillin, nafcillin / (Extended-spectrum) ampicillin, amoxicillin, piperacillin, ticarcillin / (Î²-lactamase inhibitor) clavulanate, sulbactam, tazobactam
  * **Mechanism**: Inhibit transpeptidase, resistance from Î²-lactamase, synergistic with aminoglycoside
  * **Indication**: Various bacteria, pseudomonas (piperacillin, ticarcillin)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Cephalosporins**
  * **Drug**: (1st generation) cephalexin, cefazolin, cefadroxil / (2nd generation) cefoxitin, cefaclor, cefuroxime, cefotetan, cefprozil / (3rd generation)
  ceftazidime, cefperazone, ceftriazone, cefixime, cefdinir, cefotaxime / (4th generation) cefepime / (5th generation) ceftaroline
  * **Mechanism**: Inhibit transpeptidase, Î²-lactamase resistant, penetrate CSF (cefuroxime, 3rd generation)
  * **Indication**: Various bacteria, pseudomonas (cefoperazone, ceftazidime, cefepime), gonorrhea (ceftriaxone, cefixime), MRSA (ceftaroline)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Carbapenems**
  * **Drug**: Imipenem (+ cilastatin), ertapenem, meropenem, doripenem
  * **Mechanism**: Inhibit transpeptidase, Î²-lactamase resistant, (cilastin: inhibit renal dehydropeptidase)
  * **Indication**: Various bacteria
  * **Adverse effect**: Hypersensitivity
* **Monobactam**
  * **Drug**: Aztreonam
  * **Mechanism**: Inhibit transpeptidase, Î²-lactamase resistant
  * **Indication**: Gram-negative (penicillin hypersensitivity)
* **Glycopeptides**
  * **Drug**: Vancomycin, telavancin, dalbavancin, oritavancin
  * **Mechanism**: Inhibit transglycosylase
  * **Indication**: Gram-positive (penicillin hypersensitivity), MRSA
  * **Adverse effect**: Red man syndrome, nephrotoxicity
* **Daptomycin**
  * **Drug**: Daptomycin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-positive, MRSA
  * **Adverse effect**: Myopathy
* **Polymyxin**
  * **Drug**: Polymyxin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-negative
  * **Adverse effect**: Nephrotoxicity, neurotoxicity
{: .notice--info}

### Protein Synthesis Inhibitor / ã‚¿ãƒ³ãƒ‘ã‚¯è³ªåˆæˆé˜»å®³è–¬

* **Aminoglycosides**
  * **Drug**: Streptomycin, gentamicin, tobramycin, neomycin, amikacin
  * **Mechanism**: Inhibit 30S ribosomal subunit, require active transport (anaerobe resistant), synergistic with Î²-lactam
  * **Indication**: Gram-negative, aerobe
  * **Adverse effect**: Nephrotoxic, ototoxic, neuromuscular blockade
* **Tetracyclines**
  * **Drug**: Tetracycline, demeclocycline, doxycycline, minocycline, tigecycline
  * **Mechanism**: Inhibit 30S ribosomal subunit
  * **Indication**: Rickatlsia, chlamydia, mycoplasma, acne vulgaris, MRSA (tigecycline)
  * **Adverse effect**: Tooth discoloration, growth inhibition, photosensitivity, calcium impair absorption
* **Macrolides**
  * **Drug**: Azithromycin, clarithromycin, erythromycin, telithromycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Legionella, mycoplasma
  * **Adverse effect**: QT prolongation, inhibit CYP450
* **Lincosamide**
  * **Drug**: Clindamycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Anaerobe, ance
  * **Adverse effect**: Pseudomembranous colitis
* **Oxazolidinones**
  * **Drug**: Linezolid
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Gram-positive, VRE
  * **Adverse effect**: Thrombocytopenia, serotonin syndrome
* **Amphenicol**
  * **Drug**: Chloramphenicol
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Various bacteria
  * **Adverse effect**: Aplastic anemia, hemolytic anemia (G6PD deficienct), gray baby syndrome
* **Streptogramins**
  * **Drug**: Quinupristin, dalfopristin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: VRE, MRSA
{: .notice--info}

### DNA Synthesis Inhibitor / æ ¸é…¸åˆæˆé˜»å®³è–¬

* **Antifolate drug**
  * **Drug**: Trimethoprim + sulfamethoxazole
  * **Mechanism**: Inhibit dihydropteroate synthase (sulfamethoxazole), inhibit dihydrofolate reductase (trimethoprim)
  * **Indication**: Urinary tract infections, pneumocystis pneumonia
  * **Adverse effect**: Hypenensitivity, Stevens-Johnson syndrome, hemolytic anemia (G6PD deficiency)
* **Fluoroquinolones**
  * **Drug**: Ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, moxifloxacin, gemifloxacin
  * **Mechanism**: Inhibit DNA gyrase, inhibit topoisomerase IV
  * **Indication**: Urinary tract infections, respiratory tract infections
  * **Adverse effect**: QT prolongation, tendon rupture
* **Metronidazole**
  * **Drug**: Metronidazole
  * **Mechanism**: Form free radical
  * **Indication**: Trichomonas vaginalis, pseudomembranous colitis
  * **Adverse effect**: Peripheral neuropathy, ditulfiram-like reaction
{: .notice--info}

### Antimycobacterial Drug / æŠ—çµæ ¸è–¬

* **Isoniazid**
  * **Drug**: Isoniazid
  * **Mechanism**: Inhibit mycobactarial call wall synthesis
  * **Indication**: Tuberculosis (combination), prophylaxis
  * **Adverse effect**: Peripheral nauropathy (minimized by pyridoxine), hepatotoxicity
* **Rifampin**
  * **Drug**: Rifampin
  * **Mechanism**: Inhibits RNA polymerase
  * **Indication**: Tuberculosis (combination), atypical mycobactaria, meningitis
  * **Adverse effect**: Orange-color urine
* **Ethambutol**
  * **Drug**: Ethambutol
  * **Mechanism**: Inhibit arabinosyl transfarase
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Visual disturbance
* **Pyrazinamide**
  * **Drug**: Pyrazinamide
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Hepatotoxicity
* **Dapsone**
  * **Drug**: Dapsone
  * **Mechanism**: Inhibit dihydropteroate synthase
  * **Indication**: Leprosy, pneumocystis pneumonia
  * **Adverse effect**: Hemolysis, methemoglobinemia
{: .notice--info}

### Antifungal Drug / æŠ—çœŸèŒè–¬

* **Polyene**
  * **Drug**: Amphotericin B, nystatin
  * **Mechanism**: Bind to ergosterol, form pores
  * **Indication**: Various fungus, cryptococcal meningitis (with flucytosine)
  * **Adverse effect**: Infusion-related reactions, nephrotoxicity
* **Azoles**
  * **Drug**: Itraconazole, ketoconazole, miconazole, fluconazole, clotrimazole, voriconazole, isavuconazole, posaconazole
  * **Mechanism**: Inhibit ergosterol synthesis (inhibit lanosterol methylation)
  * **Indication**: Various fungus, cryptococcal meningitis (fluconazole)
  * **Adverse effect**: Hepatotoxicity
* **Echinocandins**
  * **Drug**: Caspofungin, micafungin, anidulafungin
  * **Mechanism**: Inhibit cell wall synthesis
  * **Indication**: Candida, aspergillus
* **Flucytosine**
  * **Drug**: Flucytosine
  * **Mechanism**: Inhibit nucleic acid synthesis (converted to 5-fluorauracil)
  * **Indication**: Cryptococcal meningitis (with amphotericin B)
  * **Adverse effect**: Bone marrow supression
* **Griseofulvin**
  * **Drug**: Griseofulvin
  * **Mechanism**: Prevents spindle formation
  * **Indication**: Dermatophyte
{: .notice--info}

### Antiviral Drug / æŠ—ã‚¦ã‚¤ãƒ«ã‚¹è–¬

* **Antiherpetic drug**
  * **Drug**: Acyclovir, valacyclovir, famiciclovir / ganciclovir, valganciclovir / foscarnet / cidofovir
  * **Mechanism**: Inhbit DNA polymerase (acyclovir, valacyclovir, famiciclovir: activated by viral thymidine kinase)
  * **Indication**: HSV, VZV, EBV, CMV
  * **Adverse effect**: Nephrotoxicity, neurotoxicity, bone marrow suppression
* **Anti-influenza drug**
  * **Drug**: Amantadine, rimantadine / zanamivir, neltamivir / baloxavir marboxil
  * **Mechanism**: M2 protein inhibitor / neuraminidase inhibitor / PA protein inhibitor
  * **Indication**: Influenza, prophylaxis
  * **Adverse effect**: CNS effect, GI dysfunction
* **Anti-HCV durg (direct-acting antiviral)**
  * **Drug**: Glecaprevir, grazoprevir, paritaprevir, simeprevir / daclatasvir, elbasvir, ledipasvir, ombitasvir, pibrentasvir, velpatasvir / sofosbubir, dasabuvir
  * **Mechanism**: NS3/4A inhibitor, NS5A inhibitor, NS5B inhibitor
  * **Indication**: HCV
* **Anti-HBV drug**
  * **Drug**: Lamivudine, adefovir, entecavir, tenofovir / interferon alpha
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: HBV
{: .notice--info}

### Antiretroviral Drug / æŠ—HIVè–¬

* **Nucleoside reverse transcriptase inhibitor**
  * **Drug**: Tenofovir, abacavir, zidovudine, emtricitabine, lamivudine, didanosine, stavudine
  * **Mechanism**: Competitively inhibit reverse transcriptase (require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: Leukopenia, neuropathy, pancreatitis
* **Nonnucleoside reverse transcriptase inhibitor**
  * **Drug**: Efavirenz, nevirapine, rilpivirine, etravirine, delavirdine
  * **Mechanism**: Noncompetitively inhibit reverse transcriptase (not require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: GI dysfunction, skin reaction
* **Protease inhibitor**
  * **Drug**: Ritonavir, darunavir, atazanavir, lopinavir
  * **Mechanism**: Inhibit polyprotein cleavage
  * **Indication**: HIV
  * **Adverse effect**: Hyperglycemia, hyparlipidemia lipodystrophy
* **Integrase inhibitor**
  * **Drug**: Raltegravir, elvitegravir, dolutegravir bictegravir.
  * **Mechanism**: Prevent viral DNA integration
  * **Indication**: HIV
* **Fusion inhibitor**
  * **Drug**: Enfuvirtida
  * **Mechanism**: Block viral entry (bind gp41)
  * **Indication**: HIV
* **CCR5 antagonist**
  * **Drug**: Maraviroc
  * **Mechanism**: Block viral entry (bind CCR5)
  * **Indication**: HIV
{: .notice--info}

### Antiparasitic Drug / æŠ—å¯„ç”Ÿè™«è–¬

* **Anti-malaria drug**
  * **Drug**: Cloroquine, primaquine, quinine, atovaquone, artemether, mefloquine
  * **Indication**: Plasmodium vivax/ovale (chloroquine, primaquine), Plasmodium malaria (chloroquine), Plasmodium falciparum (quinine, atovaquone, artemther, mefloquine)
* **Anti-protozoa drug**
  * **Drug**: Metronidazole, stibogluconate sodium, nifurtimox, suramin
  * **Indication**: Entamoeba & Giardia & Trichomonas (metronidazole), Leishmania (stibogluconate sodium), trypanosoma (nifurtimox, suramin)
* **Anti-metazoa drug**
  * **Drug**: Albendazole, pyrantel pamoate, ivermectin, diethylcarbamazine, praziquantel, 
  * **Indication**: Nematode (albendazole, pyrantel pamoate, ivermectin), filaria (diethylcarbamazine), trematode & cestode (praziquantel)
{: .notice--info} -->

<!-- 

## Gram-Positive Bacterial Infection / ã‚°ãƒ©ãƒ é™½æ€§èŒæ„ŸæŸ“ç—‡

### Staphylococcus Aureus Infection / é»„è‰²ãƒ–ãƒ‰ã‚¦çƒèŒæ„ŸæŸ“ç—‡
### Staphylococcus Epidermidis Infection / è¡¨çš®ãƒ–ãƒ‰ã‚¦çƒèŒæ„ŸæŸ“ç—‡
### Streptococcus Pyogenes Infection / åŒ–è†¿ãƒ¬ãƒ³ã‚µçƒèŒæ„ŸæŸ“ç—‡
### Streptococcus Agalactiae Infection / Bç¾¤ãƒ¬ãƒ³ã‚µçƒèŒæ„ŸæŸ“ç—‡
### Streptococcus Pneumoniae Infection / è‚ºç‚çƒèŒæ„ŸæŸ“ç—‡
### Viridans Streptococci Infection / ç·‘è‰²ãƒ¬ãƒ³ã‚µçƒèŒæ„ŸæŸ“ç—‡
### Enterococcus Infection / è…¸çƒèŒæ„ŸæŸ“ç—‡
### Diphtheria / ã‚¸ãƒ•ãƒ†ãƒªã‚¢
### Listeriosis / ãƒªã‚¹ãƒ†ãƒªã‚¢ç—‡
### Anthrax / ç‚­ç–½
### Botulism / ãƒœãƒ„ãƒªãƒŒã‚¹ç—‡
### Tetanus / ç ´å‚·é¢¨
### Clostridium Perfringens Infection / ã‚¦ã‚§ãƒ«ã‚·ãƒ¥èŒæ„ŸæŸ“ç—‡
### Clostridioides Difficile Infection / ãƒ‡ã‚£ãƒ•ã‚£ã‚·ãƒ«èŒæ„ŸæŸ“ç—‡
### Non-Sporeforming Anaerobe Infection / ç„¡èŠ½èƒå«Œæ°—æ€§èŒæ„ŸæŸ“ç—‡

## Gram-Negative Bacterial Infection / ã‚°ãƒ©ãƒ é™°æ€§èŒæ„ŸæŸ“ç—‡

### Escherichia Coli Infection / å¤§è…¸èŒæ„ŸæŸ“ç—‡
### Shigellosis / ç´°èŒæ€§èµ¤ç—¢
### Typhoid Fever / è…¸ãƒãƒ•ã‚¹
### Salmonellosis / ã‚µãƒ«ãƒ¢ãƒãƒ©ç—‡
### Plague / ãƒšã‚¹ãƒˆ
### Yersinia Enterocolitica Infection / ã‚¨ãƒ«ã‚·ãƒ‹ã‚¢æ„ŸæŸ“ç—‡
### Klebsiella Pneumoniae Infection / ã‚¯ãƒ¬ãƒ–ã‚·ã‚¨ãƒ©æ„ŸæŸ“ç—‡
### Serratia Marcescens Infection / ã‚»ãƒ©ãƒã‚¢æ„ŸæŸ“ç—‡
### Cholera / ã‚³ãƒ¬ãƒ©
### Vibrio Parahaemolyticus Infection / è…¸ç‚ãƒ“ãƒ–ãƒªã‚ªæ„ŸæŸ“ç—‡
### Vibrio Vulnificus Infection / ãƒãƒ«ãƒ‹ãƒ•ã‚£ã‚«ã‚¹èŒæ„ŸæŸ“ç—‡
### Campylobacter Jejuni Infection / ã‚«ãƒ³ãƒ”ãƒ­ãƒã‚¯ã‚¿ãƒ¼æ„ŸæŸ“ç—‡
### Helicobacter Pylori Infection / ãƒ”ãƒ­ãƒªèŒæ„ŸæŸ“ç—‡
### Haemophilus Influenzae Infection / ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶èŒæ„ŸæŸ“ç—‡
### Pertussis / ç™¾æ—¥å’³
### Pseudomonas Aeruginosa Infection / ç·‘è†¿èŒæ„ŸæŸ“ç—‡
### Acinetobacter Baumannii Infection / ã‚¢ã‚·ãƒãƒˆãƒã‚¯ã‚¿ãƒ¼æ„ŸæŸ“ç—‡
### Legionellosis / ãƒ¬ã‚¸ã‚ªãƒãƒ©ç—‡
### Brucellosis / ãƒ–ãƒ«ã‚»ãƒ©ç—‡
### Tularemia / é‡å…ç—…
### Cat-Scratch Disease / ã­ã“ã²ã£ã‹ãç—…
### Neisseria Gonorrhoeae Infection / æ·‹èŒæ„ŸæŸ“ç—‡
### Neisseria Meningitidis Infection / é«„è†œç‚èŒæ„ŸæŸ“ç—‡
### Moraxella Catarrhalis Infection / ãƒ¢ãƒ©ã‚¯ã‚»ãƒ©æ„ŸæŸ“ç—‡

## Other Bacterial Infection / ãã®ä»–ã®ç´°èŒæ„ŸæŸ“ç—‡

### Actinomycosis / æ”¾ç·šèŒç—‡
### Nocardiosis / ãƒã‚«ãƒ«ã‚¸ã‚¢ç—‡
### Tuberculosis / çµæ ¸
### Nontuberculous Mycobacteriosis / éçµæ ¸æ€§æŠ—é…¸èŒç—‡
### Leprosy / Hansenç—…
### Syphilis / æ¢…æ¯’
### Borreliosis / ãƒœãƒ¬ãƒªã‚¢ç—‡
### Leptospirosis / ãƒ¬ãƒ—ãƒˆã‚¹ãƒ”ãƒ©ç—‡
### Chlamydia Infection / ã‚¯ãƒ©ãƒŸã‚¸ã‚¢æ„ŸæŸ“ç—‡
### Mycoplasma Infection / ãƒã‚¤ã‚³ãƒ—ãƒ©ã‚ºãƒæ„ŸæŸ“ç—‡
### Rickettsia Infection / ãƒªã‚±ãƒƒãƒã‚¢æ„ŸæŸ“ç—‡

## DNA Viral Infection / DNAã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

### Herpes Simplex Virus Infection / å˜ç´”ãƒ˜ãƒ«ãƒšã‚¹ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Varicella-Zoster Virus Infection / æ°´ç—˜å¸¯çŠ¶ç–±ç–¹ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Epstein-Barr Virus Infection / EBã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Cytomegalovirus Infection / ã‚µã‚¤ãƒˆãƒ¡ã‚¬ãƒ­ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Human Herpesvirus 6 & 7 Infection / ãƒ’ãƒˆãƒ˜ãƒ«ãƒšã‚¹ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Human Papillomavirus Infection / ãƒ’ãƒˆãƒ‘ãƒ”ãƒ­ãƒ¼ãƒã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Poxvirus Infection / ãƒãƒƒã‚¯ã‚¹ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Parvovirus Infection / ãƒ‘ãƒ«ãƒœã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Adenovirus Infection / ã‚¢ãƒ‡ãƒã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Hepatitis B / Bå‹è‚ç‚

## RNA Viral Infection / RNAã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

### Influenza / ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶
### COVID-19 / æ–°å‹ã‚³ãƒ­ãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### SARS / é‡ç—‡æ€¥æ€§å‘¼å¸å™¨ç—‡å€™ç¾¤
### MERS / ä¸­æ±å‘¼å¸å™¨ç—‡å€™ç¾¤
### Norovirus Infection / ãƒãƒ­ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Rotavirus Infection / ãƒ­ã‚¿ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Enterovirus Infection / ã‚¨ãƒ³ãƒ†ãƒ­ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Measles Virus Infection / éº»ç–¹ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Rubella Virus Infection / é¢¨ç–¹ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Mumps Virus Infection / ãƒ ãƒ³ãƒ—ã‚¹ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡
### Japanese Encephalitis / æ—¥æœ¬è„³ç‚
### West Nile Encephalitis / ã‚¦ã‚¨ã‚¹ãƒˆãƒŠã‚¤ãƒ«è„³ç‚
### Rabies / ç‹‚çŠ¬ç—…
### Dengue Fever / ãƒ‡ãƒ³ã‚°ç†±
### Chikungunya Fever / ãƒã‚¯ãƒ³ã‚°ãƒ‹ã‚¢ç†±
### Zika Fever / ã‚¸ã‚«ç†±
### Ebola Hemorrhagic Fever / ã‚¨ãƒœãƒ©å‡ºè¡€ç†±
### SFTS / é‡ç—‡ç†±æ€§è¡€å°æ¿æ¸›å°‘ç—‡å€™ç¾¤
### HIV Infection / HIVæ„ŸæŸ“ç—‡
### HTLV-1 Infection / HTLV-1æ„ŸæŸ“ç—‡
### Hepatitis A / Aå‹è‚ç‚
### Hepatitis C / Cå‹è‚ç‚
### Hepatitis D / Då‹è‚ç‚
### Hepatitis E / Eå‹è‚ç‚

## Fungal Infection / çœŸèŒæ„ŸæŸ“ç—‡

### Candidiasis / ã‚«ãƒ³ã‚¸ãƒ€ç—‡
### Aspergillosis / ã‚¢ã‚¹ãƒšãƒ«ã‚®ãƒ«ã‚¹ç—‡
### Mucormycosis / ãƒ ãƒ¼ã‚³ãƒ«ç—‡
### Cryptococcosis / ã‚¯ãƒªãƒ—ãƒˆã‚³ãƒƒã‚¯ã‚¹ç—‡
### Pneumocystis Infection / ãƒ‹ãƒ¥ãƒ¼ãƒ¢ã‚·ã‚¹ãƒã‚¹æ„ŸæŸ“ç—‡
### Histoplasmosis / ãƒ’ã‚¹ãƒˆãƒ—ãƒ©ã‚¹ãƒç—‡
### Coccidioidomycosis / ã‚³ã‚¯ã‚·ã‚¸ã‚ªã‚¤ãƒ‡ã‚¹ç—‡
### Blastomycosis / ãƒ–ãƒ©ã‚¹ãƒˆãƒŸã‚»ã‚¹ç—‡

## Protozoal Infection / åŸè™«æ„ŸæŸ“ç—‡

### Amebiasis / ã‚¢ãƒ¡ãƒ¼ãƒèµ¤ç—¢
### Giardiasis / ãƒ©ãƒ³ãƒ–ãƒ«é­æ¯›è™«ç—‡
### Cryptosporidiosis / ã‚¯ãƒªãƒ—ãƒˆã‚¹ãƒãƒªã‚¸ã‚¦ãƒ ç—‡
### Malaria / ãƒãƒ©ãƒªã‚¢
### Babesiosis / ãƒãƒ™ã‚·ã‚¢ç—‡
### Toxoplasmosis / ãƒˆã‚­ã‚½ãƒ—ãƒ©ã‚ºãƒç—‡
### Leishmaniasis / ãƒªãƒ¼ã‚·ãƒ¥ãƒãƒ‹ã‚¢ç—‡
### African Sleeping Sickness / ã‚¢ãƒ•ãƒªã‚«ç¡çœ ç—…
### Chagas Disease / ã‚·ãƒ£ãƒ¼ã‚¬ã‚¹ç—…
### Trichomoniasis / ãƒˆãƒªã‚³ãƒ¢ãƒŠã‚¹ç—‡

## Helminthic Infection / è •è™«æ„ŸæŸ“ç—‡

### Ascariasis / å›è™«ç—‡
### Enterobiasis / èŸ¯è™«ç—‡
### Trichuriasis / é­è™«ç—‡
### Hookworm Infection / é‰¤è™«ç—‡
### Strongyloidiasis / ç³ç·šè™«ç—‡
### Anisakiasis / ã‚¢ãƒ‹ã‚µã‚­ã‚¹
### Filariasis / ãƒ•ã‚£ãƒ©ãƒªã‚¢ç—‡
### Onchocerciasis / ã‚ªãƒ³ã‚³ã‚»ãƒ«ã‚«ç—‡
### Loiasis / ãƒ­ã‚¢ç³¸çŠ¶è™«ç—‡
### Gnathostomiasis / é¡å£è™«ç—‡
### Angiostrongyliasis / åºƒæ±ä½è¡€ç·šè™«ç—‡
### Trichinellosis / æ—‹æ¯›è™«ç—‡
### Schistosomiasis / ä½è¡€å¸è™«ç—‡
### Clonorchiasis / è‚å¸è™«ç—‡
### Metagonimiasis / æ¨ªå·å¸è™«ç—‡
### Paragonimiasis / è‚ºå¸è™«ç—‡
### Diphyllobothriasis / è£‚é ­æ¡è™«ç—‡
### Taeniasis Saginata / ç„¡é‰¤æ¡è™«ç—‡
### Taeniasis Solium / æœ‰é‰¤æ¡è™«ç—‡
### Echinococcosis / åŒ…è™«ç—‡

-->

# Neurology / ç¥çµŒç§‘

## Cerebrovascular Disorder / è„³è¡€ç®¡éšœå®³

### Atherothrombotic Infarction / ã‚¢ãƒ†ãƒ­ãƒ¼ãƒ è¡€æ “æ€§è„³æ¢—å¡

* **Overview**
  * Cerebral infarction caused by atherosclerosis in intra/extracranial major arteries, leading to cerebral ischemia and necrosis
  * Common in middle-aged and elderly, risk factors include hypertension, diabetes, dyslipidemia, smoking, heavy drinking
* **Presentation**
  * **Transient weakness, hemiplegia, numbness, amaurosis fugax**: TIA as prodromal symptoms
  * **Progressive hemiplegia, dysarthria**: Gradual onset during rest due to progressive vessel occlusion
* **Examination**
  * **[CT] Normal or early CT sign (hyperacute), low-density area (acute to chronic)**: Infarct evolution
  * **[MRI] DWI high intensity (hyperacute), T1 low/T2 & FLAIR high intensity (acute to chronic)**: Infarct evolution
  * **[CTA, MRA, Angiography] Arterial stenosis/occlusion**: Atherosclerotic changes
* **Management**
  * **[Acute] rt-PA (within 4.5h), mechanical thrombectomy (within 8h)**: Recanalization
  * **[Acute] Edaravone, antiplatelet drugs, anticoagulants, glycerol**: Neuroprotection and antithrombotic
  * **[Chronic] Risk factor management, antiplatelet therapy**: Prevention of recurrence
{: .notice--info}

### Cardioembolic Infarction / å¿ƒåŸæ€§è„³å¡æ “ç—‡

* **Overview**
  * Cerebral infarction caused by embolism from cardiac thrombus, leading to cerebral ischemia and necrosis
  * Common in patients with atrial fibrillation, recent myocardial infarction, valvular disease, infectious endocarditis
* **Presentation**
  * **Sudden hemiplegia, dysarthria, aphasia, consciousness disturbance**: Abrupt onset during daytime activity
* **Examination**
  * **[CT] Normal or early CT sign (hyperacute), low-density area (acute to chronic)**: Infarct evolution
  * **[MRI] DWI high intensity (hyperacute), T1 low/T2 & FLAIR high intensity (acute to chronic)**: Infarct evolution
  * **[CTA, MRA, Angiography] Vessel occlusion without significant atherosclerosis**: Embolic nature
  * **[Echocardiography] Cardiac thrombus**: Source of embolism
* **Management**
  * **[Acute] rt-PA (within 4.5h), mechanical thrombectomy (within 8h)**: Recanalization
  * **[Acute] Edaravone, glycerol, heparin**: Neuroprotection and anticoagulation
  * **[Chronic] DOACs or warfarin**: Prevention of recurrence
{: .notice--info}

### Lacunar Infarction / ãƒ©ã‚¯ãƒŠæ¢—å¡

* **Overview**
  * Small infarction in penetrating arteries of brain, leading to cerebral ischemia and necrosis
  * Common in elderly with hypertension
* **Presentation**
  * **Mild motor weakness, sensory disturbance, dysarthria**: Small vessel occlusion in penetrating artery territory
* **Examination**
  * **[CT] Small low-density area**: Small infarct in penetrating artery territory
  * **[MRI] Small DWI high intensity (hyperacute), T1 low/T2 & FLAIR high intensity (acute to chronic)**: Small infarct in penetrating artery territory
* **Management**
  * **[Acute] rt-PA (within 4.5h), edaravone, antiplatelet drugs**: Early treatment
  * **[Chronic] Antiplatelet therapy, blood pressure control**: Prevention of recurrence
{: .notice--info}

### Transient Ischemic Attack / ä¸€éæ€§è„³è™šè¡€ç™ºä½œ

* **Overview**
  * Temporary neurological symptoms due to focal brain ischemia without infarction, important warning sign for future stroke
  * Common in patients with atherosclerosis risk factors or cardiac diseases
* **Presentation**
  * **Sudden amaurosis fugax, weakness, hemiplegia, numbness, aphasia, dizziness (resolve in 2-15 minutes)**: Temporary brain or retinal ischemia
* **Examination**
  * **[CT, MRI] No acute infarction**: Differentiates from stroke
* **Management**
  * **Antiplatelet therapy, anticooagulation**: Prevention of atherothrombotic events or cardiac embolism
  * **Risk factor management**: Prevent recurrence
{: .notice--info}

### Wallenberg Syndrome / Wallenbergç—‡å€™ç¾¤

* **Overview**
  * Lateral medullary infarction due to vertebrobasilar artery occlusion
  * Common in patients with atherosclerosis risk factors or cardiac diseases
* **Presentation**
  * **Nystagmus, vertigo, ataxia**: Vestibular and cerebellar involvement
  * **Ipsilateral facial sensory loss, dysphagia, hoarseness, Horner's syndrome**: Cranial nerve and sympathetic pathway involvement
  * **Contralateral body temperature and pain sensory loss**: Lateral spinothalamic tract involvement
  * **No motor weakness or deep sensory loss**: Sparing of pyramidal tract and dorsal column
* **Examination**
  * **[CT, MRI] Stroke lesion in lateral medulla**: Lateral medullary infarction
* **Management**
  * **Treatments of atherothrombotic or cardioembolic stroke**: Based on underlying cause
{: .notice--info}

### Cerebellar Infarction / å°è„³æ¢—å¡

* **Overview**
  * Infarction in cerebellar territory (mainly PICA)
  * Common in patients with atherosclerosis risk factors or cardiac diseases
* **Presentation**
  * **Sudden vertigo, nausea, vomiting, ataxia, dysarthria**: Cerebellar dysfunction
  * **Consciousness disturbance**: Indicates brain stem compression
* **Examination**
  * **[CT, MRI] Stroke lesion in cerebellar region**: Cerebellar infarction
* **Management**
  * **[No compression] Conservative treatment**: Standard stroke care
  * **[Hydrocephalus] Ventricular drainage**: Relieve CSF pressure
  * **[Brain stem compression] Decompressive surgery**: Prevent herniation
{: .notice--info}

### Carotid Artery Stenosis / é ¸å‹•è„ˆç‹­çª„ç—‡

* **Overview**
  * Atherosclerotic stenosis of carotid artery, risk for cerebral infarction
  * Risk factors include hypertension, diabetes, dyslipidemia, smoking, heavy drinking
* **Presentation**
  * **Asymptomatic**: Incidental finding
  * **Transient motor weakness, amaurosis fugax, hemiplegia**: TIA symptoms
* **Examination**
  * **[Ultrasound, MRI/MRA, CTA, Angiography] Carotid artery stenosis**: Confirm diagnosis and assess severity
* **Management**
  * **Risk factor control, antiplatelet drugs**: Prevent strokes
  * **Carotid endarterectomy (CEA), carotid artery stenting (CAS)**: Based on symptoms and stenosis severity
{: .notice--info}

### Cerebral Artery Dissection / è„³å‹•è„ˆè§£é›¢

* **Overview**
  * Bleeding within walls of cerebral artery, most common in intracranial vertebral artery
  * Important cause of stroke in 40-50s
* **Presentation**
  * **Sudden posterior neck/occipital pain**: Characteristic initial symptom
  * **Stroke symptoms**: Due to ischemia or subarachnoid hemorrhage
* **Examination**
  * **[MRI/MRA, DSA] Pearl and string sign, double lumen, intimal flap**: Confirms diagnosis
* **Management**
  * **[Ischemic] Anticoagulation or antiplatelet therapy**: Recanalization
  * **[Hemorrhagic] Trapping, proximal clipping, coil embolization**: Prevent rebleeding
{: .notice--info}

### Putaminal Hemorrhage / è¢«æ®»å‡ºè¡€

* **Overview**
  * Rupture and bleeding of lenticulostriate arteries
  * Common in patients with hypertension history
* **Presentation**
  * **Sudden headache, consciousness disturbance**: Increased intracranial pressure
  * **Contralateral hemiplegia, sensory disturbance**: Damage to adjacent internal capsule
  * **Conjugate deviation towards lesion side**: Damage to PPRF
* **Examination**
  * **[CT] High-density area in putamen**: Blood in putamen
* **Management**
  * **Conservative treatment**: For hematoma â‰¤30mL
  * **Hematoma removal surgery**: For hematoma >30mL
{: .notice--info}

### Thalamic Hemorrhage / è¦–åºŠå‡ºè¡€

* **Overview**
  * Rupture and bleeding of thalamoperforating and thalamogeniculate arteries, poor prognosis in severe cases
  * Common in patients with hypertension history
* **Presentation**
  * **Sudden headache, consciousness disturbance**: Increased intracranial pressure
  * **Hemiplegia, sensory disturbance**: Damage to thalamus and internal capsule
  * **Downward and medial deviation of eyes**: Damage to superior colliculus 
* **Examination**
  * **[CT] High-density area in thalamus**: Blood in thalamus
* **Management**
  * **Conservative treatment**: Surgical intervention contraindicated due to critical location
  * **Ventricular drainage**: For intraventricular hemorrhage with impending herniation
{: .notice--info}

### Pontine Hemorrhage / æ©‹å‡ºè¡€

* **Overview**
  * Rupture and bleeding of pontine arteries, poor prognosis in severe cases
  * Common in patients with hypertension history
* **Presentation**
  * **Consciousness disturbance, respiratory disturbance**: Direct brainstem compression
  * **Quadriplegia, bilateral decerebrate rigidity**: Damage to motor pathways
  * **Fixed midline gaze, pinpoint pupils**: Damage to PPRF and sympathetic tract
* **Examination**
  * **[CT] High-density area in pons**: Blood in pons
* **Management**
  * **Conservative treatment**: Surgical intervention contraindicated due to critical location
{: .notice--info}

### Cerebellar Hemorrhage / å°è„³å‡ºè¡€

* **Overview**
  * Rupture and bleeding of cerebellar artery (mainly SCA)
  * Common in patients with hypertension history
* **Presentation**
  * **Sudden severe occipital headache**: Direct cerebellar compression
  * **Rotatory vertigo, repeated vomiting , nystagmus**: Damage to cerebellar vestibular system
  * **Gait disturbance without quadriplegia**: Cerebellar ataxia
* **Examination**
  * **[CT] High-density area in cerebellum**: Blood in cerebellum
* **Management**
  * **Conservative treatment**: For hematoma â‰¤30mL
  * **Hematoma removal surgery**: For hematoma >30mL
{: .notice--info}

### Subcortical Hemorrhage / çš®è³ªä¸‹å‡ºè¡€

* **Overview**
  * Rupture and bleeding of cortical branches of cerebral arteries
  * Common in patients with arteriovenous malformation (young) or cerebral amyloid angiopathy (elderly)
* **Presentation**
  * **Sudden headache, seizures**: Increased intracranial pressure
  * **Contralateral sensory disturbance**: Damage to parietal lobe
  * **Homonymous hemianopia**: Damage to occipital lobe
  * **Sensory aphasia, visual field defect**: Damage to temporal lobe
  * **Contralateral motor paralysis**: Damage to frontal lobe
* **Examination**
  * **[CT] High-density area in subcortical region**: Blood in affected lobe
* **Management**
  * **Conservative treatment**: For hematoma with depth >1cm from surface
  * **Hematoma removal surgery**: For hematoma with depth â‰¤1cm from surface
{: .notice--info}

### Cerebral Aneurysm / è„³å‹•è„ˆç˜¤

* **Overview**
  * Bulging of cerebral arteries due to medial defects and acquired factors, causes subarachnoid hemorrhage when ruptured
  * More common in 40-60 years adults
* **Presentation**
  * **Asymptomatic**: Found incidentally
  * **Pupil dilation, diplopia, ptosis**: IC-PC aneurysm compressing cranial nerve III
  * **Visual disturbance**: IC-Oph aneurysm compressing cranial nerve II
* **Examination**
  * **[MRA, 3D-CTA, DSA] Visible aneurysm**: Confirms diagnosis and location
* **Management**
  * **Surgical neck clipping, endovascular coil embolization**: For symptomatic or high risk aneurysm
  * **Observation, blood pressure control, lifestyle modification**: For asymptomatic and small aneurysm 
{: .notice--info}

### Subarachnoid Hemorrhage / ãã‚‚è†œä¸‹å‡ºè¡€

* **Overview**
  * Bleeding into subarachnoid space from ruptured cerebral aneurysm or AVM, rapid progression and high mortality
  * More common in 40-60 years adults
* **Presentation**
  * **Thunderclap headache**: Rupture of cerebral aneurysm
  * **Nausea, vomiting, altered consciousness, seizures**: Increased intracranial pressure
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
* **Examination**
  * **[CT] Starfish-shaped high density in suprasellar region**: Bleeding in subarachnoid space
  * **[MRI] FLAIR high signal in subarachnoid space**: When CT is negative
  * **[CSF] Bloody or xanthochromic**: When CT, MRI are negative
  * **[DSA, 3D-CTA, MRA] Identify bleeding source**: Pre-surgical planning
* **Management**
  * **[Pre-op] Blood pressure control, anti-edema drugs, sedation, anticonvulsants**: Prevent rebleeding and herniation
  * **[Definitive] Surgical neck clipping, endovascular coil embolization**: Repair ruptured cerebral arteries
  * **[Post-op] Fasudil, ozagrel sodium, Triple-H therapy**: Prevent/treat vasospasm
{: .notice--info}

### Arteriovenous Malformation / è„³å‹•é™è„ˆå¥‡å½¢

* **Overview**
  * Congenital vascular malformation with direct arteriovenous shunting and abnormal vessel cluster (nidus)
  * More common children and young adults
* **Presentation**
  * **Headache, seizures, progressive hemiparesis**: Cerebral ischemia due to steal phenomenon
  * **Sudden headache, hemiparesis, altered consciousness**: Intracerebral hemorrhage
  * **Neck stiffness, Kernig's sign**: Subarachnoid hemorrhage
* **Examination**
  * **[DSA, MRA] Dilated and tortuous vessels with nidus**: Abnormal vascular connections
  * **[MRI] Multiple flow voids**: Rapid flow rate in nidus
* **Management**
  * **Surgical excision, endovascular embolization, stereotactic radiosurgery**: For hemorrhagic or progressive cases
  * **Conservative treatment**: For non-hemorrhagic or inoperable cases
{: .notice--info}

### Moyamoya Disease / ã‚‚ã‚„ã‚‚ã‚„ç—…

* **Overview**
  * Progressive stenosis/occlusion of bilateral ICA terminus, causing formation of fragile collateral vessels
  * Common in children <10y and adults 30-40y
* **Presentation**
  * **Transient hemiparesis, altered consciousness, speech disturbance after hyperventilation (in children)**: Cerebral ischemia
  * **Focal neurological deficits (in adults)**: Intracerebral hemorrhage or ischemia
* **Examination**
  * **[MRA, DSA] Bilateral stenosis of ICA terminus and proximal ACA/MCA, abnormal vessel network**: Characteristic moyamoya vessels
  * **[MRI] Flow voids in bilateral basal ganglia**: Rapid flow rate in collateral vessels
* **Management**
  * **STA-MCA anastomosis, EMS, EDAS**: Improve blood flow by direct and indirect bypass
  * **Antiplatelet drugs, anticonvulsants**: Conservative treatment
{: .notice--info}

### Carotid-Cavernous Fistula / å†…é ¸å‹•è„ˆ-æµ·ç¶¿é™è„ˆæ´ç˜»

* **Overview**
  * Abnormal connection between internal carotid artery and cavernous sinus
  * Due to trauma or aneurysm rupture
* **Presentation**
  * **Pulsatile exophthalmos, conjunctival congestion/edema, orbital bruit**: High pressure in cavernous sinus causing venous congestion
  * **Diplopia, visual disturbance**: Extraocular muscle palsy due to cranial nerve compression
* **Examination**
  * **[DSA] Early visualization of cavernous sinus in arterial phase**: Direct arteriovenous shunting
* **Management**
  * **Endovascular surgery**: Close fistula
{: .notice--info}

### Cerebral Venous Sinus Thrombosis / è„³é™è„ˆæ´è¡€æ “ç—‡

* **Overview**
  * Thrombosis in cerebral venous sinuses leading to venous congestion
  * Associated with pregnancy/puerperium, oral contraceptives, autoimmune diseases, blood disorders, infections
* **Presentation**
  * **Severe headache, vomiting**: Increased intracranial pressure
  * **Seizures, weakness, paralysis, altered consciousness**: Brain edema or hemorrhage
* **Examination**
  * **[MRI] Brain hemorrhage, edema**: Due to venous congestion
  * **[MRV] Venous sinus occlusion**: Direct visualization of thrombus
* **Management**
  * **Heparin**: Prevent thrombus progression
{: .notice--info}

### Normal Pressure Hydrocephalus / æ­£å¸¸åœ§æ°´é ­ç—‡

* **Overview**
  * Chronic hydrocephalus with normal CSF pressure due to circulation disturbance in subarachnoid space
  * Idiopathic (60-70s) or secondary to SAH, trauma, meningitis 
* **Presentation**
  * **Gait disturbance, cognitive decline, urinary incontinence**: Due to enlarged ventricles compressing brain tissue
* **Examination**
  * **[CT/MRI] Symmetrical ventricular enlargement, dilated Sylvian fissures and basal cisterns**: Hydrocephalus involving ventricles and subarachnoid space
  * **[Lumbar puncture] Normal CSF pressure**: Distinguishes from other types of hydrocephalus
* **Management**
  * **Lumboperitoneal (L-P) or ventriculoperitoneal (V-P) shunt**: Divert excess CSF
{: .notice--info}

<!-- ### Cerebral Infarction / è„³æ¢—å¡

* **Overview**
  * Thrombus or embolus obstruct cerebral artery, ischemia and necrosis in the supplied areas, various neurological symptoms and permanent disabilities 
  * [Atherothrombotic infarction] Thrombus forms due to atherosclerosis of carotid or cerebral arteries; hypertension, diabetes, dyslipidemia, smoking, and heavy drinking increase the risk
  * [Cardioembolic infarction] Embolus forms in heart due to heart diseases (atrial fibrillation, valvular heart disease, myocardial infarction)
  * [Lacunar infarction] Lipohyalinosis (blood vessel degeneration due to prolonged hypertension) or microatheroma block small penetrating arteries (to basal ganglia, internal capsule, thalamus)
* **Presentation**
  * **Contralateral hemiplegia, sensory disturbances, dysarthria**: Damage to primary motor or somatosensory cortex
  * **Aphasia, agnosia**: Damage to association cortex
  * **Consciousness disorder**: Widespread cortical damage
  * **Dizziness, nausea, vomiting, cerebellar ataxia, dysarthria (in case of cerebellar infarction)**: Damage to cerebellar balancing and coordinating functions
  * **Temperature and pain sensation impairment of ipsilateral face and contralateral limbs, nystagmus, hoarseness, dysarthria (in case of brainstem infarction, particularly Wallenberg syndrome)**: Damage to spinothalamic tract and cranial nerve nucleus at lateral medulla
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance, with proprioception preserved (in case of spinal cord infarction, particularly anterior spinal artery syndrome)**
  * **[Atherothrombotic infarction] Occur at rest (often sleeping) and gradually worsen; sometimes preceded by transient ischemic attack**: Stasis of blood flow promotes thrombus formation, thrombus gradually enlarge and progressively block the blood flow
  * **[Cardioembolic infarction] Occur suddenly during activity and develop rapidly, often with large infarct area and severe symptoms**: Increased blood flow during activity dislodge the thrombus,  thrombus rapidly block a major cerebral artery
  * **[Lacunar infarction] Mild motor disturbances, sensory disturbances or dysarthria, without cortical symptoms**: Blockage of small penetrating artery resulting in small infarction area in deep brain
* **Examination**
  * **[CT] No obvious abnormalities in hyperacute phase, low-density region in acute and chronic phase**: No enough structural changes in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[MRI] High-signal on DWI in hyperacute phase, high signal on T2 and FLAIR in acute and chronic phase**: Water accumulate in cells with restricted diffusion in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[CTA, MRA, cerebral angiography] Vascular stenosis or occlusion**
* **Management**
  * **[Acute phase] Respiration management (intubation as needed), circulation management (avoid aggressively lowering BP), metabolism management (fluid, glucose)**: Control respiration, circulation, metabolism
  * **[Acute phase] Thrombolytics (rt-PA) or thrombectomy**: Activate plasminogen and dissolve clot, or directly remove clot endovascularly
  * **[Acute phase] Antiplatelet drugs (ozagrel, aspirin) and anticoagulants (heparin, argatroban), neuroprotective drugs (edaravone), anti-cerebral adema drugs (glycerol)**: Prevent thrombus enlargement, prevent free radical damage, prevent brain herniation
  * **[Chronic phase] Control hypertension, diabetes, dyslipidemia, obesity**: Control risk factors
  * **[Chronic phase] Antiplatelet drugs (clopidogrel, cilostazol, aspirin) for atherothrombotic and lacunar infarction, anticoagulants (dabigatran, rivaroxaban, warfarin) for cardioembolic infarction**: Prevent thrombus or embolus formation
  * **[Chronic phase] Rehabilitation**
{: .notice--info}

### Transient Ischemic Attack / ä¸€éæ€§è„³è™šè¡€ç™ºä½œ

* **Overview**
  * Thrombus or embolus obstruct peripheral arteries, transient neurological symptoms, thrombus dissolves and vessels reopen soon after, may precede cerebral infarction due to larger thrombus formation
* **Presentation**
  * **Temporary loss of vision, weakness and hemiplegia, numbness, aphasia (resolve within 2 ~ 15 minutes)**: Temporary ischemia of eye, motor cortex, sensory cortex, language cortex
  * **May develop to cerebral infarction**
* **Examination**
  * **[CT, MRI] No findings of cerebral infarction**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), anticoagulants (dabigatran, rivaroxaban, warfarin), carotid edarterectomy or carotid artery stenting, control risk factors**: Prevent thrombus or embolus formation
{: .notice--info}

### Carotid Artery Stenosis / é ¸å‹•è„ˆç‹­çª„ç—‡

* **Overview**
  * Narrowing of carotid artery due to atherosclerosis, may lead to TIA or cerebral infarction due to dislodged thrombus
* **Presentation**
  * **Asymptomatic**
  * **May cause TIA or cerebral infarction**
* **Examination**
  * **[Carotid ultrasound] Stenosis of internal carotid artery**
  * **[MRA, CTA, cerebral angiography] Stenosis of internal carotid artery**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), control hypertension, diabetes, dyslipidemia**: Prevent thrombus formation
  * **[Surgical] Carotid edarterectomy, carotid artery stenting**: Directly remove plaque or prevent plaque breaking off
{: .notice--info}

### Cerebral Hemorrhage / è„³å‡ºè¡€

* **Overview**
  * Prolonged hypertension weakens vessels walls, leading to rupture and bleeding
  * [Putaminal hemorrhage] Rupture of lenticulostriate artery
  * [Thalamic hemorrhage] Rupture of thalamoperforating or thalamogeniculate artery
  * [Brainstem hemorrhage] Rupture of pontine arteries
  * [Cerebellar hemorrhage] Rupture of superior cerebellar artery
  * [Subcortical hemorrhage] Rupture of cortical branches
* **Presentation**
  * **Headache, impaired consciousness**: Increased intracranial pressure lead to pain and brain herniation
  * **Contralateral hemiplegia, sensory disturbances**: Damage to descending or ascending fibers in internal capsule
  * **[Putaminal hemorrhage] Conjugate deviation of eyes towards affected side**: Damage to corticobulbar fibers to contralateral PPRF (horizontal gaze center)
  * **[Thalamic hemorrhage] Downward and inward deviation of eyes**: Damage to superior colliculus (vertical gaze center)
  * **[Brainstem hemorrhage] Respiratory distress,quadriplegia, fixed midline eyes, pinpoint pupils**: Damage to respiratory center, bilateral corticospinal tract, PPRF and superior colliculus, sympathetic tract
  * **[Cerebellar hemorrhage] Rotational vertigo and repeated vomiting, standing and walking difficulty**: Damage to cerebellar balancing function and coordination function
  * **[Subcortical hemorrhage] Motor disturbances, sensory disturbances, visual field defects, sensory aphasia**: Damage to frontal lobe, parietal lobe, occipital lobe, temporal lobe
* **Examination**
  * **[CT] High-density region**: Fresh blood has higher density
* **Management**
  * **[Clear consciousness] Respiration management (intubation as needed),  circulation management (systolic pressure < 140 mmHg), metabolism management (fluid), anti-cerebral adema drugs (glycerol, mannitol)**: Control respiration, circulation, metabolism, cerebral edema
  * **[Impaired consciousness] Hematoma removal surgery, ventricular drainage**: Relieve brain herniation due to hematoma or hydrocephalus
  * **[Chronic phase] Control hypertension, rehabilitation**
{: .notice--info}

### Arteriovenous Malformation / è„³å‹•é™è„ˆå¥‡å½¢

* **Overview**
  * Congenital cerebrovascular abnormality where arteries and veins directly connect without capillaries, result in a cluster of dilated and tortuous vessels (nidus), may lead to cerebral hemorrhage and secondary subarachnoid hemorrhage due to rupture
  * More common in children and young adults
* **Presentation**
  * **Headache, seizures, progressive hemiplegia**: Abnormal connection bypass capillaries and cause ischemia
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance (in case of spinal AVM)**
  * **May cause cerebral hemorrhage and secondary subarachnoid hemorrhage**
* **Examination**
  * **[Cerebral angiography, MRA] Cluster of dilated and tortuous vessels**
  * **[MRI] Multiple flow void (no signal) region**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Hemorrhage or symptomatic] Resection of nidus, embolization of nidus, gamma knife**: Prevent hemorrhage
  * **[Non-hemorrhage] Anticonvulsants**: Symptomatic treatment
{: .notice--info}

### Subarachnoid Hemorrhage / ãã‚‚è†œä¸‹å‡ºè¡€

* **Overview**
  * Bleeding into subarachnoid space due to rupture of vascular lesions, underlying diseases include cerebral aneurysm (80%) and arteriovenous malformations
* **Presentation**
  * **Sudden severe pain**: Increased intracranial pressure trigger pain
  * **Nausea, vomiting, impaired consciousness**: Increased intracranial pressure irritates brainstem
  * **Neck stiffness, Kernig sign, Brudzinski sign, positive neck flexion test**: Blood in subarachnoid space irritates meninges
  * **[Complication] Rebleeding**: Dislodge of the initial clot due to fluctuation of blood pressure
  * **[Complication] Cerebral vasospasm**: Blood breakdown products irritate and trigger contractions of vessels
  * **[Complication] Normal pressure hydrocephalus**: Blood breakdown products obstruct CSF absorption pathway
* **Examination**
  * **[CT] Star-shaped high-density area around suprasellar region**: Fresh blood pooling in subarachnoid space (which has star-shaped anatomy around suprasellar region)
  * **[MRI] High signal on FLAIR**: FLAIR suppress CSF signal but highlight abnormal fluid (blood)
  * **[CSF analysis] Blood-stained CSF or xanthochromia (yellowish CSF)**: RBC or bilirubin in CSF
  * **[DSA (4-vessel study), MRA, 3D-CTA] Cerebral aneurysm (preoperative)**
* **Management**
  * **[Preoperative] Blood pressure management (antihypertensive drugs), intracranial pressure management (anti-cerebral edema drugs), pain relief and sedation (diazepam, pentazocine)**: Prevent rebleeding and brain herniation
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: Prevent rebleeding
  * **[Postoperative] Vasodilator (fasudil), antiplatelet drug (ozagrel)**: Prevent vasospasm
{: .notice--info}

### Cerebral Aneurysm / è„³å‹•è„ˆç˜¤

* **Overview**
  * Bulge in brain vessels (particularly in branching points) due to congenital defects in tunica media and acquired factors such as hypertension and arteriosclerosis; usually asymptomatic but may lead to subarachnoid hemorrhage due to rupture
  * More common in middle age adults
* **Presentation**
  * **Asymptomatic in most cases**
  * **Mydriasis, diplopia, ptosis**: Compression of oculomotor nerve by aneurysm
  * **Vision and visual field defects**: Compression of optic nerve by aneurysm
  * **May cause subarchnoid hemorrhage** 
* **Examination**
  * **[MRA, 3D-CTA, DSA] Cerebral aneurysm**
* **Management**
  * **[Observation]**: If asymptomatic 
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: If symptomatic or high risk of rupture
{: .notice--info}

### Moyamoya Disease / ã‚‚ã‚„ã‚‚ã‚„ç—…

* **Overview**
  * Narrowing or occlusion of arteries in circle of Willis lead to ischemia, fragility of compensating collateral circulation lead to hemorrhage
  * More common in children under 10s and adults in 30s ~ 40s
* **Presentation**
  * **[Childhood] Temporary hemiplegia, sensory disturbances, altered consciousness, seizures after cooling hot food by blowing, playing wind instruments, intense crying**: Hypoventilation cause decreased CO2 levels, lead to cerebral vasoconstriction and ischemia
  * **[Adulthood] May lead to cerebral hemorrhage**
* **Examination**
  * **[DSA, MRA] Narrowing or occlusion near terminal portion of internal carotid artery, presence of moyamoya vessles near basal ganglia**
  * **[MRI] Punctate or linear flow void (no signal) region near basal ganglia**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Surgical] STA-MCA bypass**: Revascularization by connecting superficial temporal artery and middle cerebral artery
  * **[Medical] Antiplatelet drugs, anticonvulsants**: Infarction prevention and symptomatic treatment 
{: .notice--info}

### Carotid-Cavernous Fistula / å†…é ¸å‹•è„ˆ-æµ·ç¶¿é™è„ˆæ´ç˜»

* **Overview**
  * Arteriovenous fistula forms between internal carotid artery and cavernous sinus due to trauma or rupture of aneurysm, lead to increased pressure in cavernous sinus and ophthalmic veins
  * [Dural arteriovenous fistula] Arteriovenous fistula can also form in transverse sinus and sigmoid sinus
* **Presentation**
  * **Pulsatile exophthalmos, conjunctival congestion and edema**: Increased pressure in ophthalmic veins in a pulsatile fashion 
  * **Pulsatile bruit in orbital region, extraocular muscle paralysis**: Increased pressure in cavernous sinus in a pulsatile fashion 
* **Examination**
  * **[Cerebral angiography ] Visualization of cavernous sinus during arterial phase**: Arterial blood flows directly into cavernous sinus
* **Management**
  * **Endovascular embolization using coil**: Occlusion of the fistula
{: .notice--info}

### Sinus Thrombosis / é™è„ˆæ´è¡€æ “ç—‡

* **Overview**
  * Thrombus forms in venous sinus and obstructs blood return, due to dural arteriovenous fistula or hypercoagulability
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure
* **Examination**
  * **[MRV] Narrowing or occlusion of venous sinus**
* **Management**
  * **Anticoagulants (heparin)**: Prevent further thrombus formation
{: .notice--info}

### Hypertensive Encephalopathy / é«˜è¡€åœ§æ€§è„³ç—‡

* **Overview**
  * Sudden or severe increase in blood pressure impairs brainâ€™s autoregulation and blood-brain barrier, lead to cerebral edema and neurological symptoms 
* **Presentation**
  * **Headache, nausea, vomiting, consciousness disturbances**: Increased intracranial pressure
* **Examination**
  * **[MRI] High signal in localized area**: Edema
  * **[CT] Low-density in localized area**: Edema
* **Management**
  * **Calcium channel blockers (nicardipine), anti-cerebral edema drugs (glycerol, mannitol)**: Reduce blood pressure, relieve cerebral edema
{: .notice--info} -->

## Dementia / èªçŸ¥ç—‡

### Alzheimer's Disease / Alzheimerå‹èªçŸ¥ç—‡

* **Overview**
  * Most common type of dementia, neurodegenerative disease characterized by brain atrophy and presence of senile plaques and neurofibrillary tangles
  * Common in elderly 
* **Presentation**
  * **Memory loss, disorientation, impaired judgment**: Hippocampal and temporal lobe atrophy
  * **Apraxia, agnosia, aphasia, executive dysfunction**: Parietal lobe atrophy
  * **Delusions (theft), behavioral changes**: Progressive cognitive decline
* **Examination**
  * **[CT/MRI] Cortical atrophy (hippocampus), enlarged sulci and ventricles**: General brain atrophy
  * **[SPECT/PET] Decreased blood flow in parietal and temporal lobes**: Reduced brain function
  * **[Cognitive tests] Decline in memory and cognitive function**: Progressive cognitive decline
* **Management**
  * **Cholinesterase inhibitors (donepezil), NMDA receptor antagonist (memantine)**: Improve cognitive function or reduce cognitive decline
  * **Atypical antipsychotics, yokukansan**: Manage psychiatric symptoms
  * **Exercise, reminiscence therapy, recreation, music therapy**: Non-pharmacological therapy
{: .notice--info}

### Dementia with Lewy Bodies / Lewyå°ä½“å‹èªçŸ¥ç—‡

* **Overview**
  * Neurodegenerative disease characterized by cognitive impairment, visual hallucinations, and parkinsonism
  * Common in elderly
* **Presentation**
  * **Fluctuating cognitive impairment**: Progressive neurodegeneration
  * **Recurrent visual hallucinations**: May due to occipital lobe dysfunction
  * **Parkinsonism**: Due to dopaminergic neuron loss
  * **REM sleep behavior disorder**: Disruption of muscle tone in sleep
* **Examination**
  * **[SPECT/PET] Decreased occipital blood flow**: Reduced brain function
  * **[MIBG myocardial scintigraphy] Decreased MIBG uptake**: Sympathetic denervation
  * **[DAT-SPECT] Reduced striatal uptake**: Loss of dopaminergic neurons
* **Management**
  * **Cholinesterase inhibitors (donepezil)**: Improve cognitive function
  * **Yokukansan, atypical antipsychotics**: Manage hallucinations (antipsychotics may worsen parkinsonism)
  * **L-dopa**: Treat parkinsonism
  * **Clonazepam**: Treat REM sleep behavior disorder
{: .notice--info}

### Frontotemporal Dementia / å‰é ­å´é ­å‹èªçŸ¥ç—‡

* **Overview**
  * Neurodegenerative disease characterized by personality changes and behavioral abnormalities
  * Common in middle-aged adults (40-60s)
* **Presentation**
  * **Decreased initiative, emotional blunting**: Frontal lobe atrophy
  * **Disinhibition, stereotypical behaviors, lack of disease awareness**: Behavioral changes
* **Examination**
  * **[CT/MRI] Frontal and temporal lobe atrophy**: Localized brain degeneration
  * **[SPECT/PET] Decreased blood flow in frontal and temporal lobes**: Reduced brain function
* **Management**
  * **Symptomatic treatment**: No curative treatment
{: .notice--info}

### Vascular Dementia / è¡€ç®¡æ€§èªçŸ¥ç—‡

* **Overview**
  * Second most common type of dementia, caused by cerebrovascular disorders including infarctions and hemorrhages
  * Risk factors: hypertension, diabetes, dyslipidemia, atrial fibrillation, smoking
* **Presentation**
  * **Depression, reduced spontaneity, executive dysfunction, delirium, emotional incontinence**: Damage to various brain regions
  * **Patchy cognitive decline**: Specific cognitive decline based on lesion area
  * **Motor/sensory deficits, pseudobulbar palsy, parkinsonian gait**: Focal neurological symptoms based on lesion area
* **Examination**
  * **[CT/MRI] Infarcts, hemorrhages**: Evidence of cerebrovascular disease
* **Management**
  * **Blood pressure control, antiplatelet/anticoagulation therapy**: Prevent stroke recurrence
  * **Rehabilitation, lifestyle modification**: Improve functional status
{: .notice--info}

<!-- ### Alzheimerâ€™s Dementia / Alzheimerå‹èªçŸ¥ç—‡

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of amyloid Î² and phosphorylated tau protein, leading to cognitive impairment
  * Common in elderly individuals, most common type of dementia
  * Pathology shows cerebral atrophy grossly, senile plaques and neurofibrillary tangles microscopically 
* **Presentation**
  * **[Core symptoms] Memory impairment, disorientation, executive dysfunction, aphasia, apraxia, agnosia**: Degeneration of cerebral cortex, mainly temporal lobe (hippocampus) and parietal lobe 
  * **[BPSD] Insomnia, hallucinations/delusions, depressive states, anxiety/agitation, excitement/violence, unclean behavior, wandering, pica/overeating, dependency**: Disruption of normal brain functions
* **Examination**
  * **[Cognitive function test] HDS-R score <= 20, MMSE <= 23**: Cognitive impairment
  * **[CT, MRI] Atrophy, mainly temporal lobe and hippocampus**: Degeneration of temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly temporal lobe and parietal lobe**: Reduced neuronal activity leads to reduced blood flow
* **Management**
  * **Cholinesterase inhibitor (donepezil, galantamine, rivastigmine)**: Reduce breakdown and increase level of acetylcholine, improve signal transduction
  * **NMDA receptor antagonist (memantin)**: Inhibit excessive glutamate activity, reduce neuronal damage 
{: .notice--info}

### Dementia With Lewy Bodies / Lewyå°ä½“å‹èªçŸ¥ç—‡

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of Î±-synuclein, leading to cognitive impairment and Parkinsonism
Pathology shows Lewy bodies
* **Presentation**
  * **Cognitive impairment, visual hallucinations (with daily or weekly fluctuation)**: Degeneration of cerebral cortex, mainly occipital lobe
  * **Parkinsonism, REM sleep behavior disorder**: Degeneration of basal ganglia and brainstem
* **Examination**
  * **[SPECT, PET] Reduced blood flow, mainly occipital lobe**: Degeneration of occipital lobe
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fiber
  * **[Dopamine reuptake test] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Cholinesterase inhibitor (donepezil)**: For cognitive impairment
  * **Levodopa**: For Parkinsonism
  * **Benzodiazepine (clonazepam)**: For REM sleep behavior disorder
{: .notice--info}

### Frontotemporal Dementia / å‰é ­å´é ­å‹èªçŸ¥ç—‡

* **Overview**
  * Degeneration of cerebral cortex (mainly frontal and temporal lobe), leading to cognitive impairment, personality changes and behavioral abnormalities 
* **Presentation**
  * **Decreased spontaneity, emotional blunting, disinhibition, stereotyped behaviors**: Degeneration of cerebral cortex, mainly frontal lobe and temporal lobe 
* **Examination**
  * **[CT, MRI] Atrophy, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Vascular Dementia / è¡€ç®¡æ€§èªçŸ¥ç—‡

* **Overview**
  * Cerebrovascular diseases damage the brain, leading to cognitive impairment
* **Presentation**
  * **Gradual and patchy decline in cognitive function**: Gradual and partial damage to cerebral cortex
  * **Motor and sensory disturbances**: Other symptoms of cerebral infarction or hemorrhage
* **Examination**
  * **[CT, MRI] Cerebral infarction or hemorrhage**
* **Management**
  * **Control hypertension, antiplatelet drugs, anticoagulants**: Prevent relapse of infarction
{: .notice--info} -->

## Neurodegenerative Disorder / ç¥çµŒå¤‰æ€§ç–¾æ‚£

### Parkinson's Disease / Parkinsonç—…

* **Overview**
  * Neurodegenerative disorder due to loss of dopamine-producing cells in substantia nigra
  * Common in middle-aged and elderly
* **Presentation**
  * **Resting tremor (4-6 Hz)**: Reduced dopamine transmission
  * **Bradykinesia, micrographia, mask-like face**: Impaired movement initiation
  * **Muscle rigidity (cogwheel or lead-pipe)**: Increased muscle tone
  * **Postural instability, forward-leaning posture**: Impaired balance control
  * **Freezing gait, small steps, festination**: Combined effect of bradykinesia and postural instability
  * **Constipation, urinary dysfunction, orthostatic hypotension, seborrhea**: Autonomic dysfunction
* **Examination**
  * **[MIBG myocardial scintigraphy] Reduced MIBG uptake**: Sympathetic denervation
  * **[DAT-SPECT] Reduced striatal uptake**: Loss of dopaminergic neurons
* **Management**
  * **L-dopa**: Replaces dopamine
  * **Dopamine agonists**: Stimulates dopamine receptors
  * **Anticholinergics, amantadine, MAO-B inhibitors, COMT inhibitors**: Various mechanisms to improve dopamine function
  * **Deep brain stimulation**: For medication-resistant cases
{: .notice--info}

### Progressive Supranuclear Palsy / é€²è¡Œæ€§æ ¸ä¸Šæ€§éº»ç—º

* **Overview**
  * Progressive neurodegenerative disease with tau protein accumulation in basal ganglia and brainstem
  * Common in males aged 50-70 years
* **Presentation**
  * **Vertical gaze palsy (especially downward)**: Supranuclear impairment of vertical eye movements
  * **Early falls, postural instability, neck extension**: Increased axial muscle tone
  * **Bradykinesia, masked face, small voice, freezing gait**: Parkinsonism (rare resting tremor)
  * **Dysarthria, dysphagia**: Pseudobulbar palsy
  * **Subcortical dementia**: Cognitive decline
* **Examination**
  * **[CT/MRI] Midbrain tegmentum atrophy (hummingbird sign)**: Characteristic neurodegeneration pattern
* **Management**
  * **Supportive care**: No established treatment
  * **Levodopa, other antiparkinsonian drugs**: Limited effectiveness
 {: .notice--info}

### Corticobasal Degeneration / å¤§è„³çš®è³ªåŸºåº•æ ¸å¤‰æ€§ç—‡

* **Overview**
  * Progressive neurodegenerative disease with tau protein accumulation in cerebral cortex and basal ganglia
  * Common in ages 50-70 years
* **Presentation**
  * **Limb-kinetic apraxia, ideomotor apraxia, alien hand syndrome , cortical sensory loss**: Cortical symptoms
  * **Rigidity, bradykinesia, postural instability**: Parkinsonism (rare resting tremor)
  * **Myoclonus, dystonia, cognitive decline**: Other brain involvement
  * **Symptoms show marked asymmetry**: Characteristic feature
* **Examination**
  * **[CT/MRI] Asymmetric cerebral atrophy**: Underlying neurodegeneration
* **Management**
  * **Supportive care**: No established treatment
  * **Levodopa, other antiparkinsonian drugs**: Limited effectiveness
{: .notice--info}

### Huntingtonâ€™s Disease / Huntingtonç—…

* **Overview**
  * Progressive neurodegenerative disease due to CAG repeat expansion in Huntington gene
  * Autosomal dominant , onset typically 30-50 years
* **Presentation**
  * **Quick, dance-like involuntary movements of limbs**: Chorea due to striatal degeneration
  * **Personality changes, dementia, delusions, hallucinations**: Progressive psychiatric symptoms
* **Examination**
  * **[CT/MRI] Caudate nucleus atrophy, enlarged anterior horn of lateral ventricles**: Characteristic brain changes
  * **[Genetic test] CAG repeat expansion in Huntington gene**: Confirms diagnosis
* **Management**
  * **Haloperidol, tiapride, tetrabenazine**: Control chorea (levodopa worsens symptoms)
  * **Haloperidol, chlorpromazine**: Manage psychiatric symptoms
{: .notice--info}

### MSA-C / å¤šç³»çµ±èç¸®ç—‡å°è„³å‹

* **Overview**
  * Progressive degeneration of inferior olive nucleus, pons, and cerebellum
  * Common in middle-aged and elderly, non-hereditary
* **Presentation**
  * **Truncal ataxia, drunken gait, limb incoordination, dysarthria**: Cerebellar dysfunction (initial symptoms)
  * **Abnormal finger-nose, heel-knee, diadochokinesis tests**: Cerebellar dysfunction
  * **Parkinsonism, autonomic symptoms, pyramidal signs**: Disease progression affecting multiple systems
* **Examination**
  * **[CT/MRI] Cerebellar and brainstem atrophy**: Neurodegeneration
  * **[MRI T2] Hot cross bun sign in ventral pons**: Characteristic finding of MSA-C
* **Management**
  * **TRH/TRH derivatives**: For cerebellar symptoms
  * **Levodopa**: For parkinsonism
  * **Droxidopa, midodrine, Î±-blockers**: For autonomic symptoms (orthostatic hypotension, urinary dysfunction)
{: .notice--info}

### MSA-P / å¤šç³»çµ±èç¸®ç—‡ãƒ‘ãƒ¼ã‚­ãƒ³ã‚½ãƒ³å‹

* **Overview**
  * Progressive degeneration of striatum and substantia nigra
  * Common in middle-aged and elderly, non-hereditary
* **Presentation**
  * **Akinesia, rigidity, small-step gait**: Parkinsonian symptoms (rare resting tremor)
  * **Cerebellar symptoms, autonomic symptoms, pyramidal signs**: Disease progression affecting multiple systems
* **Examination**
  * **[MRI] Putaminal atrophy**: Striatal degeneration
  * **[MRI T2/FLAIR] Linear hyperintensity in lateral putamen**: Characteristic finding of MSA-P
* **Management**
  * **Levodopa**: For parkinsonism
  * **TRH/TRH derivatives**: For cerebellar symptoms
  * **Droxidopa, midodrine, Î±-blockers**: For autonomic symptoms (orthostatic hypotension, urinary dysfunction)
{: .notice--info}

### Shy-Drager Syndrome / Shy-Dragerç—‡å€™ç¾¤

* **Overview**
  * Part of multiple system atrophy characterized by primary autonomic dysfunction
  * Common in middle-aged and elderly, non-hereditary
* **Presentation**
  * **Orthostatic hypotension, postprandial hypotension, urinary dysfunction, constipation, erectile dysfunction, anhidrosis, Horner's syndrome**: Autonomic dysfunction
  * **Cerebellar symptoms, parkinsonism, pyramidal signs**: Disease progression affecting multiple systems
* **Examination**
  * **[CT/MRI] Various combinations of MSA-C and MSA-P findings**: Multiple system involvement
* **Management**
  * **Droxidopa, midodrine, Î±-blockers**: For autonomic symptoms (orthostatic hypotension, urinary dysfunction)
  * **TRH/TRH derivatives**: For cerebellar symptoms
  * **Levodopa**: For parkinsonism
{: .notice--info}

### Amyotrophic Lateral Sclerosis / ç­‹èç¸®æ€§å´ç´¢ç¡¬åŒ–ç—‡

* **Overview**
  * Progressive degeneration of both upper and lower motor neurons leads to muscle atrophy
  * Common in 60-70s, mainly sporadic but some familial
* **Presentation**
  * **Muscle weakness, atrophy, fasciculation (mainly upper limbs)**: Lower motor neuron damage
  * **Hyperreflexia, Babinski sign (mainly lower limbs)**: Upper motor neuron damage
  * **Dysphagia, dysarthria, tongue atrophy**: Bulbar palsy
  * **No eye movement disorder, sensory disturbance, bladder/bowel dysfunction, pressure sores**: Four negative symptoms characteristic of ALS
* **Examination**
  * **[EMG] Denervation potentials at rest, high amplitude potentials during voluntary contraction**: Neurogenic changes
  * **[Muscle ultrasound] Fasciculation**: Lower motor neuron damage
* **Management**
  * **Supportive care, rehabilitation**: No curative treatment , mean survival 3-5 years
  * **Riluzole, edaravone**: Limited effectiveness
{: .notice--info}

### Spinal Muscular Atrophy / è„Šé«„æ€§ç­‹èç¸®ç—‡

* **Overview**
  * Degeneration of lower motor neurons due to SMN gene deletion/mutation, four types based on age of onset and severity
* **Presentation**
  * **[Type I] Severe hypotonia (floppy infant)**: Onset at birth
  * **[Type II] Intermediate severity**: Onset by age 2
  * **[Type III] Proximal muscle weakness, Gowers' sign**: Onset age 2-18
  * **[Type IV] Very slow progression**: Adult onset
  * **Normal intelligence**: Only motor function affected
* **Examination**
  * **[Genetic testing] SMN gene deletion/mutation**: Confirms diagnosis in many cases
* **Management**
  * **Supportive care**: No curative treatment, variable progression based on types
{: .notice--info}

### Bulbospinal Muscular Atrophy / çƒè„Šé«„æ€§ç­‹èç¸®ç—‡

* **Overview**
  * Degeneration of lower motor neurons due to CAG repeat expansion in androgen receptor gene
  * X-linked recessive, common in  20-50 years males
* **Presentation**
  * **Bulbar palsy, widespread fasciculations**: Lower motor neuron degeneration
  * **Gynecomastia, hypogonadism**: Androgen receptor dysfunction
  * **Normal intelligence**: Only motor and endocrine systems affected
* **Examination**
  * **[Genetic testing] CAG repeat expansion in androgen receptor gene**: Definitive diagnosis
* **Management**
  * **Supportive care**: No curative treatment, slow progression
{: .notice--info}

<!-- ### Parkinsonâ€™s Disease / Parkinsonç—…

* **Overview**
  * Degeneration of dopamine neuron in substantia nigra pars compacta lead to dopamine deficiency, the direct pathway of basal ganglia (striatum - globus pallidus internum - thalamus) cannot be excited and making movement difficult
  * More common in middle-aged to elderly individuals 
  * Pathology reveals loss of neuromelanin-containing cells in substantia nigra and appearance of Lewy bodies in nerve cells (due to accumulation of Î±-synuclein)
* **Presentation**
  * **Akinesia (slow movement, difficulty initiating walking and short-step gait, masked face)**: Dopamine depletion disrupts movement control
  * **Resting tremor  (pill-rolling tremor, tapping tremor)**: Dopamine depletion disrupts movement control
  * **Muscle rigidity (cogwheel or lead-pipe)**: Dopamine depletion disrupts muscle tone control
  * **Postural instability (increased tendency to fall when pushed)**: Dopamine depletion disrupts balance maintenance 
  * **Depression, dementia, sleep disorder**: Dopamine depletion disrupts mood and cognition
  * **Orthostatic hypotension, urinary dysfunction, chronic constipation**: Dopamine depletion disrupts autonomic system
* **Examination**
  * **[CT, MRI] No specific findings**
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fibers
  * **[Dopamine transporter imaging] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Dopamine precursor (levodopa) + dopamine decarboxylase inhibitor (carbidopa)**: Levodopa cross blood-brain barrier and convert to dopamine (carbidopa inhibit the conversion in peripheral tissue)
  * **Dopamine agonist (bromocriptine, pergolide, cabergoline, pramipexole, ropinirole, rotigotine, apomorphine)**: Stimulate dopamine receptor
  * **Anticholinergic drugs (trihexyphenidyl, biperiden, prophenamine)**: Balance acetylcholine and dopamine level
  * **Dopamine release promoter (amantadine)**: Increase dopamine release
  * **Monoamine oxidase B inhibitor (selegiline, rasagiline)**: Inhibit breakdown of dopamine
  * **COMT inhibitor (Entacapone)**: Inhibit breakdown of levodopa
  * **Deep brain stimulation (subthalamic nucleus or globus pallidus)**: Modulate abnormal neural activity caused by dopamine deficiency 
{: .notice--info}

### Progressive Supranuclear Palsy / é€²è¡Œæ€§æ ¸ä¸Šæ€§éº»ç—º

* **Overview**
  * Degeneration of basal ganglia and brainstem due to abnormal accumulation of tau protein
* **Presentation**
  * **Increased neck muscle tone, akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
  * **Vertical gaze palsy, speech and swallowing impairment**: Degeneration of brain stem
  * **Mental disturbances**: Degeneration of frontal lobe
* **Examination**
  * **[CT, MRI] Atrophy of midbrain tegmentum (hummingbird sign)**
* **Management**
  * **No established treatment, similar to medication for Parkinsonâ€™s disease**: Limited response
{: .notice--info}

### Corticobasal Degeneration / å¤§è„³çš®è³ªåŸºåº•æ ¸å¤‰æ€§ç—‡

* **Overview**
  * Degeneration of cerebral cortex and basal ganglia due to abnormal accumulation of tau protein
* **Presentation**
  * **Motor clumsiness, apraxia, alien hand syndrome, dementia, involuntary movements (asymmetry between two sides)**: Degeneration of cerebral cortex
  * **Akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
* **Examination**
  * **[CT, MRI] Asymmetric cortical atrophy**
* **Management**
  * **No established treatment, similar to medication for Parkinsonâ€™s disease**: Limited response
{: .notice--info}

### Huntingtonâ€™s Disease / Huntingtonç—…

* **Overview**
  * Degeneration of striatum lead to overactivity of dopaminergic neurons, causing involuntary movements
Autosomal dominant inheritance, due to abnormal expansion of CAG repeats
* **Presentation**
  * **Rapid involuntary movements of limbs**: Degeneration of striatum disruptions inhibition of involuntary movements
  * **Personality change, dementia**: Degeneration of cerebral cortex
* **Examination**
  * **[CT, MRI] Atrophy of caudate nucleus, enlargement of anterior horns of lateral ventricles**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Tetrabenazine**: For involuntary movements
  * **Antipsychotics (haloperidol)**: For psychiatric symptoms
{: .notice--info}

### Amyotrophic Lateral Sclerosis / ç­‹èç¸®æ€§å´ç´¢ç¡¬åŒ–ç—‡

* **Overview**: 
  * Degeneration of upper and lower motor neurons leads to progressive muscular atrophy; mostly sporadic but sometimes hereditary 
  * More common in middle-aged to elderly individuals 
  * Pathology shows atrophy of pyramidal tract and anterior horn, with TDP-43 positive inclusions
* **Presentation**
  * **Muscle weakness, muscle atrophy, fasciculations**: Degeneration of lower motor neurons lead to reduced stimulation on muscles
  * **Increased tendon reflexes, positive Babinski sign**: Degeneration of upper motor neurons lead to reduced inhibition on lower motor neurons
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves lead to bulbar palsy
  * **No eye movement disorders, sensory impairments, bladder or rectal dysfunction, pressure sores**: Cranial nerves III IV VI, sensory neurons, autonomic neurons are spared
* **Examination**
  * **[EMG] Denervation potentials at rest**: Denervation from lower motor neurons leads to spontaneous electrical activity
  * **[EMG] High-amplitude potentials during voluntary contraction**: Degeneration of lower motor neurons leads to formation of larger motor units by remaining neurons
  * **[Muscle biopsy] Grouped atrophy**: Denervation of motor units
* **Management**
  * **No cure**: Progress to requiring mechanical ventilation or death in 3~5 years
  * **[Medication] Riluzole, edaravone**: Protect neurons by reducing glutamate activity or scavenging free radicals
{: .notice--info}

### Spinal Muscular Atrophy / è„Šé«„æ€§ç­‹èç¸®ç—‡

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; autosomal recessive inheritance
  * Type I onset at birth and die within one year, type III onset at 2~18 years and have good prognosis
* **Presentation**
  * **Muscle weakness (floppy infant, Gowersâ€™ sign), fasciculations, absent tendon reflexes**: Degeneration of lower motor neurons cause reduced stimulation on muscles
* **Examination**
  * **[Genetic test] SMN gene mutation**
* **Management**
  * **Symptomatic treatment**: Type I die within one year, type III and IV have good prognosis
{: .notice--info}

### Bulbospinal Muscular Atrophy / çƒè„Šé«„æ€§ç­‹èç¸®ç—‡

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; X-linked recessive inheritance, due to abnormal expansion of CAG repeats in androgen receptor gene
* **Presentation**
  * **Muscle weakness, muscle atrophy (primarily proximal muscles), fasciculations, tremors**: Degeneration of lower motor neurons cause reduced stimulation on muscles
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves cause bulbar palsy
  * **Gynecomastia, impotence, testicular atrophy**: Abnormal androgen receptor lead to reduced sensitivity to androgen
* **Examination**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Symptomatic treatment**: Prognosis depends on CAG repeats number
{: .notice--info}

### Multiple System Atrophy / å¤šç³»çµ±èç¸®ç—‡

* **Overview**
  * Degeneration of olivo-ponto-cerebellar system, striatonigral system, and autonomic nervous system; sporadic
  * More common in middle-aged to elderly individuals 
  * Pathology shows glial cytoplasmic inclusion (due to accumulation of Î±-synuclein)
  * [MSA-C] Cerebellar ataxia as predominant early symptom, but other symptoms present later
  * [MSA-P] Parkinsonism as predominant early symptom, but other symptoms present later
  * [Shy-Drager syndrome] Autonomic dysfunction as predominant early symptom, but other symptoms present later
* **Presentation**
  * **[Cerebellar ataxia] Truncal ataxia (staggering gait), limb coordination problems (abnormal finger-to-nose test), dysarthria**: Degeneration of olivo-ponto-cerebellar system
  * **[Parkinsonism] Bradykinesia, muscle rigidity, shuffling gait (resting tremor are rare)**: Degeneration of striatonigral system
  * **[Autonomic dysfunction] Orthostatic hypotension, bladder and rectal dysfunction, erectile dysfunction, sweating abnormalities, horner syndrome**: Degeneration of autonomic nervous system
* **Examination**
  * **[CT, MRI] Atrophy of cerebellum and brainstem, cross sign in pons**: Degeneration of olivo-ponto-cerebellar system, degeneration of transverse and longitudinal pontocerebellar fibers
  * **[CT, MRI] Atrophy of putamen, linear area of high-signal on lateral side of putamen**: Degeneration of striatonigral system, gliosis of lateral side of putamen
* **Management**
  * **[Cerebellar ataxia] TRH analog (protirelin, taltirelin)**: Stimulate neurotransmission and enhance motor control
  * **[Parkinsonism] Dopamine precursor (levodopa)**: Converted to dopamine and alleviate Parkinsonism
  * **[Autonomic dysfunction] Alpha-agonists (midodrine, droxidopa), alpha-blockers**: For orthostatic hypotension or urinary retention 
{: .notice--info}

### Spinocerebellar Ataxia / è„Šé«„å°è„³å¤±èª¿ç—‡

* **Overview**
  * Degeneration of cerebellum or spinal cord; hereditary
  * [SCA-3] Abnormal expansion of CAG repeats in ataxia-3 gene, autosomal dominant
  * [SCA-6] Abnormal expansion of CAG repeats in CACNA1A gene, autosomal dominant
  * [Dentato-rubro-pallido-luysian atrophy] Abnormal expansion of atrophin-1 gene, autosomal dominant
  * [Friedreich ataxia] Abnormal expansion of GAA repeats in frataxin genes, autosomal recessive
* **Presentation**
  * **Cerebellar ataxia, startled expression (SCA-3)**: Degeneration of cerebellum 
  * **Spinal ataxia, deep sensory loss (Friedreich ataxia)**: Degeneration of spinal cord
* **Examination**
  * **[CT. MRI] Degeneration of cerebellum and spinal cord**
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Wernicke Encephalopathy / Wernickeè„³ç—‡

* **Overview**
  * Vitamin B1 deficiency (chronic alcoholism, malnutrition, inappropriate IV infusion) damage neurons and cause necrosis (mainly around cerebral ventricles)
* **Presentation**
  * **Consciousness disturbances (somnolence, delirium)**: Impairment of thalamus
  * **Ocular movement disorders (abducens nerve palsy, nystagmus)**: Impairment of brainstem (cranial nerve nucleus)
  * **Cerebellar dysfunction (ataxic gait)**: Impairment of cerebellum 
  * **Korsakoff syndrome (memory impairment, confabulation, disorientation)**: Irreversible damage to brain if untreated
* **Examination**
  * **[MRI] High signal in third ventricle, cerebral aqueduct, fourth ventricle, mammillary body**: Neuronal damage around cerebral ventricles
  * **[Blood test] Vitamin B1 decrease**: Vitamin B1 deficiency
* **Management**
  * **Large intravenous administration of Vitamin B1**
  * **[Donâ€™t] Glucose administration alone during Vitamin B1 deficiency is contraindicated**: Further consume Vitamin B12
{: .notice--info}

### Subacute Combined Degeneration of Spinal Cord / äºœæ€¥æ€§è„Šé«„é€£åˆå¤‰æ€§ç—‡

* **Overview**
  * Vitamin B12 deficiency (total gastrectomy, autoimmune atrophic gastritis) cause degeneration of posterior column, lateral column and peripheral nerve
* **Presentation**
  * **Deep sensory impairment, positive Rombergâ€™s sign**: Impairment of posterior column
  * **Increased tendon reflexes, positive Babinski sign, spastic paralysis**: Impairment of lateral column
  * **Numbness, muscle weakness**: Impairment of peripheral nerves
  * **Anemia, Hunterâ€™s glossitis**: Impairment of DNA synthesis 
* **Examination**
  * **[Blood test] Megaloblastic anemia, vitamin B12 decrease, methylmalonic acid increase, homocysteine increase**: Vitamin B12 is crucial for DNA synthesis (RBC production), conversion of methylmalonyl-CoA to succinyl-CoA, conversion of homocysteine to methionine
  * **[MRI] High-signal in posterior column and lateral column**
* **Management**
  * **IV and oral administration of Vitamin B12**
  * **[Donâ€™t] Folic acid administration alone is contraindicated**: Mask the neurological symptoms and further consume Vitamin B12
{: .notice--info} -->

## Demyelinating Disorder / è„±é«„æ€§ç–¾æ‚£

### Multiple Sclerosis / å¤šç™ºæ€§ç¡¬åŒ–ç—‡

* **Overview**
  * Autoimmune demyelinating disease affecting central nervous system white matter
  * Multiple lesions occur in space and time with relapsing-remitting course
  * Common in women aged 15-50
* **Presentation**
  * **Sudden visual impairment, central scotoma**: Retrobulbar optic neuritis
  * **Double vision, MLF syndrome**: Brainstem involvement
  * **Muscle weakness, hyperreflexia, Babinski sign**: Pyramidal tract involvement
  * **Numbness, trigeminal neuralgia, Lhermitte's sign**: Sensory tract involvement
  * **Ataxia, tremor, nystagmus, dysarthria**: Cerebellar involvement
  * **Neurogenic bladder**: Autonomic system involvement
  * **Euphoria, depression**: Mental symptoms
* **Examination**
  * **[MRI] Multiple white matter lesions**: Spatial dissemination
  * **[CSF] IgGâ†‘, oligoclonal bands, MBPâ†‘**: Psychiatric destruction
* **Management**
  * **[Acute] Steroid pulse therapy, plasmapheresis**: Reduce inflammation
  * **[Prevention] IFN-Î², glatiramer acetate, fingolimod, natalizumab**: Prevent relapses
  * **[Symptomatic] Gabapentin/pregabalin (pain), carbamazepine (spasm), baclofen (spasticity)**: Manage symptoms
{: .notice--info}

### Neuromyelitis Optica / è¦–ç¥çµŒè„Šé«„ç‚

* **Overview**
  * Autoimmune disease with antibodies against aquaporin-4 (AQP4) in astrocytes
  * Common in 30s women, often associated with other autoimmune diseases
* **Presentation**
  * **Visual loss, blindness, horizontal hemianopia**: Severe optic neuritis
  * **Quadriparesis, sensory disturbance, bladder/bowel dysfunction**: Transverse myelitis
* **Examination**
  * **[MRI] Extensive spinal cord lesions (â‰¥3 vertebral segments)**: Extensive transverse myelitis
  * **[Blood] Anti-AQP4 antibody positive**: Confirms diagnosis
  * **[CSF] Oligoclonal bands usually negative**: Differentiate from MS
* **Management**
  * **[Acute] Steroid pulse therapy, plasmapheresis**: Reduce inflammation
  * **[Prevention] Steroids, immunosuppressants, rituximab**: Prevent relapses
{: .notice--info}

### Acute Disseminated Encephalomyelitis / æ€¥æ€§æ•£åœ¨æ€§è„³è„Šé«„ç‚

* **Overview**
  * Inflammatory demyelinating disease of central nervous system, similar to MS but with rapid onset and remission
  * Common in children, triggered by viral infections or vaccines
* **Presentation**
  * **Sudden onset of headache, vomiting, consciousness disturbances, seizures**: Acute disseminated demyelination of central nervous system
* **Examination**
  * **[MRI] Multiple demyelinating lesions**: Similar to MS but typically monophasic
* **Management**
  * **High-dose steroids, immunoglobulin**: Reduce inflammation
  * **Good prognosis**: Usually monophasic
{: .notice--info}

## Miscellaneous CNS Disorder / ãã®ä»–ã®ä¸­æ¢ç¥çµŒç–¾æ‚£

### Anti-NMDA Receptor Encephalitis / æŠ—NMDAå—å®¹ä½“æŠ—ä½“è„³ç‚

* **Overview**
  * Autoimmune encephalitis mainly affecting limbic system through anti-NMDA receptor antibodies
  * Common in young females, associated with tumors especially ovarian teratoma
* **Presentation**
  * **Fever, headache**: Prodromal phase
  * **Agitation, hallucinations, delusions**: Psychiatric phase
  * **Decreased consciousness, reduced movement, respiratory depression**: Unresponsive phase
  * **Dystonia, orofacial dyskinesia, myoclonus, seizures**: Movement disorder phase
* **Examination**
  * **[Blood/CSF] Anti-NMDA receptor antibodies**: Confirms diagnosis
  * **[MRI] Abnormal signals in limbic system**: Inflammation in limbic system
* **Management**
  * **Tumor removal**: If present
  * **Steroid pulse therapy, IVIg, plasmapheresis**: Suppress immune response
{: .notice--info}

### Wernicke's Encephalopathy / Wernickeè„³ç—‡

* **Overview**
  * Acute/subacute inflammation and necrosis in periventricular areas due to vitamin B1 deficiency
  * Often seen in alcoholism, post-gastrointestinal surgery, hyperemesis gravidarum
* **Presentation**
  * **Altered consciousness, delirium, confusion**: Thalamus involvement
  * **Eye movement disorders, nystagmus**: Brainstem involvement
  * **Trunk ataxia, unsteady gait**: Cerebellar dysfunction
* **Examination**
  * **[MRI] T2/FLAIR high signal in periventricular areas**: Periventricular inflammation and necrosis
  * **[Blood] Low vitamin B1, lactic acidosis**: Thiamine deficiency and metabolic derangement
* **Management**
  * **Immediate high-dose IV thiamine (before glucose administration)**: Replace deficiency
  * **May progress to Korsakoff syndrome**: Amnesia, disorientation, confabulation
{: .notice--info}

### Subacute Combined Degeneration of Spinal Cord / äºœæ€¥æ€§è„Šé«„é€£åˆå¤‰æ€§ç—‡

* **Overview**
  * Vitamin B12 deficiency causing degeneration of peripheral and central nervous system
  * Common after total gastrectomy due to malabsorption of B12
* **Presentation**
  * **Macrocytic anemia, Hunter glossitis**: Vitamin B12 deficiency
  * **Romberg sign, impaired proprioception**: Posterior column damage
  * **Hyperreflexia, Babinski sign, spastic paralysis**: Lateral column (pyramidal tract) damage
  * **Numbness and weakness in extremities**: Peripheral nerve damage
* **Examination**
  * **[Blood] Vitamin B12â†“, methylmalonic acidâ†‘, homocysteineâ†‘**: B12 deficiency disrupts folate and fatty acid metabolism
  * **[Urine] Methylmalonic acid excretionâ†‘**: Same
* **Management**
  * **Intramuscular vitamin B12**: Replace deficiency
  * **Avoid folic acid alone**: Can worsen neurological symptoms
{: .notice--info}

### Spinal Cord Infarction / è„Šé«„æ¢—å¡

* **Overview**
  * Infarction of anterior 2/3 of spinal cord due to anterior spinal artery occlusion
  * Common causes: Aortic dissection, aortic surgery, atherosclerosis
* **Presentation**
  * **Motor weakness, sensory loss (pain, temperature)**: Anterior and lateral columns involvement
  * **Preserved position/vibration sense**: Posterior column sparing
* **Examination**
  * **[MRI] T2 high signal in anterior spinal cord**: Anterior spinal cord infarction
* **Management**
  * **Edaravone, anti-edema drugs, corticosteroids**: Neuroprotection
{: .notice--info}

### Spinal Arteriovenous Malformation / è„Šé«„å‹•é™è„ˆå¥‡å½¢

* **Overview**
  * Abnormal arteriovenous shunts in spinal cord vasculature, classified as intramedullary AVM, perimedullary AVF, dural AVF
* **Presentation**
  * **Acute motor and sensory disturbances, headache, vomiting, consciousness disturbances**: Acute intramedullary or subarachnoid hemorrhage
  * **Gradual motor and sensory disturbances**: Venous hypertension causes congestion and edema in spinal cord
* **Examination**
  * **[MRI] Flow void lesions of nidus or shunt, T2 high signal in spinal cord**: Arteriovenous malformation, spinal edema
  * **[Angiography] Nidus, shunt**: Definitive diagnosis
* **Management**
  * **[Surgical treatment]**: Direct removal of AVM/AVF
  * **[Endovascular treatment]**: Catheter-based embolization
{: .notice--info}

### Syringomyelia / è„Šé«„ç©ºæ´ç—‡

* **Overview**
  * Fluid-filled cavity formation within spinal cord causing neurological deficits
  * Common in 20-40s, often associated with Chiari malformation
* **Presentation**
  * **Upper limb temperature and pain sensory loss (unilateral first and bilateral cape-like later)**: Damage to spinothalamic tract (central spinal cord)
  * **Upper limb muscle atrophy, lower limb spastic paralysis**: Progress to involve anterior horn and lateral column
  * **Bulbar palsy, Hornerâ€™s syndrome**: Progress to involve upper and lower levels of spinal cord
* **Examination**
  * **[MRI] Cavity formation within spinal cord**: Confirm diagnosis
* **Management**
  * **Foramen magnum decompression**: Primary treatment for Chiari-associated cases
  * **Syrinx-subarachnoid shunt**: Direct treatment of syrinx
{: .notice--info} 

### Brown-SÃ©quard Syndrome / Brown-SÃ©quardç—‡å€™ç¾¤

* **Overview**
  * Hemisection of spinal cord resulting in distinct neurological deficits
  * Causes include trauma, tumor, infection
* **Presentation**
  * **[At level of injury] Ipsilateral all sensory loss**: Damage to dorsal root entry
  * **[At level of injury] Ipsilateral muscle weakness**: Damage to anterior horn exit
  * **[Below level of injury] Ipsilateral proprioceptive loss**: Damage to dorsal column before crossing
  * **[Below level of injury] Ipsilateral spastic paralysis**: Damage to pyramidal tract after crossing
  * **[Below level of injury] Contralateral pain and temperature loss**: Damage to lateral spinothalamic tract after crossing
* **Examination**
  * **[Physical] Characteristic sensory and motor loss**
* **Management**
  * **Treat underlying cause**
{: .notice--info} 

<!-- ### Multiple Sclerosis / å¤šç™ºæ€§ç¡¬åŒ–ç—‡

* **Overview**
  * Autoimmune-related Inflammatory demyelination throughout white matter of CNS (spatial dissemination), leading to various neurological symptoms that recur and remit (temporal dissemination); PNS usually spared
  * Relapsing-remitting type (more) characterized by relapse and remission at first and progress without remission later; primary progressive type (less) progress without remission from onset
  * More common in young women (autoimmune) and high latitude region
* **Presentation**
  * **Vision loss, central scotomas (recover in 1-2 weeks, relapse latter)**: Impairment of optic nerve (optic neuritis)
  * **Internuclear ophthalmoplegia**: Impairment of medial longitudinal fasciculus
  * **Ataxia, tremor, nystagmus, dysarthria**: Impairment of cerebellum
  * **Weakness of extremities, spasticity, hyperreflexia, clonus**: Impairment of motor pathway
  * **Numbness, electric shock-like sensation during neck movement (Lhermitteâ€™s sign), trigeminal neuralgia**: Impairment of sensory pathway
  * **Bladder and bowel dysfunction**: Impairment of autonomic nervous system
* **Examination**
  * **[MRI] Multiple high-signal plaque lesion in brain and spinal cord**: Demyelination of CNS white matter
  * **[CSF analysis] Lymphocytes increased, IgG increased, oligoclonal band present, myelin binding protein present**: Autoimmune destruction of myelin in CNS
  * **Abnormal evoked potential (especially visual)**: Demyelination of the corresponding pathway
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Interferon-beta, glatiramer (MBP-mimicking peptide), natalizumab (anti-Î±4 integrin antibody), fingolimod (S1PR modulator)**: Immunomodulatory or immunosuppressive drugs
  * **[Symptomatic treatment] Muscle relaxant, anticonvulsant (gabapentin, pregabalin), anticholinergic drugs or alpha-blockers**: For spasticity, neuropathic pain, urinary symptoms
{: .notice--info}

### Neuromyelitis Optica / è¦–ç¥çµŒè„Šé«„ç‚

* **Overview**
  * Anti-AQP4 autoantibody damage astrocytes, lead to inflammatory demyelination causing relapsing optic neuritis and myelitis
More common in middle age women (autoimmune)
* **Presentation**
  * **Vision loss, visual field defects**: Impairment of optic nerve (optic neuritis)
  * **Motor disturbances, sensory disturbances, bladder and bowel dysfunction**: Impairment of spinal cord (myelitis)
* **Examination**
  * **[MRI] High-signal lesion in brain and spinal cord (>3 vertebral segments)**: Demyelination of optic nerve and spinal cord
  * **[Blood] Anti-AQP4 antibody positive**: Autoimmune nature
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Steroid, immunosuppressant, rituximab (anti -CD20 antibody)**
{: .notice--info}

### Acute Disseminated Encephalomyelitis / æ€¥æ€§æ•£åœ¨æ€§è„³è„Šé«„ç‚

* **Overview**
  * Inflammatory demyelination of throughout CNS (spatial dissemination) with acute and monophasic course (compared to multiple sclerosis), preceded by viral infection or vaccination (hypersensitivity)
* **Presentation**
  * **Fever, headache, vomiting (acute onset and rapid remission)**: Inflammation of brain
* **Examination**
  * **[Blood] WBC increase, ESR increase, CRP increase**: Inflammation
  * **[MRI] Scattered high-signal lesions in brain**: Disseminated demyelination of CNS
* **Management**
  * **Steroid pulse therapy, plasmapheresis, high-dose immunoglobulin therapy**: Suppress acute inflammation
{: .notice--info}

### Adrenoleukodystrophy / å‰¯è…ç™½è³ªã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼

* **Overview**
  * X-linked recessive disorder, defects of peroxisome prevent breakdown of very long-chain fatty acids, which accumulate in white matter of brain (progressive demyelination) and adrenal gland (adrenal insufficiency)
* **Presentation**
  * **Personality and behavioral abnormalities (aggression), intellectual disability**: Impairment of commissural fibers of brain
  * **Gait disturbances (ataxic gait)**: Impairment of spinal cord
  * **Vision and hearing impairment**: Impairment of visual and auditory pathway
* **Examination**
  * **[Blood] Cortisol decrease, very long-chain fatty acids increase**: Adrenal insufficiency, fatty acid metabolism defect
  * **[MRI] High-signal lesion in brain**: Demyelination of CNS
  * **[Genetic test] ABCD1 mutation**
* **Management**
  * **Steroid hormone**: For adrenal insufficiency 
  * **No cure, dead in 1~5 years**
{: .notice--info} -->

## Peripheral Nerve Disorder / æœ«æ¢¢ç¥çµŒéšœå®³

### Guillain-BarrÃ© Syndrome / Guillain-BarrÃ©ç—‡å€™ç¾¤

* **Overview**
  * Acute immune-mediated polyneuropathy affecting myelin/axons of peripheral nerves, generally self-limiting but can be severe
  * Usually preceded by respiratory or gastrointestinal infection
* **Presentation**
  * **Ascending symmetric flaccid paralysis, respiratory difficulty (severe cases)**: Lower motor neuron damage
  * **Sensory disturbances in limbs, decreased tendon reflexes**: Peripheral nerve dysfunction
  * **Facial paralysis, bulbar palsy, diplopia**: Cranial nerve involvement
* **Examination**
  * **[Blood] Anti-ganglioside antibodies (anti-GM1)**: Autoimmune nature
  * **[CSF] Proteinâ†‘, cellâ†’**: Inflammation but no infection
  * **[Nerve conduction] Decreased conduction velocity, conduction block**: Demyelination/axonal damage
* **Management**
  * **[Mild] Conservative treatment**: Self-limiting nature
  * **[Moderate] IV immunoglobulin, plasma exchange**: Modulate immune response
  * **[Severe] Respiratory support**: For respiratory muscle paralysis
{: .notice--info}

### Chronic Inflammatory Demyelinating Polyradiculoneuropathy / æ…¢æ€§ç‚ç—‡æ€§è„±é«„æ€§å¤šç™ºæ ¹ãƒ‹ãƒ¥ãƒ¼ãƒ­ãƒ‘ãƒãƒ¼

* **Overview**
  * Chronic autoimmune demyelinating peripheral neuropathy
  * Progress over >2 months, 	no preceding infection
* **Presentation**
  * **Progressive weakness and sensory disturbances in limbs, decreased tendon reflexes**: Demyelination of peripheral nerves
* **Examination**
  * **[Nerve conduction] Decreased conduction velocity, conduction block**: Demyelination
  * **[CSF] Proteinâ†‘, cellâ†’**: Inflammation but no infection
  * **[MRI] Thickening and enhancement of nerve roots and plexus**: Chronic inflammation of nerve roots
  * **[Nerve biopsy] Demyelination, remyelination, inflammatory cell infiltration**: Confirms diagnosis
* **Management**
  * **Corticosteroids, IV immunoglobulin, plasma exchange**: Modulate immune response
{: .notice--info}

### Charcot-Marie-Tooth Disease / Charcot-Marie-Toothç—…

* **Overview**
  * Hereditary progressive peripheral neuropathy caused by mutations in myelin-related genes 
  * Autosomal dominant inheritance, onset in 10-30s
* **Presentation**
  * **Distal leg weakness, calf atrophy (drop foot), gait disturbance (steppage gait)**: Progressive motor neuropathy
  * **Mild sensory disturbance, decreased tendon reflexes**: Peripheral nerve dysfunction
* **Examination**
  * **[Nerve conduction] Decreased conduction velocity**: Demyelination
  * **[Genetic testing] Myelin-related genes mutation**: Confirms diagnosis
  * **[Nerve biopsy] Onion bulb formation**: Chronic demyelination and remyelination
* **Management**
  * **Supportive care**: No specific treatment available
  * **Good life prognosis**: Very slow progression
{: .notice--info}

### Familial Amyloid Polyneuropathy / å®¶æ—æ€§ã‚¢ãƒŸãƒ­ã‚¤ãƒ‰ãƒãƒªãƒ‹ãƒ¥ãƒ¼ãƒ­ãƒ‘ãƒãƒ¼

* **Overview**
  * Hereditary amyloid deposition in multiple organs, caused by mutant transthyretin produced in liver
  * Autosomal dominant inheritance, onset in 20-40s
* **Presentation**
  * **Progressive sensory disturbances**: Sensory nerve involvement
  * **Diarrhea, constipation, erectile dysfunction, orthostatic hypotension**: Autonomic nerve involvement
  * **Progressive muscle weakness and atrophy**: Motor nerve involvement
  * **Heart failure, arrhythmia, kidney dysfunction, eye dysfunction**: Systemic amyloid deposition
* **Examination**
  * **[Blood] Abnormal transthyretin**: Genetic mutation
  * **[Nerve conduction] Decreased amplitude, reduced conduction velocity**: Axonal and myelin damage
  * **[Biopsy] Congo red positive amyloid deposits**: Confirmation of amyloid
  * **[Genetic testing] Transthyretin gene mutation**: Definitive diagnosis
* **Management**
  * **Liver transplantation**: Limited indication
  * **Poor prognosis**
{: .notice--info}

### Diabetic Neuropathy / ç³–å°¿ç—…æ€§ãƒ‹ãƒ¥ãƒ¼ãƒ­ãƒ‘ãƒãƒ¼

* **Overview**
  * Complication of diabetes, caused by metabolic disorders and vascular damage to nerves
  * Usually occurs after 5-10 years of diabetes
* **Presentation**
  * **Symmetric glove-stocking sensory disturbance, decreased vibration sense, absent Achilles reflex**: Sensory nerve involvement
  * **Orthostatic hypotension, urinary dysfunction, erectile dysfunction, GI symptoms**: Autonomic nerve involvement
  * **Eye movement disorders, carpal tunnel syndrome, proximal muscle atrophy**: Mononeuropathy
* **Examination**
  * **[Clinical] History of diabetes**: Essential for diagnosis
* **Management**
  * **Blood glucose control**: Prevent disease progression
  * **NSAIDs, antidepressants, pregabalin**: Pain control
  * **Aldose reductase inhibitors, vitamin B12**: Metabolic improvement
{: .notice--info}

### Trigeminal Neuralgia / ä¸‰å‰ç¥çµŒç—›

* **Overview**
  * Paroxysmal severe pain along trigeminal nerve distribution, mainly caused by vascular compression
  * Common in middle-aged females
* **Presentation**
  * **Sudden severe stabbing pain in unilateral face (seconds to minutes)**: Compressed trigeminal nerve irritation
  * **Pain triggered by touching or moving face**: Hypersensitivity of affected nerve
* **Examination**
  * **[MRI] Vascular compression of trigeminal nerve**: Cause of idiopathic trigeminal neuralgia
* **Management**
  * **Anticonvulsants (carbamazepine, pheytoin, valproic acid), pregabalin**: Stabilize neuronal activity
  * **Trigeminal nerve block, microvascular decompression surgery**: For medication-resistant cases
{: .notice--info}

### Bell's Palsy and Ramsay Hunt Syndrome / Belléº»ç—ºãƒ»Ramsay Huntç—‡å€™ç¾¤

* **Overview**
  * **[Bell's Palsy]** HSV-1 reactivation causing CN VII inflammation, good prognosis (95% recovery)
  * **[Ramsay Hunt]** VZV reactivation causing CN VII/VIII inflammation, worse prognosis (60-70% recovery)
  * Common in 50s adults (Bell), 20s and 50s adults (Ramsay Hunt)
* **Presentation**
  * **Unable to close eye, wrinkle forehead, raise mouth (sudden unilateral facial weakness)**: CN VII Motor component involvement
  * **Ear pain, hyperacusis, decreased taste, decreased tear/saliva production**: CN VII sensory and autonomic component involvement
  * **[Ramsay Hunt] Painful vesicles in ear/oral cavity**: VZV reactivation
  * **[Ramsay Hunt] Hearing loss, tinnitus, vertigo**: CN VIII involvement
* **Examination**
  * **[Bell's] Exclusion of other causes**: Diagnosis of exclusion
  * **[Ramsay Hunt] Vesicles in ear/oral cavity**: Herpes zoster
* **Management**
  * **Corticosteroids**: Reduce inflammation and edema
  * **Antiviral drugs (acyclovir)**: Suppress viral replication
  * **Vitamin B**: Promote nerve regeneration
  * **Facial nerve decompression**: For severe cases
{: .notice--info}

## Muscular Disorder / ç­‹ç–¾æ‚£

### Duchenne and Becker Muscular Dystrophy / Duchenneå‹ãƒ»Beckerå‹ç­‹ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼

* **Overview**
  * Congenital progressive muscle weakness due to deficiency of dystrophin protein, Duchenne is severe form and Becker is milder form
  * X-linked recessive inheritance, mainly affects boys
* **Presentation**
  * **Delayed walking, abnormal gait (waddling)**: Progressive muscle weakness
  * **Gowers' sign, calf pseudohypertrophy**: Proximal muscle weakness
* **Examination**
  * **[Blood] CKâ†‘, aldolaseâ†‘, ASTâ†‘, ALTâ†‘, LDHâ†‘**: Muscle cell damage
  * **[Urine] Creatine/creatinine ratioâ†‘**: Decreased utilization of creatine by muscle cells
  * **[EMG] Myogenic changes**: Muscle fiber degeneration
  * **[Genetic test] Dystrophin gene mutation**: Confirms diagnosis
* **Management**
  * **Corticosteroids**: Slow disease progression
  * **Physical therapy**: Maintain function
  * **Ventilatory support**: For respiratory failure
 {: .notice--info}

### Myotonic Dystrophy / ç­‹å¼·ç›´æ€§ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼

* **Overview**
  * Hereditary myopathy with delayed muscle relaxation and muscle weakness
  * Autosomal dominant disorder, common in 20-30s adults
* **Presentation**
  * **Grip myotonia, tongue deformation**: Delayed muscle relaxation
  * **Distal muscle weakness and atrophy, dysphagia, dysarthria**: Progressive muscle degeneration
  * **Hatchet face**: Facial, temporal, and masseter muscle atrophy
  * **Frontal baldness, cataracts, diabetes, cardiac conduction defects**: Multi-system involvement
* **Examination**
  * **[Blood] CKâ†‘, IgGâ†“**: Muscle damage and immune changes
  * **[EMG] Myotonic discharge (dive bomber sound)**: Characteristic electrical activity
  * **[Genetic test] Abnormal expansion in DMPK gene**: Confirms diagnosis
* **Management**
  * **Supportive care**: No definitive treatment
  * **Phenytoin**: For severe myotonia
{: .notice--info}

### Mitochondrial Encephalomyopathy (MELAS) / ãƒŸãƒˆã‚³ãƒ³ãƒ‰ãƒªã‚¢è„³ç­‹ç—‡

* **Overview**
  * CNS and muscular disorder caused by mitochondrial DNA mutations
  * Maternal inheritance, common in 5-15 years old
* **Presentation**
  * **Headache, vomiting, seizures, altered consciousness, hemiparesis**: Characteristic of MELAS
  * **Cognitive decline, sensorineural hearing loss, muscle weakness, fatigue**: Mitochondrial dysfunction
  * **Short stature, diabetes, cardiomyopathy**: Multi-system involvement
* **Examination**
  * **[Blood/CSF] Lactateâ†‘, pyruvateâ†‘, L/P ratioâ†‘**: Impaired mitochondrial energy production
  * **[Muscle biopsy] Ragged-red fibers**: Abnormal mitochondrial accumulation
  * **[Genetic test] Mitochondrial DNA mutation**: Confirms diagnosis
* **Management**
  * **Vitamins, Coenzyme Q, L-arginine, pyruvate**: Support mitochondrial function and metabolism
{: .notice--info}

### Periodic Paralysis / å‘¨æœŸæ€§å››è‚¢éº»ç—º

* **Overview**
  * Periodic episodes of flaccid paralysis due to serum potassium abnormalities
  * Common in children to 30s males, often secondary to hyperthyroidism or primary aldosteronism
* **Presentation**
  * **Flaccid paralysis of limbs, often after intense exercise**: Hypokalemia causes flaccid paralysis
  * **Episodes fully reversible but often relapse**: Recurrent potassium imbalance
* **Examination**
  * **[Blood] Kâ†“ or â†‘ during attacks**: Hypokalemia or hyperkalemia
  * **[Blood] Thyroid hormoneâ†‘, aldosteroneâ†‘**: Hyperthyroidism or primary aldosteronism
* **Management**
  * **Potassium correction, avoid triggers**: Prevent episode
  * **Treat underlying condition**: Especially thyroid disease
{: .notice--info}

### Myasthenia Gravis / é‡ç—‡ç­‹ç„¡åŠ›ç—‡

* **Overview**
  * Autoimmune disease affecting neuromuscular junction with anti-AChR (acetylcholine receptor) antibodies
  * Common in children, women 20-40s, men 50-60s
* **Presentation**
  * **Ptosis, diplopia**: Early symptoms due to external ocular muscle weakness
  * **Muscle weakness worsening throughout day**: Neuromuscular junction fatigue without muscle atrophy
  * **Dysarthria, dysphagia, tongue weakness**: Bulbar symptoms in generalized type
* **Examination**
  * **[Edrophonium test] Temporary improvement**: ACh increases in neuromuscular junction
  * **[EMG] Waning phenomenon**: Decremental response to repetitive nerve stimulation
  * **[Blood] Anti-AChR antibodies or anti-MuSK antibodies (+)**: Autoimmune nature
  * **[Chest X-ray, CT] Thymoma or thymic hyperplasia**: Associated thymic abnormalities
* **Management**
  * **[Ocular type] Anticholinesterase drugs, steroids**: Symptomatic treatment
  * **[Generalized type] Extended thymectomy, steroids, immunosuppressants**: Radical treatment
  * **[Myasthenic crisis] Plasmapheresis**: Emergency treatment
{: .notice--info}

### Lambert-Eaton Myasthenic Syndrome / Lambert-Eatonç—‡å€™ç¾¤

* **Overview**
  * Autoimmune disease affecting neuromuscular junction with anti-VGCC (voltage-gated calcium channel) antibodies
  * Paraneoplastic syndrome, commonly in middle-aged men with small cell lung cancer
* **Presentation**
  * **Muscle weakness (predominantly proximal lower limbs), decreased reflexes**: Reduced acetylcholine release
  * **Diurnal variation in muscle weakness, temporary improvement with repetitive movement**: Variation in Ca2+ in muscle cells
* **Examination**
  * **[EMG] Waxing phenomenon**: Increased response with repeated stimulation
  * **[Blood] Anti-VGCC antibodies**: Autoimmune nature
* **Management**
  * **[With malignancy] Treatment of underlying cancer**: Primary treatment
  * **[Without malignancy] Steroids, immunosuppressants, anticholinesterase drugs, plasmapheresis**: Symptomatic treatment
{: .notice--info}

## Infectious Disorder / æ„ŸæŸ“æ€§ç–¾æ‚£

### Bacterial Meningitis / ç´°èŒæ€§é«„è†œç‚

* **Overview**
  * Acute bacterial infection of meninges, medical emergency with high mortality
* **Presentation**
  * **Fever, headache, vomiting (within 1 week)**: Meningeal inflammation
  * **Altered consciousness**: Severe inflammation affecting brain function
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
* **Examination**
  * **[CSF] Pressureâ†‘, WBCâ†‘ (neutrophils) , proteinâ†‘, glucoseâ†“**: Bacterial infection and inflammation
  * **[CSF] Culture, antigen detection, PCR**: Identify causative bacteria
* **Management**
  * **Empiric antibiotics**: Immediate treatment based on age
  * **Targeted antibiotics**: Switch to narrow-spectrum after pathogen identification
  * **Corticosteroids**: Reduce inflammation
{: .notice--info}

### Tuberculous Meningitis / çµæ ¸æ€§é«„è†œç‚

* **Overview**
  * Subacute meningitis caused by M. tuberculosis
  * Common in children 1-6 years
* **Presentation**
  * **Fever, headache, vomiting (over 2-4 weeks)**: Meningeal inflammation
  * **Altered consciousness**: Severe inflammation affecting brain function
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
  * **Cranial nerve palsies (III, VI, VII, VIII)**: Basilar inflammation
* **Examination**
  * **[CSF] Pressureâ†‘, lymphocytesâ†‘, proteinâ†‘, glucoseâ†“, Clâ†“, fibrin formation, ADAâ†‘**: TB infection
  * **[CSF] PCR, acid-fast stain, culture**: Identify TB bacteria
  * **[Contrast CT/MRI] Basilar enhancement, hydrocephalus**: Characteristic findings
* **Management**
  * **Anti-TB drugs (INH, RFP, PZA, EB)**: Multiple drug combination
  * **Corticosteroids**: Reduce inflammation
{: .notice--info}


### Fungal Meningitis / çœŸèŒæ€§é«„è†œç‚

* **Overview**
  * Fungal infection of meninges, mainly by Cryptococcus neoformans
  * Common in AIDS and immunocompromised patients
* **Presentation**
  * **Fever, headache, altered consciousness (over 2-4 weeks)**: Meningeal inflammation
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
* **Examination**
  * **[CSF] Pressureâ†‘, lymphocytesâ†‘, proteinâ†‘, glucoseâ†“**: Inflammatory response
  * **[CSF] India ink stain, latex agglutination, PCR, culture**: Identify fungal pathogen
* **Management**
  * **IV Amphotericin B + oral Flucytosine**: Standard combination therapy
  * **Fluconazole**: For maintenance or in renal dysfunction
{: .notice--info}

### Viral Meningitis / ã‚¦ã‚¤ãƒ«ã‚¹æ€§é«„è†œç‚

* **Overview**
  * Viral infection of meninges, mainly by enteroviruses
  * Common in children
* **Presentation**
  * **Fever, headache, vomiting (within 1 week)**: Meningeal inflammation
  * **Mild neck stiffness, photophobia**: Meningeal irritation
* **Examination**
  * **[CSF] Pressureâ†‘, lymphocytesâ†‘, proteinâ†‘, glucoseâ†’**: Viral inflammation
  * **[CSF] Negative stain and culture, PCR, antibody titer**: Rules out bacterial infection, Identify viral pathogen
* **Management**
  * **Bed rest**: Self-limiting
  * **Anti-edema drugs**: If increased intracranial pressure
  * **Acyclovir**: For HSV or VZV infections
{: .notice--info}

### Brain Abscess / è„³è†¿ç˜

* **Overview**
  * Pus collection in brain parenchyma, commonly in fronto-temporal lobes
  * Secondary to adjacent infections (middle ear, sinuses) or hematogenous spread (heart infection)
* **Presentation**
  * **Fever, headache**: Infection and increased intracranial pressure
  * **Seizures, focal neurological deficits**: Local brain tissue damage
* **Examination**
  * **[Blood] WBCâ†‘, ESRâ†‘, CRPâ†‘**: Infection and inflammation
  * **[CT/MRI] Ring-enhancing lesion with low-density center**: Pus surrounded by capsule
* **Management**
  * **High-dose systemic antibiotics + metronidazole**: Target aerobic and anaerobic bacteria
  * **Anti-edema drugs (corticosteroids, glycerol)**: Reduce brain swelling
  * **Surgical drainage**: For large (>2cm) or expanding abscesses
{: .notice--info}

### Herpes Simplex Encephalitis / å˜ç´”ãƒ˜ãƒ«ãƒšã‚¹è„³ç‚

* **Overview**
  * Most common sporadic encephalitis caused by HSV, predilection for temporal lobe, poor prognosis and often with sequela
* **Presentation**
  * **Fever, headache, vomiting, neck stiffness**: Meningeal irritation
  * **Mental symptoms, memory disturbance**: Temporal lobe involvement
  * **Consciousness disturbance, seizures**: Severe brain inflammation
* **Examination**
  * **[CSF] Pressureâ†‘, lymphocytesâ†‘, proteinâ†‘, glucoseâ†’**: Viral inflammation
  * **[MRI] High signal in temporal lobe on T2/FLAIR**: Brain inflammation and edema
  * **[EEG] Periodic lateralized epileptiform discharges (PLEDs)**: Abnormal brain activity
  * **[CSV] HSV-DNA detection, anti-HSV antibodyâ†‘**: Confirmatory tests
* **Management**
  * **Antiviral drugs (acyclovir, vidarabine)**: Antiviral therapy
  * **Anti-edema drugs (glycerol)**: Reduce brain edema
  * **Antiepileptic drugs (diazepam, phenobarbital)**: Control seizures
  * **Corticosteroids**: Reduce inflammation
{: .notice--info}

### Influenza-Associated Encephalopathy / ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶è„³ç—‡

* **Overview**
  * Acute encephalopathy due to influenza infection, with rapid progression and poor prognosis
  * Primarily affects children under 5 years
* **Presentation**
  * **Rapid onset of consciousness disturbance**: Primary manifestation
  * **Seizures, abnormal behavior**: Brain dysfunction
* **Examination**
  * **[CT/MRI] Various patterns of brain edema**: Brain damage
* **Management**
  * **Oxygen, fluid therapy, temperature control**: Maintain vital functions
  * **Antiepileptic drugs (diazepam, midazolam)**: Control seizures
  * **Anti-edema drugs (D-mannitol)**: Reduce brain edema
  * **Antiviral drugs (oseltamivir, zanamivir)**: Target influenza virus
  * **Steroid pulse therapy, high-dose Î³-globulin therapy**: Reduce inflammation
{: .notice--info}

### Reye Syndrome / Reyeç—‡å€™ç¾¤

* **Overview**
  * Acute encephalopathy with diffuse microvesicular fatty liver
  * Primarily affects children and adolescents
* **Presentation**
  * **Vomiting, consciousness disturbances, seizures**: Brain damage
* **Examination**
  * **[Blood] ASTâ†‘, ALTâ†‘, ammoniaâ†‘**: Impaired liver dysfunction
* **Management**
  * **D-mannitol**: Reduce brain edema
  * **Glucose infusion**: Correct hypoglycemia
  * **Aspirin contraindicated**: May cause Reye syndrome in children with viral infections
{: .notice--info}

### Subacute Sclerosing Panencephalitis / äºœæ€¥æ€§ç¡¬åŒ–æ€§å…¨è„³ç‚

* **Overview**
  * Progressive CNS disease occurring years after measles infection or vaccination
  * Commonly affects children with measles/vaccination history before age 1
* **Presentation**
  * **Cognitive decline, personality changes**: Progressive brain degeneration
  * **Myoclonus, seizures**: Neurological manifestation of brain inflammation
  * **Akinetic mutism**: Terminal stage of disease
* **Examination**
  * **[CSF] Elevated IgG, oligoclonal bands, high measles antibody titer**: Immune response to measles virus
  * **[EEG] Periodic synchronous discharge with high-amplitude slow waves**: Characteristic finding
* **Management**
  * **Inosine pranobex (oral), interferon or ribavirin (intrathecal)**: Antiviral and immunomodulatory effect
  * **Anticonvulsants**: Control myoclonus and seizures
  * **Poor prognosis**: Death within few years
{: .notice--info}

### Progressive Multifocal Leukoencephalopathy / é€²è¡Œæ€§å¤šå·£æ€§ç™½è³ªè„³ç—‡

* **Overview**
  * Demyelinating CNS disease caused by JC virus reactivation in immunocompromised patients
* **Presentation**
  * **Cognitive dysfunction, hemiplegia, aphasia**: Demyelinating diseases of brain
  * **Akinetic mutism**: Terminal stage of disease
* **Examination**
  * **[MRI] Multiple demyelinating lesions in white matter**: Characteristic finding
  * **[CSF] JC virus PCR positive**: Confirms diagnosis
* **Management**
  * **No curative treatment**: Supportive care only
  * **Poor prognosis**: Fatal within months of onset
{: .notice--info}

### Creutzfeldt-Jakob Disease / Creutzfeldt-Jakobç—…

* **Overview**
  * Caused by accumulation of abnormal prion protein (PrPSc) in brain
  * More common in elderly adults, usually sporadic but can be hereditary or acquired
* **Presentation**
  * **Gait disturbance, visual problems**: Early neurological manifestations
  * **Rapidly progressive dementia, myoclonus**: Progressive brain degeneration
  * **Akinetic mutism**: Terminal stage of disease
* **Examination**
  * **[MRI] Progressive cerebral atrophy, high signals in DWI**: Brain tissue changes
  * **[EEG] Periodic synchronous discharge with high-amplitude sharp waves**: Characteristic finding
  * **[CSF] Elevated neuron-specific enolase, 14-3-3 protein, total tau protein**: Markers of neuronal damage
* **Management**
  * **No currative treatment**: Supportive care only
  * **Poor prognosis**: Death within 1-2 years
{: .notice--info}

## Functional Disorder / æ©Ÿèƒ½æ€§ç–¾æ‚£

### Migraine / ç‰‡é ­ç—›

* **Overview**
  * Moderate to severe throbbing headache mainly in temporal region, related to trigeminal nerve excitation and cerebral vasodilation
  * Common in women aged 20-40s
* **Presentation**
  * **Visual aura**: Precedes headache
  * **Throbbing temporal headache (1-5 attacks per month)**: Due to cerebral vasodilation, worsens with daily activities
  * **Photophobia, phonophobia, osmophobia, nausea, vomiting**: Associated symptoms due to sensory hypersensitivity
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **[Attack] Triptans, NSAIDs, acetaminophen, rest in dark**: Vasoconstriction, pain relief (triptans contraindicated in MI/stroke)
  * **[Prevention] Ca channel blockers, antiepileptics, antidepressants, Î²-blockers, lifestyle modification**: Reduce frequency and severity of attacks
{: .notice--info}

### Tension-type Headache / ç·Šå¼µå‹é ­ç—›

* **Overview**
  * Mild to moderate non-throbbing headache mainly in neck and occipital regions, due to muscle tension
  * Most common primary headache
* **Presentation**
  * **Band-like pressure or heavy sensation around head**: Non-pulsatile, bilateral pain due to muscle tension
  * **No photophobia, phonophobia, nausea, vomiting, not aggravated by activity**: Distinguishes from migraine
* **Examination**
  * **Clinical diagnosis**
  * **[Physical] Tenderness around skull**: Due to muscle tension
* **Management**
  * **Stretching, head exercises, cognitive behavioral therapy**: Reduce muscle tension and stress
  * **NSAIDs, antidepressants**: Pain relief, attack prevention
{: .notice--info}

### Cluster Headache / ç¾¤ç™ºé ­ç—›

* **Overview**
  * Severe unilateral pain in orbital and temporal region
  * More common in men aged 20-40s
* **Presentation**
  * **Sudden severe unilateral orbital pain (at night, ~1 hour)**: Unknown cause
  * **Attacks occur at same time daily (clustering ~1 month)**: Circadian rhythm involvement
  * **Lacrimation, conjunctival injection, nasal congestion/discharge, Horner syndrome**: Autonomic symptoms
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **[Attack] Subcutaneous triptan injection, 100% oxygen inhalation**: Rapid pain relief
  * **[Prevention] Calcium channel blockers (verapamil)**: Reduce frequency of attacks
{: .notice--info}

### Rolandic Epilepsy / ãƒ­ãƒ¼ãƒ©ãƒ³ãƒ‰ã¦ã‚“ã‹ã‚“

* **Overview**
  * Childhood partial epilepsy characterized by centrotemporal spikes
  * Common in boys aged 2-12 years, spontaneous remission in adolescence
* **Presentation**
  * **Facial and limb convulsions during sleep**: Simple partial seizures
  * **Speech arrest and drooling during awakening**: Focal seizures without impairment of consciousness
* **Examination**
  * **[EEG] High-amplitude centrotemporal spikes during interictal period**: Characteristic finding for diagnosis
* **Management**
  * **Observation**: For seizures not affecting daily life
  * **Carbamazepine**: For seizure needing control
{: .notice--info}

### Temporal Lobe Epilepsy / å´é ­è‘‰ã¦ã‚“ã‹ã‚“

* **Overview**
  * Symptomatic partial epilepsy originating in temporal lobe, commonly caused by hippocampal sclerosis
  * One of the most common epilepsy
* **Presentation**
  * **Epigastric discomfort, dÃ©jÃ  vu/jamais vu, anxiety, phantom smells**: Simple partial seizures with autonomic and psychic symptoms
  * **Staring, lip smacking, chewing movements, wandering, loss of consciousness**: Complex partial seizures with automatisms
* **Examination**
  * **[EEG] Unilateral anterior temporal spikes during interictal period**: Localizes epileptic focus
  * **[MRI] Hippocampal sclerosis**: Common structural cause
* **Management**
  * **Ccarbamazepine, lamotrigine, levetiracetam**: For partial epilepsy
  * **Amygdalohippocampectomy, temporal lobectomy, vagus nerve stimulation**: For drug-resistant cases
{: .notice--info}

### Childhood Absence Epilepsy / å°å…æ¬ ç¥ã¦ã‚“ã‹ã‚“

* **Overview**
  * Idiopathic generalized epilepsy characterized by absence seizures
  * More common in girls aged 4-10 years
* **Presentation**
  * **Brief interruption of activity and consciousness (~10 seconds per episode, multiple episodes per day)**: Absence seizures
* **Examination**
  * **[EEG] 3 Hz spike-and-wave complexes during ictal and interictal periods**: Diagnostic finding
* **Management**
  * **Valproic acid**: First-line treatment
  * **Ethosuximide, lamotrigine**: Second-line treatment
  * **Good prognosis**: 95% remission rate
{: .notice--info}

### Juvenile Myoclonic Epilepsy / è‹¥å¹´ãƒŸã‚ªã‚¯ãƒ­ãƒ‹ãƒ¼ã¦ã‚“ã‹ã‚“

* **Overview**
  * Idiopathic generalized epilepsy characterized by myoclonic seizures
  * More common in adolescence
* **Presentation**
  * **Sudden bilateral upper limb jerks**: Myoclonic seizures
  * **Generalized tonic-clonic seizures**: Present in almost all cases
  * **Photosensitivity**: Sensory hypersensitivity
* **Examination**
  * **[EEG] Polyspike-wave complexes during ictal and interictal periods**: Diagnostic finding
* **Management**
  * **Valproic acid**: First-line treatment
  * **Levetiracetam, lamotrigine, topiramate, clonazepam**: Second-line treatments
  * **Generally good prognosis**
{: .notice--info}

### West Syndrome / Westç—‡å€™ç¾¤

* **Overview**
  * Generalized epilepsy in infants, mostly due to perinatal problems, congenital malformations, metabolic disorders, or tuberous sclerosis
  * More common in infants under 1 year 
* **Presentation**
  * **Head drops, sudden limb elevation**: Epileptic spasms occurring in clusters
  * **Developmental delay or regression**: Impact on psychomotor development
* **Examination**
  * **[EEG] Chaotic high-amplitude slow waves with spikes during interictal period**: Characteristic hypsarrhythmia
* **Management**
  * **ACTH therapy**: First-line treatment
  * **Vigabatrin**: Second-line treatment
  * **Poor prognosis**: 10-50% progress to Lennox-Gastaut syndrome
{: .notice--info}

### Lennox-Gastaut Syndrome / Lennox-Gastautç—‡å€™ç¾¤

* **Overview**
  * Symptomatic generalized epilepsy in early childhood, may develop from West syndrome or organic brain disorders
  * More common in children 1-8 years
* **Presentation**
  * **Neck/trunk flexion, atypical absence, sudden falls**: Multiple seizure types
  * **Developmental delay**: Impact on psychomotor development
* **Examination**
  * **[EEG] Slow spike-wave complexes during interictal period**: Diagnostic finding
* **Management**
  * **Valproic acid, lamotrigine, clonazepam, rufinamide**: Multiple antiepileptic drugs
  * **Ketogenic diet, corpus callosotomy**: Alternative treatments
  * **Poor prognosis**: <20% remission rate
{: .notice--info}

### Dravet Syndrome / Dravetç—‡å€™ç¾¤

* **Overview**
  * Severe epilepsy caused by ion channel gene mutations
  * Onset in infancy
* **Presentation**
  * **Generalized tonic-clonic seizures**: Triggered by fever or bathing
  * **Multiple seizure types develop**: Treatment-resistant epilepsy
* **Examination**
  * **[Genetic testing] SCN1A gene mutation**: Common finding
* **Management**
  * **Multiple antiepileptic drugs**: Often refractory to treatment
  * **Poor prognosis**: High mortality in early childhood
{: .notice--info}

### Febrile Seizures / ç†±æ€§ã‘ã„ã‚Œã‚“

* **Overview**
  * Seizures occurring with fever â‰¥38Â°C, due to increased brain excitability during fever
  * Common in infants/toddlers 6 months-6 years
* **Presentation**
  * **Symmetric tonic-clonic seizures (1-2 minutes)**: Brief episodes
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **Temperature control, observation**: Mostly self-limiting
 {: .notice--info}

### Status Epilepticus / ã¦ã‚“ã‹ã‚“é‡ç©

* **Overview**
  * Continuous or recurring seizures without recovery, can cause irreversible brain damage after 30 minutes
  * Various causes: epilepsy, stroke, head trauma, encephalitis, toxicity
* **Presentation**
  * **Generalized tonic-clonic seizures**: Convulsive status epilepticus
  * **Impaired consciousness, automatisms**: Non-convulsive status epilepticus
* **Examination**
  * **Seizures >5 minutes**: Key diagnostic criterion
* **Management**
  * **Immediate airway management, oxygen**: Basic life support
  * **IV diazepam**: First-line emergency treatment
{: .notice--info}

### Cerebral Palsy / è„³æ€§éº»ç—º

* **Overview**
  * Non-progressive brain damage during developmental period, commonly due to perinatal injury (premature birth, asphyxia)
* **Presentation**
  * **Abnormal posture, increased/decreased muscle tone**: Impaired coordination between flexor and extensor muscles
  * **Developmental delay, epilepsy, joint contracture**: Complication during development
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **Rehabilitation**: Improve motor function
{: .notice--info}

## Neurocutaneous Syndrome / æ¯æ–‘ç—‡

### Tuberous Sclerosis / çµç¯€æ€§ç¡¬åŒ–ç—‡

* **Overview**
  * Autosomal dominant genetic disorder causing multiple nodular lesions (hamartomas) in various organs
* **Presentation**
  * **Hypopigmented macules (ash-leaf spots), facial angiofibromas , shagreen patches**: Characteristic skin lesions
  * **Seizures, developmental delay**: Cortical tubers in brain
* **Examination**
  * **[CT] Multiple calcifications around lateral ventricles**: Brain hamartomas (subependymal giant cell astrocytoma, subependymal nodule)
  * **[MRI] Nodular lesions in cortex/subependymal areas**: Brain hamartomas (subependymal giant cell astrocytoma, subependymal nodule)
* **Management**
  * **Symptomatic treatment**: Tailored to individual manifestations
{: .notice--info}

### Neurofibromatosis Type 1 / ç¥çµŒç·šç¶­è…«ç—‡ï¼‘å‹

* **Overview**
  * Autosomal dominant genetic disorder (50-70% due to new mutations) causing multiple neurofibroma
* **Presentation**
  * **Multiple cafÃ©-au-lait spots (by age 2)**: Light to dark brown patches
  * **Axillary/inguinal freckling (age 3-5)**: Clustered small brown spots
  * **Cutaneous neurofibromas**: Soft and hemispherical nodules on skin
  * **Lisch nodules**: Gray-brown nodules on iris
* **Examination**
  * **Based on clinical presentation**
* **Management**
  * **Symptomatic treatment**: Tailored to individual manifestations
{: .notice--info}

### Neurofibromatosis Type 2 / ç¥çµŒç·šç¶­è…«ç—‡ï¼’å‹

* **Overview**
  * Autosomal dominant genetic disorder causing acoustic schwannomas
  * Typically onset in 20-30s
* **Presentation**
  * **Bilateral hearing loss, tinnitus**: Due to acoustic schwannomas
  * **Vertigo, facial nerve palsy**: Involvement of other cranial nerves
  * **Early-onset cataracts**: Ocular manifestation
* **Examination**
  * **[MRI] Bilateral acoustic schwannomas**: Characteristic finding
* **Management**
  * **Surgical removal of tumors**: Challenging to improve neurological symptoms
{: .notice--info}

### Sturge-Weber Syndrome / Sturge-Weberç—‡å€™ç¾¤

* **Overview**
  * Non-hereditary neurocutaneous disorder characterized by facial angioma simplex, leptomeningeal angioma, and choroidal vascular lesions
* **Presentation**
  * **Unilateral facial port-wine stain**: Facial angioma simplex (present at birth, following trigeminal nerve distribution)
  * **Seizures, hemiparesis, intellectual disability**: Leptomeningeal angioma  (contralateral to port-wine stain)
  * **Glaucoma**: Choroidal vascular lesions (Ipsilateral to port-wine stain)
* **Examination**
  * **[Contrast MRI] Enhanced leptomeningeal angioma**: Vascularized angioma
  * **[Skull X-ray] Gyriform calcifications**: Leptomeningeal involvement
* **Management**
  * **Laser therapy**: For facial port-wine stain
  * **Anticonvulsants,**: For seizure control
  * **Intraocular pressure reduction (trabeculotomy, trabeculectomy)**: For glaucoma treatment
{: .notice--info}

### von Hippel-Lindau Disease / von Hippel-Lindauç—…

* **Overview**
  * Autosomal dominant genetic disorder causing hemangioblastomas in CNS and cystic tumors in multiple organs
  * Typically onset in 20-40s
* **Presentation**
  * **Dizziness, nystagmus, ataxia**: Cerebellar hemangioblastomas
  * **Headache, vomiting**: Increased intracranial pressure
  * **Visual disturbances, eye pain**: Hemangioblastomas in retina
  * **Tumors or cysts in kidneys, adrenal glands, pancreas, spleen**: Multi-organ involvement
* **Examination**
  * **[CT, MRI] Multiple cystic tumors with mural nodules in cerebellum**: Hemangioblastomas
* **Management**
  * **Surgical resection or radiotherapy**:  For hemangioblastomas
{: .notice--info}

## Brain Tumor / è„³è…«ç˜

### Diffuse Astrocytoma / ã³ã¾ã‚“æ€§æ˜Ÿç´°èƒè…«

* **Overview**
  * Low-grade (Grade II) astrocytoma with high differentiation
  * Common in young adults, usually in cerebral hemispheres
* **Presentation**
  * **Epileptic seizures, paralysis, aphasia**: Focal brain symptoms
  * **Headache, vomiting**: Increased intracranial pressure
* **Examination**
  * **[CT] Ill-defined low-density mass**: Infiltrative nature of tumor
  * **[MRI] T1: ill-defined low signal, T2: high signal**: Tumor characteristics
  * **[Contrast CT/MRI] No enhancement**: Low-grade nature
  * **[Genetic testing] IDH1 mutation**: Associated with better prognosis
* **Management**
  * **Surgical resection**: Aim for maximal safe resection
  * **Radiation therapy**: Additional treatment post-surgery
{: .notice--info}

### Pilocytic Astrocytoma / æ¯›æ§˜ç´°èƒæ€§æ˜Ÿç´°èƒè…«

* **Overview**
  * Most benign (Grade I) astrocytoma, non-invasive and rare malignant transformation
  * Common in childhood to adolescence, often in cerebellum or optic nerve/chiasm
* **Presentation**
  * **Cerebellar ataxia**: Cerebellar involvement
  * **Headache, vomiting**: Increased intracranial pressure
  * **Visual impairment, visual field defects**: Optic nerve/chiasm involvement
* **Examination**
  * **[Imaging] Well-defined tumor in cerebellum or optic pathway**: Characteristic locations
  * **[Genetic testing] NF1 gene mutation**: Association with neurofibromatosis type 1
* **Management**
  * **Surgical resection**: Curative for accessible tumors
  * **Chemotherapy**: For optic pathway tumors where resection is difficult
{: .notice--info}

### Glioblastoma / è† èŠ½è…«

* **Overview**
  * Highest grade (Grade IV) astrocytoma with low differentiation, rapidly progressing with extremely poor prognosis
  * Common in middle-aged and older adults, often in cerebral hemispheres
* **Presentation**
  * **Rapidly progressing headache, vomiting**: Increased intracranial pressure
  * **Personality changes, epileptic seizures, paralysis, aphasia**: Focal brain symptoms
* **Examination**
  * **[MRI] T1: ill-defined low signal, T2: heterogeneous high signal**: Tumor characteristics
  * **[Contrast MRI] Ring-like enhancement**: Typical pattern
  * **[Pathology] Microvascular proliferation, necrosis, pseudopalisading**: Characteristic histological features
  * **[Genetic testing] IDH mutation**: For further classification
* **Management**
  * **Surgical resection**: Primary treatment
  * **Postoperative radiotherapy and chemotherapy**: Adjuvant treatment
  * **Prognosis**: Usually fatal within 2 years
{: .notice--info}

### Oligodendroglioma / ä¹çªèµ·è† è…«

* **Overview**
  * Low-grade (Grade II) glioma originating from oligodendroglia, slow growth
  * Common in adults aged 20-50 years, often in cerebral white matter
* **Presentation**
  * **Epileptic seizures**: Focal brain irritation
  * **Headache**: Increased intracranial pressure
* **Examination**
  * **[CT] Low to iso-density mass, often with calcification**: Characteristic finding
  * **[MRI] T1: low signal, T2: high signal, well-defined mass**: Tumor characteristics
  * **[Genetic testing] 1p/19q co-deletion**: Diagnostic and prognostic marker
  * **[Pathology] Honeycomb structure, fried egg appearance**: Characteristic histological features
* **Management**
  * **Surgical resection**: Aim for total removal
  * **Postoperative radiotherapy**: High sensitivity to radiation
{: .notice--info}

### Ependymoma / ä¸Šè¡£è…«

* **Overview**
  * Grade II brain tumor originating from ependymal cells
  * Peak incidence at 5-9 years, often near ventricles (especially 4th ventricle)
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure due to non-communicating hydrocephalus
* **Examination**
  * **[CT] Iso to high-density mass, often with cysts/calcification**: Characteristic findings
  * **[MRI] T1: low signal, T2: high signal, well-defined mass**: Tumor characteristics
  * **[Pathology] Perivascular pseudorosettes, ependymal rosettes**: Diagnostic histological features
* **Management**
  * **Surgical resection**: Aim for total removal
  * **Postoperative radiotherapy**: Additional treatment
{: .notice--info}

### Medulloblastoma / é«„èŠ½è…«

* **Overview**
  * Malignant embryonal tumor (Grade IV) derived from undifferentiated neuroepithelial cells
  * Most common malignant brain tumor in children, predilection for cerebellar vermis
* **Presentation**
  * **Headache, projectile vomiting, papilledema**: Increased intracranial pressure due to non-communicating hydrocephalus
  * **Inability to maintain sitting, gait instability, falls**: Cerebellar symptoms
* **Examination**
  * **[CT] Iso to high-density mass , often calcified**: Tumor characteristics
  * **[MRI] T1: low signal, T2: high signal**: Tumor characteristics
  * **[Contrast MRI] Homogeneous enhancement**: Tumor vascularity
  * **[Pathology] Tumor cells with scant cytoplasm, Homer Wright rosettes**: Diagnostic features
  * **[Genetic testing] WNT, SHH, MYC abnormalities**: For subclassification
* **Management**
  * **Surgical resection**: Primary treatment
  * **Postoperative radiotherapy and chemotherapy**: Adjuvant treatment
{: .notice--info}

### Germ Cell Tumor / èƒšç´°èƒè…«ç˜

* **Overview**
  * Tumors derived from germ cells, mainly germinomas and teratomas
  * Common in male children, mostly in suprasellar and pineal regions
* **Presentation**
  * **Polyuria, growth retardation, delayed puberty**: Hypothalamic-pituitary dysfunction (suprasellar tumor)
  * **Visual disturbances**: Optic nerve/chiasm compression (suprasellar tumor)
  * **Headache, vomiting**: Increased intracranial pressure due to hydrocephalus (pineal tumor)
  * **Upward gaze palsy (Parinaud syndrome), light-near dissociation (Argyll Robertson pupils)**: Midbrain involvement (pineal tumor)
* **Examination**
  * **[CT/MRI] Mass in suprasellar region**: Suprasellar tumor
  * **[CT/MRI] Mass in pineal region , calcification, ventricular enlargement**: Pineal tumor
* **Management**
  * **Radiotherapy + chemotherapy**: For germinoma
  * **Surgical resection + radiotherapy/chemotherapy**: For teratoma
{: .notice--info}

### Malignant Lymphoma / æ‚ªæ€§ãƒªãƒ³ãƒ‘è…«

* **Overview**
  * Intracranial lymphoid tumor, mostly primary non-Hodgkin's lymphoma
  * More common in 50-70s adults and males
* **Presentation**
  * **Headache, vomiting, papilledema**: Increased intracranial pressure
  * **Paralysis, aphasia, memory impairment**: Focal brain symptoms
* **Examination**
  * **[CT] Iso to high-density lesions**: Tumor characteristics
  * **[MRI] T1: iso to slow signal, T2: high signal**: Tumor characteristics
  * **[Contrast CT/MRI] Homogeneous enhancement**: Highly vascular tumor
  * **[Blood, CSF] Soluble IL-2 receptorâ†‘ (blood), Î²2-microglobulinâ†‘ (CSF)**: Tumor marker
* **Management**
  * **High-dose methotrexate + radiotherapy**: Standard treatment
{: .notice--info}

### Hemangioblastoma / è¡€ç®¡èŠ½è…«

* **Overview**
  * Benign tumor rich in capillaries with intratumoral cysts, associated with von Hippel-Lindau disease
  * More common in 20-70s adults, mostly in cerebellar hemisphere
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure
  * **Dizziness, nystagmus, ataxia**: Cerebellar symptoms
  * **Polycythemia**: Due to erythropoietin production by tumor
* **Examination**
  * **[MRI] T1: iso to low signal, T2: high signal, cystic lesion**: Tumor characteristics
  * **[Contrast MRI] Enhancing mural nodule**: Highly vascular tumor component
* **Management**
  * **Surgical resection**: Primary treatment
  * **Radiation therapy**: For inoperable cases or residual
{: .notice--info}

### Meningioma / é«„è†œè…«

* **Overview**
  * Benign tumor (Grade I) originating from arachnoid cells, grows slowly and compresses surrounding brain tissue
  * More common in 40-70s women
* **Presentation**
  * **Headache, epileptic seizures**: Due to compression of brain tissue
* **Examination**
  * **[X-ray/CT] Bone thickening, destruction, calcification**: Tumor effects on adjacent bone
  * **[MRI] T1: iso to low signal, T2: iso to high signal**: Tumor characteristics
  * **[Contrast CT/MRI] Well-defined homogeneous enhancement, dural tail sign**: Highly vascular nature
  * **[External carotid angiography] Sunburst appearance**: Tumor vasculature
* **Management**
  * **Surgical resection**: Primary treatment
  * **Stereotactic radiosurgery**: For small or residual tumors
  * **Observation**: For small asymptomatic tumors
{: .notice--info}

### Schwannoma / ç¥çµŒé˜è…«

* **Overview**
  * Benign tumor (Grade I) originating from Schwann cells, 90% of intracranial cases occur on vestibulocochlear nerve
  * More common in 40-60s adults
* **Presentation**
  * **Unilateral high-frequency hearing loss, tinnitus**: Cochlear nerve involvement
  * **Horizontal nystagmus towards healthy side, Bruns nystagmus, vertigo**: Vestibular nerve involvement
* **Examination**
  * **[CT] Internal auditory canal enlargement, low to iso-density mass in cerebellopontine angle**: Tumor growth and characteristics
  * **[MRI] T1: low signal, T2: iso signal**: Tumor characteristics
  * **[Contrast CT/MRI] Marked enhancement**: Highly vascular nature
* **Management**
  * **Surgery**: For large symptomatic tumors
  * **Radiation therapy**: For tumors <3 cm or residual tumors
  * **Observation**: For small asymptomatic tumors
{: .notice--info}

### Pituitary Adenoma / ä¸‹å‚ä½“è…ºè…«

* **Overview**
  * Benign tumor originating from anterior pituitary cells, classified as functional or non-functional
  * Common in adults
* **Presentation**
  * **Acromegaly, hyperprolactinemia, Cushing disease**: Hormone overproduction (functional adenoma)
  * **Visual field defects (bitemporal hemianopsia), headache, pituitary hormone deficiency**: Compression of optic chiasm/normal pituitary
* **Examination**
  * **[X-ray] Ballooning/double floor of sella turcica**: Bone shadows changes due to tumor growth
  * **[CT/MRI] Mass in suprasellar cistern, T1: iso to low signal, T2: iso to high signal**: Microadenoma or macroadenoma in sella turcica
* **Management**
  * **Dopamine agonists**: For prolactin-secreting tumors
  * **Transsphenoidal surgery (TSS)**: For other types of tumors
  * **Radiotherapy**: For inoperable cases or residual tumors
  * **Observation**: For small asymptomatic tumors
{: .notice--info}

### Craniopharyngioma / é ­è“‹å’½é ­è…«

* **Overview**
  * Benign tumor (Grade I) originating from craniopharyngeal duct remnants (Rathke's pouch)
  * Bimodal age distribution of children and adults , common in suprasellar region
* **Presentation**
  * **Visual field defects (bitemporal hemianopsia), optic atrophy**: Optic chiasm compression
  * **Short stature, delayed puberty, hypogonadism, amenorrhea**: Anterior pituitary dysfunction
  * **Hypothermia, consciousness disturbance, memory loss, depression**: Hypothalamic dysfunction
* **Examination**
  * **[X-ray] Flattened sella turcica**: Tumor effect on surrounding bone
  * **[CT] Scattered calcifications, cystic components in suprasellar region**: Characteristic tumor features
  * **[Contrast CT/MRI] Enhancement of cyst wall and solid components**: Tumor vascularity
* **Management**
  * **Surgery**: Primary treatment
  * **Radiation therapy**: For residual tumor or recurrence
{: .notice--info}

### Metastatic Brain Tumor / è»¢ç§»æ€§è„³è…«ç˜

* **Overview**
  * Malignant tumors from extracranial sites metastasizing to the brain
* **Presentation**
  * **Headache, neurological deficits, seizures**: Symptoms vary based on location and size
* **Examination**
  * **[CT/MRI] Multiple lesions, ring-like enhancement with contrast**: Characteristic imaging features
* **Management**
  * **Whole-brain radiation therapy**: Primary treatment
  * **Stereotactic radiosurgery**: For selected cases
  * **Surgery**: For large and accessible single lesions
{: .notice--info}

## Congenital Anomaly / å…ˆå¤©å¥‡å½¢

### Myelomeningocele / è„Šé«„é«„è†œç˜¤

* **Overview**
  * Severe form of spinal bifida with exposed spinal cord, due to failure of caudal neural tube closure
  * Often associated with Chiari II malformation and hydrocephalus
* **Presentation**
  * **Skin defect, exposed spinal cord (in lumbosacral region)**: Failed neural tube closure
  * **Lower limb motor/sensory disorders, deformities, bladder/bowel dysfunction**: Spinal cord dysfunction
* **Examination**
  * **[Prenatal] Maternal serum AFPâ†‘, amniotic fluid AFPâ†‘**: Neural tube defect
  * **[Prenatal US/MRI] Ventricle enlargement, lumbosacral mass**: Hydrocephalus and spinal defect
  * **[MRI] Herniation of medulla/cerebellar vermis/fourth ventricle, enlarged ventricles**: Chiari II malformation, hydrocephalus
* **Management**
  * **Early closure surgery (within 48h after birth)**: Prevent CSF infection and spinal cord degeneration
  * **Post-operative care**: Management of urinary dysfunction, limb deformities
{: .notice--info}

### Spina Bifida Occulta / æ½œåœ¨æ€§äºŒåˆ†è„Šæ¤

* **Overview**
  * Hidden form of spina bifida often with spinal lipoma, can develop tethered cord syndrome with growth
  * More common in females
* **Presentation**
  * **Subcutaneous mass, dimpling, nevus, localized hypertrichosis (in lumbosacral region)**: Associated skin findings
  * **Lower limb motor/sensory disorders, deformities, scoliosis, bladder/bowel dysfunction (with growth)**: Due to tethered spinal cord
* **Examination**
  * **[MRI] Spinal lipoma, tethered spinal cord**: Confirms diagnosis
* **Management**
  * **Surgical untethering**: Removal of lipoma
{: .notice--info}

### Cranium Bifidum / äºŒåˆ†é ­è“‹

* **Overview**
  * Defect in cranial midline due to failure of rostral neural pore closure, complete failure leads to anencephaly (incompatible with life)
* **Presentation**
  * **Midline cranial swelling**: Herniation of intracranial contents through skull defect
* **Examination**
  * **[MRI] Herniation of meninges (+ brain tissue)**: Meningocele, encephalomeningocele
* **Management**
  * **Surgical repair**: Removal of herniated sac and closure of skull defect
{: .notice--info}

### Chiari Malformation Type I / Chiari I å‹å¥‡å½¢

* **Overview**
  * Herniation of cerebellar tonsils into spinal canal, often associated with syringomyelia
  * Can occur in adults and children
* **Presentation**
  * **Headache, neck and shoulder pain (worsen with coughing)**: Pressure from herniated cerebellar tonsils
* **Examination**
  * **[MRI] Herniated cerebellar tonsils into spinal canal**: Confirms diagnosis
  * **[MRI] Syringomyelia**: Common associated finding
* **Management**
  * **Observation**: For asymptomatic cases
  * **Foramen magnum decompression**: Removal of occipital bone and C1 lamina
{: .notice--info}

### Chiari Malformation Type II / Chiari II å‹å¥‡å½¢

* **Overview**
  * Herniation of lower brainstem, fourth ventricle, and cerebellar vermis into spinal canal
  * Associated with myelomeningocele and hydrocephalus
* **Presentation**
  * **Myelomeningocele, hydrocephalus**: Present at birth
  * **Inspiratory stridor, apnea, dysphagia**: Brainstem compression
* **Examination**
  * **[MRI] Herniated medulla, fourth ventricle, cerebellar vermis**: Confirms diagnosis
  * **[MRI] Enlarged ventricles**: Associated hydrocephalus
* **Management**
  * **[0-2 days] Myelomeningocele closure**: Primary repair
  * **[1-2 weeks] CSF drainage or VP shunt**: Treat hydrocephalus
  * **[1-2 months] Foramen magnum decompression**: For brainstem symptoms
{: .notice--info}

### Dandy-Walker Syndrome / Dandy-Walkerç—‡å€™ç¾¤

* **Overview**
  * Malformation characterized by cerebellar vermis hypoplasia and cystic dilation of fourth ventricle
  * Often associated with multiple congenital anomalies (corpus callosum agenesis, occipital encephalocele, VSD, PDA)
* **Presentation**
  * **Hydrocephalus symptoms**: Increased intracranial pressure
  * **Developmental delay**: Brain malformation effects
* **Examination**
  * **[MRI] Hypoplastic cerebellar vermis, cystic dilation of fourth ventricle**: Primary findings
* **Management**
  * **Ventriculoperitoneal (VP) shunt, cystoperitoneal (CP) shunt**: Treat hydrocephalus and fourth ventricle cyst
{: .notice--info}

### Craniosynostosis / é ­è“‹ç¸«åˆæ—©æœŸç™’åˆç—‡

* **Overview**
  * Premature fusion of cranial sutures causing skull deformity and restriction
* **Presentation**
  * **Skull and facial deformity, bony ridge at suture**: Abnormal growth due to premature suture fusion
  * **Signs of increased intracranial pressure**: Compression of brain tissue
* **Examination**
  * **[X-ray, 3D-CT] Absent suture lines, skull deformity, thickened/sclerotic bone at fusion site, copper-beaten appearance**: Confirms diagnosis
* **Management**
  * **Fronto-orbital advancement, cranial vault remodeling**: Relieve brain compression, correct cosmetic deformity
{: .notice--info}

## Head Injury / é ­éƒ¨å¤–å‚·

### Skull Fracture / é ­è“‹éª¨éª¨æŠ˜

* **Overview**
  * Fracture of skull, classified by location (vault/base) and type (open/closed)
* **Presentation**
  * **[Vault] Variable symptoms**: Depends on open/closed status
  * **[Anterior Base] Raccoon eyes, CSF rhinorrhea, anosmia, visual disturbance**: Injury to frontal base and CN I/II
  * **[Middle Base] Battle's sign, CSF otorrhea, facial paralysis, hearing loss**: Injury to temporal bone and CN VII/VIII
  * **[Posterior Base] Dysphasia, dysarthria, respiratory inhibitions**: Injury to occipital bone and CN IX~XII/brainstem
* **Examination**
  * **[X-ray, CT] Linear or depressed fracture lines**: Direct visualization of bone injury
  * **[CT] Pneumocephalus**: Indicates communication with exterior
* **Management**
  * **[Closed fracture] Conservative treatment**: Observation
  * **[Open fracture] Emergency surgery**: Debridement and closure
  * **[CSF leak] Head elevation, antibiotics**: Prevent infection
{: .notice--info}

### Acute Epidural Hematoma / æ€¥æ€§ç¡¬è†œå¤–è¡€è…«

* **Overview**
  * Bleeding between skull and dura mater due to skull fracture, most commonly from middle meningeal artery (temporal region)
* **Presentation**
  * **Trauma followed by lucid interval**: Time before blood accumulates
  * **Sudden deterioration of consciousness**: Increased intracranial pressure from expanding hematoma
* **Examination**
  * **[X-ray] Skull fracture**: Trauma
  * **[CT] Lens-shaped high-density area (at trauma site)**: Blood collection between skull and dura
  * **[CT] Compressed ventricles, midline shift**: Mass effect from expanding hematoma
* **Management**
  * **Emergency craniotomy**: Remove hematoma and achieve hemostasis
{: .notice--info}

### Acute Subdural Hematoma / æ€¥æ€§ç¡¬è†œä¸‹è¡€è…«

* **Overview**
  * Bleeding in subdural space due to head trauma, most commonly from cortical vessels or bridging veins
* **Presentation**
  * **Trauma followed by immediate loss of consciousness**: Severe brain injury with contusion
* **Examination**
  * **[CT] Crescent-shaped high-density area (at opposite site)**: Blood collection in subdural space
* **Management**
  * **Emergency craniotomy**: Remove hematoma and achieve hemostasis
  * **Poor prognosis**: High mortality even with early surgery
{: .notice--info}

### Cerebral Contusion / è„³æŒ«å‚·

* **Overview**
  * Brain tissue damage with localized contusion, small hemorrhages, and edema from head trauma
* **Presentation**
  * **Trauma followed by progressive deterioration of consciousness**: Due to increasing edema and mass effect
* **Examination**
  * **[CT] High density spots**: Punctate hemorrhages
  * **[CT] Low-density areas around hemorrhage**: Surrounding edema
* **Management**
  * **Conservative or surgical treatment**: Based on mass effect severity
{: .notice--info}

### Chronic Subdural Hematoma / æ…¢æ€§ç¡¬è†œä¸‹è¡€è…«

* **Overview**
  * Gradual expansion of encapsulated blood in subdural space, develops 2-3 months after minor head trauma
  * Common in elderly and alcoholics
* **Presentation**
  * **Headache, cognitive decline, gait disturbance, hemiparesis**: Gradual brain compression
* **Examination**
  * **[CT] Crescent-shaped low to high-density area**: Varying blood density due to chronicity
  * **[MRI] High signal on T1 and T2**: Chronic blood products
* **Management**
  * **Burr hole drainage**: Remove hematoma
{: .notice--info}

### Diffuse Axonal Injury / ã³ã¾ã‚“æ€§è»¸ç´¢æå‚·

* **Overview**
  * Widespread axonal damage due to rotational acceleration forces
* **Presentation**
  * **Trauma followed by prolonged unconsciousness**: Due to widespread neural damage
  * **Higher brain dysfunction**: Due to extensive white matter damage
* **Examination**
  * **[CT] No significant findings**: Microscopic nature of damage
  * **[MRI] High signal areas at tissue boundaries**: Displacement between tissues during acceleration
* **Management**
  * **Conservative treatment**: No direct treatment
{: .notice--info}

<!-- ## Cerebral Infarction / è„³æ¢—å¡

### Atherothrombotic Infarction / ã‚¢ãƒ†ãƒ­ãƒ¼ãƒ è¡€æ “æ€§è„³æ¢—å¡
### Cardioembolic Infarction / å¿ƒåŸæ€§è„³å¡æ “ç—‡
### Lacunar Infarction / ãƒ©ã‚¯ãƒŠæ¢—å¡
### Transient Ischemic Attack / ä¸€éæ€§è„³è™šè¡€ç™ºä½œ
### Carotid Artery Stenosis / é ¸å‹•è„ˆç‹­çª„ç—‡
### Cerebellar Infarction / å°è„³æ¢—å¡
### Wallenberg Syndrome / Wallenbergç—‡å€™ç¾¤

## Cerebral Hemorrhage / è„³å‡ºè¡€

### Putaminal Hemorrhage / è¢«æ®»å‡ºè¡€
### Thalamic Hemorrhage / è¦–åºŠå‡ºè¡€
### Brainstem Hemorrhage / è„³å¹¹å‡ºè¡€
### Cerebellar Hemorrhage / å°è„³å‡ºè¡€
### Subcortical Hemorrhage / çš®è³ªä¸‹å‡ºè¡€
### Subarachnoid Hemorrhage / ãã‚‚è†œä¸‹å‡ºè¡€

## Other Cerebrovascular Disease / ãã®ä»–ã®è„³è¡€ç®¡ç–¾æ‚£

### Cerebral Aneurysm / è„³å‹•è„ˆç˜¤
### Arteriovenous Malformation / è„³å‹•é™è„ˆå¥‡å½¢
### Moyamoya Disease / ã‚‚ã‚„ã‚‚ã‚„ç—…
### Carotid-Cavernous Fistula / å†…é ¸å‹•è„ˆæµ·ç¶¿é™è„ˆæ´ç˜»
### Dural Arteriovenous Fistula / ç¡¬è†œå‹•é™è„ˆç˜»
### Sinus Thrombosis / é™è„ˆæ´è¡€æ “ç—‡
### Hypertensive Encephalopathy / é«˜è¡€åœ§æ€§è„³ç—‡
### Spinal Arteriovenous Malformation / è„Šé«„å‹•é™è„ˆå¥‡å½¢
### Spinal Cord Infarction / è„Šé«„æ¢—å¡

## Dementia / èªçŸ¥ç—‡

### Alzheimer Type Dementia / Alzheimerå‹èªçŸ¥ç—‡
### Vascular Dementia / è¡€ç®¡æ€§èªçŸ¥ç—‡
### Dementia with Lewy Bodies / Lewyå°ä½“å‹èªçŸ¥ç—‡
### Frontotemporal Lobar Degeneration / å‰é ­å´é ­è‘‰å¤‰æ€§ç—‡

## Neurodegenerative Disease / ç¥çµŒå¤‰æ€§ç–¾æ‚£

### Parkinson's Disease / Parkinsonç—…
### Progressive Supranuclear Palsy / é€²è¡Œæ€§æ ¸ä¸Šæ€§éº»ç—º
### Corticobasal Degeneration / å¤§è„³çš®è³ªåŸºåº•æ ¸å¤‰æ€§ç—‡
### Huntington's Disease / Huntingtonç—…
### MSA-C / MSA-C
### MSA-P / MSA-P
### Shy-Drager Syndrome / Shy-Dragerç—‡å€™ç¾¤
### Cortical Cerebellar Atrophy / çš®è³ªæ€§å°è„³èç¸®ç—‡
### SCA-3 / SCA-3
### SCA-6 / SCA-6
### Dentato-Rubro-Pallido-Luysian Atrophy / æ­¯çŠ¶æ ¸èµ¤æ ¸æ·¡è’¼çƒãƒ«ã‚¤ä½“èç¸®ç—‡
### Friedreich Ataxia / Friedreiché‹å‹•å¤±èª¿ç—‡
### Syringomyelia / è„Šé«„ç©ºæ´ç—‡
### Subacute Combined Degeneration of Spinal Cord / äºœæ€¥æ€§é€£åˆæ€§è„Šé«„å¤‰æ€§ç—‡
### Amyotrophic Lateral Sclerosis / ç­‹èç¸®æ€§å´ç´¢ç¡¬åŒ–ç—‡
### Spinal Muscular Atrophy / è„Šé«„æ€§ç­‹èç¸®ç—‡
### Spinal and Bulbar Muscular Atrophy / çƒè„Šé«„æ€§ç­‹èç¸®ç—‡

## Demyelinating Disease / è„±é«„æ€§ç–¾æ‚£

### Multiple Sclerosis / å¤šç™ºæ€§ç¡¬åŒ–ç—‡
### Neuromyelitis Optica / è¦–ç¥çµŒè„Šé«„ç‚
### Acute Disseminated Encephalomyelitis / æ€¥æ€§æ•£åœ¨æ€§è„³è„Šé«„ç‚
### Adrenoleukodystrophy / å‰¯è…ç™½è³ªã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼
### Metachromatic Leukodystrophy / ç•°æŸ“æ€§ç™½è³ªã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼

## Peripheral Neuropathy / æœ«æ¢¢ç¥çµŒéšœå®³

### Guillain-BarrÃ© Syndrome / Guillain-BarrÃ©ç—‡å€™ç¾¤
### Chronic Inflammatory Demyelinating Polyneuropathy / æ…¢æ€§ç‚ç—‡æ€§è„±é«„æ€§å¤šç™ºç¥çµŒç‚
### Charcot-Marie-Tooth Disease / Charcot-Marie-Toothç—…
### Familial Amyloid Polyneuropathy / å®¶æ—æ€§ã‚¢ãƒŸãƒ­ã‚¤ãƒ‰ãƒãƒªãƒ‹ãƒ¥ãƒ¼ãƒ­ãƒ‘ãƒãƒ¼
### Diabetic Neuropathy / ç³–å°¿ç—…æ€§ç¥çµŒéšœå®³
### Wernicke Encephalopathy / Wernickeè„³ç—‡
### Carcinomatous Neuropathy / ç™Œæ€§ãƒ‹ãƒ¥ãƒ­ãƒ‘ãƒãƒ¼
### Crow-Fukase Syndrome / Crow-Fukaseç—‡å€™ç¾¤
### Trigeminal Neuralgia / ä¸‰å‰ç¥çµŒç—›
### Bell's Palsy / Belléº»ç—º
### Ramsay Hunt Syndrome / Ramsay Huntç—‡å€™ç¾¤

## Muscular Disease / ç­‹ç–¾æ‚£

### Duchenne Muscular Dystrophy / Duchenneå‹ç­‹ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼
### Becker Muscular Dystrophy / Beckerå‹ç­‹ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼
### Limb-Girdle Muscular Dystrophy / LGå‹ç­‹ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼
### Fascioscapulohumeral Muscular Dystrophy / FSHå‹ç­‹ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼
### Congenital Muscular Dystrophy / å…ˆå¤©æ€§ç­‹ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼
### Myotonic Dystrophy / ç­‹å¼·ç›´æ€§ã‚¸ã‚¹ãƒˆãƒ­ãƒ•ã‚£ãƒ¼
### Mitochondrial Encephalomyopathy / ãƒŸãƒˆã‚³ãƒ³ãƒ‰ãƒªã‚¢è„³ç­‹ç—‡
### Periodic Paralysis / å‘¨æœŸæ€§å››è‚¢éº»ç—º
### Myasthenia Gravis / é‡ç—‡ç­‹ç„¡åŠ›ç—‡
### Lambert-Eaton Myasthenic Syndrome / Lambert-Eatonç—‡å€™ç¾¤

## Phacomatosis / æ¯æ–‘ç—‡

### Neurofibromatosis Type 1 / ç¥çµŒç·šç¶­è…«ç—‡ï¼‘å‹
### Neurofibromatosis Type 2 / ç¥çµŒç·šç¶­è…«ç—‡ï¼’å‹
### Tuberous Sclerosis / çµç¯€æ€§ç¡¬åŒ–ç—‡
### Von Hippel-Lindau Disease / Von Hippel-Lindauç—…
### Sturge-Weber Syndrome / Sturge-Weberç—‡å€™ç¾¤

## Infectious Disease / æ„ŸæŸ“æ€§ç–¾æ‚£

### Bacterial Meningitis / ç´°èŒæ€§é«„è†œç‚
### Tuberculous Meningitis / çµæ ¸æ€§é«„è†œç‚
### Fungal Meningitis / çœŸèŒæ€§é«„è†œç‚
### Viral Meningitis / ã‚¦ã‚¤ãƒ«ã‚¹æ€§é«„è†œç‚
### Herpes Simplex Encephalitis / å˜ç´”ãƒ˜ãƒ«ãƒšã‚¹è„³ç‚ç—‡
### HIV-Associated Neurocognitive Disorder / HIV é–¢é€£ç¥çµŒèªçŸ¥éšœå®³
### HTLV-1 Associated Myelopathy / HTLV-1 é–¢é€£è„Šé«„ç—‡
### Subacute Sclerosing Panencephalitis / äºœæ€¥æ€§ç¡¬åŒ–æ€§å…¨è„³ç‚
### Progressive Multifocal Leukoencephalopathy / é€²è¡Œæ€§å¤šå·£æ€§ç™½è³ªè„³ç—‡
### Creutzfeldt-Jakob Disease / Creutzfeldt-Jakobç—…
### Brain Abscess / è„³è†¿ç˜
### Neurosyphilis / ç¥çµŒæ¢…æ¯’
### Acute Encephalopathy / æ€¥æ€§è„³ç—‡
### Reye Syndrome / Reyeç—‡å€™ç¾¤
### Acute Cerebellar Ataxia / æ€¥æ€§å°è„³å¤±èª¿ç—‡

## Brain Tumor / è„³è…«ç˜

### Diffuse Astrocytoma / ã³ã¾ã‚“æ€§æ˜Ÿç´°èƒè…«
### Glioblastoma / è† èŠ½è…«
### Oligodendroglioma / ä¹çªèµ·è† è…«
### Ependymoma / ä¸Šè¡£è…«
### Medulloblastoma / é«„èŠ½è…«
### Meningioma / é«„è†œè…«
### Schwannoma / ç¥çµŒé˜è…«
### Pituitary Adenoma / ä¸‹å‚ä½“è…ºè…«
### Craniopharyngioma / é ­è“‹å’½é ­è…«
### Germ Cell Tumor / èƒšç´°èƒè…«ç˜
### Hemangioblastoma / è¡€ç®¡èŠ½è…«
### Malignant Lymphoma / æ‚ªæ€§ãƒªãƒ³ãƒ‘è…«
### Metastatic Brain Tumor / è»¢ç§»æ€§è„³è…«ç˜
### Spinal Cord Tumor / è„Šé«„è…«ç˜

## Functional Disease / æ©Ÿèƒ½æ€§ç–¾æ‚£

### Rolandic Epilepsy / Rolandã¦ã‚“ã‹ã‚“
### Temporal Lobe Epilepsy / å´é ­è‘‰ã¦ã‚“ã‹ã‚“
### Childhood Absence Epilepsy / å°å…æ¬ ç¥ã¦ã‚“ã‹ã‚“
### Juvenile Myoclonic Epilepsy / è‹¥å¹´ãƒŸã‚ªã‚¯ãƒ­ãƒ‹ãƒ¼ã¦ã‚“ã‹ã‚“
### West Syndrome / Westç—‡å€™ç¾¤
### Lennox-Gastaut Syndrome / Lennox-Gastautç—‡å€™ç¾¤
### Dravet Syndrome / Dravetç—‡å€™ç¾¤
### Febrile Seizure / ç†±æ€§ã‘ã„ã‚Œã‚“
### Cerebral Palsy / è„³æ€§éº»ç—º
### Migraine / ç‰‡é ­ç—›
### Tension-Type Headache / ç·Šå¼µæ€§é ­ç—›
### Cluster Headache / ç¾¤ç™ºé ­ç—›
### Restless Legs Syndrome / ã‚€ãšã‚€ãšè„šç—‡å€™ç¾¤

## Head Injury / é ­éƒ¨å¤–å‚·

### Skull Base Fracture / é ­è“‹åº•éª¨æŠ˜
### Cranial Vault Fracture / å††è“‹éƒ¨éª¨æŠ˜
### Acute Epidural Hematoma / æ€¥æ€§ç¡¬è†œå¤–è¡€è…«
### Acute Subdural Hematoma / æ€¥æ€§ç¡¬è†œä¸‹è¡€è…«
### Chronic Subdural Hematoma / æ…¢æ€§ç¡¬è†œä¸‹è¡€è…«
### Cerebral Contusion / è„³æŒ«å‚·
### Diffuse Axonal Injury / ã³ã¾ã‚“æ€§è»¸ç´¢æå‚·
### Spinal Cord Injury / è„Šé«„æå‚·
### Normal Pressure Hydrocephalus / æ­£å¸¸åœ§æ°´é ­ç—‡ -->

# Psychiatry / ç²¾ç¥ç§‘

## Schizophrenia / çµ±åˆå¤±èª¿ç—‡

## Mood Disorder / æ°—åˆ†éšœå®³

## Neurotic Disorder / ç¥çµŒç—‡æ€§éšœå®³

## Physiologic Disorder / ç”Ÿç†çš„éšœå®³

## Personality Disorder / äººæ ¼éšœå®³

## Developmental Disorder / ç™ºé”éšœå®³

## Organic Mental Disorder / å™¨è³ªæ€§ç²¾ç¥éšœå®³

## Substance Related Disorder / ç‰©è³ªé–¢é€£éšœå®³

# Ophthalmology / çœ¼ç§‘

## Functional Disorder / æ©Ÿèƒ½éšœå®³

## Conjunctiva Disorder / çµè†œç–¾æ‚£

## Cornea Disorder / è§’è†œç–¾æ‚£

## Uvea Disorder / ã¶ã©ã†è†œç–¾æ‚£

## Retina Disorder / ç¶²è†œç–¾æ‚£

## Cataract / ç™½å†…éšœ

## Glaucoma / ç·‘å†…éšœ

## Optic Nerve Disorder / è¦–ç¥çµŒç–¾æ‚£

## Eyelid and Lacrimal Apparatus Disorder / çœ¼ç¼ãƒ»æ¶™å™¨ç–¾æ‚£

## Miscellaneous Ophthalmic Disorder / ãã®ä»–ã®çœ¼ç§‘ç–¾æ‚£

# Otolaryngology / è€³é¼»å’½å–‰ç§‘

## External and Middle Ear Disorder / å¤–è€³ãƒ»ä¸­è€³ç–¾æ‚£

## Inner Ear Disorder / å†…è€³ç–¾æ‚£

## Nose and Paranasal Sinus Disorder / é¼»ãƒ»å‰¯é¼»è…”ç–¾æ‚£

## Oral Cavity and Tonsil Disorder / å£è…”ãƒ»æ‰æ¡ƒç–¾æ‚£

## Pharynx and Larynx Disorder / å’½é ­ãƒ»å–‰é ­ç–¾æ‚£

## Cervical and Facial Disorder / é ¸éƒ¨ãƒ»é¡”é¢ç–¾æ‚£

<!-- ### Upper Respiratory Tract / ä¸Šæ°—é“ -->

<!-- * **Nose**
  * **Structure**: Palatine, nasal septum (medial), ethmoid, 3 nasal choncha
  * **Histology**: Pseudostratified columnar epithelium, olfactory mucosa (olfactory cell, subtentacular cell, basal cell)
  * **Artery**: Anterior and posterior ethmoidal artery (ophthalmic artery), inferior labial artery (facial artery), sphenopalatine artery (maxillary artery)
  * **Nerve**: Olfactory nerve (CN I), anterior ethmoidal nerve (CN V2), nasopalatine nerve (CN V3)
  * **Nasal meatus**: Sphenoethmoidal recess (sphenoid sinus), superior meatus (posterior ethmoid sinus), middle meatus (other paranasal sinus), inferior meatus (nasolacrimal duct)
  * **Paranasal sinus**: Frontal sinus, sphenoid sinus, ethmoid sinus, sphenoid sinus
* **Pharynx**
  * **Structure**: Nasopharynx (nasal cavity), oropharynx (oral cavity), laryngopharynx (trachea, esophagus)
  * **Histology**: Pseudostratified columnar (nasopharynx), stratified squamous (oropharynx, laryngopharynx)
  * **Nerve**: CN V2 (nasopharynx), CN IX (oropharynx), CN X (laryngopharynx)
* **Larynx**
  * **Structure**: Thyroid cartilage, cricoid cartilage (C6), arytenoid cartilage, vestibular fold, vocal fold
  * **Muscle**: Cricothyroideus (tense), lateral cricoarytenoideus (close), posterior cricoarytenoideus (open), thyroarytenoideus (relax), transverse arytenoideus (close), oblique arytenoideus (constrict), vocalis (control)
  * **Nerve**: External laryngeal nerve (CN X, cricothyroideus), internal laryngeal nerve (CN X, sensation above vocal fold), recurrent laryngeal nerve (CN X, other muscle, left loop aoric arch, right loop subclavian artery)
{: .notice--info} -->

# Dermatology / çš®è†šç§‘

## Eczema / æ¹¿ç–¹

## Urticaria / è•éº»ç–¹

## Erythema / ç´…æ–‘ç—‡

## Bullous Dermatoses / æ°´ç–±ç—‡

## Keratosis / è§’åŒ–ç—‡

## Pigmentary Disorder / è‰²ç´ ç•°å¸¸ç—‡

## Nevus / æ¯æ–‘

## Skin Tumor / çš®è†šè…«ç˜

## Skin Infection / çš®è†šæ„ŸæŸ“ç—‡

## Epidermal Appendage Disorder / çš®è†šé™„å±å™¨ç–¾æ‚£

## Dermis Disorder / çœŸçš®ç–¾æ‚£

## Collagen Disease / è† åŸç—…

## Metabolism Disorder / ä»£è¬ç•°å¸¸ç—‡

## Physical Disorder / ç‰©ç†çš„éšœå®³


<!-- ## Eczema and Dermatitis / æ¹¿ç–¹ãƒ»çš®è†šç‚

### Contact Dermatitis /  æ¥è§¦çš®è†šç‚
### Atopic Dermatitis / ã‚¢ãƒˆãƒ”ãƒ¼æ€§çš®è†šç‚
### Asteatotic Eczema / çš®è„‚æ¬ ä¹æ€§æ¹¿ç–¹
### Seborrheic Dermatitis / è„‚æ¼æ€§çš®è†šç‚
### Nummular Eczema / è²¨å¹£çŠ¶æ¹¿ç–¹
### Autosensitization Dermatitis / è‡ªå®¶æ„Ÿä½œæ€§çš®è†šç‚
### Stasis Dermatitis / ã†ã£æ»æ€§çš®è†šç‚
### Lichen Vidal / Vidalè‹”ç™¬
### Pompholyx / æ±—ç–±

## Urticaria and Pruritis / è•éº»ç–¹ãƒ»æ»ç—’

### Urticaria / è•éº»ç–¹
### Angioedema / è¡€ç®¡æ€§æµ®è…«
### Prurigo / ç—’ç–¹
### Pruritus Cutaneous / çš®è†šç˜™ç—’ç—‡

## Erythema and Drug Eruption / ç´…æ–‘ç—‡ãƒ»è–¬ç–¹

### Erythema Exsudativum Multiforme / å¤šå½¢æ»²å‡ºæ€§ç´…æ–‘
### Erythema Nodosum / çµç¯€æ€§ç´…æ–‘
### Erythema Induratum / ç¡¬çµæ€§ç´…æ–‘
### Sweet's Disease / Sweetç—…
### Drug Eruption / è–¬ç–¹
### Fixed Drug Eruption / å›ºå®šè–¬ç–¹
### Stevens-Johnson Syndrome / Stevens-Johnsonç—‡å€™ç¾¤
### Toxic Epidermal Necrolysis / ä¸­æ¯’æ€§è¡¨çš®å£Šæ­»ç—‡
### Drug-Induced Hypersensitivity Syndrome / è–¬å‰¤æ€§éæ•ç—‡ç—‡å€™ç¾¤
### Skin Disorders Caused by Anticancer Drugs / æŠ—ãŒã‚“è–¬ã«ã‚ˆã‚‹çš®è†šéšœå®³
### Erythroderma / ç´…çš®ç—‡
### Graft-Versus-Host Disease / ç§»æ¤ç‰‡å¯¾å®¿ä¸»ç—…

## Bullous Dermatoses and Pustulosis / æ°´ç–±ç—‡ãƒ»è†¿ç–±ç—‡

### Pemphigus Vulgaris / å°‹å¸¸æ€§å¤©ç–±ç˜¡
### Pemphigus Foliaceus / è½è‘‰çŠ¶å¤©ç–±ç˜¡
### Bullous Pemphigoid / æ°´ç–±æ€§é¡å¤©ç–±ç˜¡
### Dermatitis Herpetiformis Duhring / Duhringç–±ç–¹çŠ¶çš®è†šç‚
### Epidermolysis Bullosa Acquisita / å¾Œå¤©æ€§è¡¨çš®æ°´ç–±ç—‡
### Epidermolysis Bullosa Hereditaria / å…ˆå¤©æ€§è¡¨çš®æ°´ç–±ç—‡
### Palmoplantar Pustulosis / æŒè¹ è†¿ç–±ç—‡

## Keratosis / è§’åŒ–ç—‡

### Psoriasis Vulgaris / å°‹å¸¸æ€§ä¹¾ç™¬
### Guttate Psoriasis / æ»´çŠ¶ä¹¾ç™¬
### Pustular Psoriasis / è†¿ç–±æ€§ä¹¾ç™¬
### Psoriatic Erythroderma / ä¹¾ç™¬æ€§ç´…çš®ç—‡
### Parapsoriasis En Plaques / å±€é¢çŠ¶é¡ä¹¾ç™¬
### Pityriasis Lichenoides / è‹”ç™¬çŠ¶ç²ƒç³ ç–¹
### Lichen Planus / æ‰å¹³è‹”ç™¬
### Pityriasis Rosea Gibert / Gibertã°ã‚‰è‰²ç²ƒç³ ç–¹
### Pityriasis Rubra Pilaris / æ¯›å­”æ€§ç´…è‰²ç²ƒç³ ç–¹
### Keratosis Pilaris / æ¯›å­”æ€§è§’åŒ–ç—‡
### Clavus and Callus / é¶çœ¼ãƒ»èƒ¼èƒ
### Acanthosis Nigricans / é»’è‰²è¡¨çš®è…«
### Ichthyosis Vulgaris / å°‹å¸¸æ€§é­šé±—ç™¬
### X-Linked Ichthyosis / Xé€£é–æ€§é­šé±—ç™¬
### Congenital Ichthyosiform Erythroderma / å…ˆå¤©æ€§é­šé±—ç™¬æ§˜ç´…çš®ç—‡
### Epidermolytic Ichthyosis / è¡¨çš®èè§£æ€§é­šé±—ç™¬
### Palmoplantar Keratoderma / æŒè¹ è§’åŒ–ç—‡
### Darier's Disease / Darierç—…

## Pigmentary Disorder / è‰²ç´ ç•°å¸¸ç—‡

### Oculocutaneous Albinism / çœ¼çš®è†šç™½çš®ç—‡
### Vitiligo Vulgaris / å°‹å¸¸æ€§ç™½æ–‘
### Nevus Depigmentosus / è„±è‰²ç´ æ€§æ¯æ–‘
### Vogt-Koyanagi-Harada Disease / Vogt-å°æŸ³-åŸç”°ç—…
### Leucoderma Sutton / Suttonç™½æ–‘
### Ephelides / é›€åµæ–‘
### Melasma / è‚æ–‘
### Senile Lentigo / è€äººæ€§è‰²ç´ æ–‘

## Nevus / æ¯æ–‘

### Epidermal Nevus / è¡¨çš®æ¯æ–‘
### Sebaceous Nevus / è„‚è…ºæ¯æ–‘
### Melanocytic Nevus / è‰²ç´ æ€§æ¯æ–‘
### Spitz Nevus / Spitzæ¯æ–‘
### Nevus Spilus / æ‰å¹³æ¯æ–‘
### Nevus of Ota / å¤ªç”°æ¯æ–‘
### Mongolian Spot / è’™å¤æ–‘
### Blue Nevus / é’è‰²æ¯æ–‘

## Skin Tumor / çš®è†šè…«ç˜

### Seborrheic Keratosis / è„‚æ¼æ€§è§’åŒ–ç—‡
### Porokeratosis / æ±—å­”è§’åŒ–ç—‡
### Epidermal Cyst / è¡¨çš®åš¢è…«
### Hypertrophic Scar and Keloid / è‚¥åšæ€§ç˜¢ç—•ãƒ»ã‚±ãƒ­ã‚¤ãƒ‰
### Mastocytoma / è‚¥æº€ç´°èƒç—‡
### Infantile Hamangioma / ä¹³å…è¡€ç®¡è…«
### Glomus Tumor / ã‚°ãƒ­ãƒ ã‚¹è…«ç˜
### Kasabach-Merritt Syndrome / Kasabach-Merrittç—‡å€™ç¾¤
### Capillary Malformation / æ¯›ç´°è¡€ç®¡å¥‡å½¢
### Basal Cell Carcinoma / åŸºåº•ç´°èƒç™Œ
### Squamous Cell Carcinoma / æœ‰æ£˜ç´°èƒç™Œ
### Keratoacanthoma / ã‚±ãƒ©ãƒˆã‚¢ã‚«ãƒ³ãƒˆãƒ¼ãƒ
### Solar Keratosis / æ—¥å…‰è§’åŒ–ç—‡
### Bowen's Disease / Bowenç—…
### Extramammary Paget's Disease / ä¹³æˆ¿å¤–Pagetç—…
### Merkel Cell Carcinoma / Merkelç´°èƒç™Œ
### Malignant Melanoma / æ‚ªæ€§é»’è‰²è…«
### Angiosarcoma / è¡€ç®¡è‚‰è…«
### Kaposi's Sarcoma / Kaposiè‚‰è…«
### Mycosis Fungoides / èŒçŠ¶æ¯è‚‰ç—‡
### SÃ©zary Syndrome / SÃ©zaryç—‡å€™ç¾¤

## Skin Infection / çš®è†šæ„ŸæŸ“ç—‡

### Folliculitis / æ¯›åŒ…ç‚
### Furuncle and Carbuncle / ç™¤ãƒ»ç™°
### Paronychia / çˆªå›²ç‚
### Erysipelas / ä¸¹æ¯’
### Cellulitis / èœ‚å·£ç‚
### Necrotizing Fasciitis / å£Šæ­»æ€§ç­‹è†œç‚
### Gas Gangrene / ã‚¬ã‚¹å£Šç–½
### Impetigo Contagiosa / ä¼æŸ“æ€§è†¿ç—‚ç–¹
### Staphylococcal Scalded Skin Syndrome / ãƒ–ãƒ‰ã‚¦çƒèŒæ€§ç†±å‚·æ§˜çš®è†šç—‡å€™ç¾¤
### Toxic Shock Syndrome / ãƒˆã‚­ã‚·ãƒƒã‚¯ã‚·ãƒ§ãƒƒã‚¯ç—‡å€™ç¾¤
### Scarlet Fever / çŒ©ç´…ç†±
### Tuberculosis Cutis / çš®è†šçµæ ¸
### Nontuberculous Mycobacteriosis / éçµæ ¸æ€§æŠ—é…¸èŒç—‡
### Leprosy / Hansenç—…
### Herpes Simplex / å˜ç´”ç–±ç–¹
### Varicella / æ°´ç—˜
### Herpes Zoster / å¸¯çŠ¶ç–±ç–¹
### Hand Foot and Mouth Disease / æ‰‹è¶³å£ç—…
### Measles / éº»ç–¹
### Rubella / é¢¨ç–¹
### Exanthema Subitum / çªç™ºæ€§ç™ºç–¹
### Erythema Infectiosum / ä¼æŸ“æ€§ç´…æ–‘
### Gianotti Disease / Gianottiç—…
### Verruca Vulgaris / å°‹å¸¸æ€§ç–£è´…
### Verruca Plana / æ‰å¹³ç–£è´…
### Molluscum Contagiosum / ä¼æŸ“æ€§è»Ÿå±è…«
### Dermatophytosis / ç™½ç™¬
### Cutaneous Candidiasis / çš®è†šã‚«ãƒ³ã‚¸ãƒ€ç—‡
### Malassezia Infection / ãƒãƒ©ã‚»ãƒã‚¢æ„ŸæŸ“ç—‡
### Sporotrichosis / ã‚¹ãƒãƒ­ãƒˆãƒªã‚³ãƒ¼ã‚·ã‚¹
### Dematiaceous Fungal Infection / é»’è‰²çœŸèŒç—‡
### Scabies / ç–¥ç™¬
### Pediculosis / ã‚·ãƒ©ãƒŸç—‡
### Lyme Disease / ãƒ©ã‚¤ãƒ ç—…
### Scrub Typhus / ãƒ„ãƒ„ã‚¬ãƒ ã‚·ç—… 

## Epidermal Appendage Disease / çš®è†šé™„å±å™¨ã®ç–¾æ‚£

### Miliaria / æ±—ç–¹
### Hyperhidrosis / å¤šæ±—ç—‡
### Anhidrosis / ç„¡æ±—ç—‡
### Bromidrosis / è‡­æ±—ç—‡
### Acne Valgaris / å°‹å¸¸æ€§ç—¤ç˜¡
### Acneiform Eruption / ç—¤ç˜¡æ§˜ç™ºç–¹
### Rosacea / é…’çš¶
### Rosacea-Like Dermatitis / é…’çš¶æ§˜çš®è†šç‚
### Androgenetic Alopecia / ç”·æ€§å‹è„±æ¯›ç—‡
### Alopecia Areata / å††å½¢è„±æ¯›ç—‡
### Trichotillomania / æŠœæ¯›ç—‡
### Ingrown Nail / é™¥å…¥çˆª
-->

# Orthopedic Surgery / æ•´å½¢å¤–ç§‘

## Upper Limb Disorder / ä¸Šè‚¢ç–¾æ‚£

## Lower Limb Disorder / ä¸‹è‚¢ç–¾æ‚£

## Trunk Disorder / ä½“å¹¹ç–¾æ‚£

## Joint Disorder / é–¢ç¯€ç–¾æ‚£

## Peripheral Nerve Disorder / æœ«æ¢¢ç¥çµŒç–¾æ‚£

## Trauma / å¤–å‚·

## Metabolic Disorder / ä»£è¬æ€§ç–¾æ‚£

## Infectious Disorder / æ„ŸæŸ“æ€§ç–¾æ‚£

## Bone Tumor / éª¨è…«ç˜

# Urology / æ³Œå°¿å™¨ç§‘

## Urinary Tract Infection and Stone / å°¿è·¯æ„ŸæŸ“ç—‡ãƒ»çµçŸ³

## Urinary Tract Tumor / å°¿è·¯è…«ç˜

## Urinary Tract Dysfunction / å°¿è·¯æ©Ÿèƒ½éšœå®³

## Urinary Tract Congenital Anomaly / å°¿è·¯å…ˆå¤©ç•°å¸¸

## Penis Disorder / é™°èŒç–¾æ‚£

## Testicle Disorder / ç¾ä¸¸ç–¾æ‚£

## Prostate Disorder / å‰ç«‹è…ºç–¾æ‚£


<!-- ### Male Genital Organ / ç”·æ€§å™¨

* **Scrotum**
  * **Structure**: Skin, smooth muscle (dartos)
  * **Artery**: Anterior scrotal artery (external pudendal artery), posterior scrotal artery (perineal artery)
  * **Nerve**: Scrotal nerve (perineal nerve)
  * **Spermatic cord**: Ductus deferens, tesicular artery, pampiniform plexus, genitofemoral nerve
* **Testis**
  * **Structure**: External fascia (external oblique), middle fascia (internal oblique), internal fascia (fascia transversalis), tunica vaginalis (peritoneum), tunica albuginea, lobule, seminoferous tube
  * **Artery**: Testicular artery (abdominal aorta)
  * **Vein**: Right testicular vein (inferior vena cava), left testicular vein (left renal vein)
  * **Spermatogenesis**: Spermatogonia, 1st spermatocyte, 2nd spermatocyte, spermatid, sperm
  * **Cell**: Sertoli cell (blood-testis barrier, activin, inhibin, MIF), Leydig cell (testosterone)
  * **Genital tracty**: Seminoferous tubule (spermatogenic cell, Sertoli cell), tubuli recti (Sertoli cell), rete testis (simple cuboidal), ductuli efferentes (simple columnar), epididymis (pseudostratified columnar, steriocelia), vas deferens (pseudostratified columnar, steriocelia)
* **Gland**
  * **Siminal vesicle**: Into prostate seminal coliculus
  * **Prostate**: Into prostatic sinus, central zone, peripheral zone (adenocarcinoma), transitional zone (BPH)
  * **Bulbourethral gland**: Into uretra
* **Penis**
  * **Structure**: 2 corpus cavernosa (crura, with tunica albuginea), 1 corpus spongisum (blub, glans)
  * **Artery**: Deep artery of penis (corpus cavernosa, perineal artery), artery of bulb (corpus spongiosum, perineal artery), dorsal artery of penis (glans, perineal artery)
  * **Nerve**: Dorsal nerve of penis (perineal nerve)
  * **Function**: Erection (parasympathetic, inferior hypogastric ganglion), ejaculation (sympathetic, superior hypogastric ganglion)
{: .notice--info} -->

<!-- ## Urinary Tract Dysfunction / å°¿è·¯æ©Ÿèƒ½éšœå®³

### Hydronephrosis / æ°´è…ç—‡
### Neurogenic Bladder / ç¥çµŒå› æ€§è†€èƒ±
### Overactive Bladder / éæ´»å‹•è†€èƒ±
### Stress Incontinence / è…¹åœ§æ€§å°¿å¤±ç¦

## Urinary Tract and Genital Infection / å°¿è·¯ãƒ»æ€§å™¨æ„ŸæŸ“ç—‡

### Pyelonephritis / è…ç›‚è…ç‚
### Renal Abscess / è…è†¿ç˜
### Cystitis / è†€èƒ±ç‚
### Urinary Tuberculosis / å°¿è·¯çµæ ¸
### Urethritis / å°¿é“ç‚
### Prostatitis / å‰ç«‹è…ºç‚
### Epididymitis / ç²¾å·£ä¸Šä½“ç‚
### Orchitis / ç²¾å·£ç‚

## Urinary Tract and Genital Tumor / å°¿è·¯ãƒ»æ€§å™¨è…«ç˜

### Urinary Stone / å°¿è·¯çµçŸ³
### Renal Cell Carcinoma / è…ç´°èƒç™Œ
### Renal Pelvic and Ureteral Cancer / è…ç›‚ãƒ»å°¿ç®¡ç™Œ
### Bladder Cancer / è†€èƒ±ç™Œ
### Penile Cancer / é™°èŒç™Œ
### Benign Prostatic Hyperplasia / å‰ç«‹è…ºè‚¥å¤§ç—‡
### Prostatic Cancer / å‰ç«‹è…ºç™Œ
### Testicular Tumor / ç²¾å·£è…«ç˜

## Genital Dysfunction / æ€§å™¨æ©Ÿèƒ½ç•°å¸¸
### Varicocele / ç²¾ç´¢é™è„ˆç˜¤
### Testicular Torsion / ç²¾å·£æ»è»¢ç—‡
### Phimosis / åŒ…èŒ
### Erectile Dysfunction / å‹ƒèµ·éšœå®³
### Priapism / æŒç¶šå‹ƒèµ·ç—‡
### Male Infertility / ç”·æ€§ä¸å¦Šç—‡ -->

# Gynecology / å©¦äººç§‘

## Sexuel Development Disorder / æ€§åˆ†åŒ–ç–¾æ‚£

## Endocrine Disorder / å†…åˆ†æ³Œã®ç•°å¸¸

## Aging-Related Disorder / åŠ é½¢ã«ã‚ˆã‚‹ç–¾æ‚£

## Genital Infection / æ€§å™¨æ„ŸæŸ“ç—‡

## Valvar and Vaginal Disorder / å¤–é™°ãƒ»è…Ÿç–¾æ‚£

## Uterine Disorder / å­å®®ç–¾æ‚£

## Ovarian Disorder / åµå·£ç–¾æ‚£

## Breast Disorder / ä¹³è…ºç–¾æ‚£

## Infertility / ä¸å¦Šç—‡

<!-- ## Endocrine Disorder / å†…åˆ†æ³Œã®ç•°å¸¸

### Anovulatory Cycle / ç„¡æ’åµå‘¨æœŸç—‡

### Luteal Insufficiency / é»„ä½“æ©Ÿèƒ½ä¸å…¨

### Premenstrual Syndrome / æœˆçµŒå‰ç—‡å€™ç¾¤

### Dysmenorrhea / æœˆçµŒå›°é›£ç—‡

### Hyperprolactinemia / é«˜ãƒ—ãƒ­ãƒ©ã‚¯ãƒãƒ³è¡€ç—‡

### Anorexia Nervosa / ç¥çµŒæ€§ã‚„ã›ç—‡

### Amenorrhea Due to Weight Loss / å˜ç´”æ€§ä½“é‡æ¸›å°‘æ€§ç„¡æœˆçµŒ

### Sheehan Syndrome / Sheehanç—‡å€™ç¾¤

### Polycystic Ovary Syndrome / å¤šåš¢èƒæ€§åµå·£ç—‡å€™ç¾¤

## Sex Development Disorder / æ€§åˆ†åŒ–ç–¾æ‚£

### Congenital Adrenocortical Hyperplasia / å…ˆå¤©æ€§å‰¯è…çš®è³ªéå½¢æˆç—‡

### Androgen Insensitivity Syndrome / ã‚¢ãƒ³ãƒ‰ãƒ­ã‚²ãƒ³ä¸å¿œç—‡

### Turner Syndrome / Turnerç—‡å€™ç¾¤

### Klinefelter Syndrome / Klinefelterç—‡å€™ç¾¤ -->

# Obstetrics / ç”£ç§‘

## Early Pregnancy Disorder / å¦Šå¨ åˆæœŸã®ç•°å¸¸

## Later Pregnancy Disorder / å¦Šå¨ ä¸­ãƒ»å¾ŒæœŸã®ç•°å¸¸

## Complicated Pregnancy / åˆä½µç—‡å¦Šå¨ 

## Mother to Children Infection / æ¯å­æ„ŸæŸ“ç—‡

## Delivery Disorder / åˆ†å¨©ã®ç•°å¸¸

## Puerperium Disorder / ç”£è¤¥ã®ç•°å¸¸

# Pediatrics / å°å…ç§‘

## Neonate Disorder / æ–°ç”Ÿå…ç–¾æ‚£

## Congenital Disorder / å…ˆå¤©ç•°å¸¸

## Cardiovascular Disorder / å¾ªç’°å™¨ç–¾æ‚£

## Respiratory Disorder / å‘¼å¸å™¨ç–¾æ‚£

## Gastrointestinal Disorder / æ¶ˆåŒ–å™¨ç–¾æ‚£

## Endocrine and Metabolism Disorder / å†…åˆ†æ³Œãƒ»ä»£è¬ç–¾æ‚£

## Renal and Urologic Disorder / è…ãƒ»æ³Œå°¿å™¨ç–¾æ‚£

## Hematologic Disorder / è¡€æ¶²ç–¾æ‚£

## Immunologic Disorder / å…ç–«ç–¾æ‚£

## Infectious Disorder / æ„ŸæŸ“æ€§ç–¾æ‚£

## Neurologic Disorder / ç¥çµŒç–¾æ‚£

## Mental Disorder / ç²¾ç¥ç–¾æ‚£

## Neoplasm / æ–°ç”Ÿç‰©

<!-- ## Cardiovascular Disease / å¾ªç’°å™¨ç–¾æ‚£

### Atrial Septal Defect / å¿ƒæˆ¿ä¸­éš”æ¬ æç—‡
### Ventricular Septal Defect / å¿ƒå®¤ä¸­éš”æ¬ æç—‡
### Atrioventricular Septal Defect / æˆ¿å®¤ä¸­éš”æ¬ æç—‡
### Patent Ductus Arteriosus / å‹•è„ˆç®¡é–‹å­˜ç—‡
### Coarctation of the Aorta / å¤§å‹•è„ˆç¸®çª„ç—‡
### Eisenmenger Syndrome / Eisenmengerç—‡å€™ç¾¤
### Tetralogy of Fallot / Fallotå››å¾´ç—‡
### Complete Transposition of Great Arteries / å®Œå…¨å¤§è¡€ç®¡è»¢ä½ç—‡
### Total Anomalous Pulmonary Venous Return / ç·è‚ºé™è„ˆé‚„æµç•°å¸¸ç—‡
### Double Outlet Right Ventricle / ä¸¡å¤§è¡€ç®¡å³å®¤èµ·å§‹ç—‡
### Hypoplastic Left Heart Syndrome / å·¦å¿ƒä½å½¢æˆç—‡å€™ç¾¤
### Pulmonary Stenosis / è‚ºå‹•è„ˆç‹­çª„ç—‡
### Pure Pulmonary Atresia / ç´”å‹è‚ºå‹•è„ˆé–‰é–
### Truncus Arteriosus Communis / ç·å‹•è„ˆå¹¹ç—‡
### Ruptured Aneurysm of the sinus of Valsalva / Valsalvaæ´å‹•è„ˆç˜¤ç ´è£‚
### Tricuspid Atresia / ä¸‰å°–å¼é–‰é–ç—‡
### Ebstein's Disease / Ebsteinç—…
### Single Ventricle / å˜å¿ƒå®¤ç—‡

## Gastrointestinal Disease / æ¶ˆåŒ–å™¨ç–¾æ‚£

### Congenital Esophageal Atresia / å…ˆå¤©æ€§é£Ÿé“é–‰é–
### Hypertrophic Pyloric Stenosis / è‚¥åšæ€§å¹½é–€ç‹­çª„ç—‡
### Congenital Duodenal Atresia or Stenosis / å…ˆå¤©æ€§åäºŒæŒ‡è…¸é–‰é–ãƒ»ç‹­çª„ç—‡
### Congenital Intestinal Atresia or Stenosis / å…ˆå¤©æ€§å°è…¸é–‰é–ãƒ»ç‹­çª„ç—‡
### Intestinal Malrotation / è…¸å›è»¢ç•°å¸¸ç—‡
### Meckel Diverticulum / Meckelæ†©å®¤
### Intussusception / è…¸é‡ç©ç—‡
### Hirschsprung Disease / Hirschsprungç—…
### Necrotizing Enterocolitis / å£Šæ­»æ€§è…¸ç‚
### Anal Atresia / é–è‚› 
### Bochdalek Hernia / Bochdalekå­”ãƒ˜ãƒ«ãƒ‹ã‚¢
### Omphalocele / è‡å¸¯ãƒ˜ãƒ«ãƒ‹ã‚¢
### Gastroschisis / è…¹å£ç ´è£‚
### Gilbert Syndrome / Gilbertç—‡å€™ç¾¤
### Crigler-Najjar Syndrome / Cirgler-Najjarç—‡å€™ç¾¤
### Dubin-Johnson Syndrome / Dubin-Johnsonç—‡å€™ç¾¤
### Rotor Syndrome / Rotorç—‡å€™ç¾¤
### Biliary Atresia / èƒ†é“é–‰é–ç—‡
### Congenital Biliary Dilatation / å…ˆå¤©æ€§èƒ†é“æ‹¡å¼µç—‡

## Metabolism Disease / ä»£è¬ç–¾æ‚£

### Phenylketonuria / ãƒ•ã‚§ãƒ‹ãƒ«ã‚±ãƒˆãƒ³å°¿ç—‡
### Maple Syrup Urine Disease / ãƒ¡ãƒ¼ãƒ—ãƒ«ã‚·ãƒ­ãƒƒãƒ—å°¿ç—‡
### Homocystinurea / ãƒ›ãƒ¢ã‚·ã‚¹ãƒãƒ³å°¿ç—‡
### Urea Cycle Defect / å°¿ç´ ã‚µã‚¤ã‚¯ãƒ«ç•°å¸¸ç—‡
### Von Gierke Disease / Von Gierkeç—…
### Pompe Disease / Pompeç—…
### Galactosemia / ã‚¬ãƒ©ã‚¯ãƒˆãƒ¼ã‚¹è¡€ç—‡
### Lactose Intolerance / ä¹³ç³–ä¸è€ç—‡
### Mucopolysaccharidoses / ãƒ ã‚³å¤šç³–ç—‡
### Tay-Sachs Disease / Tay-Sachsç—…
### Fabry Disease / Fabryç—…
### Gaucher Disease / Gaucherç—…
### Nieman-Pick Disease / Nieman-Pickç—…
### Lesch-Nyhan Syndrome / Lesch-Nyhanç—‡å€™ç¾¤
### Wilson's Disease / Wilsonç—…
### Menkes Disease / Menkesç—…
### Marfan Syndrome / Marfanç—‡å€™ç¾¤
### Ehlers-Danlos Syndrome / Ehlers-Danlosç—‡å€™ç¾¤
### Ketotic Hypoglycemia / ã‚±ãƒˆãƒ³æ€§ä½è¡€ç³–ç—‡
### Acetonic Vomiting / ã‚¢ã‚»ãƒˆãƒ³è¡€æ€§å˜”åç—‡
### Osteomalacia / éª¨è»ŸåŒ–ç—‡
### Osteogenesis Imperfecta / éª¨å½¢æˆä¸å…¨ç—‡
### Chondrodysplasia / è»Ÿéª¨ç•°å½¢æˆç—‡

## Endocrine Disease / å†…åˆ†æ³Œç–¾æ‚£

### Growth Hormone Deficiency / æˆé•·ãƒ›ãƒ«ãƒ¢ãƒ³æ¬ ä¹ç—‡
### Congenital Hypothyroidism / å…ˆå¤©æ€§ç”²çŠ¶è…ºæ©Ÿèƒ½ä½ä¸‹ç—‡
### Precocious Puberty / æ—©ç™ºæ€§æ€æ˜¥æœŸ
### McCune-Albright Syndrome / McCune-Albrightç—‡å€™ç¾¤
### Turner Syndrome / Turnerç—‡å€™ç¾¤
### Klinefelter Syndrome / Klinefelterç—‡å€™ç¾¤
### Kallman Syndrome / Kallmanç—‡å€™ç¾¤
### Prader-Willi Syndrome / Prader-Williç—‡å€™ç¾¤
### Congenital Adrenocortical Hyperplasia / å…ˆå¤©æ€§å‰¯è…çš®è³ªéå½¢æˆ
### Androgen Insensitivity Syndrome / ã‚¢ãƒ³ãƒ‰ãƒ­ã‚²ãƒ³ä¸å¿œç—‡

## Renal and Urologic Disease / è…ãƒ»æ³Œå°¿å™¨ç–¾æ‚£

### Polycystic Kidney Disease / å¤šç™ºæ€§åš¢èƒè…
### Sponge Kidney / æµ·ç¶¿è…
### Horseshoe Kidney / é¦¬è¹„è…
### Congenital Hydronephrosis / å…ˆå¤©æ€§æ°´è…ç—‡
### Duplicated Renal Pelvis and Ureter / é‡è¤‡è…å­Ÿå°¿ç®¡
### Ectopic Ureter / å°¿ç®¡ç•°æ‰€é–‹å£
### Ureterocele / å°¿ç®¡ç˜¤
### Vesicourethral Reflux / è†€èƒ±å°¿ç®¡é€†æµ
### Hypospadias / å°¿é“ä¸‹è£‚
### Cryptorchidism / åœç•™ç²¾å·£
### Hydrocele Testis / é™°åš¢æ°´è…«

## Hematologic Disease / è¡€æ¶²ç–¾æ‚£

### Hemophilia / è¡€å‹ç—…
### Von Willebrand Disease / Von Willebrandç—…
### Bernard-Soulier Syndrome / Bernard-Soulierç—‡å€™ç¾¤
### Glanzmann Thrombasthenia / è¡€å°æ¿ç„¡åŠ›ç—‡

## Immune Disease / å…ç–«ç–¾æ‚£

### Severe Combined Immunodeficiency / é‡ç—‡è¤‡åˆå…ç–«ä¸å…¨ç—‡
### X-linked Agammaglobulinemia / Xé€£é–ç„¡Î³-ã‚°ãƒ­ãƒ–ãƒªãƒ³è¡€ç—‡
### Hyper-IgM Syndrome / é«˜IgMç—‡å€™ç¾¤
### Wiskott-Aldrich Syndrome / Wiskott-Aldrichç—‡å€™ç¾¤
### Ataxia Telangiectasia / æ¯›ç´°è¡€ç®¡æ‹¡å¼µæ€§é‹å‹•å¤±èª¿ç—‡
### DiGeorge Syndrome / DiGeorgeç—‡å€™ç¾¤
### ChÃ©diak-Higashi Syndrome / ChÃ©diak-Higashiç—‡å€™ç¾¤
### Chronic Granulomatous Disease / æ…¢æ€§è‚‰èŠ½è…«ç—‡

## Neurological Disease / ç¥çµŒç–¾æ‚£

### Craniosynostosis / é ­è“‹ç¸«åˆæ—©æœŸç™’åˆç—‡
### Spina Bifida / äºŒåˆ†è„Šæ¤
### Cranium Bifidum / äºŒåˆ†é ­è“‹
### Congenital Hydrocephalus / å…ˆå¤©æ€§æ°´é ­ç—‡
### Chiari Malformation / Chiariå¥‡å½¢
### Dandy-Walker Syndrome / Dandy-Walkerç—‡å€™ç¾¤
### Arachnoid Cyst / ãã‚‚è†œåš¢èƒ

## Neoplasm / æ–°ç”Ÿç‰©

### Hepatoblastoma / è‚èŠ½è…«
### Wilms' Tumor / Wilmsè…«ç˜ -->

<!-- # Emergency Medicine / æ•‘æ€¥ç§‘

## Shock / ã‚·ãƒ§ãƒƒã‚¯

### Cardiopulmonary Arrest / å¿ƒè‚ºåœæ­¢
### Hypovolemic Shock / å¾ªç’°è¡€æ¶²é‡æ¸›å°‘æ€§ã‚·ãƒ§ãƒƒã‚¯
### Anaphylactic Shock / ã‚¢ãƒŠãƒ•ã‚£ãƒ©ã‚­ã‚·ãƒ¼ã‚·ãƒ§ãƒƒã‚¯
### Neurogenic Shock / ç¥çµŒåŸæ€§ã‚·ãƒ§ãƒƒã‚¯
### Septic Shock / æ•—è¡€ç—‡æ€§ã‚·ãƒ§ãƒƒã‚¯
### Cardiogenic Shock / å¿ƒåŸæ€§ã‚·ãƒ§ãƒƒã‚¯
### Extracardiac Obstructive Shock / å¿ƒå¤–é–‰å¡æ€§ã‚·ãƒ§ãƒƒã‚¯

## Emergency Disease / æ•‘æ€¥ç–¾æ‚£

### Airway Foreign Body / æ°—é“ç•°ç‰©
### Gastrointestinal Foreign Body / æ¶ˆåŒ–ç®¡ç•°ç‰©
### Status Epilepticus / ã¦ã‚“ã‹ã‚“é‡ç©çŠ¶æ…‹
### Acute Abdomen / æ€¥æ€§è…¹ç—‡
### Multiple Organ Dysfunction Syndrome / å¤šè‡“å™¨ä¸å…¨

## Thoracic Injury / èƒ¸éƒ¨å¤–å‚·

### Tracheobronchial Injury / æ°—ç®¡ãƒ»æ°—ç®¡æ”¯æå‚·
### Pulmonary Contusion / è‚ºæŒ«å‚·
### Flail Chest / èƒ¸éƒ­å‹•æº
### Open Pneumothorax / é–‹æ”¾æ€§æ°—èƒ¸
### Tension Pneumothorax / ç·Šå¼µæ€§æ°—èƒ¸
### Aortic Injury / å¤§å‹•è„ˆæå‚·
### Massive Hemothorax / å¤§é‡è¡€èƒ¸

## Abdominal Injury / è…¹éƒ¨å¤–å‚·

### Liver Injury / è‚æå‚·
### Splenic Rupture / è„¾ç ´è£‚
### Kidney Injury / è…å¤–å‚·
### Urethral Injury / å°¿é“å¤–å‚·
### Bladder Injury / è†€èƒ±å¤–å‚·
### Testicular Injury / ç²¾å·£å¤–å‚·

## Other Injury / ãã®ä»–ã®å¤–å‚·

### High Energy Trauma / é«˜ã‚¨ãƒãƒ«ã‚®ãƒ¼å¤–å‚·
### Crush Syndrome / åœ§æŒ«ç—‡å€™ç¾¤
### Compartment Syndrome / ã‚³ãƒ³ãƒ‘ãƒ¼ãƒˆãƒ¡ãƒ³ãƒˆç—‡å€™ç¾¤
### Fat Embolism Syndrome / è„‚è‚ªå¡æ “ç—‡å€™ç¾¤
### Burns / ç†±å‚·
### Smoke Inhalation Injury / æ°—é“ç†±å‚·

## Diseases due to Physical Factors / ç‰©ç†çš„è¦å› ã«ã‚ˆã‚‹ç–¾æ‚£

### Heat Illness / ç†±ä¸­ç—‡
### Accidental Hypothermia / å¶ç™ºæ€§ä½ä½“æ¸©ç—‡
### Altitude Sickness / é«˜å±±ç—…
### Decompression Sickness / æ¸›åœ§ç—‡

## Poisoning / ä¸­æ¯’

### Food Poisoning / é£Ÿä¸­æ¯’
### Drug Poisoning / è–¬ç‰©ä¸­æ¯’
### Organic Solvent Poisoning / æœ‰æ©Ÿæº¶å‰¤ä¸­æ¯’
### Toxic Gas Poisoning / æœ‰æ¯’ã‚¬ã‚¹ä¸­æ¯’
### Metal Poisoning / é‡‘å±ä¸­æ¯’
### Pesticide Poisoning / è¾²è–¬ä¸­æ¯’ -->
